WorldWideScience

Sample records for teriparatide final results

  1. Sequential Treatment of Severe Postmenopausal Osteoporosis Following Teriparatide: Final Results of the Randomized, Controlled European Study of Forsteo (EUROFORS): Trial registration: clinicaltrials.gov identifier NCT00191425 (Trial registration date: 12 September 2005)

    DEFF Research Database (Denmark)

    Eastell, Richard; Nickelsen, Thomas; Marin, Fernando

    2009-01-01

    .5% with teriparatide, 2.3% with raloxifene, and 0.5% with no active treatment; the respective changes at the femoral neck were 3.5%, 3.1%, and 1.3%. The study had insufficient power to assess antifracture efficacy. In conclusion, BMD increases progressively over 2 yr of teriparatide therapy in women with severe......, antiresorptive with raloxifene, or no active treatment) after 1 yr of teriparatide. Postmenopausal women with osteoporosis and a recent fragility fracture received open-label teriparatide (20 mug/d) for 12 mo before they were randomized (3:1:1) to continue teriparatide (n=305), switch to raloxifene 60 mg/d (n...

  2. Does Teriparatide Improve Femoral Neck Fracture Healing: Results From A Randomized Placebo-controlled Trial.

    Science.gov (United States)

    Bhandari, Mohit; Jin, Ling; See, Kyoungah; Burge, Russel; Gilchrist, Nigel; Witvrouw, Richard; Krohn, Kelly D; Warner, Margaret R; Ahmad, Qasim I; Mitlak, Bruce

    2016-05-01

    There is a medical need for therapies that improve hip fracture healing. Teriparatide (Forteo(®)/ Forsteo(®), recombinant human parathyroid hormone) is a bone anabolic drug that is approved for treatment of osteoporosis and glucocorticoid-induced osteoporosis in men and postmenopausal women at high fracture risk. Preclinical and preliminary clinical data also suggest that teriparatide may enhance bone healing. We wished to test the hypotheses that treatment with teriparatide versus placebo would improve femoral neck fracture healing after internal fixation as measured by (1) frequency of revision surgery, (2) radiographic fracture healing, and (3) other outcomes including pain control, gait speed, and safety. We initiated two separate, but identically designed, clinical trials to meet FDA requirements to provide substantial evidence to support approval of a new indication. The two prospective, randomized double-blind, placebo-controlled Phase III studies were designed to evaluate the effect of subcutaneous teriparatide (20 μg/day) for 6 months versus placebo on fracture healing at 24 months. The trials were conducted concurrently with a planned enrollment of 1220 patients per trial. However, enrollment was stopped owing to very slow patient accrual, and an a priori decision was made to pool the results of those studies for statistical analyses before study completion; pooling was specified in both protocols. Randomization was stratified by fixation (sliding hip screw or multiple cancellous screws) and fracture type (displaced or nondisplaced). An independent Central Adjudication Committee reviewed revision surgical procedures and radiographs. A total of 159 patients were randomized in the two trials (81 placebo, 78 teriparatide). The combined program had very low power to detect the originally expected treatment effect but had approximately 80% power to detect a larger difference of 12% between treatment groups for risk of revision surgery. The proportion of

  3. Back pain during different sequential treatment regimens of teriparatide: results from EUROFORS

    DEFF Research Database (Denmark)

    Lyritis, G; Marin, F; Barker, C

    2010-01-01

    To investigate changes in back pain in postmenopausal women with severe osteoporosis who received teriparatide for 24 months or switched at 12 months to raloxifene or no active treatment.......To investigate changes in back pain in postmenopausal women with severe osteoporosis who received teriparatide for 24 months or switched at 12 months to raloxifene or no active treatment....

  4. Teriparatide - Indications beyond osteoporosis

    Directory of Open Access Journals (Sweden)

    Marilyn Lee Cheng

    2012-01-01

    Full Text Available Osteoporosis is a condition of impaired bone strength that results in an increased risk of fracture. The current and most popular pharmacological options for the treatment of osteoporosis include antiresorptive therapy, in particular, oral bisphosphonates (alendronate, risedronate, ibandronate. Anabolic agents like teriparatide have widened our therapeutic options. They act by directly stimulating bone formation and improving bone mass quantity and quality. Two forms of recombinant human parathyroid hormone (PTH are available : full-length PTH (PTH 1-84; approved in the EU only and the 1-34 N-terminal active fragment of PTH (teriparatide, US FDA approved. This review aims to discuss the benefits of teriparatide beyond the currently licensed indications like fracture healing, dental stability, osteonecrosis of jaw, hypoparathyroidism, and hypocalcemia.

  5. Effectiveness of teriparatide in postmenopausal women with osteoporosis and glucocorticoid use: 3-year results from the EFOS study.

    Science.gov (United States)

    Karras, Dimitrios; Stoykov, Ivaylo; Lems, Willem F; Langdahl, Bente L; Ljunggren, Östen; Barrett, Annabel; Walsh, J Bernard; Fahrleitner-Pammer, Astrid; Rajzbaum, Gerald; Jakob, Franz; Marin, Fernando

    2012-03-01

    To describe clinical fracture rates, back pain, and health-related quality of life (HRQOL) in postmenopausal women with osteoporosis who are receiving glucocorticoids (GC), during a 36-month study of teriparatide treatment for up to 18 months, with an additional 18-month followup period when patients were receiving other osteoporosis medications. A prospective, multinational, observational study. Data for clinical fractures, back pain (by visual analog scale; VAS) and HRQOL (by EQ-5D) were collected over 36 months. Fracture data were summarized in 6-month segments and analyzed using logistic regression with repeated measures. Changes from baseline in back pain VAS and EQ-VAS were analyzed. Of 1581 enrolled women with followup data, 294 (18.6%) had antecedents of GC use. Of these, 49 (16.7%) patients sustained a total of 69 fractures during the 36-month study period. Adjusted odds of fracture were significantly decreased during the last year of followup compared with the first 6 months of teriparatide treatment: an 81% decrease in the 24 to < 30-month period (p < 0.05), and an 89% decrease in the 30 to < 36-month period (p < 0.05). There were significant reductions in back pain and improvements in HRQOL in both groups of GC users and nonusers. Postmenopausal women with severe osteoporosis receiving GC, who were treated with teriparatide for up to 18 months, showed a reduced incidence of clinical fractures during the third year while receiving sequential osteoporosis treatments compared with the first 6 months, together with reduced back pain and improved HRQOL. Our results should be interpreted in the context of an uncontrolled observational study in a routine clinical setting.

  6. Effectiveness of Teriparatide in women over 75 years of age with severe osteoporosis: 36-month results from the European Forsteo Observational Study (EFOS).

    Science.gov (United States)

    Walsh, J Bernard; Lems, Willem F; Karras, Dimitrios; Langdahl, Bente L; Ljunggren, Osten; Fahrleitner-Pammer, Astrid; Barrett, Annabel; Rajzbaum, Gerald; Jakob, Franz; Marin, Fernando

    2012-05-01

    This predefined analysis of the European Forsteo Observational Study (EFOS) aimed to describe clinical fracture incidence, back pain, and health-related quality of life (HRQoL) during 18 months of teriparatide treatment and 18 months post-teriparatide in the subgroup of 589 postmenopausal women with osteoporosis aged ≥75 years. Data on clinical fractures, back pain (visual analogue scale, VAS), and HRQoL (EQ-5D) were collected over 36 months. Fracture data were summarized in 6-month intervals and analyzed using logistic regression with repeated measures. A repeated-measures model analyzed changes from baseline in back pain VAS and EQ-VAS. During the 36-month observation period, 87 (14.8 %) women aged ≥75 years sustained a total of 111 new fractures: 37 (33.3 %) vertebral fractures and 74 (66.7 %) nonvertebral fractures. Adjusted odds of fracture was decreased by 80 % in the 30 to <36-month interval compared with the first 6-month interval (P < 0.009). Although the older subgroup had higher back pain scores and poorer HRQoL at baseline than the younger subgroup, both age groups showed significant reductions in back pain and improvements in HRQoL postbaseline. In conclusion, women aged ≥75 years with severe postmenopausal osteoporosis treated with teriparatide in normal clinical practice showed a reduced clinical fracture incidence by 30 months compared with baseline. An improvement in HRQoL and, possibly, an early and significant reduction in back pain were also observed, which lasted for at least 18 months after teriparatide discontinuation when patients were taking other osteoporosis medication. The results should be interpreted in the context of an uncontrolled observational study.

  7. Degradation of teriparatide by gastro-intestinal proteolytic enzymes.

    Science.gov (United States)

    Werle, Martin; Samhaber, Annette; Bernkop-Schnürch, Andreas

    2006-04-01

    Teriparatide, a recombinant parathyroid hormone (1-34) is the first approved agent for the treatment of osteoporosis that stimulates new bone formation. Currently, the drug is administered daily by s.c. injection. Because of the obvious advantages of oral teriparatide administration, the development of such a delivery system would be of great benefit. Besides other barriers, the enzymatic barrier caused by gastro-intestinal (GI) proteolytic enzymes is believed to be responsible for negligible teriparatide oral bioavailability. It was therefore the aim of the study to evaluate the stability of teriparatide towards a variety of GI proteases under physiological conditions. Results indicate that teriparatide is entirely degraded by trypsin, chymotrypsin and pepsin within 5 min. In contrast, even after 3 h of incubation with elastase about 85% of undegraded teriparatide could still be detected. Within an incubation period of 3 h in the presence of rat small intestinal mucosa, approximately half of the teriparatide was degraded. Experiments with isolated aminopeptidase N demonstrated that this membrane bound peptidase is primarily involved in the degradation process. Results gained from and recorded in this study provide a precise characterisation of the enzymatic barrier for oral teriparatide administration and represents a prerequisite for the development of oral teriparatide delivery systems.

  8. Effect of Teriparatide on Unstable Pertrochanteric Fractures

    Directory of Open Access Journals (Sweden)

    Tsan-Wen Huang

    2015-01-01

    Full Text Available We retrospectively analyzed the radiographic and clinical outcomes of unstable pertrochanteric fractures (AO/OTA 31-A2 in 44 patients who underwent dynamic hip screw (DHS fixation and compared the results with 29 patients who received teriparatide in addition to DHS fixation. A significantly shorter time for fracture healing was recorded in the teriparatide-treated group than in the control group. Rates of lag screw sliding, femoral shortening, and varus collapse were all significantly reduced in the teriparatide-treated group. There were no significant differences with regard to superficial wound infection, pneumonia, urinary tract infection, mortality, malunion, and cutting of the lag screw. The mean overall mobility scores were significantly better in the teriparatide-treated group at 3 and 6 months (P<0.001 and P<0.001, resp. but not at 12 months or the last follow-up. The pain scores were also significantly better in the teriparatide-treated group at 3 and 6 months (P=0.040 and P=0.041, resp. but not at 12 months or the last follow-up. Teriparatide improves radiographic outcomes and yields better clinical outcomes at 3 and 6 months postoperatively. The improvement in union time may be important for elderly populations with unstable pertrochanteric fractures to enable them to return to daily activities and reduce morbidity and mortality.

  9. Effectiveness of Teriparatide in Postmenopausal Women with Osteoporosis and Glucocorticoid Use: 3-Year Results from the EFOS Study

    NARCIS (Netherlands)

    Karras, D.; Stoykov, I.; Lems, W.F.; Langdahl, B.L.; Ljunggren, O.; Barrett, A.; Walsh, J.B.; Fahrleitner-Pammer, A.; Rajzbaum, G.; Jakob, F.; Marin, F.

    2012-01-01

    Objective. To describe clinical fracture rates, back pain, and health-related quality of life (HRQOL) in postmenopausal women with osteoporosis who are receiving glucocorticoids (GC), during a 36-month study of teriparatide treatment for up to 18 months, with an additional 18-month followup period

  10. Teriparatide Induced Delayed Persistent Hypercalcemia

    Directory of Open Access Journals (Sweden)

    Nirosshan Thiruchelvam

    2014-01-01

    Full Text Available Teriparatide, a recombinant PTH, is an anabolic treatment for osteoporosis that increases bone density. Transient hypercalcemia is a reported side effect of teriparatide that is seen few hours following administration of teriparatide and resolves usually within 16 hours of drug administration. Persistent hypercalcemia, although not observed in clinical trials, is rarely reported. The current case describes a rare complication of teriparatide induced delayed persistent hypercalcemia.

  11. Effectiveness of Teriparatide in Women Over 75 Years of Age with Severe Osteoporosis: 36-Month Results from the European Forsteo Observational Study (EFOS)

    NARCIS (Netherlands)

    Walsh, J.B.; Lems, W.F.; Karras, D.; Langdahl, B.L.; Ljunggren, O.; Fahrleitner-Pammer, A.; Barrett, A.; Rajzbaum, G.; Jakob, F.; Marin, F.

    2012-01-01

    This predefined analysis of the European Forsteo Observational Study (EFOS) aimed to describe clinical fracture incidence, back pain, and health-related quality of life (HRQoL) during 18 months of teriparatide treatment and 18 months post-teriparatide in the subgroup of 589 postmenopausal women with

  12. The influence of teriparatide in induced tooth movement: A systematic review

    Science.gov (United States)

    Souza-Silva, Bianca-Núbia; Rodrigues, José-Lucas-Sani-de Alcântara; Moreira, Jefferson-Chaves; Matos, Felipe-de Souza; Cesar, Carla-Patrícia-Hernandez-Alves-Ribeiro; Repeke, Carlos-Eduardo-Palanch

    2016-01-01

    Background Teriparatide is a synthetic drug similar than PTH (parathyroid hormone), which is currently used as long-term treatment option for patients with bone chronic diseases, as osteoporosis; and this drug can interfere in a positive way in orthodontic movement. Objectives: The medical literature was assessed in the present systematic review in order to determine the level of scientific evidence supporting the influence of teriparatide in induced tooth movement. Material and Methods The PRISMA Checklist was followed in this systematic review. Four electronic databases (PubMed; Scopus; ScienceDirect; OpenGrey) were searched without implementing restrictions of year, status, and language of publications. The inclusion criteria consisted of selecting only experimental studies comparing the influence of teriparatide in tooth movement of male Wistar rats. The exclusion criteria consisted of experiments with female rats or other experimental animals, and animals with pathologic conditions. The eligible studies were evaluated based on methodological quality. Two trained examiners performed all the research steps. Results The initial sample comprised 700 studies, which was reduced to 664 after the exclusion of duplicates (n=36). Three articles were selected for the final qualitative analysis. The local administration of parathyroid hormone (PTH) 1-34 or PTH 1-84 revealed major effectiveness when compared with control groups and systematic administration. Additionally, the dilution of PTH 1-34 within methyl cellulose (MC) gel increased the time range for drug release, enabling to reduce the drug concentration without decreasing the effectiveness of tooth movement. Conclusions Teriparatide demonstrated potential acceleration of tooth movement in Wistar rats depending on the drug concentration; drug administration; and time for drug release. Key words:Teriparatide, tooth movement, parathyroid hormone, orthodontics. PMID:27957280

  13. Induction and antagonism of pica induced by teriparatide in rats.

    Science.gov (United States)

    Yamamoto, Kouichi; Kato, Naoto; Isogai, Yukihiro; Kuroda, Tatsuhiko; Ishida, Takayuki; Yamatodani, Atsushi

    2015-10-05

    Intermittent subcutaneous injection of teriparatide, an active fragment of human parathyroid hormone, is clinically used for the treatment of osteoporosis. Patients suffer from nausea, which is one of the side effects teriparatide induces; however, the etiology of teriparatide-induced nausea remains unknown. We have reported pica, kaolin ingestion behavior, can be used as an assessment of nausea-related response in rats. In this study, we investigated the characteristics of teriparatide-induced pica and the abilities of anti-emetic drugs to inhibit teriparatide-induced pica. Male and female adolescent (4-week-old), young (8-week-old), and adult (30-week-old) naive rats, and ovariectomized (OVX: 17-week-old) and sham-operated (17-week-old) rats subcutaneously received teriparatide (0.4 mg/kg, n=4), and their kaolin and food intakes were monitored for 24 h after the injection. Among the tested rats, we found that OVX rats, rather than male, female, and sham-operated rats, showed marked teriparatide-induced pica (0 mg/kg: 0.17±0.07 g, 0.4 mg/kg: 6.18±0.91 g). Teriparatide-induced pica in OVX rats was inhibited by intraperitoneal pretreatment with serotonin 5-HT3 (granisetron 0.5 mg/kg), dopamine D2 (prochlorperazine 0.5 mg/kg), neurokinin NK1 (fosaprepitant 1 mg/kg), and histamine H1 (diphenhydramine 10 mg/kg) receptor antagonists to 70%, 11%, 19%, and 59% of that in vehicle-treated control, respectively. These results suggest that teriparatide-induced pica in OVX rats has the potential to reflect teriparatide-induced nausea; 5-HT3, D2, NK1, and H1 receptor activation is involved in the development of this behavior; antagonists of these receptors have the potential to be medical candidates used as treatments for teriparatide-induced nausea in human patients. Copyright © 2015. Published by Elsevier B.V.

  14. Effect of Teriparatide or Risedronate in Elderly Patients With a Recent Pertrochanteric Hip Fracture

    DEFF Research Database (Denmark)

    Malouf-Sierra, Jorge; Tarantino, Umberto; García-Hernández, Pedro A

    2017-01-01

    We present final results of a study comparing teriparatide 20 μg every day (QD) with risedronate 35 mg once per week (QW) started within 2 weeks after surgery for a pertrochanteric hip fracture. Patients with BMD T-score ≤ -2.0 and 25OHD ≥9.2 ng/mL were randomized to receive 26-week double.......19%; p = 0.003), with no significant between-group difference in TH BMD. Timed up-and-go (TUG) test was significantly faster with teriparatide at 6, 12, 18, and 26 weeks (differences: -3.2 to -5.9 s; p = 0.045 for overall difference). Hip pain during TUG test by 100 mm VAS was significantly lower...

  15. Fracture Incidence, Quality of Life, and Back Pain during 18-Months Treatment with Teriparatide in Greek Postmenopausal Women with Osteoporosis: Results from the European Forsteo Observational Study

    Directory of Open Access Journals (Sweden)

    K. Aloumanis

    2011-01-01

    Full Text Available Objective. To evaluate fracture incidence, effects on health-related quality of life(QoL, back pain (BP occurrence and treatment compliance in Greek post-menopausal osteoporotic women treated with teriparatide (TPTD for up to 18 months, in a naturalistic setting. Methods. 301 patients provided baseline information on demographic characteristics, fracture history, osteoporosis-related medication and risk factors. During treatment, QoL and BP severity were evaluated. Results. Mean (SD age was 69.5 (±8.5 years. Fracture history was reported by 92.5% of patients. Incidence of fractures (per 10,000 patients/years ranged from 402 during 0–6 months of treatment, to 346 during 12–18 months. All 5 dimensions of QoL showed improvement. At baseline and 18 months, BP was reported by 93.2% and 64.2% of patients, respectively. BP and limitation of activities were quantified as moderate or severe by 89.9% and 62.3% of patients at baseline versus 32.4% and 14.8% at 18 months. Patients on treatment at 6, 12, 17, and 18 months were 92.6%, 88.3%, 79.6%, and 36.5%, respectively. Conclusions. In the Greek EFOS study cohort, patients prescribed TPTD were severely osteoporotic, with considerable health-related problems. Significant improvements in QoL and BP together with low fracture rates and high compliance have been recorded during treatment.

  16. Fracture Incidence, Quality of Life, and Back Pain during 18-Months Treatment with Teriparatide in Greek Postmenopausal Women with Osteoporosis: Results from the European Forsteo Observational Study.

    Science.gov (United States)

    Aloumanis, K; Karras, D; Drossinos, V; Korelis, E; Polydorakis, A

    2011-01-01

    Objective. To evaluate fracture incidence, effects on health-related quality of life(QoL), back pain (BP) occurrence and treatment compliance in Greek post-menopausal osteoporotic women treated with teriparatide (TPTD) for up to 18 months, in a naturalistic setting. Methods. 301 patients provided baseline information on demographic characteristics, fracture history, osteoporosis-related medication and risk factors. During treatment, QoL and BP severity were evaluated. Results. Mean (SD) age was 69.5 (±8.5) years. Fracture history was reported by 92.5% of patients. Incidence of fractures (per 10,000 patients/years) ranged from 402 during 0-6 months of treatment, to 346 during 12-18 months. All 5 dimensions of QoL showed improvement. At baseline and 18 months, BP was reported by 93.2% and 64.2% of patients, respectively. BP and limitation of activities were quantified as moderate or severe by 89.9% and 62.3% of patients at baseline versus 32.4% and 14.8% at 18 months. Patients on treatment at 6, 12, 17, and 18 months were 92.6%, 88.3%, 79.6%, and 36.5%, respectively. Conclusions. In the Greek EFOS study cohort, patients prescribed TPTD were severely osteoporotic, with considerable health-related problems. Significant improvements in QoL and BP together with low fracture rates and high compliance have been recorded during treatment.

  17. Transacsys PLC - Final Results

    CERN Multimedia

    2002-01-01

    Final results from Transacsys PLC. A subsidary of this company was set up to develop the CERN EDH system into a commercial product but incurred too much financial loss so the project was cancelled (1/2 page).

  18. Comparative Effects of Teriparatide and Risedronate in Glucocorticoid-Induced Osteoporosis in Men: 18-Month Results of the EuroGIOPs Trial

    Science.gov (United States)

    Glüer, Claus-C; Marin, Fernando; Ringe, Johann D; Hawkins, Federico; Möricke, Rüdiger; Papaioannu, Nikolaos; Farahmand, Parvis; Minisola, Salvatore; Martínez, Guillermo; Nolla, Joan M; Niedhart, Christopher; Guañabens, Nuria; Nuti, Ranuccio; Martín-Mola, Emilio; Thomasius, Friederike; Kapetanos, Georgios; Peña, Jaime; Graeff, Christian; Petto, Helmut; Sanz, Beatriz; Reisinger, Andreas; Zysset, Philippe K

    2013-01-01

    Data on treatment of glucocorticoid-induced osteoporosis (GIO) in men are scarce. We performed a randomized, open-label trial in men who have taken glucocorticoids (GC) for ≥3 months, and had an areal bone mineral density (aBMD) T-score ≤ –1.5 standard deviations. Subjects received 20 μg/d teriparatide (n = 45) or 35 mg/week risedronate (n = 47) for 18 months. Primary objective was to compare lumbar spine (L1–L3) BMD measured by quantitative computed tomography (QCT). Secondary outcomes included BMD and microstructure measured by high-resolution QCT (HRQCT) at the 12th thoracic vertebra, biomechanical effects for axial compression, anterior bending, and axial torsion evaluated by finite element (FE) analysis from HRQCT data, aBMD by dual X-ray absorptiometry, biochemical markers, and safety. Computed tomography scans were performed at 0, 6, and 18 months. A mixed model repeated measures analysis was performed to compare changes from baseline between groups. Mean age was 56.3 years. Median GC dose and duration were 8.8 mg/d and 6.4 years, respectively; 39.1% of subjects had a prevalent fracture, and 32.6% received prior bisphosphonate treatment. At 18 months, trabecular BMD had significantly increased for both treatments, with significantly greater increases with teriparatide (16.3% versus 3.8%; p = 0.004). HRQCT trabecular and cortical variables significantly increased for both treatments with significantly larger improvements for teriparatide for integral and trabecular BMD and bone surface to volume ratio (BS/BV) as a microstructural measure. Vertebral strength increases at 18 months were significant in both groups (teriparatide: 26.0% to 34.0%; risedronate: 4.2% to 6.7%), with significantly higher increases in the teriparatide group for all loading modes (0.005 < p < 0.015). Adverse events were similar between groups. None of the patients on teriparatide but five (10.6%) on risedronate developed new clinical fractures (p = 0.056). In conclusion, in this

  19. Final results on $\

    CERN Document Server

    Eskut, E; Onengüt, G; Van Beuzekom, M G; Van Dantzig, R; De Jong, M; Konijn, J; Melzer, O; Oldeman, R G C; Pesen, E; Van der Poel, C A F J; Visschers, J L; Güler, M; Köse, U; Serin-Zeyrek, M; Sever, R; Tolun, P; Zeyrek, M T; Armenise, N; Cassol, F; Catanesi, M G; De Serio, M; Muciaccia, M T; Radicioni, E; Righini, P; Simone, S; Vivolo, L; Bülte, A; Winter, Klaus; Van der Donckt, M; Van de Vyver, B; Vilain, P; Wilquet, G; Saitta, B; Di Capua, E; Luppi, C; Ishii, Y; Kazuno, M; Ogawa, S; Shibuya, H; Brunner, J; Chizhov, M; Cussans, D; Doucet, M; Fabre, Jean-Paul; Flegel, W; Hristova, I R; Kawamura, T; Kolev, D; Litmaath, M; Meinhard, H; Niu, E; Øverås, H; Panman, J; Papadopoulos, I M; Ricciardi, S; Rozanov, A; Saltzberg, D; Tsenov, R; Uiterwijk, J W E; Weinheimer, C; Wong, H; Zucchelli, P; Goldberg, J; Chikawa, M; Arik, E; Mailov, A A; Song, J S; Yoon, C S; Kodama, K; Ushida, N; Aoki, S; Hara, T; Brooijmans, G; Delbar, T; Favart, D; Grégoire, G; Hérin, J; Kalinin, S; Makhlioueva, I; Artamonov, A; Gorbunov, P; Khovansky, V; Shamanov, V; Tsukerman, I; Bonekämper, D; Bruski, N; Frekers, D; Rondeshagen, D; Wolff, T; Hoshino, K; Kawada, J; Komatsu, M; Kotaka, Y; Kozaki, T; Miyanishi, M; Nakamura, M; Nakano, T; Narita, K; Niu, K; Niwa, K; Nonaka, N; Obayashi, Y; Sato, O; Toshito, T; Buontempo, S; Cocco, A G; D'Ambrosio, N; De Lellis, G; De Rosa, G De Lellis G; Di Capua, F; Ereditato, A; Fiorillo, G; Marotta, M; Messina, M; Migliozzi, P; Palladino, V; Scotto-Lavina, L; Strolin, P; Tioukov, V; Nakamura, K; Okusawa, T; Capone, A; De Pedis, D; Di Liberto, S; Dore, U; Ludovici, P F Loverre L; Maslennikov, A; Mazzoni, M A; Piredda, G; Santacesaria, G Rosa R; Satta, A; Spada, F R; Barbuto, E; Bozza, C; Grella, G; Romano, G; Sirignano, C; Sorrentino, S; Sato, Y; Tezuka, I

    2008-01-01

    The final oscillation analysis of the complete set of data collected by CHORUS in the years 1994-1997 is presented. Reconstruction algorithms of data extracted by electronic detectors were improved and the data recorded in the emulsion target were analysed by new automated scanning systems, allowing the use of a new method for event reconstruction in emulsion. CHORUS has applied these new techniques to the sample of 1996-1997 events for which no muons were observed in the electronic detectors. Combining the new sample with the data analysed in previous papers, the overall sensitivity of the experiment to the $\

  20. Teriparatide (rDNA origin) Injection

    Science.gov (United States)

    ... have any questions about how to inject this medication.Teriparatide injection comes in a pen that contains enough medication ... injection.Do not let anyone else use your medication. Never share a teriparatide injection pen. Ask your pharmacist any questions you have ...

  1. Teriparatide (recombinant human parathyroid hormone 1-34 in postmenopausal women with osteoporosis: systematic review

    Directory of Open Access Journals (Sweden)

    Virgínia Fernandes Moça Trevisani

    Full Text Available CONTEXT AND OBJECTIVE: Osteoporosis is defined as a disease characterized by low bone mass and deterioration of the bone tissue microarchitecture. Teriparatide stimulates the formation and action of osteoblasts, which are responsible for bone formation, thus promoting bone tissue increase. The aim was to assess the effectiveness and safety of teriparatide for treating postmenopausal osteoporosis. METHODS: A systematic review was conducted using the Cochrane Collaboration methodology. RESULTS: 1 Teriparatide 20 µg or 40 µg versus placebo: there was a benefit from teriparatide, considering the following outcomes: reduction in the number of new vertebral and non-vertebral fractures, and increased whole-body, lumbar and femoral bone mineral density. 2 Teriparatide 40 µg versus alendronate 10 mg/day for 14 months: there was no statistical difference regarding the incidence of new vertebral or non-vertebral fractures, although in the group that received teriparatide there was greater bone mineral density increase in the whole body, lumbar column and femur. 3 Estrogen plus teriparatide 25 µg versus estrogen: there was a benefit, considering the following outcomes: reduction in the number of new vertebral fractures, and increased whole-body, lumbar and femoral bone mineral density after three years. CONCLUSIONS: When teriparatide is intermittently administered in low doses, it reduces the incidence of vertebral fractures (67% and non-vertebral fractures (38% and increases bone mineral density in the lumbar column and femur. There is a need for studies with longer observation in order to allow conclusions regarding the safety and duration of the therapeutic effects.

  2. Successful treatment of nonunion with teriparatide after failed ankle arthrodesis for Charcot arthropathy.

    Science.gov (United States)

    Tamai, K; Takamatsu, K; Kazuki, K

    2013-10-01

    We describe a case of successful treatment to nonunion after multiple arthrodesis operations for Charcot arthropathy with teriparatide. We describe the case of a 25-year-old woman with severe Type I diabetes mellitus that resulted in nonunion after multiple arthrodesis operations for Charcot arthropathy. The woman sustained a femoral shaft fracture for which she underwent surgery with intramedullary nail fixation. Immediately after surgery, an empiric course of teriparatide was initiated. Femoral shaft fracture healing was observed after 2 weeks, and the woman was able to walk 12 weeks after the surgery, at which point plain film and computed tomography images revealed complete union of the ankle.

  3. Report on Final Workshop results

    DEFF Research Database (Denmark)

    Cavalli, Valentino; Dyer, John; Robertson, Dale

    The SERENATE project held its Final Workshop in Bad Nauheim, Germany on 16-17 June 2003. More than ninety representatives of research and education networking organisations, national governments and funding bodies, network operators, equipment manufacturers and the scientific and education...

  4. Fracture rate and back pain during and after discontinuation of teriparatide: 36-month data from the European Forsteo Observational Study (EFOS).

    Science.gov (United States)

    Fahrleitner-Pammer, A; Langdahl, B L; Marin, F; Jakob, F; Karras, D; Barrett, A; Ljunggren, Ö; Walsh, J B; Rajzbaum, G; Barker, C; Lems, W F

    2011-10-01

    months after teriparatide discontinuation. These results should be interpreted in the context of the design of an observational study.

  5. The cost effectiveness of teriparatide as a first-line treatment for glucocorticoid-induced and postmenopausal osteoporosis patients in Sweden.

    Science.gov (United States)

    Murphy, Daniel R; Smolen, Lee J; Klein, Timothy M; Klein, Robert W

    2012-10-30

    This paper presents the model and results to evaluate the use of teriparatide as a first-line treatment of severe postmenopausal osteoporosis (PMO) and glucocorticoid-induced osteoporosis (GIOP). The study's objective was to determine if teriparatide is cost effective against oral bisphosphonates for two large and high risk cohorts. A computer simulation model was created to model treatment, osteoporosis related fractures, and the remaining life of PMO and GIOP patients. Natural mortality and additional mortality from osteoporosis related fractures were included in the model. Costs for treatment with both teriparatide and oral bisphosphonates were included. Drug efficacy was modeled as a reduction to the relative fracture risk for subsequent osteoporosis related fractures. Patient health utilities associated with age, gender, and osteoporosis related fractures were included in the model. Patient costs and utilities were summarized and incremental cost-effectiveness ratios (ICERs) for teriparatide versus oral bisphosphonates and teriparatide versus no treatment were estimated.For each of the PMO and GIOP populations, two cohorts differentiated by fracture history were simulated. The first contained patients with both a historical vertebral fracture and an incident vertebral fracture. The second contained patients with only an incident vertebral fracture. The PMO cohorts simulated had an initial Bone Mineral Density (BMD) T-Score of -3.0. The GIOP cohorts simulated had an initial BMD T-Score of -2.5. The ICERs for teriparatide versus bisphosphonate use for the one and two fracture PMO cohorts were €36,995 per QALY and €19,371 per QALY. The ICERs for teriparatide versus bisphosphonate use for the one and two fracture GIOP cohorts were €20,826 per QALY and €15,155 per QALY, respectively. The selection of teriparatide versus oral bisphosphonates as a first-line treatment for the high risk PMO and GIOP cohorts evaluated is justified at a cost per QALY threshold

  6. Hypercalcemic encephalopathy due to milk alkali syndrome and injection teriparatide

    Directory of Open Access Journals (Sweden)

    Sandeep Kharb

    2012-01-01

    Full Text Available An 82-year-old male, a known case of severe osteoporosis with vertebral fracture and prostatic carcinoma, was treated with gonadotropin releasing hormone analogue, calcium carbonate, cholecalciferol sachet and injection teriparatide. His diet consisted of milk and curd. He developed altered behavior and generalized weakness, and on investigation, hypercalcemia, hypokalemia, and metabolic alkalosis with low parathyroid hormone levels were detected. Injection teriparatide was stopped and he was managed with forced saline diuresis and injection zoledronic acid. He was diagnosed as a case of milk alkali syndrome in whom teriparatide and prolonged immobilization played a permissive role in the development of hypercalcemic encephalopathy.

  7. Evaluation of chronic low back pain in osteoporotic patients in treatment with teriparatide

    Directory of Open Access Journals (Sweden)

    Renata Alvarenga Nunes

    2014-03-01

    Full Text Available OBJECTIVE: The objective was to assess the improvement of chronic low back pain in osteoporotic patients treated with teriparatide (TPTD. METHODS: This was an observational study with a convenience sample of 21 patients with osteoporosis using TPTD, 20 mcg/day, between 2006 and 2010, with chronic low back pain (more than three months. Dorsolumbar radiographs and bone densitometry (DXA were performed before and after treatment. For pain measurement the VAS pain scale was used. Data were entered in Excel and processed in STATA/SE 8.0 with Chi2 square or Fisher (p < 0.05. RESULTS: twenty-one patients aged 40-90 (mean 70 years, eight (40% had senile osteoporosis and thirteen (60% had osteoporosis secondary to medications. Seventeen (80% had previous dorsolumbar fractures. Ten (47.5% used TPTD for 24 months, six (27.5 % used the medication for 18 months, four (20% for 12 months and one (5% for six months. Eight patients (40% received previous anti-reabsortive therapy. Thirteen patients (60% exhibited bone mass gain between 0% and 9% while eight (40%, between 10% and 15%. The final average VAS was 2.6 representing an improvement of 4.7 (p< 0.05. CONCLUSION: There was a significant reduction in the severity of low back pain with the use of TPTD (initial mean VAS: 7.3, final VAS: 2.6, improvement: 4.7.

  8. Preparation, characterization and in vivo evaluation of a combination delivery system based on hyaluronic acid/jeffamine hydrogel loaded with PHBV/PLGA blend nanoparticles for prolonged delivery of Teriparatide.

    Science.gov (United States)

    Bahari Javan, Nika; Montazeri, Hamed; Rezaie Shirmard, Leila; Jafary Omid, Nersi; Barbari, Ghullam Reza; Amini, Mohsen; Ghahremani, Mohammad Hossein; Rafiee-Tehrani, Morteza; Abedin Dorkoosh, Farid

    2017-04-01

    In the current study, biodegradable PHBV/PLGA blend nanoparticles (NPs) containing Teriparatide were loaded in hyaluronic acid/jeffamine (HA-JEF ED-600) hydrogel to prepare a combination delivery system (CDS) for prolonged delivery of Teriparatide. The principal purpose of the present study was to formulate an effective and prolonged Teriparatide delivery system in order to reduce the frequency of injection and thus enhance patient's compliance. Morphological properties, swelling behaviour, crosslinking efficiency and rheological characterization of HA-JEF ED-600 hydrogel were evaluated. The CDS was acquired by adding PHBV/PLGA NPs to HA-JEF ED-600 hydrogel simultaneously with crosslinking reaction. The percentage of NPs incorporation within the hydrogel as well as the loading capacity and morphology of Teriparatide loaded CDS were examined. Intrinsic fluorescence and circular dichroism spectroscopy proved that Teriparatide remains stable after processing. The release profile represented 63% Teriparatide release from CDS within 50days with lower burst release compared to NPs and hydrogel. MTT assay was conducted by using NIH3T3 cell line and no sign of reduction in cell viability was observed. Based on Miller and Tainter method, LD50 of Teriparatide loaded CDS was 131.8mg/kg. In vivo studies demonstrated that Teriparatide loaded CDS could effectively increase serum calcium level after subcutaneous injection in mice. Favourable results in the current study introduced CDS as a promising candidate for controlled delivery of Teriparatide and pave the way for future investigations in the field of designing prolonged delivery systems for other peptides and proteins. Copyright © 2017 Elsevier B.V. All rights reserved.

  9. Individual and combining effects of anti-RANKL monoclonal antibody and teriparatide in ovariectomized mice

    Directory of Open Access Journals (Sweden)

    Naoto Tokuyama

    2015-06-01

    Full Text Available We examined the individual and combined effects of teriparatide and anti-RANKL (receptor activator of nuclear factor κB ligand monoclonal antibody in ovariectomized mice. Three-month-old female C57BL/6 mice were ovariectomized (OVX or sham operated. Four weeks after OVX, they were assigned to 3 different groups to receive anti-RANKL monoclonal antibody (Ab alone (5 mg/kg single injection at 4 weeks after OVX, Ab group, teriparatide alone (80 μg/kg daily injection for 4 weeks from 4 weeks after OVX, PTH group, or mAb plus teriparatide (Ab + PTH group. Mice were sacrificed 8 weeks after OVX. Bone mineral density (BMD was measured at the femur and lumbar spine. Hind limbs were subjected to histological and histomorphometric analysis. Serum osteocalcin and CTX-I levels were measured to investigate the bone turnover. Compared with Ab group, Ab + PTH group showed a significant increase in BMD at distal femur and femoral shaft. Cortical bone volume was significantly increased in PTH and Ab + PTH groups compared with Ab group. Bone turnover in Ab + PTH group was suppressed to the same degree as in Ab group. The number of TRAP-positive multinucleated cells was markedly reduced in Ab and Ab + PTH groups. These results suggest that combined treatment of teriparatide with anti-RANKL antibody has additive effects on BMD in OVX mice compared with individual treatment.

  10. Norcal Prototype LNG Truck Fleet: Final Results

    Energy Technology Data Exchange (ETDEWEB)

    2004-07-01

    U.S. DOE and National Renewable Energy Laboratory evaluated Norcal Waste Systems liquefied natural gas (LNG) waste transfer trucks. Trucks had prototype Cummins Westport ISXG engines. Report gives final evaluation results.

  11. Improvement in health-related quality of life in osteoporosis patients treated with teriparatide

    Directory of Open Access Journals (Sweden)

    Papaioannou Alexandra

    2008-11-01

    Full Text Available Abstract Background Individuals with osteoporosis and recent vertebral fractures suffer from pain and impaired health-related quality of life (HRQL. To determine whether patients with osteoporosis treated with teriparatide experienced improvement in HRQL and pain symptoms after several months of therapy. Methods We retrospectively studied a sample of osteoporosis patients treated with teriparatide in a Canadian rheumatology practice. We included patients that received teriparatide therapy with baseline and follow-up Mini-Osteoporosis Quality of Life Questionnaire (OQLQ data. Follow-up data was measured at three or six months. We used a paired Student's t-test to compare baseline and follow-up measurements for each of the questionnaire's ten questions (five domains. Statistical analysis was also repeated to only include patients who suffered a prior vertebral fracture. Results 57 patients were included in the study, including 47 women. The mean age was 63.8 years (standard deviation 12.1 years. About sixty five percent (37/57 had previously sustained one or more osteoporotic fractures and about 38.6% (22/57 had suffered a prior vertebral fracture. About 44% (25/57 of individuals were taking one or more types of pain medications regularly prior to starting therapy. At follow-up, significant improvements were observed in the OQLQ domains of pain symptoms. This was seen when all patients on teriparatide were included, and also when only patients with prior vertebral fractures were included. There was also an improvement in emotional functioning, relating to fear of falling at 3 months follow-up (p = 0.019. Respondents also reported improvement in the domain of activities of daily living, relating to vacuuming at 6 months follow-up (p = 0.036, and an improvement in the leisure domain, relating to ease of traveling in the prior vertebral fracture population at 3 months follow-up (p = 0.012. However, there was no significant improvement observed in the

  12. The cost effectiveness of teriparatide as a first-line treatment for glucocorticoid-induced and postmenopausal osteoporosis patients in Sweden

    Directory of Open Access Journals (Sweden)

    Murphy Daniel R

    2012-10-01

    Full Text Available Abstract Background This paper presents the model and results to evaluate the use of teriparatide as a first-line treatment of severe postmenopausal osteoporosis (PMO and Glucocorticoid-induced osteoporosis (GIOP. The study’s objective was to determine if teriparatide is cost effective against oral bisphosphonates for two large and high risk cohorts. Methods A computer simulation model was created to model treatment, osteoporosis related fractures, and the remaining life of PMO and GIOP patients. Natural mortality and additional mortality from osteoporosis related fractures were included in the model. Costs for treatment with both teriparatide and oral bisphosphonates were included. Drug efficacy was modeled as a reduction to the relative fracture risk for subsequent osteoporosis related fractures. Patient health utilities associated with age, gender, and osteoporosis related fractures were included in the model. Patient costs and utilities were summarized and incremental cost-effectiveness ratios (ICERs for teriparatide versus oral bisphosphonates and teriparatide versus no treatment were estimated. For each of the PMO and GIOP populations, two cohorts differentiated by fracture history were simulated. The first contained patients with both a historical vertebral fracture and an incident vertebral fracture. The second contained patients with only an incident vertebral fracture. The PMO cohorts simulated had an initial Bone Mineral Density (BMD T-Score of −3.0. The GIOP cohorts simulated had an initial BMD T-Score of −2.5. Results The ICERs for teriparatide versus bisphosphonate use for the one and two fracture PMO cohorts were €36,995 per QALY and €19,371 per QALY. The ICERs for teriparatide versus bisphosphonate use for the one and two fracture GIOP cohorts were €20,826 per QALY and €15,155 per QALY, respectively. Conclusions The selection of teriparatide versus oral bisphosphonates as a first-line treatment for the high risk PMO

  13. Radiographic features of teriparatide-induced healing of femoral fractures

    Directory of Open Access Journals (Sweden)

    Youngwoo Kim

    2015-12-01

    Full Text Available Teriparatide is a drug that is used to increase bone remodeling, formation, and density for the treatment of osteoporosis. We present three cases of patients with a femoral insufficiency fracture. The patients were administered teripatatide in an attempt to treat severe osteoporosis and to enhance fracture healing. We found several radiographic features around the femoral fractures during the healing period. 1 Callus formation was found at a very early stage in the treatment. Teriparatide substantially increased the unusually abundant callus formation around the fracture site at 2 weeks. Moreover, this callus formation continued for 8 weeks and led to healing of the fracture. 2 Abundant callus formation was found circumferentially around the cortex with a ‘cloud-like’ appearance. 3 Remodeling of the teriparatide-induced callus formation was found to be part of the normal fracture healing process. After 1 year, normal remodeling was observed on plain radiographs. These findings indicate that teriparatide can be used as an adjuvant therapy in the management of femoral insufficiency fractures.

  14. Teriparatide and vertebral fracture healing in Ankylosing Spondylitis

    Directory of Open Access Journals (Sweden)

    Izolda Biro

    2017-12-01

    This case is unique as complete healing was achieved without preceding surgical intervention. Further exploration of the use of Teriparatide in spinal fractures in patients with AS is recommended to support the theories generated by this and other existing cases in the literature.

  15. Turning research into results, final report

    Energy Technology Data Exchange (ETDEWEB)

    1993-05-01

    In September 1989, the ACEC Research and Management Foundation (ACEC/RMF) submitted a proposal to the US Department of Energy (DOE) in response to the Existing Buildings Efficiency Program`s Solicitation Number DE-PS01-89CE21034. On May 15, 1990, DOE informed ACEC/RMF that it had been selected for a grant award; the final agreement was signed on July 23, 1990. The purpose of the effort was to develop an information package showing engineering firms that energy services can be sold to owners and developers successfully and profitably, that not every design that goes beyond code results in a lawsuit, that owners can be shown the value of paying for the additional design analysis that energy efficiency design requires. The package was envisioned to include examples of buildings that succeed in terms of energy, cost, and design team benefits. It was further conceptualized as both a technical and marketing resource to provide helpful facts, references to relevant documents, graphic materials to be used during client presentations, and guidance on the latest in useful research results.

  16. Multiple vertebral fractures associated with glucocorticoid-induced osteoporosis treated with teriparatide followed by kyphosis correction fusion: a case report.

    Science.gov (United States)

    Uei, Hiroshi; Tokuhashi, Yasuaki; Maseda, Masafumi; Nakahashi, Masahiro; Nakayama, Enshi

    2018-02-23

    Surgical treatment of multiple vertebral fractures in patients with glucocorticoid-induced osteoporosis is difficult because of a high rate of secondary fracture postoperatively. A case is described in which initial treatment with teriparatide to improve osteoporosis followed by treatment of kyphosis with correction fusion achieved a favorable outcome. Secondary fracture frequently occurs after treatment of vertebral fracture with vertebroplasty and balloon kyphoplasty in patients with glucocorticoid-induced osteoporosis, but effective treatment of multiple vertebral fractures has rarely been reported. Thus, a treatment of kyphosis following multiple vertebral fractures associated with glucocorticoid-induced osteoporosis is required. The patient was a 24-year-old woman diagnosed with glucocorticoid-induced osteoporosis who was under treatment with oral alendronate, vitamin D, and elcatonin injection. Secondary multiple vertebral fractures occurred despite these treatments and low back pain gradually aggravated. Vertebroplasty or balloon kyphoplasty was not performed in the early phase. Instead, treatment with teriparatide was used for initial improvement of osteoporosis. Kyphosis in the center of the residual thoracolumbar junction was then treated with posterior correction fusion. At 2 years after surgery, the corrected position has been maintained and no new fracture has occurred. There is no established method for treatment of multiple vertebral fractures caused by glucocorticoid-induced osteoporosis. Initial treatment with teriparatide to improve osteoporosis followed by treatment of kyphosis with correction fusion may result in a more favorable outcome.

  17. Effectiveness of teriparatide treatment on back pain-related functional limitations in individuals affected by severe osteoporosis: a prospective pilot study

    Science.gov (United States)

    Iolascon, Giovanni; Gimigliano, Francesca; Malavolta, Nazzarena; Tarantino, Umberto; Fornari, Rachele; Greco, Emanuela; Di Pietro, Gioconda; Gimigliano, Raffaele; Lenzi, Andrea; Resmini, Giuseppina; Migliaccio, Silvia

    2012-01-01

    Summary Introduction Vertebral fractures have been associated with back pain, functional limitations and reduced health-related quality of life (HRQoL). Teriparatide is the first effective anabolic agent that demonstrated to significantly reduce the risk of vertebral fracture by 65%, as compared to placebo. The aims of this study were to evaluate the effectiveness of teriparatide treatment on back pain-related functional limitations and to investigate on patients HRQoL. Materials and methods In this prospective observational pilot study osteoporotic patients, who were prescribed teriparatide therapy and a supplementation of calcium and vitamin D, were asked to answer to two self-administered questionnaires: the Spine Pain Index (SPI) and the SF-12 (at the recruitment, after 6, 12, and 18 months). Results Fifty-two women were evaluated (mean age of 70.58 yrs). The mean SPI score passed from 50.01 at baseline to 32.20 at 18 months. The mean SF-12 PCS score passed from 30.00 at baseline to 36.79 at 18 months, while the mean SF-12 MCS score was already within the normality range at baseline, constantly improving during the 18 months. Conclusion In conclusion, 18 months of treatment with teriparatide has to be considered an effective therapeutic option for women with severe osteoporosis and vertebral fractures, in a real-life clinical setting, to improve both back pain related disability and quality of life. PMID:23289031

  18. Final results of the MEG experiment

    Science.gov (United States)

    Mori, Toshinori; MEG Collaboration

    2017-07-01

    Transitions of charged leptons from one generation to another are basically prohibited in the Standard Model because of the mysteriously tiny neutrino masses, although such flavor-violating transitions have long been observed for quarks and neutrinos. Supersymmetric Grand Unified Theories (SUSY GUT), which unify quarks and leptons as well as their forces, predict that charged leptons should also make such transitions at small but experimentally observable rates. The MEG experiment was the first to have explored one of such transitions, μ^+ to e^+ γ decays, down to the branching ratios predicted by SUSY GUT. Here we report the final results of the MEG experiment based on the full dataset collected from 2009 to 2013 at the Paul Scherrer Institut, corresponding to a total of 7.5× 10^{14} stopped muons on target. No excess for μ^+ to e^+ γ decays was found. Thus the most stringent upper bound was placed on the branching ratio, B( μ+_{}↦e+ γ) theories. We are now preparing the upgraded experiment MEG II with the aim to achieve a sensitivity of 4× 10^{-14} after three years of data taking. It is expected to start late in 2017.

  19. Transient severe hypotension with once-weekly subcutaneous injection of teriparatide in osteoporotic patient: a case report and insight for the drug interaction between hypotensive agents and teriparatide.

    Science.gov (United States)

    Enishi, Tetsuya; Uemura, Hirokazu; Katoh, Shinsuke; Inatsugi, Masanori; Minato, Sho; Inatsugi, Kei; Inatsugi, Mikiko; Sato, Nori; Siryo, Koichi

    2015-01-01

    Teriparatide, a recombinant form of parathyroid hormone, were well recognized as a useful option for the treatment of the osteoporosis. Although some side effects of teriparatide include headache, nausea, dizziness, and limb pain were reported. Here we present a 80-year-old woman of transient asymptomatic hypotension with once-weekly subcutaneous injection of teriparatide for the treatment of osteoporosis with hypertension disease as acute-phase reactions. Systolic blood pressure decreased in both 30 min and 60 min after injection compared with before injection. Heart rate increased with passage of time. Statistically significant were observed among before, 30 min, 60 min after injection of teriparatide. Slight nausea was seen as subjective symptoms with the first and second injection after 30 min. This case indicates careful attention, at least 1 hr, was recommended with weekly subcutaneous injections of teriparatide in the treatment for osoteoproteic patient with hypertension decreases. This is a first report, to the best of our knowledge, to demonstrate the transient asymptomatic hypotension after once-weekly injection of teriparatide with hypertension disease. Transient hypotension occurred after injection of teriparatide during the treatment period and was asymptomatic except for the first 2 injections.

  20. Preparation, statistical optimisation and in vitro characterisation of poly (3-hydroxybutyrate-co-3-hydroxyvalerate)/poly (lactic-co-glycolic acid) blend nanoparticles for prolonged delivery of teriparatide.

    Science.gov (United States)

    Bahari Javan, Nika; Rezaie Shirmard, Leila; Jafary Omid, Nersi; Akbari Javar, Hamid; Rafiee Tehrani, Morteza; Abedin Dorkoosh, Farid

    2016-07-17

    The purpose of this study was the preparation, optimisation and in vitro characterisation of PHBV and PLGA blend nanoparticles (NPs) for prolonged delivery of Teriparatide. Double emulsion solvent evaporation technique was employed for the fabrication of NPs. The nanoformulation was optimised using the Box-Behnken methodology. The morphological properties of NPs were assessed by both SEM and transmission electron microscopy (TEM). Encapsulation of Teriparatide within the NPs and lacking of chemical bonds between drug and copolymers were proved by XRPD, FTIR and DSC. The structural stability of Teriparatide after processing was confirmed by fluorescence spectrometry. The average size of optimised NPs was 250.0 nm with entrapment efficiency (EE) of 89.5% and drug loading (DL) of 5.0%. Teriparatide release from optimised NPs led to 64.4% release over 30 days and it showed a diffusion-based mechanism. Based on the favourable results, PHBV/PLGA blend NPs could be a promising candidate for designing a controlled release formulation of Teriparatide.

  1. Atypical femoral fracture in an osteogenesis imperfecta patient successfully treated with teriparatide

    DEFF Research Database (Denmark)

    Holm, Jakob; Eiken, Pia; Hyldstrup, Lars

    2014-01-01

    OBJECTIVE: We report a case of a successfully healed atypical femoral fracture (AFF) following treatment with teriparatide in a patient with osteogenesis imperfecta (OI). To our knowledge, no successful treatment of AFFs with teriparatide in this subpopulation has ever been described. METHODS...

  2. Evaluation of Teriparatide for Treatment of Osteoporosis in Four Patients with Cystic Fibrosis: A Case Series

    Directory of Open Access Journals (Sweden)

    Oranan Siwamogsatham

    2014-01-01

    Full Text Available Introduction. Bone disease is a common complication of cystic fibrosis (CF. To date, there have been no reports on the effectiveness of teriparatide, recombinant human parathyroid hormone, to treat CF-related bone disease. Case Presentation. We report on four patients with CF-related bone disease who were treated with teriparatide. Three patients completed two years of therapy with teriparatide, and all had significant improvements in their bone mineral density (BMD. One patient was unable to tolerate teriparatide and discontinued treatment 1 week into therapy. Conclusion. Teriparatide may be a potential treatment option for CF-related bone disease. This report highlights the need for further investigation into the use of teripartide in the CF population.

  3. Barwood CNG Cab Fleet Study: Final Results

    Energy Technology Data Exchange (ETDEWEB)

    Whalen, P.; Kelly, K.; John, M.

    1999-05-03

    This report describes a fleet study conducted over a 12-month period to evaluate the operation of dedicated compress natural gas (CNG) Ford Crown Victoria sedans in a taxicab fleet. In the study, we assess the performance and reliability of the vehicles and the cost of operating the CNG vehicles compared to gasoline vehicles. The study results reveal that the CNG vehicles operated by this fleet offer both economic and environmental advantages. The total operating costs of the CNG vehicles were about 25% lower than those of the gasoline vehicles. The CNG vehicles performed as well as the gasoline vehicles, and were just as reliable. Barwood representatives and drivers have come to consider the CNG vehicles an asset to their business and to the air quality of the local community.

  4. Teriparatide increases the insertional torque of pedicle screws during fusion surgery in patients with postmenopausal osteoporosis.

    Science.gov (United States)

    Inoue, Gen; Ueno, Masaki; Nakazawa, Toshiyuki; Imura, Takayuki; Saito, Wataru; Uchida, Kentaro; Ohtori, Seiji; Toyone, Tomoaki; Takahira, Naonobu; Takaso, Masashi

    2014-09-01

    The object of this study was to examine the efficacy of preoperative teriparatide treatment for increasing the insertional torque of pedicle screws during fusion surgery in postmenopausal women with osteoporosis. Fusion surgery for the thoracic and/or lumbar spine was performed in 29 postmenopausal women with osteoporosis aged 65-82 years (mean 72.2 years). The patients were divided into 2 groups based on whether they were treated with teriparatide (n = 13) or not (n = 16) before the surgery. In the teriparatide-treated group, patients received preoperative teriparatide therapy as either a daily (20 μg/day, n = 7) or a weekly (56.5 μg/week, n = 6) injection for a mean of 61.4 days and a minimum of 31 days. During surgery, the insertional torque was measured in 212 screws inserted from T-7 to L-5 and compared between the 2 groups. The correlation between the insertional torque and the duration of preoperative teriparatide treatment was also investigated. The mean insertional torque value in the teriparatide group was 1.28 ± 0.42 Nm, which was significantly higher than in the control group (1.08 ± 0.52 Nm, p osteoporosis. Preoperative teriparatide treatment might be an option for maximizing the purchase of the pedicle screws to the bone at the time of fusion surgery.

  5. Teriparatide for osteoporosis in patients with sarcoidosis: Report on risk-benefit ratio in four cases.

    Science.gov (United States)

    Challal, Salima; Semerano, Luca; Nunes, Hilario; Valeyre, Dominique; Boissier, Marie-Christophe; Saidenberg-Kermanac'h, Nathalie

    2016-05-01

    For patients with sarcoidosis, no consensus exists about the management of osteoporosis, whether related or unrelated to glucocorticoid therapy. We report the first series of 4patients with histologically documented sarcoidosis who received teriparatide therapy for severe osteoporosis manifesting as a fracture cascade with multilevel vertebral fractures. When teriparatide was started, 1patient was receiving 10mg of prednisone equivalents per day, 1 was progressively tapering glucocorticoid dose, 2 had never received any glucocorticoid treatment. In all 4patients, teriparatide was effective in halting the fracture cascade, including in the 2patients who remained on long-term glucocorticoid therapy. None of the patients developed hypercalcemia. During teriparatide therapy, 3patients underwent a flare or a complication of sarcoidosis. Only the patient on stable glucocorticoid treatment did not present any adverse event. Before teriparatide initiation, sarcoidosis had been well controlled in all 3patients for several years. Even if the implication of teriparatide is unclear, the appearance of adverse events in 3 out of 4patients in this small series suggest caution in the use of teriparatide in patients with sarcoidosis. Copyright © 2015 Société française de rhumatologie. Published by Elsevier SAS. All rights reserved.

  6. QCD and Final State Results from ATLAS

    CERN Document Server

    Gray, HM; The ATLAS collaboration

    2010-01-01

    # Inclusive charged particle production with the ATLAS detector The first measurements with the ATLAS detector at the LHC on the properties of proton-proton interactions are presented. The charged-particle density, its dependence on transverse momentum and pseudorapidity, and the relationship between transverse momentum and charged-particle multiplicity are measured for events with at least one charged particle in the kinematic range abs(eta)< 2.5 and pT > 500 MeV. The measurements are compared to minimum bias Monte Carlo models and to results from other experiments. # Jet studies with charged particles with the ATLAS detector The precise measurements of reconstructed tracks in inelastic pp interactions as measured with the ATLAS detectorat the LHC allows the study of so called 'track jets'. This analysis makes use of the ATLAS inner tracking detector with a coverage in pseudorapidity of abs(eta)<2.5. This approach is completely independent on information from the calorimeters and thus co...

  7. Final Results of Shuttle MMOD Impact Database

    Science.gov (United States)

    Hyde, J. L.; Christiansen, E. L.; Lear, D. M.

    2015-01-01

    The Shuttle Hypervelocity Impact Database documents damage features on each Orbiter thought to be from micrometeoroids (MM) or orbital debris (OD). Data is divided into tables for crew module windows, payload bay door radiators and thermal protection systems along with other miscellaneous regions. The combined number of records in the database is nearly 3000. Each database record provides impact feature dimensions, location on the vehicle and relevant mission information. Additional detail on the type and size of particle that produced the damage site is provided when sampling data and definitive spectroscopic analysis results are available. Guidelines are described which were used in determining whether impact damage is from micrometeoroid or orbital debris impact based on the findings from scanning electron microscopy chemical analysis. Relationships assumed when converting from observed feature sizes in different shuttle materials to particle sizes will be presented. A small number of significant impacts on the windows, radiators and wing leading edge will be highlighted and discussed in detail, including the hypervelocity impact testing performed to estimate particle sizes that produced the damage.

  8. Patient experience with a new teriparatide delivery device.

    Science.gov (United States)

    Dore, Robin K; Feldman, Robert G; Taylor, Kathleen A; See, Kyoungah; Dalsky, Gail P; Warner, Margaret R

    2009-10-01

    To determine functionality and acceptability of a new teriparatide (Forteo, Eli Lilly and Company, Indianapolis, IN, USA) delivery device by patients with osteoporosis. This was an eight week, single-arm, multicenter, open-label clinical trial. Patients received teriparatide 20 microg/day by subcutaneous injection using a new delivery device. Men and postmenopausal women with osteoporosis at high risk for fracture were stratified to Current User (n = 92) or Not Current User (n = 107) groups. Current Users had used the original delivery device for > or =8 weeks, including uninterrupted use for four weeks before enrollment. ClinicalTrials.gov, NCT00577863. The primary objective was to detect common complaints (> or =3% for all patients) regarding the functionality and acceptability of the new device. Complaints were categorized as functional (e.g., malfunction), nonfunctional (e.g., size), or user manual. Secondary objectives included questionnaire assessment of preference of the new versus original device, features of the new delivery device, and analysis of adverse events. A total of 31 patients (16%) reported 47 complaints (four functional, 27 nonfunctional, and 16 user manual). There were two common complaints: device size (4.0%) and lack of information on alcohol swabs (3.5%). Overall, patients agreed that the new device was easy to use (99.5%), easy to learn to use (99%), easy to attach a needle (97%), easy to hold while injecting (95%), and that it reduced their reluctance to take injections (90%). Most Current Users (92%) preferred the new delivery device over the original device. Adverse events reported by > or =2% of patients were upper respiratory infection (3.5%), urinary tract infection (2%), influenza (2%), and headache (2%). Limitations include the one-arm study design and the short (eight week) duration of the study. Patients found the new teriparatide delivery device easy to use and Current Users preferred the new delivery device over the original

  9. Management of glucocorticoids-induced osteoporosis: role of teriparatide

    Directory of Open Access Journals (Sweden)

    Silvia Migliaccio

    2009-04-01

    Full Text Available Silvia Migliaccio1, Marina Brama1, Nazzarena Malavolta21Dipartimento di Fisiopatologia Medica, Policlinico Umberto I, Università degli Studi Sapienza di Roma, Italy; 2Dipartimento di Medicina Interna, Policlinico S Orsola Malpighi, Bologna, ItalyAbstract: Glucocorticoids (GC-induced osteoporosis (GIOP is the most common cause of secondary osteoporosis, which leads to an increased fracture risk in patients. The normal bone turnover depends on a balance between osteoblasts and osteoclasts activity and GC can cause a rapid bone loss, decreasing bone formation and increasing bone resorption. The decreased bone formation is mainly due to the GC-induced apoptosis of both osteoblasts and osteocytes, while the increased bone resorption is due to the increased life-span of pre-existing osteoclasts. Bisphosphonates are clearly effective in preventing and treating GIOP but anabolic therapeutic strategies are the new promising therapeutic alternative. Experimental and clinical studies indicate that teriparatide, the active (1–34 parathyroid hormone (PTH molecule, is efficacious for the treatment of GIOP, being able to induce an increase in bone mass in these patients. Intermittent administration of human PTH (1–34 stimulates bone formation by increasing osteoblast number. Additionally, human PTH (1–34 modulates the level and/or activity of locally produced growth factors and cytokines. Teriparatide has been demonstrated in several clinical studies to significantly decrease the incidence of fractures in patients affected by GIOP. It has recently received an indication for GIOP and its label indication has also been expanded.Keywords: glucocorticoids, osteoblasts, osteoclasts, osteoporosis, teriparatide

  10. Final Technical Report: Results of Phase 1

    Energy Technology Data Exchange (ETDEWEB)

    Narang, David, J.; Hambrick, Joshua; Srinivasan, Devarajan; Ayyannar, Raja; O' Brien, Kathleen; Bebic, Jovan; Schelenz, Owen

    2011-09-28

    Arizona Public Service Company (APS) expects that by 2027, renewable energy will account for 6,590 GWh in energy consumption by its customers. While much of this future energy will come from large centrally-located power plants, distributed renewable energy, sited at the point of end-use will also play an important role in meeting the needs of APS customers and is expected to provide 1,734 GWh. With increasing penetration of residential and commercial photovoltaic (PV) systems at the point of end-use, PV power generation not only offsets the load, but could also cause significant shifts in power flow patterns through the distribution system, and could possibly cause reversal of flow through some branches of a distribution circuit. Significant changes to power flow introduced into existing distribution systems due to the increased amount of PV systems may cause operational issues, including over-voltage on the distribution feeder (loss of voltage regulation) and incorrect operation of control equipment, which may lead to an increase in the number of operations and related equipment wear that could affect equipment reliability and customer power quality. Additionally, connecting generation resources to a distribution feeder can introduce additional sources of short-circuit current to the distribution system. This could potentially result in increased short-circuit currents, potentially reaching damaging levels, causing protection desensitization and a potential loss of protection coordination. These effects may be further compounded by variability of PV production due to shading by clouds. The effects of these phenomena in distributed PV applications are not well understood, and there is a great need to characterize this variability. This project will contribute to understanding the effects of high-penetration solar electricity on the design and operation of distribution systems by demonstrating how a high penetration of PV systems affects grid operations of a

  11. Teriparatide in postmenopausal women with osteoporosis and mild or moderate renal impairment.

    Science.gov (United States)

    Miller, P D; Schwartz, E N; Chen, P; Misurski, D A; Krege, J H

    2007-01-01

    The prevalence of both osteoporosis and renal impairment increases with age. Using data from the Fracture Prevention Trial, the safety and efficacy of teriparatide [rhPTH(1-34)] in postmenopausal women with osteoporosis and renal impairment were explored. Patients were required to have serum creatinine concentrations assessments to have normal (GFR > or =80 ml/min), mildly impaired (GFR 50-79 ml/min), or moderately impaired (GFR 30-49 ml/min) renal function for bone mineral density (BMD) and amino-terminal extension peptide of procollagen type 1 (PINP) analyses, and normal (GFR > or =80 ml/min) or impaired (GFR 0.05). Similarly, teriparatide-mediated vertebral and nonvertebral fracture risk reductions were similar and did not differ significantly between patients with normal or impaired renal function (treatment-by-subgroup interactions p>0.05). The incidences of treatment-emergent and renal-related adverse events were consistent across treatment assignment in the normal, mildly impaired, and moderately impaired renal function subgroups. Teriparatide induced changes in mean GFR were unaffected by baseline renal function (treatment-by-renal function interaction p>0.05 for normal, mildly impaired, or moderately impaired subgroups). Patients in all renal function categories treated with teriparatide 20 or 40 mcg had an increased incidence of 4-6-h postdose serum calcium >10.6 mg/dl (the upper limit of normal) versus placebo; however, teriparatide 20 mcg/day was not associated with significantly increased incidence of 4-6-h postdose serum calcium >11 mg/dl in any renal function category. Teriparatide therapy was associated with increased incidence of elevated uric acid, with the incidences being highest in patients with moderately impaired renal function and in those receiving teriparatide 40 mcg/day. Even so, adverse event data did not suggest an increased incidence of gout or arthralgia or of nephrolithiasis events in teriparatide-treated patients with normal, mild

  12. Reduction in fracture rate and back pain and increased quality of life in postmenopausal women treated with teriparatide: 18-month data from the European Forsteo Observational Study (EFOS).

    Science.gov (United States)

    Langdahl, Bente L; Rajzbaum, Gerald; Jakob, Franz; Karras, Dimitrios; Ljunggren, Osten; Lems, Willem F; Fahrleitner-Pammer, Astrid; Walsh, J Bernard; Barker, Clare; Kutahov, Alexey; Marin, Fernando

    2009-12-01

    The European Forsteo Observational Study was designed to examine the effectiveness of teriparatide in postmenopausal women with osteoporosis treated for up to 18 months in normal clinical practice in eight European countries. The incidence of clinical vertebral and nonvertebral fragility fractures, back pain, and health-related quality of life (HRQoL, EQ-5D) were assessed. Spontaneous reports of adverse events were collected. All 1,648 enrolled women were teriparatide treatment-naive, 91.0% of them had previously received other anti-osteoporosis drugs, and 72.8% completed the 18-month study. A total of 168 incident clinical fractures were sustained by 138 (8.8%) women (821 fractures/10,000 patient-years). A 47% decrease in the odds of fracture in the last 6-month period compared to the first 6-month period was observed (P < 0.005). Mean back pain VAS was reduced by 25.8 mm at end point (P < 0.001). Mean change from baseline in EQ-VAS was 13 mm by 18 months. The largest improvements were reported in the EQ-5D subdomains of usual activities and pain/discomfort. There were 365 adverse events spontaneously reported, of which 48.0% were considered related to teriparatide; adverse events were the reason for discontinuation for 79 (5.8%) patients. In conclusion, postmenopausal women with severe osteoporosis who were prescribed teriparatide in standard clinical practice had a significant reduction in the incidence of fragility fractures and a reduction in back pain over an 18-month treatment period. This was associated with a clinically significant improvement in HRQoL. Safety was consistent with current prescribing information. These results should be interpreted in the context of the open-label, noncontrolled design of the study.

  13. ANABOLIC BONE WINDOW WITH WEEKLY TERIPARATIDE THERAPY IN POSTMENOPAUSAL OSTEOPOROSIS: A PILOT STUDY.

    Science.gov (United States)

    Gopalaswamy, Vinaya; Dhibar, Deba Prasad; Gupta, Vipin; Arya, Ashutosh Kumar; Khandelwal, Niranjan; Bhansali, Anil; Garg, Sudhir Kumar; Agarwal, Neelam; Rao, Sudhaker D; Bhadada, Sanjay Kumar

    2017-06-01

    Osteoporosis is a major public health problem that reduces bone strength and increases fracture risk. Teriparatide is an established and the only currently available anabolic therapy for the treatment of postmenopausal osteoporosis (PMO) with a recommended daily dose of 20 μg given subcutaneously. However, there are limited data regarding the long-term effect of once-weekly teriparatide therapy on bone mineral density (BMD), bone turnover markers (BTMs), and anabolic bone window. In this prospective observational study, 26 patients with PMO were treated with weekly teriparatide therapy (60 μg) for 2 years. BMD was measured at baseline, 12 months, and 24 months. The bone formation marker type 1 collagen C-terminal propeptide (P1NP) and the bone resorption marker C-terminal telopeptide of type 1 collagen (CTx) were measured at baseline; 6 weeks; and 6, 12, 18, and 24 months. BMDs at the lumbar spine increased by 3.1% and 10.8% after 1 and 2 years of weekly teriparatide therapy, respectively. The T-score increased significantly at the lumbar spine compared to baseline after 2 years of therapy (P = .015). Serum P1NP levels increased significantly at 6 months (P = .024), peaked at 1 year, and remained above the baseline even after 2 years. Serum CTx levels decreased significantly at 6 months (P = .025) and remained below baseline after 2 years of teriparatide therapy. Weekly teriparatide therapy (60 μg) appears to be as effective as daily teriparatide for the treatment of PMO by extending the anabolic bone window. AE = adverse event; BMD = bone mineral density; BTM = bone turnover marker; CTx = C-terminal telopeptide of type 1 collagen; DXA = dual-energy X-ray absorptiometry; iPTH = intact parathyroid hormone; P1NP = type 1 collagen C-terminal propeptide; PMO = postmenopausal osteoporosis.

  14. Effective osteoporosis treatment with teriparatide is associated with enhanced quality of life in postmenopausal women with osteoporosis: the European Forsteo Observational Study.

    Science.gov (United States)

    Ljunggren, Östen; Barrett, Annabel; Stoykov, Ivaylo; Langdahl, Bente L; Lems, Willem F; Walsh, J Bernard; Fahrleitner-Pammer, Astrid; Rajzbaum, Gerald; Jakob, Franz; Karras, Dimitrios; Marin, Fernando

    2013-08-22

    To describe changes in health-related quality of life (HRQoL) of postmenopausal women with osteoporosis treated with teriparatide for up to 18 months and followed-up for a further 18 months, and to assess the influence of recent prior and incident fractures. The European Forsteo Observational Study (EFOS) is an observational, prospective, multinational study measuring HRQoL using the EQ-5D. The primary objective was to assess changes in HRQoL during 36 months in the whole study population. A secondary post-hoc analysis examined fracture impact on HRQoL in four subgroups classified based on recent prior fracture 12 months before baseline and incident clinical fractures during the study. Changes from baseline were analysed using a repeated measures model. Of the 1581 patients, 48.4% had a recent prior fracture and 15.6% of these patients had an incident fracture during follow-up. 10.9% of the 816 patients with no recent prior fracture had an incident fracture. Baseline mean EQ-VAS scores were similar across the subgroups. In the total study cohort (n = 1581), HRQoL (EQ-VAS and EQ-5D index scores) improved significantly from baseline to 18 months and this improvement was maintained over the 18-month post-teriparatide period. Improvements were seen across all five EQ-5D domains during teriparatide treatment that were maintained after teriparatide was discontinued. Subjects with incident clinical fractures had significantly less improvement in EQ-VAS than those without incident fractures. Recent prior fracture did not influence the change in EQ-VAS during treatment. EFOS is the first longitudinal study in women with severe postmenopausal osteoporosis in the real world setting to show a substantial improvement in HRQoL during teriparatide treatment that was sustained during subsequent treatment with other medications. The increase in HRQoL was lower in the subgroups with incident fracture but was not influenced by recent prior fracture. The results should be

  15. Fracture rate and back pain during and after discontinuation of teriparatide: 36 month data from the European Forsteo Observational Study

    NARCIS (Netherlands)

    Fahrleitner-Pammer, A.; Langdahl, B.; Marin, F.; Jakob, F.; Karras, D.; Barrett, A.; Ljunggren, O.; Walsh, J.B.; Rajzbaum, G.; Barker, C.; Lems, W.F.

    2011-01-01

    Summary: In this observational study in postmenopausal women with severe osteoporosis, the incidence of fractures was decreased during 18 months of teriparatide treatment with no evidence of further change in the subsequent 18-month post-teriparatide period when most patients took other osteoporosis

  16. Cassandra - D7.3 - final report : Dissemination results

    NARCIS (Netherlands)

    Klievink, A.J.

    2014-01-01

    This deliverable is the final report on the dissemination activities and results in the CASSANDRA project. During the project, several status reports were made and published. In this report, the results of the dissemination activities that have taken place during the project are described. During

  17. Role of Teriparatide in Medication-Related Osteonecrosis of the Jaws (MRONJ

    Directory of Open Access Journals (Sweden)

    Yong-Dae Kwon

    2016-11-01

    Full Text Available While the optimal treatment concept of medication-related osteonecrosis of the jaws (MRONJ is still in debate, several adjunct therapies have been introduced. Among these adjunctive measures, recombinant human parathyroid hormone (rhPTH, teriparatide seems to be the most promising treatment modality. Several studies have presented the beneficial effect of short-term teriparatide; they have shown an improved level of bone markers and radiographic evidence of bone healing. Although clinical validation by a controlled trial with prospective design would be essential, short-term teripratide therapy would be a good treatment option for MRONJ patients with impaired bone remodeling.

  18. First results from the HDMS experiment in the final setup

    Science.gov (United States)

    Klapdor-Kleingrothaus, H. V.; Dietz, A.; Heusser, G.; Krivosheina, I. V.; Mazza, D.; Strecker, H.; Tomei, C.

    2003-02-01

    The Heidelberg dark matter search (HDMS) is an experiment designed for the search for weakly interacting massive particle dark matter. It is using a special configuration of Ge detectors, to efficiently reduce the background in the low-energy region below 100 keV. After one year of running the HDMS detector prototype in the Gran Sasso Underground Laboratory, the inner crystal of the detector has been replaced with a HPGe crystal of enriched 73Ge. The final setup started data taking in Gran Sasso in August 2000. The performance and the first results of the measurement with the final setup are discussed.

  19. 76 FR 16604 - Certain Preserved Mushrooms From the People's Republic of China: Final Results and Final...

    Science.gov (United States)

    2011-03-24

    ... International Trade Administration Certain Preserved Mushrooms From the People's Republic of China: Final... preserved mushrooms from the People's Republic of China (PRC) for Shandong Fengyu Edible Fungus Corporation... Mushrooms from the People's Republic of China: Preliminary Results of Antidumping Duty New Shipper Reviews...

  20. HERA results on jets and hadronic final states

    Science.gov (United States)

    Verbytskyi, Andrii; H1 Collaboration; ZEUS Collaboration

    2017-01-01

    We discuss the recent results on the measurements of jets and hadronic final states in e± p collisions at HERA by the ZEUS and H1 experiments. The studies of jet production are presented with the measurements of multijets in low-Q2 region. Results of further measurements of isolated photons in different kinematic regions are provided as well as multiple results on exclusive meson production. The recently performed searches are presented with the searches of strange pentaquarks and QCD instanton induced processes.

  1. Teriparatide and the treatment of bisphosphonate-related osteonecrosis of the jaw: a rat model

    NARCIS (Netherlands)

    Ersan, N.; van Ruijven, L.J.; Bronckers, A.L.J.J.; Olgaç, V.; Ìlgüy, D.; Everts, V.

    2014-01-01

    Objectives: The objectives of this study were to establish a bisphosphonate-related osteonecrosis of the jaw (BRONJ) rat model and to analyse the effects of teriparatide (TP) on this model. Methods: Sprague-Dawley rats were divided into three groups: I—zoledronic acid (ZA, n = 10); II—ZA and

  2. Predictors of teriparatide treatment failure in patients with low bone mass

    Directory of Open Access Journals (Sweden)

    Tarig Elraiyah

    2016-06-01

    Conclusion: These data suggest that prior bisphosphonate or vitamin D exposure may predict response failure to teriparatide therapy. Although these findings may, in part, reflect increased severity or longer duration of disease, this knowledge should help guide clinicians and patients when therapy choices are made.

  3. Final Results from the Jefferson Lab Qweak Experiment

    Science.gov (United States)

    Smith, Gregory

    2017-09-01

    The Qweak collaboration has unblinded our final result. We briefly describe the e-> p elastic scattering experiment used to extract the asymmetries measured in the two distinct running periods which constituted the experiment. The precision obtained on the final combined asymmetry is +/- 9.3 ppb. Some of the backgrounds and corrections applied in the experiment will be explained and quantified. We then provide the results of several methods we have used to extract consistent values of the proton's weak charge QWp from our asymmetry measurements. We also present results for the strange and axial form factors obtained from a fit to existing parity-violating electron scattering data. In conjunction with existing atomic parity violation results on 133Cs we extract the vector weak quark couplings C1u and C1d. The latter are combined to obtain the neutron's weak charge. From the proton's weak charge we obtain a result for sin2θW at the energy scale of our experiment, a sensitive SM test of the running of sin2θW . We also show the mass reach for new beyond-the-Standard-Model physics obtained from our determination of the proton's weak charge and its uncertainty, and discuss sensitivity to specific models. This work was supported by the U.S. Department of Energy, Office of Science, under Contract DE-AC05-06OR23177, the Natural Sciences and Engineering Research Council of Canada (NSERC), and the National Science Foundation (NSF).

  4. Effects of teriparatide versus alendronate for treatment of postmenopausal osteoporosis: A meta-analysis of randomized controlled trials.

    Science.gov (United States)

    Wang, Ya-Kang; Qin, Si-Qing; Ma, Tao; Song, Wei; Jiang, Ren-Qi; Guo, Jian-Bin; Li, Kun; Zhang, Yu-Min

    2017-05-01

    Osteoporosis remains a clinical challenge. Teriparatide is an anabolic drug and alendronate is an antiresorptive agent; both are used in the treatment of osteoporosis. Comprehensive reviews investigating the comparative safety and efficacy of teriparatide versus alendronate are scarce. Therefore, we conducted a systematic review and meta-analysis of randomized controlled trials (RCTs) to evaluate the safety and efficacy of teriparatide versus alendronate for the treatment of postmenopausal osteoporosis. We conducted a comprehensive literature review of the PubMed, EMBASE, Cochrane Controlled Trials Registry, and the China Academic Journal Network Publishing databases for relevant RCTs of teriparatide versus alendronate in postmenopausal osteoporosis patients. Outcome measures were percentage change in lumbar spine and femoral neck bone mineral density (BMD) and incidence of vertebral and nonvertebral fractures. Effect size was reported as weighted mean differences (WMDs) for continuous outcomes and odds ratios (OR) for dichotomous outcomes, with associated 95% confidence intervals (CIs). Six trials involving 618 patients were included. The meta-analysis demonstrated a significant increase in lumbar spine BMD (WMD: 3.46, 95% CI: 2.15-4.77, P osteoporosis patients treated with teriparatide compared with alendronate for 6 to 18 months. These beneficial effects were apparent in the lumbar spine at 12 months of treatment (WMD: 4.49, 95% CI: 2.57-6.40, P osteoporosis. The efficacy and safety of long-term teriparatide and alendronate treatment in postmenopausal osteoporosis should be further investigated in clinical trials.

  5. Teriparatide and the risk of nonvertebral fractures in women with postmenopausal osteoporosis.

    Science.gov (United States)

    Krege, J H; Wan, X

    2012-01-01

    In the Fracture Prevention Trial, the risks of any nonvertebral fracture (relative risk [RR] 0.65, P=0.04) and any fragility nonvertebral fracture (RR 0.47, P=0.02) were significantly reduced in the teriparatide 20 μg/day (teriparatide) versus placebo group. The purpose of this analysis was to examine the efficacy of teriparatide versus placebo on a variety of other nonvertebral fracture outcomes. The Fracture Prevention Trial was a double-blind trial of postmenopausal women with osteoporosis and vertebral fractures randomly assigned to teriparatide (N=541) or placebo (N=544) administered by daily self-injection for a median of 19 months and a median follow-up of 21 months. All patients received calcium and vitamin D supplementation. Reports of nonvertebral fractures were collected from patients at each visit and confirmed by review of a radiograph or written radiology report. Nonvertebral fractures were recorded for the following sites: distal radius/wrist, humerus, rib/clavicle, hip, ankle, distal foot, pelvis, or other. Pathological fractures and fractures of the face, skull, metacarpals, fingers and toes were excluded. Fractures were classified by investigators as fragility or traumatic fractures. The three endpoints considered were six nonvertebral sites (nonvert-6), a set of common nonvertebral fractures described in a Food and Drug Administration Guidance document for the treatment and prevention of postmenopausal osteoporosis (FDA), and a European Union major set (major) of nonvertebral fractures. For teriparatide versus placebo, the point estimates for the RR of nonvert-6 (RR 0.54, P=0.06; fragility RR 0.32, P=0.014), FDA (RR 0.60, P=0.15; fragility RR 0.38, P=0.05), and major (RR 0.52, P=0.02; fragility RR 0.38, P=0.02) nonvertebral fracture endpoints were smaller than for the all nonvertebral fracture endpoint. Lower RRs were observed when the outcomes were limited to fragility fractures, and significant reductions in traumatic nonvertebral fractures

  6. Final results of the PICASSO dark matter search experiment

    Science.gov (United States)

    Behnke, E.; Besnier, M.; Bhattacharjee, P.; Dai, X.; Das, M.; Davour, A.; Debris, F.; Dhungana, N.; Farine, J.; Fines-Neuschild, M.; Gagnebin, S.; Giroux, G.; Grace, E.; Jackson, C. M.; Kamaha, A.; Krauss, C. B.; Lafrenière, M.; Laurin, M.; Lawson, I.; Lessard, L.; Levine, I.; Marlisov, D.; Martin, J.-P.; Mitra, P.; Noble, A. J.; Plante, A.; Podviyanuk, R.; Pospisil, S.; Scallon, O.; Seth, S.; Starinski, N.; Stekl, I.; Wichoski, U.; Zacek, V.

    2017-04-01

    The PICASSO dark matter search experiment operated an array of 32 superheated droplet detectors containing 3.0 kg of C4F10 and collected an exposure of 231.4 kgd at SNOLAB between March 2012 and January 2014. We report on the final results of this experiment which includes for the first time the complete data set and improved analysis techniques including acoustic localization to allow fiducialization and removal of higher activity regions within the detectors. No signal consistent with dark matter was observed. We set limits for spin-dependent interactions on protons of σpSD = 1.32 × 10-2 pb (90% C.L.) at a WIMP mass of 20 GeV/c2. In the spin-independent sector we exclude cross sections larger than σpSI = 4.86 × 10-5 pb (90% C.L.) in the region around 7 GeV/c2. The pioneering efforts of the PICASSO experiment have paved the way forward for a next generation detector incorporating much of this technology and experience into larger mass bubble chambers.

  7. Final Results of the PICASSO Dark Matter Search Experiment

    CERN Document Server

    Behnke, E; Bhattacharjee, P; Dai, X; Das, M; Davour, A; Debris, F; Dhungana, N; Farine, J; Fines-Neuschild, M; Gagnebin, S; Giroux, G; Grace, E; Jackson, C M; Kamaha, A; Krauss, C B; Lafrenière, M; Laurin, M; Lawson, I; Lessard, L; Levine, I; Marlisov, D; Martin, J -P; Mitra, P; Noble, A J; Plante, A; Podviyanuk, R; Pospisil, S; Scallon, O; Seth, S; Starinski, N; Stekl, I; Wichoski, U; Zacek, V

    2016-01-01

    The PICASSO dark matter search experiment operated an array of 32 superheated droplet detectors containing 3.2 kg of C$_{4}$F$_{10}$ and collected an exposure of 231.4 kg days at SNOLAB between March 2012 and January 2014. We report on the final results of this experiment which includes for the first time the complete data set and improved analysis techniques including acoustic localization to allow fiducialization and removal of higher activity regions within the detectors. No signal consistent with dark matter was observed. We set limits for spin-dependent interactions on protons of $\\sigma_p^{SD}$ = 1.32 $\\times$ 10$^{-2}$ pb (90% C.L.) at a WIMP mass of 20 GeV/c$^{2}$. In the spin-independent sector we exclude cross sections larger than $\\sigma_p^{SI}$ = 4.86 $\\times$ 10$^{-5 }$ pb (90% C.L.) in the region around 7 GeV/c$^{2}$. The pioneering efforts of the PICASSO experiment have paved the way forward for a next generation detector incorporating much of this technology and experience into larger mass bub...

  8. The Final Results from the Sudbury Neutrino Observatory

    CERN Multimedia

    CERN. Geneva

    2010-01-01

    The Sudbury Neutrino Observatory (SNO) was a water Cherenkov detector dedicated to investigate elementary particles called neutrinos. It successfully took data between 1999 and 2006. The detector was unique in its use of heavy water as a detection medium, permitting it to make a solar model-independent test of solar neutrino mixing. In fact, SNO conclusively showed that solar neutrinos oscillate on their way from the core of the Sun to the Earth. This groundbreaking observation was made during three independent phases of the experiment. Even if data taking ended, SNO is still in a mode of precise determination of the solar neutrino oscillation parameters because all along SNO had developed several methods to tell charged-current events apart from neutral-current events. This ability is crucial for the final and ultimate data analysis of all the phases. The physics reach of a combined three-phase solar analysis will be reviewed together with results and subtleties about solar neutrino physics.

  9. Effects of Teriparatide Compared with Risedronate on Recovery After Pertrochanteric Hip Fracture

    DEFF Research Database (Denmark)

    Aspenberg, Per; Malouf, Jorge; Tarantino, Umberto

    2016-01-01

    BACKGROUND: Osteoporosis drugs might affect fracture-healing. We therefore studied the effects of teriparatide in comparison with risedronate on recovery after pertrochanteric hip fractures. METHODS: The study was a randomized, multicenter, active-controlled, 78-week trial comparing teriparatide...... received study medication with oral or injectable placebo plus calcium and vitamin D in a double-blinded fashion. Secondary (Timed Up-and-Go [TUG] test, hip pain, Short Form [SF]-36 health status, and safety) and exploratory (radiographic outcomes and ability to walk) 26-week end points are reported...... weeks (differences of -5.7, -4.4, -3.1, and -3.1 seconds, respectively; p = 0.021 for the overall difference). They also reported less pain on a visual analog scale immediately after the TUG test at 12 and 18 weeks (adjusted absolute differences of 10.6 and 11.9 mm, respectively; p

  10. Romosozumab (sclerostin monoclonal antibody) versus teriparatide in postmenopausal women with osteoporosis transitioning from oral bisphosphonate therapy

    DEFF Research Database (Denmark)

    Langdahl, Bente L; Libanati, Cesar; Crittenden, Daria B

    2017-01-01

    before screening and alendronate the year before screening; an areal BMD T score of -2·5 or lower at the total hip, femoral neck, or lumbar spine; and a history of fracture. Patients were randomly assigned (1:1) via an interactive voice response system to receive subcutaneous romosozumab (210 mg once......%) patients in the romosozumab group compared with 12 (6%) in the teriparatide group with adverse events leading to investigational product withdrawal. INTERPRETATION: Transition to a bone-forming agent is common practice in patients treated with bisphosphonates, such as those who fracture while on therapy....... In such patients, romosozumab led to gains in hip BMD that were not observed with teriparatide. These data could inform clinical decisions for patients at high risk of fracture. FUNDING: Amgen, Astellas, and UCB Pharma....

  11. King County Metro Transit Hybrid Articulated Buses: Final Evaluation Results

    Energy Technology Data Exchange (ETDEWEB)

    Chandler, K.; Walkowicz, K.

    2006-12-01

    Final technical report compares and evaluates new diesel and diesel hybrid-electric articulated buses operated as part of the King County Metro Transit (KC Metro) fleet in Seattle, Washington. The evaluation lasted 12 months.

  12. Teriparatide Treatment Following Osteoporotic Hip Fracture in a Male Patient with Multiple Sclerosis and Current Recommendations

    Directory of Open Access Journals (Sweden)

    Sibel Başaran

    2015-12-01

    Full Text Available A 58-year-old male patient with a diagnosis of multiple sclerosis (MS who had been operated due to a low-energy subtrochanteric femoral fracture was admitted in order to plan anti-osteoporotic treatment and rehabilitation at post-operative first week. Although the patient had a history of glucocorticoid use, he had never received any preventative treatment for osteoporosis. T-scores detected by Dual energy x-ray absorptiometry (DXA method were -4.7, -4.9 and -3.3 at femoral neck, total hip and L1-L4 vertebrae, respectively. Since the patient had severe osteoporosis, teriparatide treatment was planned. Following vitamin D supplementation, teriparatide 20 mcg/day was started. After 6 months of treatment, patient improved significantly in terms of symptoms and DXA scores. T-scores of the femoral neck, total hip and L1-L4 vertebrae improved to -3.4, -3.9 and -3.0, respectively. When teriparatide therapy was continued up to 18 months, further increase in DXA values was observed (T-scores of femoral neck, total hip and L1-L4 vertebrae were -2.9, -2.4 and -2.2, respectively. No adverse event was seen during the treatment period. Following the cessation of teriparatide therapy, alendronate and cholecalciferol combination (70 mg/2800 IU was started. Bone health and vitamin D level are affected negatively in patients with MS due to multifactorial reasons. In order to avoid serious consequences such as hip fracture, awareness about osteoporosis should be increased and preventative strategies should be tailored from the early stages of the disease

  13. Long-term safety, efficacy, and patient acceptability of teriparatide in the management of glucocorticoid-induced osteoporosis

    Directory of Open Access Journals (Sweden)

    Dore RK

    2013-05-01

    Full Text Available Robin K DoreDavid Geffen School of Medicine, University of California, Los Angeles, CA, USAAbstract: Glucocorticoids are commonly prescribed medications to treat multiple diseases across many medical specialties. One of the most common yet largely unappreciated side effect of glucocorticoid use is increased risk of fracture. Many different therapies are indicated to prevent and treat this condition; many guidelines exist that suggest appropriate use of both glucocorticoids and the medications approved to prevent this common side effect of glucocorticoid therapy. Nevertheless, 30%–50% of patients on long-term glucocorticoid therapy sustain a fracture. Teriparatide, recombinant human parathyroid hormone (1–34, is a daily self-injectable therapy for 24 months approved for use in patients taking long-term glucocorticoids. Teriparatide has been shown to increase bone mineral density and reduce vertebral fracture risk in glucocorticoid-treated patients. Glucocorticoids have many adverse effects on bone that teriparatide has been shown to prevent or negate. Given the fact that preventive therapy for glucocorticoid-induced osteoporosis is often not prescribed, one wonders whether a daily self-injectable therapy for this condition would be prescribed by physicians and accepted by patients. This article reviews the epidemiology, pathophysiology, treatment, guidelines, and persistence data (when available for patients with glucocorticoid-induced osteoporosis treated with teriparatide.Keywords: glucocorticoid-induced osteoporosis, teriparatide, anabolic, PTH, parathyroid hormone

  14. Hipparcos to deliver its final results catalogue soon

    Science.gov (United States)

    1995-10-01

    perspective, when the results are delivered to them at the end of March 1996. The final product of the Hipparcos mission, a monumental 14-volume catalogue, with page upon page of astronomical results of unprecedented accuracy, will be published by ESA and the scientific teams at the end of March 1997. The four leaders of he European scientific teams, who have been involved in the project since its earliest days, announced hat he Hipparcos and Tycho Catalogues have passed all he test that they have been able to devise to assess he quality of he data. Professor Jean Kovalevsky (Observatoire de la Cote d'Azur, Grasse, France), Dr Lennart Lindegren (Lund Observatory, Sweden), Professor Erik Hog (Copenhagen Observatory, Denmark), and Dr Catherine Turon (Observatoire de Paris-Meudon), and other scientific representatives from the ESA member states, are delighted with he latest developments. "There will be thousands of direct and indirect users of the Hipparcos results over the coming years", said Catherine Turon who lead the team responsible for putting together the satellite's observing programme, "and they will not only have access to a magnificent catalogue, but one which has been finalised somewhat more rapidly than our expectations before launch ". Some ten thousand known double star systems have been observed by Hipparcos, and nearly ten thousand more have been discovered for the first time. In these binary systems, two stars orbit around each other, and Hipparcos promises to provide measurements of the masses of he stars in such systems, information which is impossible to determine in any other way. "Many of our scientific colleagues who have waited patiently for the results of this mission will be astonished with what the final catalogue contains" said Professor Hog, originator of he Tycho Catalogue concept, and one of the hiving forces behind the mission. In thousands of cases, the stars are seen to be variable by Hipparcos. In these cases, the light output from he star

  15. 75 FR 18151 - Certain Preserved Mushrooms from India: Notice of Amended Final Results Pursuant to Final Court...

    Science.gov (United States)

    2010-04-09

    ... International Trade Administration Certain Preserved Mushrooms from India: Notice of Amended Final Results... amending the final results of the 2000-2001 administrative review of certain preserved mushrooms from India... mushrooms from India covering the period of review of February 1, 2000, through January 31, 2001. See...

  16. 78 FR 29322 - Silicon Metal From the People's Republic of China: Final Results and Final No Shipments...

    Science.gov (United States)

    2013-05-20

    ... International Trade Administration Silicon Metal From the People's Republic of China: Final Results and Final No... the antidumping duty order on silicon metal from the People's Republic of China (``PRC'').\\1\\ The...\\ See Silicon Metal From the People's Republic of China: Preliminary Results of Antidumping Duty...

  17. The 'gender gap' in final examination results at Oxford University.

    Science.gov (United States)

    Mellanby, J; Martin, M; O'Doherty, J

    2000-08-01

    A lower proportion of women than men obtain first class degrees at British universities (the so-called gender gap). At Oxford University, this difference is not seen in all degree subjects but is found both in some Arts and in some Science subjects. We have used a questionnaire administered under supervision to undergraduates 2 to 3 months before their final examination to assess factors which might be expected to affect examination performance. These included measures of verbal and non-verbal reasoning (Alice Heim AH6 test), self-esteem, motivation, responses to stresses of examinations and of personal relationships, happiness, risk-taking and working patterns. We have also obtained a detailed breakdown of the marks the students were given in the examination. Women scored higher on negative emotions while men scored higher on self-esteem, their perception of their own academic efficacy and on risk-taking strategies, but none of these factors predicted outcome. Verbal reasoning ability did predict outcome but there was no gender difference. Hence, it is concluded that the gender gap is not due to any of these individual differences and is more likely to be related to the nature of the academic assessment system.

  18. 76 FR 57713 - Wooden Bedroom Furniture From the People's Republic of China: Amended Final Results of...

    Science.gov (United States)

    2011-09-16

    ... International Trade Administration Wooden Bedroom Furniture From the People's Republic of China: Amended Final...'') published the final results of the antidumping duty administrative review of wooden bedroom furniture from...\\ See Wooden Bedroom Furniture From the People's Republic of China: Final Results and Final Rescission...

  19. 76 FR 37321 - Fresh Garlic From the People's Republic of China: Final Results and Final Rescission, in Part, of...

    Science.gov (United States)

    2011-06-27

    ... International Trade Administration Fresh Garlic From the People's Republic of China: Final Results and Final... duty order on Fresh Garlic from the People's Republic of China (PRC) covering the period of review (POR... the 2008-2009 administrative review of the antidumping duty order on fresh garlic from the PRC. See...

  20. Final Results from U.S. FCEV Learning Demonstration (Presentation)

    Energy Technology Data Exchange (ETDEWEB)

    Wipke, K.; Sprik, S.; Kurtz, J.; Ramsden, T.; Ainscough, C.; Saur, G.

    2012-05-01

    This presentation discusses the objectives of the U.S. DOE Fuel Cell Electric Vehicle Learning Demonstration Project, describes NREL's technology validation approach, and summarizes key technical results from the project.

  1. First final results from CDF RunII

    CERN Multimedia

    CERN. Geneva

    2012-01-01

    The Tevatron collider was shut down at the end of September 2011, ending a period of operation lasted ten years ("Run II"). First results are now becoming available from the analysis of the full CDF Run II sample of 10fb-1. I will cover highlights of the CDF program from charm, bottom, top and Higgs sectors.

  2. MAGO-3 results of the experiment. Final report

    Energy Technology Data Exchange (ETDEWEB)

    Garanin, S.F.; Mokhov, V.N.; Volkov, G.I.; Ivanov, V.A. [All-Russian Scientific Research Institute of Experimental Physics, Novgorod (Russian Federation)] [and others

    1996-12-31

    In this report the results of joint LANL-VNIIEF experiment MAGO-3 are given. The experiment was aimed to investigate the of magnetized plasma parameters when it overflows trough Laval nozzel. The details of the experiment are described, data obtained by VNIIEF experts are given.

  3. Final Report on SSD2 pilot results in Denmark

    DEFF Research Database (Denmark)

    Andersen, Jens Hinge; Jørgensen, Kevin; Jensen, Louise Grønhøj Hørbye

    This document is the “Report on SSD2 pilot results” of the project OC/EFSA/DCM/2013/05: “Pilot project on the implementation of SSD2 in the frame of the electronic transmission of harmonised data collection of analytical results to EFSA”. The report includes a description of the software and tool...

  4. Teriparatide (PTH 1-34) treatment increases peripheral hematopoietic stem cells in postmenopausal women.

    Science.gov (United States)

    Yu, Elaine W; Kumbhani, Ruchit; Siwila-Sackman, Erica; DeLelys, Michelle; Preffer, Frederic I; Leder, Benjamin Z; Wu, Joy Y

    2014-06-01

    Cells of the osteoblast lineage play an important role in regulating the hematopoietic stem cell (HSC) niche and early B-cell development in animal models, perhaps via parathyroid hormone (PTH)-dependent mechanisms. There are few human clinical studies investigating this phenomenon. We studied the impact of long-term daily teriparatide (PTH 1-34) treatment on cells of the hematopoietic lineage in postmenopausal women. Twenty-three postmenopausal women at high risk of fracture received teriparatide 20 mcg sc daily for 24 months as part of a prospective longitudinal trial. Whole blood measurements were obtained at baseline, 3, 6, 12, and 18 months. Flow cytometry was performed to identify hematopoietic subpopulations, including HSCs (CD34+/CD45(moderate); ISHAGE protocol) and early transitional B cells (CD19+, CD27-, IgD+, CD24[hi], CD38[hi]). Serial measurements of spine and hip bone mineral density (BMD) as well as serum P1NP, osteocalcin, and CTX were also performed. The average age of study subjects was 64 ± 5 years. We found that teriparatide treatment led to an early increase in circulating HSC number of 40% ± 14% (p = 0.004) by month 3, which persisted to month 18 before returning to near baseline by 24 months. There were no significant changes in transitional B cells or total B cells over the course of the study period. In addition, there were no differences in complete blood count profiles as quantified by standard automated flow cytometry. Interestingly, the peak increase in HSC number was inversely associated with increases in bone markers and spine BMD. Daily teriparatide treatment for osteoporosis increases circulating HSCs by 3 to 6 months in postmenopausal women. This may represent a proliferation of marrow HSCs or increased peripheral HSC mobilization. This clinical study establishes the importance of PTH in the regulation of the HSC niche within humans. © 2014 American Society for Bone and Mineral Research. © 2014 American Society for

  5. A new contralateral atypical femoral fracture despite sequential therapy with teriparatide and strontium ranelate.

    Science.gov (United States)

    Nguyen, Hanh H; Milat, Frances; Ebeling, Peter R

    2017-06-01

    Atypical femoral fractures (AFFs) are a rare association of anti-resorptive therapy for osteoporosis. Limited evidence-based management guidelines on their optimal treatment exist, with observational studies suggesting a role for teriparatide (TPTD) in AFF healing. We report a case of a 65-year-old woman with postmenopausal osteoporosis who sustained an AFF following long-term bisphosphonate therapy, and who subsequently developed a new contralateral AFF after completion of TPTD therapy and initiation of strontium ranelate (SR) treatment. The sequence of events in this case report showed that TPTD and SR did not prevent the development of a new AFF, and questions the optimal treatment of these stress fractures.

  6. 76 FR 18519 - Polyethylene Terephthalate Film, Sheet, and Strip From Taiwan: Amended Final Results of...

    Science.gov (United States)

    2011-04-04

    ... 9745 (February 22, 2011) (Final Results) and accompanying Issues and Decision Memorandum (IDM). DATES.... \\10\\ See id. \\11\\ See IDM at Comment 1. Amended Final Results Therefore, in accordance with section...

  7. Modeling Results For the ITER Cryogenic Fore Pump. Final Report

    Energy Technology Data Exchange (ETDEWEB)

    Pfotenhauer, John M. [University of Wisconsin, Madison, WI (United States); Zhang, Dongsheng [University of Wisconsin, Madison, WI (United States)

    2014-03-31

    A numerical model characterizing the operation of a cryogenic fore-pump (CFP) for ITER has been developed at the University of Wisconsin – Madison during the period from March 15, 2011 through June 30, 2014. The purpose of the ITER-CFP is to separate hydrogen isotopes from helium gas, both making up the exhaust components from the ITER reactor. The model explicitly determines the amount of hydrogen that is captured by the supercritical-helium-cooled pump as a function of the inlet temperature of the supercritical helium, its flow rate, and the inlet conditions of the hydrogen gas flow. Furthermore the model computes the location and amount of hydrogen captured in the pump as a function of time. Throughout the model’s development, and as a calibration check for its results, it has been extensively compared with the measurements of a CFP prototype tested at Oak Ridge National Lab. The results of the model demonstrate that the quantity of captured hydrogen is very sensitive to the inlet temperature of the helium coolant on the outside of the cryopump. Furthermore, the model can be utilized to refine those tests, and suggests methods that could be incorporated in the testing to enhance the usefulness of the measured data.

  8. Final model independent result of DAMA/LIBRA-phase1

    Energy Technology Data Exchange (ETDEWEB)

    Bernabei, R.; D' Angelo, S.; Di Marco, A. [Universita di Roma ' ' Tor Vergata' ' , Dipartimento di Fisica, Rome (Italy); INFN, sez. Roma ' ' Tor Vergata' ' , Rome (Italy); Belli, P. [INFN, sez. Roma ' ' Tor Vergata' ' , Rome (Italy); Cappella, F.; D' Angelo, A.; Prosperi, D. [Universita di Roma ' ' La Sapienza' ' , Dipartimento di Fisica, Rome (Italy); INFN, sez. Roma, Rome (Italy); Caracciolo, V.; Castellano, S.; Cerulli, R. [INFN, Laboratori Nazionali del Gran Sasso, Assergi (Italy); Dai, C.J.; He, H.L.; Kuang, H.H.; Ma, X.H.; Sheng, X.D.; Wang, R.G. [Chinese Academy, IHEP, Beijing (China); Incicchitti, A. [INFN, sez. Roma, Rome (Italy); Montecchia, F. [INFN, sez. Roma ' ' Tor Vergata' ' , Rome (Italy); Universita di Roma ' ' Tor Vergata' ' , Dipartimento di Ingegneria Civile e Ingegneria Informatica, Rome (Italy); Ye, Z.P. [Chinese Academy, IHEP, Beijing (China); University of Jing Gangshan, Jiangxi (China)

    2013-12-15

    The results obtained with the total exposure of 1.04 ton x yr collected by DAMA/LIBRA-phase1 deep underground at the Gran Sasso National Laboratory (LNGS) of the I.N.F.N. during 7 annual cycles (i.e. adding a further 0.17 ton x yr exposure) are presented. The DAMA/LIBRA-phase1 data give evidence for the presence of Dark Matter (DM) particles in the galactic halo, on the basis of the exploited model independent DM annual modulation signature by using highly radio-pure NaI(Tl) target, at 7.5{sigma} C.L. Including also the first generation DAMA/NaI experiment (cumulative exposure 1.33 ton x yr, corresponding to 14 annual cycles), the C.L. is 9.3{sigma} and the modulation amplitude of the single-hit events in the (2-6) keV energy interval is: (0.0112{+-}0.0012) cpd/kg/keV; the measured phase is (144{+-}7) days and the measured period is (0.998{+-}0.002) yr, values well in agreement with those expected for DM particles. No systematic or side reaction able to mimic the exploited DM signature has been found or suggested by anyone over more than a decade. (orig.)

  9. Permeability changes in coal resulting from gas desorption. Final report

    Energy Technology Data Exchange (ETDEWEB)

    Levine, J.R.; Johnson, P.W.

    1992-11-30

    This report documents studies on the effects of gas sorption on coal, with the intent of eventually evaluating how sorption and strain affect permeability. These studies were, carried out at the University of Alabama during the period from 1989 through 1992. Two major experimental methods were developed and used. In the strain experiments, electronic strain gauges were attached to polished blocks of coal in order to measure linear and volumetric swelling due to gas sorption. The effects of bedding plane orientation, of gas type, and of coal type were investigated. In the gravimetric experiment the weight of small samples of coal was measured during exposure to high pressure gases. Sample measurements were corrected for buoyancy effects and for sample swelling, and the results were plotted in the form of Langmuir isotherms. Experiments were conducted to determine the effect of grain size, coal type, moisture, and of sorbant gas. The advantage of this method is that it can be applied to very small samples, and it enabled comparison liptinite versus vitrinite concentrates, and kerogen rich versus kerogen depleted oil shales. Also included is a detailed discussion of the makeup of coal and its effect on gas sorption behavior.

  10. Final Technical Report. Results of Phases 2-5

    Energy Technology Data Exchange (ETDEWEB)

    Narang, David [Arizona Public Service Company (APS), Phoenix, AZ (United States); Ayyanar, Raja [Arizona State Univ., Mesa, AZ (United States); Gemin, Paul [General Electric, Fairfield, CT (United States); Baggu, Murali [National Renewable Energy Lab. (NREL), Golden, CO (United States); Srinivasan, Devarajan [ViaSol Energy Solutions, LLC, Tempe, AZ (United States)

    2015-02-27

    APS’s renewable energy portfolio, driven in part by Arizona’s Renewable Energy Standard (RES) currently includes more than 1100 MW of installed capacity, equating to roughly 3000 GWh of annual production. Overall renewable production is expected to grow to 6000 GWh by 2025. It is expected that distributed photovoltaics, driven primarily by lower cost, will contribute to much of this growth and that by 2025, distributed installations will account for half of all renewable production (3000GHW). As solar penetration increases, additional analysis may be required for routine utility processes to ensure continued safe and reliable operation of the electric distribution network. Such processes include residential or commercial interconnection requests and load shifting during normal feeder operations. Circuits with existing high solar penetration will also have to be studied and results will need to be evaluated for adherence to utility practices or strategy. Increased distributed PV penetration may offer benefits such as load offsetting, but it also has the potential to adversely impact distribution system operation. These effects may be exacerbated by the rapid variability of PV production. Detailed effects of these phenomena in distributed PV applications continue to be studied. Comprehensive, high-resolution electrical models of the distribution system were developed to analyze the impacts of PV on distribution circuit protection systems (including coordination and anti-islanding), predict voltage regulation and phase balance issues, and develop volt/VAr control schemes. Modeling methods were refined by validating against field measurements. To augment the field measurements, methods were developed to synthesize high resolution load and PV generation data to facilitate quasi-static time series simulations. The models were then extended to explore boundary conditions for PV hosting capability of the feeder and to simulate common utility practices such as feeder

  11. 77 FR 21961 - Uncovered Innerspring Units From the People's Republic of China: Final Results and Final...

    Science.gov (United States)

    2012-04-12

    ... the Preliminary Results. We find that Reztec Industries Sdn Bhd (``Reztec'') did not sell subject... rescinding the administrative review, in part, with respect to Reztec. We additionally find that Goodnite Sdn...

  12. Characterization of patients in the European Forsteo Observational Study (EFOS): postmenopausal women entering teriparatide treatment in a community setting

    DEFF Research Database (Denmark)

    Rajzbaum, Gerald; Jakob, Franz; Karras, Dimitrios

    2007-01-01

    OBJECTIVE: The European Forsteo Observational Study (EFOS) study was primarily designed to assess fracture incidence, degree of pain, health-related quality of life (HRQoL) and compliance in women prescribed teriparatide in a community setting. This report describes the design of the study...

  13. Early changes in biochemical markers of bone turnover and their relationship with bone mineral density changes after 24 months of treatment with teriparatide

    DEFF Research Database (Denmark)

    Blumsohn, A; Marin, F; Nickelsen, T

    2011-01-01

    with osteoporosis treated with teriparatide and determined: (1) whether the response is associated with prior osteoporosis therapy, (2) which marker shows the best performance for detecting a response to therapy, and (3) the correlations between early changes in bone markers and subsequent bone mineral density (BMD......We report the changes in biochemical markers of bone formation during the first 6 months of teriparatide therapy in postmenopausal women with osteoporosis according to previous antiresorptive treatment. Prior therapy does not adversely affect the response to teriparatide treatment. Similar bone...... markers levels are reached after 6 months of treatment. INTRODUCTION: The response of biochemical markers of bone turnover with teriparatide therapy in subjects who have previously received osteoporosis drugs is not fully elucidated. We examined biochemical markers of bone formation in women...

  14. 78 FR 73825 - Frontseating Service Valves From the People's Republic of China; Final Results of Antidumping...

    Science.gov (United States)

    2013-12-09

    ... Memorandum. Final Results of the Review As a result of this review, we determine that the following weighted... covered by the final results of this review and for future deposits of estimated duties, where applicable... Results of Antidumping Duty Administrative Review; 2011-2012 AGENCY: Enforcement and Compliance, formerly...

  15. 78 FR 22235 - Certain Magnesia Carbon Bricks From the People's Republic of China: Final Results of and Final...

    Science.gov (United States)

    2013-04-15

    ... International Trade Administration Certain Magnesia Carbon Bricks From the People's Republic of China: Final... of the countervailing duty (CVD) order on certain magnesia carbon bricks from the People's Republic... Results of Review'' section below. \\1\\ See Certain Magnesia Carbon Bricks From the People's Republic of...

  16. 75 FR 19357 - Honey From the People's Republic of China: Notice of Amended Final Results Pursuant to Final...

    Science.gov (United States)

    2010-04-14

    ... International Trade Administration Honey From the People's Republic of China: Notice of Amended Final Results...''), which challenged certain aspects of the Department of Commerce's (``the Department'') findings in Honey... honey from the People's Republic of China (``PRC''). On September 13, 2007, the CIT remanded the...

  17. 77 FR 11486 - Fresh Garlic From the People's Republic of China: Partial Final Results and Partial Final...

    Science.gov (United States)

    2012-02-27

    ... International Trade Administration Fresh Garlic From the People's Republic of China: Partial Final Results and... antidumping duty order on fresh garlic from the People's Republic of China (PRC) covering the period of review... administrative review of the antidumping duty order on fresh garlic from the PRC. See Fresh Garlic From the...

  18. 75 FR 50992 - Wooden Bedroom Furniture From the People's Republic of China: Final Results and Final Rescission...

    Science.gov (United States)

    2010-08-18

    ... Final Results Analysis Memo. For all CEP sales, we have calculated inventory carrying costs based only....90.99 ] Comment 29: Inventory Carrying Costs for Direct Shipments Comment 30: Financial Ratios Comment 31: Unreported Sales Comment 32: Credit Expenses and Inventory Carrying Costs Comment 33: Nanjing...

  19. A new contralateral atypical femoral fracture despite sequential therapy with teriparatide and strontium ranelate

    Directory of Open Access Journals (Sweden)

    Hanh H Nguyen

    2017-06-01

    Full Text Available Atypical femoral fractures (AFFs are a rare association of anti-resorptive therapy for osteoporosis. Limited evidence-based management guidelines on their optimal treatment exist, with observational studies suggesting a role for teriparatide (TPTD in AFF healing. We report a case of a 65-year-old woman with postmenopausal osteoporosis who sustained an AFF following long-term bisphosphonate therapy, and who subsequently developed a new contralateral AFF after completion of TPTD therapy and initiation of strontium ranelate (SR treatment. The sequence of events in this case report showed that TPTD and SR did not prevent the development of a new AFF, and questions the optimal treatment of these stress fractures.

  20. 78 FR 58520 - Extruded Rubber Thread From Malaysia; Notice of Amended Final Results of Antidumping Duty...

    Science.gov (United States)

    2013-09-24

    ...). Following the publication of the final results, Heveafil Sdn. Bhd.\\2\\ and Filmax Sdn. Bhd. (collectively... CIT affirmed the Department's Final Results in relevant part.\\3\\ \\2\\ Heveafil Sdn. Bhd. is also known as Heveafil Sdn. \\3\\ See Heveafil et al. v. United States, Slip Op. 2001-23 (CIT 2001). While the CIT...

  1. 77 FR 36253 - Honey From Argentina: Final Results of Antidumping Duty Administrative Review

    Science.gov (United States)

    2012-06-18

    ... International Trade Administration Honey From Argentina: Final Results of Antidumping Duty Administrative Review... 2009-2010 administrative review of the antidumping duty order on honey from Argentina.\\1\\ The review... in the ``Final Results of Review'' section of this notice. \\1\\ See Honey From Argentina: Preliminary...

  2. Recurrence of bilateral atypical femoral fractures associated with the sequential use of teriparatide and denosumab: a case report.

    Science.gov (United States)

    Ramchand, S K; Chiang, C Y; Zebaze, R M; Seeman, E

    2016-02-01

    We report that a postmenopausal woman with osteoporosis developed bilateral incomplete atypical femoral fractures (AFFs) after seven years of bisphosphonate therapy. Cessation of the bisphosphonate and treatment with teriparatide was associated with near complete radiological resolution of the AFFs. After 12 months without treatment, denosumab was commenced to prevent structural deterioration. Six months later she developed recurrent bilateral AFFs. This case highlights the management dilemma in patients with ongoing bone loss but prone to stress fractures associated with antiresorptive therapy. Stopping the antiresorptive is recommended but structural decay will recur predisposing to fragility fractures. If the antiresorptive is continued, bone material composition will be further compromised predisposing to atypical fractures. Teriparatide may assist healing of stress fractures and improvement in bone matrix composition. Later antiresosrptive therapy to preserve bone microstructure may compromise material composition.

  3. Regulatory T cells are expanded by Teriparatide treatment in humans and mediate intermittent PTH-induced bone anabolism in mice.

    Science.gov (United States)

    Yu, Mingcan; D'Amelio, Patrizia; Tyagi, Abdul Malik; Vaccaro, Chiara; Li, Jau-Yi; Hsu, Emory; Buondonno, Ilaria; Sassi, Francesca; Adams, Jonathan; Weitzmann, M Neale; DiPaolo, Richard; Pacifici, Roberto

    2017-11-20

    Teriparatide is a bone anabolic treatment for osteoporosis, modeled in animals by intermittent PTH (iPTH) administration, but the cellular and molecular mechanisms of action of iPTH are largely unknown. Here, we show that Teriparatide and iPTH cause a ~two-threefold increase in the number of regulatory T cells (Tregs) in humans and mice. Attesting in vivo relevance, blockade of the Treg increase in mice prevents the increase in bone formation and trabecular bone volume and structure induced by iPTH Therefore, increasing the number of Tregs is a pivotal mechanism by which iPTH exerts its bone anabolic activity. Increasing Tregs pharmacologically may represent a novel bone anabolic therapy, while iPTH-induced Treg increase may find applications in inflammatory conditions and transplant medicine. © 2017 The Authors.

  4. Effective treatment of severe pregnancy and lactation-related osteoporosis with teriparatide: case report and review of the literature.

    Science.gov (United States)

    Polat, Sefika Burcak; Evranos, Berna; Aydin, Cevdet; Cuhaci, Neslihan; Ersoy, Reyhan; Cakir, Bekir

    2015-07-01

    Pregnancy or lactation-related osteoporosis (PLO) is a very rare and debilitating condition which is usually diagnosed during the last trimester of the pregnancy or early postpartum period. Herein, we report a case with severe PLO and multiple vertebral compression fractures that were successfully treated with teriparatide. Twenty-three-year-old female patient was admitted to our clinic two months after her first spontaneous vaginal delivery with the complaint of severe back pain. Bone mineral density was measured using dual energy X-ray absorptiometry (DEXA), and low T- and Z-scores were observed in lumbar vertebrae. In vertebral MRI, severe height loss was detected in thoracic (T) 5,7,10,11,12 vertebrae. After exclusion of the other possible causes of OP, she was diagnosed to have PLO and the lactation was stopped. She was treated with calcium 1000 mg/day, cholecalciferol 800 mg/day and teriparatide 20 µg/day. At the 12th and 18th month of therapy, BMD was increased by 8% and 27%, respectively, at the lumbar spine and pain was completely relieved in few months. There are pharmacological therapy modalities that can be used in PLO. Bisphosphonates are effective, but there are some concerns that they accumulate in bone and may expose fetus in subsequent pregnancies. Teriparatide is a strong candidate to be the optimal medical therapy in severe cases since it is effective and safe.

  5. Effects of teriparatide on bone mineral density and quality of life in Duchenne muscular dystrophy related osteoporosis: a case report.

    Science.gov (United States)

    Catalano, A; Vita, G L; Russo, M; Vita, G; Lasco, A; Morabito, N; Messina, S

    2016-12-01

    Duchenne muscular dystrophy (DMD) is an X-linked recessive muscle disease characterized by secondary osteoporosis and increased fractures. We describe the case of a 20-year-old boy with DMD suffering from back pain due to multiple vertebral fractures who was treated with teriparatide. Improvement of bone density, pain, and quality of life was achieved. DMD is an X-linked recessive muscle disease with secondary osteoporosis and related frequently occurring fractures. To date, only bisphosphonates have been used to treat osteoporosis in DMD. Black bear parathyroid hormone has been previously reported to enhance bone mass in the dystrophin-deficient mouse. This study reports the positive effect of osteoanabolic treatment with once-daily recombinant human parathyroid hormone 1-34 (rhPTH 1-34, teriparatide) in a 20-year-old DMD boy suffering from multiple vertebral fractures causing back pain. Bone formation and resorption markers (osteocalcin and C-telopeptide of type I collagen, respectively), as expected, increased within 6 months and intensity of back pain early decreased, with no pain reported after 6 months at visual analog scale. Over a 18-month period of treatment with teriparatide, bone mineral density and quality of life, assessed by the 36-item short-form questionnaire, considerably improved and no side effects were reported. Further studies on large cohorts are warranted to test the efficacy of this promising treatment for DMD related osteoporosis.

  6. Atypical femoral fractures during prolonged use of bisphosphonates: short-term responses to strontium ranelate and teriparatide.

    Science.gov (United States)

    Carvalho, N N C; Voss, L A; Almeida, M O P; Salgado, C L; Bandeira, F

    2011-09-01

    Atypical femoral fractures have rarely been reported in women taking bisphosphonates, but this is still a controversial issue. Data are derived mainly from observation studies because a post hoc analysis from a randomized clinical trial did not find any such association. The aim of this study was to report three cases of what are considered atypical femoral fractures and their responses to the use of strontium ranelate and teriparatide. We studied three postmenopausal women with a diagnosis of osteoporosis who suffered fractures of the subtrochanteric region and femoral diaphysis with no major trauma while on long-term use of bisphosphonates. All the major features of atypical femoral fractures highlighted in the Task Force Report of the American Society for Bone and Mineral Research were present in the three cases. They had had unconsolidated fractures for approximately 1 yr before being referred to our center. After 3 months on strontium ranelate 2 g/d, serum osteocalcin and serum β-carboxyterminal telopeptide had increased in case 1 by 125 and 100%, respectively, and in case 2 by 50 and 22%, respectively, with total closure of the fracture. In case 3, after 1 month on teriparatide 20 μg/d, a radiographic closure of the fracture was achieved, and 3 months later serum osteocalcin and serum β-carboxyterminal telopeptide had increased by 300 and 22%, respectively. Our finding showed that both teriparatide and strontium ranelate had a rapid bone anabolic effect on unhealed atypical fractures associated with chronic bisphosphonate use.

  7. 76 FR 48802 - Certain Steel Concrete Reinforcing Bars From Turkey; Notice of Amended Final Results of...

    Science.gov (United States)

    2011-08-09

    ... International Trade Administration Certain Steel Concrete Reinforcing Bars From Turkey; Notice of Amended Final... antidumping duty order on certain steel concrete reinforcing bars (rebar) from Turkey. See Certain Steel Concrete Reinforcing Bars From Turkey; Final Results of Antidumping Duty Administrative Review and...

  8. 77 FR 54900 - Aluminum Extrusions From the People's Republic of China: Final Results of Changed Circumstances...

    Science.gov (United States)

    2012-09-06

    ... Guangdong Zhongya. The petitioner in this proceeding, Aluminum Extrusions Fair Trade Committee, did not... International Trade Administration Aluminum Extrusions From the People's Republic of China: Final Results of Changed Circumstances Review AGENCY: Import Administration, International Trade Administration, Department...

  9. Do continuous assessment results affect final exam outcomes? Evidence from a microeconomics course

    Directory of Open Access Journals (Sweden)

    Juan Carlos Reboredo

    2017-04-01

    Full Text Available Continuous assessment aims to enhance student learning and understanding of a subject and so achieve better educational outcomes. We investigated how continuous assessment grades affected final exam grades. Using a dataset for six academic post-Bologna Process years (2009-2015 for a first-year undergraduate microeconomics course offered at a Spanish public university, we examined conditional dependence between continuous assessment and final exam grades. Our results would indicate a limited contribution of continuous assessment results to final exam results: the probability of the final exam performance improving on the continuous assessment grade was lower than the probability of the opposite occurring. A consistent exception, however, was students who obtained an A grade for continuous assessment. Our results would cast some doubt on the beneficial effects of continuous assessment advocated by the Bologna Process.

  10. Evaluation of persistence and adherence to teriparatide treatment in patients affected by severe osteoporosis (PATT): a multicenter observational real life study

    Science.gov (United States)

    Migliaccio, Silvia; Resmini, Giuseppina; Buffa, Angela; Fornari, Rachele; Di Pietro, Gioconda; Cerocchi, Irene; Dormi, Ada; Gimigliano, Francesca; Mulè, Rita; Celi, Monica; Frigato, Marilena; Lenzi, Andrea; Tarantino, Umberto; Iolascon, Giovanni; Malavolta, Nazzarena

    2013-01-01

    Summary Introduction. Osteoporosis is a chronic condition leading to an increased risk of developing fractures, with high morbidity and mortality in aging population. Efficacy of anti-osteoporotic treatment is based on drug potency but also on compliance and persistence to treatment regimen, which is very low, as already described for other diseases. Teriparatide (TPTD) is the first anabolic agent developed for the treatment of osteoporosis. Since it appears that persistence to Teriparatide declines over time, aim of this pilot multicenter observational study was to evaluate persistence and adherence to TPTD (20 μg daily injection regimen for 18 months) treatment (PATT) in patients affected by severe osteoporosis in an every day clinical practice. Methods. Patients affected by severe osteoporosis were selected among those who referred to 5 different specialized centers for osteoporosis in North, Center and South of Italy. A sample of 475 women with severe postmenopausal osteoporosis treated with TPTD in accordance to the Italian osteoporosis guidelines was included. At the beginning of TPTD treatment patients were instructed on the use of the device by the referring specialist of the center, a resident fellow or a nurse. Bone biochemical markers were evaluated the same morning and after 1, 3, 6, 12 and 18 months. Patients were visited at time 0 and after 6, 12 and 18 months for clinical follow up. Results. The results included observations of 441/475 patients (98% women) who completed the 18 months treatment; mean age for women was 73±8 and for men 65±9. After 6 months of TPTD treatment persistence was of 89,79%, 87,75% after 12 months and 86,85% after 18 months. Adherence was of 100% at 6,12 and 18 months. Total dropouts were 13,15% (71/441), which was usually higher within the first 6 months of TPTD treatment. Most common adverse events (arthralgies 2,7%, dizziness 1,8%, migraine 1,8%, depression 1,6%, hypertension 1,1%) were reported in 62/441 patients (14

  11. 78 FR 56860 - Honey From the People's Republic of China: Final Results of Antidumping Duty Administrative...

    Science.gov (United States)

    2013-09-16

    ... International Trade Administration Honey From the People's Republic of China: Final Results of Antidumping Duty... Preliminary Results \\1\\ of the 2011-2012 administrative review of the antidumping duty order on honey from the... Results of Review'' section below. \\1\\ See Honey From the People's Republic of China: Preliminary Results...

  12. 76 FR 1599 - Stainless Steel Bar From Brazil: Final Results of Antidumping Duty Administrative Review

    Science.gov (United States)

    2011-01-11

    ... International Trade Administration Stainless Steel Bar From Brazil: Final Results of Antidumping Duty... results of its administrative review of the antidumping duty order on stainless steel bar from Brazil. The... stainless steel bar (SSB) from Brazil. See Stainless Steel Bar From Brazil: Preliminary Results of...

  13. 75 FR 23674 - Honey from Argentina: Final Results of Antidumping Duty Administrative Review and Determination...

    Science.gov (United States)

    2010-05-04

    ... International Trade Administration A-357-812 Honey from Argentina: Final Results of Antidumping Duty... antidumping duty order on honey from Argentina. See Honey from Argentina: Preliminary Results of Antidumping... preliminary results of the administrative review of the antidumping duty order on honey from Argentina for the...

  14. 75 FR 56989 - Magnesium Metal From the Russian Federation: Final Results of Antidumping Duty Administrative Review

    Science.gov (United States)

    2010-09-17

    ... International Trade Administration Magnesium Metal From the Russian Federation: Final Results of Antidumping... results of the administrative review of the antidumping duty order on magnesium metal from the Russian... preliminary results of the administrative review of the antidumping duty order on magnesium metal from the...

  15. 75 FR 51440 - Solid Urea from the Russian Federation: Final Results of Antidumping Duty Administrative Review

    Science.gov (United States)

    2010-08-20

    ...On April 15, 2010, the Department of Commerce (the Department) published the preliminary results of the administrative review of the antidumping duty order on solid urea from the Russian Federation. The solid urea subject to this review was produced and exported by MCC EuroChem (EuroChem). The period of review (POR) is July 1, 2008, through June 30, 2009. Based on our analysis of comments received, we have made changes in the margin calculation for EuroChem. Therefore, the final results are different from the preliminary results. The final weighted-average dumping margin for EuroChem is listed below in the section entitled ``Final Results of the Administrative Review.''

  16. Successful teriparatide treatment of atypical fracture after long-term use of alendronate without surgical procedure in a postmenopausal woman: a case report.

    Science.gov (United States)

    Huang, Hsuan-Ti; Kang, Lin; Huang, Peng-Ju; Fu, Yin-Chih; Lin, Sung-Yen; Hsieh, Chih-Hsin; Chen, Jian-Chih; Cheng, Yuh-Min; Chen, Chung-Hwan

    2012-12-01

    Bisphosphonates are used as first-line therapy for postmenopausal osteoporosis owing to their potent inhibition of bone resorption. Long-term use of bisphosphonates may lead to low-energy femoral subtrochanteric or shaft fractures in a very few patients. The aim of this study was to describe the clinical course of a patient treated with alendronate for 3 years who developed an atypical femoral fracture and to hypothesize the beneficial effects of teriparatide on the healing of the patient's atypical femoral fracture. A 63-year-old Asian woman had a lumbar osteoporotic fracture and received 70 mg of alendronate for 3 years. Pain and soreness in the thigh presented initially and exacerbated thereafter. X-ray revealed a right femoral diaphysis stress fracture. She then received teriparatide for the treatment of osteoporosis and the femoral atypical fracture. Pain and tenderness improved remarkably after teriparatide treatment for 1 month, and these symptoms disappeared after teriparatide treatment for 9 months. The patient also received raloxifen as further therapy, and the fracture line had completely disappeared by 15 months after treatment. Even though a previous study has reported that teriparatide healed stress fractures in a rat model and even with the time course of fracture healing in our patient, we are still not certain that teriparatide played a primary role in the positive response to therapy. Vitamin D therapy, calcium, and alendronate discontinuation may have played secondary roles. This case report may serve to introduce a direction for future research into the pharmacological treatment of atypical femoral fractures. Surgical treatment of incomplete atypical femoral fractures may be a safer method.

  17. 76 FR 67142 - Certain Activated Carbon From the People's Republic of China: Final Results and Partial...

    Science.gov (United States)

    2011-10-31

    ... International Trade Administration Certain Activated Carbon From the People's Republic of China: Final Results... administrative review of the antidumping duty order on certain activated carbon from the People's Republic of...\\ See Certain Activated Carbon From the People's Republic of China: Preliminary Results of the Third...

  18. 75 FR 70208 - Certain Activated Carbon From the People's Republic of China: Final Results and Partial...

    Science.gov (United States)

    2010-11-17

    ... International Trade Administration Certain Activated Carbon From the People's Republic of China: Final Results... of the antidumping duty order on certain activated carbon from the People's Republic of China (``PRC''). See Certain Activated Carbon From the People's Republic of China: Notice of Preliminary Results of the...

  19. 78 FR 22845 - Certain Lined Paper Products From India: Final Results of Countervailing Duty Administrative...

    Science.gov (United States)

    2013-04-17

    ... International Trade Administration Certain Lined Paper Products From India: Final Results of Countervailing Duty... countervailing duty (CVD) order on certain lined paper products from India for the January 1, 2010, through...'' section. \\1\\ See Certain Lined Paper Products From India: Preliminary Results of Countervailing Duty...

  20. 75 FR 38076 - Carbazole Violet Pigment 23 from India: Final Results of Antidumping Duty Administrative Review

    Science.gov (United States)

    2010-07-01

    ... International Trade Administration Carbazole Violet Pigment 23 from India: Final Results of Antidumping Duty... administrative review of the antidumping duty order on carbazole violet pigment 23 (CVP 23) from India. The... Pigment 23 from India: Preliminary Results of Antidumping Duty Administrative Review, 74 FR 68038...

  1. 75 FR 33243 - Carbazole Violet Pigment 23 From India: Final Results of Countervailing Duty Administrative Review

    Science.gov (United States)

    2010-06-11

    ... International Trade Administration Carbazole Violet Pigment 23 From India: Final Results of Countervailing Duty... results of administrative review of the countervailing duty order on carbazole violet pigment 23 from India for the period January 1, 2007, through December 31, 2007. See Carbazole Violet Pigment 23 from...

  2. 78 FR 12034 - Certain Preserved Mushrooms From India: Final Results of Antidumping Duty Administrative Review...

    Science.gov (United States)

    2013-02-21

    ... International Trade Administration Certain Preserved Mushrooms From India: Final Results of Antidumping Duty... preliminary results of the administrative review of the antidumping duty order on certain preserved mushrooms... the antidumping duty order on certain preserved mushrooms (mushrooms) from India.\\1\\ We invited...

  3. 78 FR 34037 - Certain Preserved Mushrooms From the People's Republic of China: Final Results of Antidumping...

    Science.gov (United States)

    2013-06-06

    ... International Trade Administration Certain Preserved Mushrooms From the People's Republic of China: Final... results of the administrative review of the antidumping duty order on certain preserved mushrooms from the... Preserved Mushrooms From the People's Republic of China: Preliminary Results of Antidumping Duty...

  4. 77 FR 24461 - Citric Acid and Certain Citrate Salts From Canada: Final Results of Antidumping Duty...

    Science.gov (United States)

    2012-04-24

    ..., which are intermediate products in the production of citric acid, sodium citrate, and potassium citrate... International Trade Administration Citric Acid and Certain Citrate Salts From Canada: Final Results of... the preliminary results of the administrative review of the antidumping duty order on citric acid and...

  5. 76 FR 34044 - Citric Acid and Certain Citrate Salts From Canada: Final Results of Antidumping Duty...

    Science.gov (United States)

    2011-06-10

    ... tricalcium citrate tetrahydrate, which are intermediate products in the production of citric acid, sodium... International Trade Administration Citric Acid and Certain Citrate Salts From Canada: Final Results of... preliminary results of the first administrative review of the antidumping duty order on citric acid and...

  6. 77 FR 39467 - Stainless Steel Bar From India: Final Results of the Antidumping Duty Administrative Review

    Science.gov (United States)

    2012-07-03

    ... International Trade Administration Stainless Steel Bar From India: Final Results of the Antidumping Duty... the administrative review of the antidumping duty order on stainless steel bar from India. The review..., 2012, the Department published Stainless Steel Bar From India: Preliminary Results and Partial...

  7. 75 FR 39663 - Stainless Steel Bar From Brazil: Final Results of Antidumping Duty Administrative Review

    Science.gov (United States)

    2010-07-12

    ... International Trade Administration Stainless Steel Bar From Brazil: Final Results of Antidumping Duty... of its administrative review of the antidumping duty order on certain stainless steel bar from Brazil... results of its administrative review of the antidumping duty order on certain stainless steel bar from...

  8. 75 FR 54090 - Stainless Steel Bar From India: Final Results of Antidumping Duty Administrative Review

    Science.gov (United States)

    2010-09-03

    ...] Stainless Steel Bar From India: Final Results of Antidumping Duty Administrative Review AGENCY: Import... the antidumping duty order on stainless steel bar (``SSB'') from India for the period February 1, 2008, through January 31, 2009. See Stainless Steel Bar From India: Preliminary Results of Antidumping Duty...

  9. 76 FR 74044 - Honey From Argentina: Final Results of Antidumping Duty New Shipper Review

    Science.gov (United States)

    2011-11-30

    ... International Trade Administration Honey From Argentina: Final Results of Antidumping Duty New Shipper Review... 2009-2010 new shipper review of the antidumping duty order on honey from Argentina.\\1\\ This review... Honey From Argentina: Preliminary Results of Antidumping Duty New Shipper Review, 76 FR 54202 (August 31...

  10. 78 FR 67335 - Solid Urea From the Russian Federation: Final Results of Antidumping Duty Administrative Review...

    Science.gov (United States)

    2013-11-12

    ...On August 1, 2013, the Department of Commerce (the Department) published the preliminary results of the administrative review of the antidumping duty order on solid urea from the Russian Federation (Russia). For the final results, we continue to find that MCC EuroChem has not sold subject merchandise at less than normal value.

  11. 76 FR 56396 - Magnesium Metal from the Russian Federation: Final Results of Antidumping Duty Administrative Review

    Science.gov (United States)

    2011-09-13

    ... International Trade Administration Magnesium Metal from the Russian Federation: Final Results of Antidumping... of the administrative review of the antidumping duty order on magnesium metal from the Russian... metal from the Russian Federation. See Magnesium Metal From the Russian Federation: Preliminary Results...

  12. 78 FR 36168 - Fresh Garlic From the People's Republic of China: Final Results of Antidumping Duty...

    Science.gov (United States)

    2013-06-17

    ... International Trade Administration Fresh Garlic From the People's Republic of China: Final Results of... fresh garlic from the People's Republic of China (PRC). The period of review (POR) is November 1, 2010...'' section below. \\1\\ See Fresh Garlic From the People's Republic of China: Preliminary Results of...

  13. Case report: Teriparatide treatment in a case of severe pregnancy -and lactation- associated osteoporosis.

    Science.gov (United States)

    Lampropoulou-Adamidou, Kalliopi; Trovas, George; Stathopoulos, Ioannis P; Papaioannou, Nikolaos A

    2012-01-01

    Pregnancy- and lactation-associated osteoporosis (PLO) is an uncommon disease. The majority of cases are seen in the third trimester or early post-partum in primagravid women and the prominent clinical feature of PLO is severe and prolonged back pain and height loss. The prevalence and aetiology of this disorder are as yet unclear and there are no guidelines for its treatment. We report the outcomes of teriparatide (TRP) treatment in a woman suffering from severe PLO with 6 vertebral fragility fractures, severe back pain and very low BMD. Thirteen months after the initiation of therapy, the patient was almost free of back pain. There was no new clinical vertebral fracture. Her laboratory tests were all normal. BMD increased by 24.4% at the lumbar spine, 9.9% and 4.6% at the left and the right total hip and 12.6% and 7.8% at the left and right femur neck, respectively. TRP treatment simultaneously with weaning and calcium and vitamin D supplementation seems to considerably increase BMD, improve severe back pain and quality of life and prevent further occurrence of vertebral fractures, making TRP a helpful tool in restoring bone strength in PLO patients.

  14. 76 FR 66690 - Solid Urea From the Russian Federation: Final Results of Antidumping Duty Administrative Review

    Science.gov (United States)

    2011-10-27

    ...On June 17, 2011, the Department of Commerce (the Department) published the preliminary results of the administrative review of the antidumping duty order on solid urea from the Russian Federation. The solid urea subject to this review was produced and exported by MCC EuroChem (EuroChem). The period of review (POR) is July 1, 2009, through June 30, 2010. Based on our analysis of comments received, we have not made any changes in the margin calculation for EuroChem. The final weighted- average dumping margin for EuroChem is listed below in the section entitled ``Final Results of the Administrative Review.''

  15. Characterization of patients in the European Forsteo Observational Study (EFOS): postmenopausal women entering teriparatide treatment in a community setting.

    Science.gov (United States)

    Rajzbaum, Gerald; Jakob, Franz; Karras, Dimitrios; Ljunggren, Osten; Lems, Willem F; Langdahl, Bente L; Fahrleitner-Pammer, Astrid; Walsh, J Bernard; Gibson, Anthony; Tynan, Aodán J; Marin, Fernando

    2008-02-01

    The European Forsteo Observational Study (EFOS) study was primarily designed to assess fracture incidence, degree of pain, health-related quality of life (HRQoL) and compliance in women prescribed teriparatide in a community setting. This report describes the design of the study and characteristics of the patients at entry. At entry, 1645 postmenopausal women with a diagnosis of osteoporosis and about to initiate teriparatide treatment were enrolled in eight European countries. Baseline data were collected on demographic characteristics, medical and osteoporosis history, disease status, prior use of medications and HRQoL. The mean (standard deviation [SD]) age of patients was 71.5 (8.4) years, lumbar spine bone mineral density (BMD) T-score was -3.3 (1.2), the mean number of previous fractures reported after 40 years of age was 2.9 (2.0), 70% had two or more vertebral deformities and 91.7% were pre-treated with bisphosphonates. HRQoL, evaluated by the health state value (HSV) (median: 0.59, Q1; Q3: 0.08; 0.71) and visual analogue scale (VAS) (median 50.0, Q1; Q3: 35.0; 69.0) status of the European quality of life questionnaire (EQ-5D) was poor. Extreme problems were reported by 31% of patients for the pain/discomfort dimension, mobility was limited in 69% and anxiety/depression was reported by 57% of patients. Chronic or intermittent back pain was reported by 91% of patients, which occurred every day or almost every day within the last month in 66% of patients. The post-menopausal women prescribed teriparatide were severely osteoporotic, with a high fracture risk and poor HRQoL, despite previous therapy for osteoporosis. Moderate to severe back pain was very common.

  16. 75 FR 51981 - Polychloroprene Rubber from Japan: Final Results of Sunset Review and Revocation of Finding

    Science.gov (United States)

    2010-08-24

    ... International Trade Administration Polychloroprene Rubber from Japan: Final Results of Sunset Review and... review of the antidumping finding on polychloroprene rubber from Japan. Because the domestic interested... polychloroprene rubber from Japan. See Polychloroprene Rubber from Japan, 38 FR 33593 (December 6, 1973). On...

  17. Tank 241-BY-109, cores 201 and 203, analytical results for the final report

    Energy Technology Data Exchange (ETDEWEB)

    Esch, R.A.

    1997-11-20

    This document is the final laboratory report for tank 241-BY-109 push mode core segments collected between June 6, 1997 and June 17, 1997. The segments were subsampled and analyzed in accordance with the Tank Push Mode Core Sampling and Analysis Plan (Bell, 1997), the Tank Safety Screening Data Quality Objective (Dukelow, et al, 1995). The analytical results are included.

  18. 75 FR 17376 - Certain Preserved Mushrooms from the People's Republic of China: Amended Final Results Pursuant...

    Science.gov (United States)

    2010-04-06

    ... International Trade Administration Certain Preserved Mushrooms from the People's Republic of China: Amended... order on certain preserved mushrooms from the PRC for the period February 1, 2002, through January 31... the final results of the 2002-2003 administrative review of certain preserved mushrooms from the...

  19. 76 FR 56732 - Certain Preserved Mushrooms From the People's Republic of China: Final Results of Antidumping...

    Science.gov (United States)

    2011-09-14

    ... International Trade Administration Certain Preserved Mushrooms From the People's Republic of China: Final... preliminary results of administrative review of the antidumping duty order on certain preserved mushrooms from the People's Republic of China (PRC). See Certain Preserved Mushrooms From the People's Republic of...

  20. 77 FR 54563 - Silicon Metal from the People's Republic of China: Final Results of Antidumping Duty...

    Science.gov (United States)

    2012-09-05

    ...] Silicon Metal from the People's Republic of China: Final Results of Antidumping Duty Administrative Review... administrative review of the antidumping duty order on silicon metal from the People's Republic of China (``PRC..., respectively. SUPPLEMENTARY INFORMATION: On March 7, 2012, the Department published Silicon Metal from the...

  1. Final Analysis and Results of the Phase II SIMPLE Dark Matter Search

    Energy Technology Data Exchange (ETDEWEB)

    Felizardo, M.; Girard, T. A.; Morlat, Thomas; Fernandes, A. C.; Ramos, A. R.; Marques, J. G.; Kling, Andreas; Puibasset, Joel; Auguste, M.; Boyer, D.; Cavaillou, A.; Poupeney, J.; Sudre, C.; Miley, Harry S.; Payne, Rosara F.; Carvalho, F. P.; Prudencio, M. I.; Gouveia, A.; Marques, R.

    2012-05-18

    We report the final results of the Phase II SIMPLE measurements, comprising two run stages of 15 superheated droplet detectors each, with the second stage including an improved neutron shielding. The analyses include a refined signal analysis, and revised nucleation efficiency based on a reanalysis of previously reported monochromatic neutron irradiations.

  2. 78 FR 64914 - Citric Acid and Certain Citrate Salts From Canada: Final Results of Antidumping Duty...

    Science.gov (United States)

    2013-10-30

    ... International Trade Administration Citric Acid and Certain Citrate Salts From Canada: Final Results of... of the antidumping duty order on citric acid and certain citrate salts from Canada.\\1\\ The review... period of review (POR) is May 1, 2011, through April 30, 2012. \\1\\ See Citric Acid and Certain Citrate...

  3. 77 FR 77029 - Honey from Argentina; Final Results of Antidumping and Countervailing Duty Changed Circumstances...

    Science.gov (United States)

    2012-12-31

    ... International Trade Administration Honey from Argentina; Final Results of Antidumping and Countervailing Duty... orders on honey from Argentina because we have concluded that substantially all domestic producers lack..., the Department published the antidumping and countervailing duty orders on honey from Argentina.\\1\\ On...

  4. 76 FR 29192 - Honey From Argentina: Final Results of Antidumping Duty Administrative Review

    Science.gov (United States)

    2011-05-20

    ... International Trade Administration Honey From Argentina: Final Results of Antidumping Duty Administrative Review... 2008-2009 administrative review of the antidumping duty order on honey from Argentina. See Honey From...., Patagonik S.A., and TransHoney S.A.; all three exporters of honey from Argentina to the United States during...

  5. 77 FR 20358 - Certain Frozen Warmwater Shrimp From the Socialist Republic of Vietnam: Final Results of...

    Science.gov (United States)

    2012-04-04

    ... vannemei), banana prawn (Penaeus merguiensis), fleshy prawn (Penaeus chinensis), giant river prawn... exported from Thong Thuan entered, or withdrawn from warehouse, for consumption on or after the publication... exported by Thong Thuan, the cash deposit rate will be the rate established in the final results of this...

  6. 78 FR 27185 - Magnesium Metal From the People's Republic of China: Final Results of Antidumping Duty...

    Science.gov (United States)

    2013-05-09

    ... International Trade Administration Magnesium Metal From the People's Republic of China: Final Results of... on magnesium metal from the People's Republic of China (``PRC''), in which it found that the one... TMI had no reviewable transactions of subject merchandise during the POR. \\1\\ See Magnesium Metal from...

  7. 76 FR 61342 - Magnesium Metal from the Russian Federation: Amended Final Results of Antidumping Duty...

    Science.gov (United States)

    2011-10-04

    ... International Trade Administration Magnesium Metal from the Russian Federation: Amended Final Results of... magnesium metal from the Russian Federation. See Magnesium Metal from the Russian Federation: Preliminary... ``Administrative Review of the Antidumping Duty Order on Magnesium Metal from the Russian Federation-- Amended...

  8. 75 FR 61128 - Polyethylene Retail Carrier Bags From Malaysia: Final Results of Antidumping Duty Administrative...

    Science.gov (United States)

    2010-10-04

    ... From the Federal Register Online via the Government Publishing Office DEPARTMENT OF COMMERCE International Trade Administration Polyethylene Retail Carrier Bags From Malaysia: Final Results of Antidumping... administrative review of the antidumping duty order on polyethylene retail carrier bags (PRCBs) from Malaysia...

  9. MASTICATION, PHONETICS AND ESTHETICS AS A FINAL RESULT OF PARTIAL OR COMPLETE DENTURE TREATMENT.

    Directory of Open Access Journals (Sweden)

    Kalina Georgieva

    2015-08-01

    Full Text Available Three target groups- dentists/ dental students, dental technicians and patients were asked to fill in an anonymous questionnaire about their satisfaction of the final results after prosthetic treatment with removable dentures using a scale from 1 to 5 (1- completely dissatisfied, 2-dissatisfied, 3-indifferent, 4-satisfied, 5-completely satisfied. The mean results (including colour, shape and size of artificial teeth, arrangement of front teeth, colour of artificial gums, phonetics, mastication, natural smile, enough space for tongue for all three groups of respondents were compared. Dental technicians (4,34 are more satisfied than dentists/dental students (3,62 and patients (3,53. A successful outcome of prosthetic treatment depends on one hand on the professional approach of the dental team and on the other hand on the patient’s motivation and cooperation. The predictive final results and realistic expectations lead to satisfaction of all participants in the treatment process.

  10. 75 FR 11116 - Certain Pasta from Italy: Notice of Amended Final Results of the Twelfth Antidumping Duty...

    Science.gov (United States)

    2010-03-10

    ... convert Garofalo's reported warehousing costs (DWAREHU) in the Final Results. During the Final Results... value data for entries made by PAM during the POR. Specifically, the Department erred by not adding...

  11. 78 FR 10130 - Narrow Woven Ribbons With Woven Selvedge From the People's Republic of China: Final Results of...

    Science.gov (United States)

    2013-02-13

    ... Reinforcing Bars from Turkey; Final Results and Rescission of Antidumping Duty Administrative Review in Part... discredits the selected AFA rate. \\38\\ See, e.g., Fresh Cut Flowers from Mexico; Final Results of Antidumping...

  12. 78 FR 22230 - Certain Magnesia Carbon Bricks From the People's Republic of China: Final Results and Final...

    Science.gov (United States)

    2013-04-15

    ... International Trade Administration Certain Magnesia Carbon Bricks From the People's Republic of China: Final... first administrative review of the antidumping duty order on certain magnesia carbon bricks from the..., through August 31, 2011. \\1\\ See Certain Magnesia Carbon Bricks From the People's Republic of China...

  13. Effective osteoporosis treatment with teriparatide is associated with enhanced quality of life in postmenopausal women with osteoporosis: the European Forsteo Observational Study

    NARCIS (Netherlands)

    Ljunggren, O.; Barrett, A.; Stoykov, I.; Langdahl, B.L.; Lems, W.F.; Walsh, J.B.; Fahrleitner-Pammer, A.; Rajzbaum, G.; Jakob, F.; Karras, D.; Marin, F.

    2013-01-01

    Background: To describe changes in health-related quality of life (HRQoL) of postmenopausal women with osteoporosis treated with teriparatide for up to 18 months and followed-up for a further 18 months, and to assess the influence of recent prior and incident fractures. Methods. The European Forsteo

  14. Gender differences for initiating teriparatide therapy: baseline data from the Direct Assessment of Nonvertebral Fracture in the Community Experience (DANCE) study.

    Science.gov (United States)

    Wong, M; Wan, X; Ruff, V; Krohn, K; Taylor, K

    2012-04-01

    The prospective, observational Direct Assessment of Nonvertebral Fracture in the Community Experience (DANCE) study shows that, among patients with risk factors for osteoporosis, women are more likely to be screened and to receive appropriate treatment than men. There needs to be greater awareness that osteoporosis affects both men and women. The prospective, observational DANCE study evaluated teriparatide use in the mainland USA and Puerto Rico in patients with osteoporosis in a community setting. This analysis compares baseline characteristics of women and men that may contribute to differences in initiation of teriparatide therapy. Investigators prescribed teriparatide 20 μg/day subcutaneous injection for ≤24 months to 3,698 patients (3,342 women, 356 men) whom they considered appropriate candidates for therapy. Study entry was guided by product labeling. Specific timing and frequency of office visits were not mandated. Treatment decisions were based on the clinical judgment of study investigators and local standards of care. At baseline, similar proportions of women and men had prior fragility fractures (57% and 59%, respectively) and comorbid conditions that increase fracture risk (83% and 84%, respectively). Women were older than men (mean age 68 vs. 65 year; P gender may influence the reasons physicians initiate teriparatide therapy in a community setting.

  15. 76 FR 7811 - Silicon Metal From the People's Republic of China: Amended Final Results of Antidumping Duty...

    Science.gov (United States)

    2011-02-11

    ... International Trade Administration Silicon Metal From the People's Republic of China: Amended Final Results of... the final results of the antidumping duty administrative review of silicon metal from the People's Republic of China (``PRC''). See Silicon Metal From the People's Republic of China: Final Results and...

  16. Comparative effects of teriparatide and ibandronate on spine bone mineral density (BMD) and microarchitecture (TBS) in postmenopausal women with osteoporosis: a 2-year open-label study.

    Science.gov (United States)

    Senn, C; Günther, B; Popp, A W; Perrelet, R; Hans, D; Lippuner, K

    2014-07-01

    Treatment effects over 2 years of teriparatide vs. ibandronate in postmenopausal women with osteoporosis were compared using lumbar spine bone mineral density (BMD) and trabecular bone score (TBS). Teriparatide induced larger increases in BMD and TBS compared to ibandronate, suggesting a more pronounced effect on bone microarchitecture of the bone anabolic drug. The trabecular bone score (TBS) is an index of bone microarchitecture, independent of bone mineral density (BMD), calculated from anteroposterior spine dual X-ray absorptiometry (DXA) scans. The potential role of TBS for monitoring treatment response with bone-active substances is not established. The aim of this study was to compare the effects of recombinant human 1-34 parathyroid hormone (teriparatide) and the bisphosphonate ibandronate (IBN), on lumbar spine (LS) BMD and TBS in postmenopausal women with osteoporosis. Two patient groups with matched age, body mass index (BMI), and baseline LS BMD, treated with either daily subcutaneous teriparatide (N = 65) or quarterly intravenous IBN (N = 122) during 2 years and with available LS BMD measurements at baseline and 2 years after treatment initiation were compared. Baseline characteristics (overall mean ± SD) were similar between groups in terms of age 67.9 ± 7.4 years, body mass index 23.8 ± 3.8 kg/m(2), BMD L1-L4 0.741 ± 0.100 g/cm(2), and TBS 1.208 ± 0.100. Over 24 months, teriparatide induced a significantly larger increase in LS BMD and TBS than IBN (+7.6 % ± 6.3 vs. +2.9 % ± 3.3 and +4.3 % ± 6.6 vs. +0.3 % ± 4.1, respectively; P osteoporosis, a 2-year treatment with teriparatide led to a significantly larger increase in LS BMD and TBS than IBN, suggesting that teriparatide had more pronounced effects on bone microarchitecture than IBN.

  17. Tank 241-T-204, core 188 analytical results for the final report

    Energy Technology Data Exchange (ETDEWEB)

    Nuzum, J.L.

    1997-07-24

    TANK 241-T-204, CORE 188, ANALYTICAL RESULTS FOR THE FINAL REPORT. This document is the final laboratory report for Tank 241 -T-204. Push mode core segments were removed from Riser 3 between March 27, 1997, and April 11, 1997. Segments were received and extruded at 222-8 Laboratory. Analyses were performed in accordance with Tank 241-T-204 Push Mode Core Sampling and analysis Plan (TRAP) (Winkleman, 1997), Letter of instruction for Core Sample Analysis of Tanks 241-T-201, 241- T-202, 241-T-203, and 241-T-204 (LAY) (Bell, 1997), and Safety Screening Data Qual@ Objective (DO) ODukelow, et al., 1995). None of the subsamples submitted for total alpha activity (AT) or differential scanning calorimetry (DC) analyses exceeded the notification limits stated in DO. The statistical results of the 95% confidence interval on the mean calculations are provided by the Tank Waste Remediation Systems Technical Basis Group and are not considered in this report.

  18. Do peer-tutors perform better in examinations? An analysis of medical school final examination results.

    Science.gov (United States)

    Iwata, Kazuya; Furmedge, Daniel S; Sturrock, Alison; Gill, Deborah

    2014-07-01

    Peer-assisted learning (PAL) is recognised as an effective learning tool and its benefits are well documented in a range of educational settings. Learners find it enjoyable and their performances in assessments are comparable with those of students taught by faculty tutors. In addition, PAL tutors themselves report the development of improved clinical skills and confidence through tutoring. However, whether tutoring leads to actual improvement in performance has not been fully investigated. As high-achieving students are already en route to succeeding in final examinations, we wanted to examine whether participation in a peer-tutoring programme in itself leads to better final-year examination performance. We conducted a retrospective analysis of results on final-year written and clinical examinations at University College London Medical School during 2010-2012. Z-scores were calculated and the performances of PAL tutors and students who were not PAL tutors were compared using analysis of covariance (ancova). Year 4 examination results were used as indicators of previous academic attainment. Of the 1050 students who attempted the final examination, 172 were PAL tutors in the final year. Students who acted as PAL tutors outperformed students who did not in all examination components by 1-3%. Z-scores differed by approximately 0.2 and this was statistically significant, although the significance of this difference diminished when controlling for Year 4 results. Students who acted as PAL tutors who had scored in the top quartile in Year 4 examinations scored significantly better in a long-station objective structured clinical examination (LSO). Although students who acted as PAL tutors performed better than students who did not in final-year examinations, this difference was small and attributable to the students' background academic abilities. High-achieving students appear to be self-selecting as peer-tutors and their enhanced performance in LSOs may reflect their

  19. Final results from DELPHI on the searches for SM and MSSM Neutral Higgs bosons

    CERN Document Server

    Abdallah, J; Abreu, P; Adam, W; Adzic, P; Albrecht, T; Alderweireld, T; Alemany-Fernandez, R; Allmendinger, T; Allport, P P; Amaldi, Ugo; Amapane, N; Amato, S; Anashkin, E; Andreazza, A; Andringa, S; Anjos, N; Antilogus, P; Apel, W D; Arnoud, Y; Ask, S; Åsman, B; Augustin, J E; Augustinus, A; Baillon, Paul; Ballestrero, A; Bambade, P; Barbier, R; Bardin, Dimitri Yuri; Barker, G; Baroncelli, A; Battaglia, Marco; Baubillier, M; Becks, K H; Begalli, M; Behrmann, A; Ben-Haim, E; Benekos, N C; Benvenuti, Alberto C; Bérat, C; Berggren, M; Berntzon, L; Bertrand, D; Besançon, M; Besson, N; Bloch, D; Blom, M; Bluj, M; Bonesini, M; Boonekamp, M; Booth, P S L; Borisov, G; Botner, O; Bouquet, B; Bowcock, T J V; Boyko, I; Bracko, M; Brenner, R; Brodet, E; Brückman, P; Brunet, J M; Bugge, L; Buschmann, P; Calvi, M; Camporesi, T; Canale, V; Carena, F; Castro, N; Cavallo, F R; Chapkin, M M; Charpentier, P; Checchia, P; Chierici, R; Shlyapnikov, P; Chudoba, J; Chung, S U; Cieslik, K; Collins, P; Contri, R; Cosme, G; Cossutti, F; Costa, M J; Crawley, B; Crennell, D J; Cuevas-Maestro, J; D'Hondt, J; Dalmau, J; Da Silva, T; Da Silva, W; Della Ricca, G; De Angelis, A; de Boer, Wim; De Clercq, C; De Lotto, B; De Maria, N; De Min, A; De Paula, L S; Di Ciaccio, Lucia; Di Simone, A; Doroba, K; Drees, J; Dris, M; Eigen, G; Ekelöf, T J C; Ellert, M; Elsing, M; Espirito-Santo, M C; Fanourakis, G K; Fassouliotis, D; Feindt, M; Fernández, J; Ferrer, A; Ferro, F; Flagmeyer, U; Föth, H; Fokitis, E; Fulda-Quenzer, F; Fuster, J A; Gandelman, M; García, C; Gavillet, P; Gazis, E N; Gokieli, R; Golob, B; Gómez-Ceballos, G; Gonçalves, P; Graziani, E; Grosdidier, G; Grzelak, K; Guy, J; Haag, C; Hallgren, A; Hamacher, K; Hamilton, K; Hansen, J; Haug, S; Hauler, F; Hedberg, V; Hennecke, M; Herr, H; Hoffman, J; Holmgren, S O; Holt, P J; Houlden, M A; Hultqvist, K; Jackson, J N; Jarlskog, G; Jarry, P; Jeans, D; Johansson, E K; Johansson, P D; Jonsson, P; Joram, C; Jungermann, L; Kapusta, F; Katsanevas, S; Katsoufis, E C; Kernel, G; Kersevan, Borut P; Kiiskinen, A P; King, B T; Kjaer, N J; Kluit, P; Kokkinias, P; Kourkoumelis, C; Kuznetsov, O; Krumshtein, Z; Kucharczyk, M; Lamsa, J; Leder, G; Ledroit, F; Leinonen, L; Leitner, R; Lemonne, J; Lepeltier, V; Lesiak, T; Liebig, W; Liko, D; Lipniacka, A; Lopes, J H; López, J M; Loukas, D; Lutz, P; Lyons, L; MacNaughton, J; Malek, A; Maltezos, S; Mandl, F; Marco, J; Marco, R; Maréchal, B; Margoni, M; Marin, J C; Mariotti, C; Markou, A; Martínez-Rivero, C; Masik, J; Mastroyiannopoulos, N; Matorras, F; Matteuzzi, C; Mazzucato, F; Mazzucato, M; McNulty, R; Meroni, C; Meyer, W T; Migliore, E; Mitaroff, W A; Mjörnmark, U; Moa, T; Moch, M; Mönig, K; Monge, R; Montenegro, J; Moraes, D; Moreno, S; Morettini, P; Müller, U; Münich, K; Mulders, M; Mundim, L M; Murray, W; Muryn, B; Myatt, Gerald; Myklebust, T; Nassiakou, M; Navarria, Francesco Luigi; Nawrocki, K; Nicolaidou, R; Nikolenko, M; Oblakowska-Mucha, A; Obraztsov, V F; Olshevskii, A G; Onofre, A; Orava, Risto; Österberg, K; Ouraou, A; Oyanguren, A; Paganoni, M; Paiano, S; Palacios, J P; Palka, H; Papadopoulou, T D; Pape, L; Parkes, C; Parodi, F; Parzefall, U; Passeri, A; Passon, O; Peralta, L; Perepelitsa, V F; Perrotta, A; Petrolini, A; Piedra, J; Pieri, L; Pierre, F; Pimenta, M; Piotto, E; Podobnik, T; Poireau, V; Pol, M E; Polok, G; Poropat, P; Pozdnyakov, V; Pukhaeva, N; Pullia, Antonio; Rames, J; Ramler, L; Read, A; Rebecchi, P; Rehn, J; Reid, D; Reinhardt, R; Renton, P B; Richard, F; Rídky, J; Rivero, M; Rodríguez, D; Romero, A; Ronchese, P; Rosenberg, E I; Roudeau, Patrick; Rovelli, T; Ruhlmann-Kleider, V; Ryabtchikov, D; Sadovskii, A; Salmi, L; Salt, J; Savoy-Navarro, A; Schwickerath, U; Segar, A; Sekulin, R L; Siebel, M; Sissakian, A N; Smadja, G; Smirnova, O G; Sokolov, A; Sopczak, A; Sosnowski, R; Spassoff, Tz; Stanitzki, M; Stocchi, A; Strauss, J; Stugu, B; Szczekowski, M; Szeptycka, M; Szumlak, T; Tabarelli de Fatis, T; Taffard, A C; Tegenfeldt, F; Timmermans, J; Tkatchev, L G; Tobin, M; Todorovova, S; Tomé, B; Tonazzo, A; Tortosa, P; Travnicek, P; Treille, D; Tristram, G; Trochimczuk, M; Troncon, C; Turluer, M L; Tyapkin, I A; Tyapkin, P; Tzamarias, S; Uvarov, V; Valenti, G; van Dam, P; Van Eldik, J; Van Lysebetten, A; Van Remortel, N; Van Vulpen, I B; Vegni, G; Veloso, F; Venus, W A; Verbeure, F; Verdier, P; Verzi, V; Vilanova, D; Vitale, L; Vrba, V; Wahlen, H; Washbrook, A J; Weiser, C; Wicke, D; Wickens, J H; Wilkinson, G; Winter, M; Witek, M; Yushchenko, O P; Zalewska-Bak, A; Zalewski, Piotr; Zavrtanik, D; Zhuravlov, V; Zimin, N I; Zinchenko, A I; Zupan, M

    2004-01-01

    These final results from DELPHI searches for the Standard Model (SM) Higgs boson, together with benchmark scans of the Minimal Supersymmetric Standard Model (MSSM) neutral Higgs bosons, used data taken at centre-of-mass energies between 200 and 209 GeV with a total integrated luminosity of 224 pb^-1. The data from 192 to 202 GeV are reanalysed with improved b-tagging for MSSM final states decaying to four b-quarks. The 95% confidence level lower mass bound on the Standard Model Higgs boson is 114.1 GeV/c2. Limits are also given on the lightest scalar and pseudo-scalar Higgs bosons of the MSSM.

  20. EFFECTS OF SWIMMING TECHIQUES ON FINAL RESULT IN 200M INDIVIDUAL MEDLEY

    Directory of Open Access Journals (Sweden)

    Goran Dimitrić

    2013-07-01

    Full Text Available Swimming results are permanently improving. Results in individual medley disciplines are also improving. Individual medley disciplines are consist of all four swimming techiques. Results in these disciplines depende amongother things, on the swimming quality in all techniques. In 200m individual medley, each techinque implies 50m swimming, in following order: butterfly, backstroke, breast stroke and free style. The aim of this paper is to determine individual affect of each swimming technique on 200m individual medley final result. Reasearh was based on the achieved times of 30 male and 30 female swimmers who participated in 200m individual medley qualifications on European chanpionship - Szczecin 2011, Poland. According to adequate statistical methods and analysis of results, certain conclusions will be derived

  1. Final result of the CALLISTO-experiment. Formation of sodium hassate(VIII)

    Energy Technology Data Exchange (ETDEWEB)

    Zweidorf, A. von; Angert, R.; Bruechle, W. [Gesellschaft fuer Schwerionenforschung mbH, Darmstadt (DE)] (and others)

    2004-07-01

    In the present work, the final result of the CALLISTO project (Continuously Working Arrangement For CLusterLess Transport of In-SiTu Produced Volatile Oxides), started in 1998, will be presented. It was developed independently from the other major project to investigate the chemical properties of hassium [9]. Both projects use the ability of hassium to form in-situ a volatile oxide, presumably the tetroxide, which can be tranported through PTFE capillaries at room temperature. In the CALLISTO project, its tendency to undergo a chemical reaction with a substrate involving the solid and the gaseous phase was investigated. (orig.)

  2. Tank 241-T-105, cores 205 and 207 analytical results for the final report

    Energy Technology Data Exchange (ETDEWEB)

    Esch, R. A.

    1997-10-21

    This document is the final laboratory report for tank 241-T-105 push mode core segments collected between June 24, 1997 and June 30, 1997. The segments were subsampled and analyzed in accordance with the {ital Tank Push Mode Core Sampling and Analysis Plan} (TSAP) (Field,1997), the {ital Tank Safety Screening Data Quality Objective} (Safety DQO) (Dukelow, et al., 1995) and {ital Tank 241-T-105 Sample Analysis} (memo) (Field, 1997a). The analytical results are included in Table 1. None of the subsamples submitted for the differential scanning calorimetry (DSC) analysis or total alpha activity (AT) exceeded the notification limits as stated in the TSAP (Field, 1997). The statistical results of the 95% confidence interval on the mean calculations are provided by the Tank Waste Remediation Systems (TWRS) Technical Basis Group in accordance with the Memorandum of Understanding (Schreiber, 1997) and not considered in this report.

  3. 75 FR 34688 - Ball Bearings and Parts Thereof from France: Final Results of Changed-Circumstances Review

    Science.gov (United States)

    2010-06-18

    ... from John M. Andersen, Acting Deputy Assistant Secretary for Antidumping and Countervailing Duty..., Italy, Japan, Singapore, and the United Kingdom: Final Results of Antidumping Duty Administrative...

  4. 77 FR 51754 - Wooden Bedroom Furniture From the People's Republic of China: Final Results and Final Rescission...

    Science.gov (United States)

    2012-08-27

    ... Amini met with the Department.\\5\\ \\3\\ See letter from Amini to the Honorable John Bryson, Acting... Results, we also found that (1) Baigou Crafts Factory of Fengkai, (2) Locke Furniture Factory; Kai Chan Furniture Co., Ltd.; Kai Chan (Hong Kong) Enterprise Ltd.; Taiwan Kai Chan Co., Ltd, (collectively, Locke...

  5. Final test results for the ground operations demonstration unit for liquid hydrogen

    Science.gov (United States)

    Notardonato, W. U.; Swanger, A. M.; Fesmire, J. E.; Jumper, K. M.; Johnson, W. L.; Tomsik, T. M.

    2017-12-01

    Described herein is a comprehensive project-a large-scale test of an integrated refrigeration and storage system called the Ground Operations and Demonstration Unit for Liquid Hydrogen (GODU LH2), sponsored by the Advanced Exploration Systems Program and constructed at Kennedy Space Center. A commercial cryogenic refrigerator interfaced with a 125,000 l liquid hydrogen tank and auxiliary systems in a manner that enabled control of the propellant state by extracting heat via a closed loop Brayton cycle refrigerator coupled to a novel internal heat exchanger. Three primary objectives were demonstrating zero-loss storage and transfer, gaseous liquefaction, and propellant densification. Testing was performed at three different liquid hydrogen fill-levels. Data were collected on tank pressure, internal tank temperature profiles, mass flow in and out of the system, and refrigeration system performance. All test objectives were successfully achieved during approximately two years of testing. A summary of the final results is presented in this paper.

  6. The final results of the Mi-Beta Cryogenic Experiment towards the CUORICINO Experiment

    Science.gov (United States)

    Pirro, S.; Arnaboldi, C.; Brofferio, C.; Bucci, C.; Capelli, S.; Cremonesi, O.; Fiorini, E.; Giuliani, A.; McDonald, R. J.; Nucciotti, A.; Pavan, M.; Pedretti, M.; Pessina, G.; Pobes, C.; Previtali, E.; Sisti, M.; Vanzini, M.; Zanotti, L.

    2002-02-01

    We present the final results on neutrinoless Double Beta Decay (DBD) of 130Te obtained with an array of 20 cryogenic detectors. The Mi-Beta Experiment is operating since 3 years and was upgraded in March 2001. The background in the DBD energy region was reduced thanks to a new Roman lead shield framed inside the dilution unit and a neutron shield mounted outside the cryostat. We also improved the energy threshold using a cold electronic stage inside the cryostat. The new set-up represents also a good test for the CUORICINO Experiment. CUORICINO will start by the beginning of 2002 and will consist of 56 Tellurium Oxide Crystal with an overall bolometric mass of 42 kg. .

  7. Final results from an extensive ageing test of bakelite Resistive Plate Chambers

    CERN Document Server

    Carboni, G; De Capua, S; Dominici, Daniele; Messi, R; Passaleva, G; Santovetti, E; Veltri, M

    2004-01-01

    We present the final results of an extensive aging test, performed at the CERN Gamma Irradiation Facility on two bakelite Resistive Plate Chambers (RPC) detectors. With a method based on a model describing the behaviour of an RPC under high particle flux conditions, we have periodically measured the electrode resistivity rho of the two RPC prototypes over 3 years. We observed a large spontaneous increase of rho with time, from the initial value of about 10**1**0 Omega cm to more than 200 multiplied by 10**1**0 Omega cm. A corresponding degradation of the RPC rate capabilities, from more than 3 kHz/cm**2 to less than 200 Hz/cm**2, was observed; the reversibility of the process, using a humid gas mixture, has also been studied. We also present a study of the effects of humidity on the bakelite resistivity using two 10 multiplied by 10 cm**2 bakelite samples.

  8. Teriparatide vs. alendronate as a treatment for osteoporosis: changes in biochemical markers of bone turnover, BMD and quality of life.

    Science.gov (United States)

    Panico, Annalisa; Lupoli, Gelsy Arianna; Marciello, Francesca; Lupoli, Roberta; Cacciapuoti, Marianna; Martinelli, Addolorata; Granieri, Luciana; Iacono, Daniela; Lupoli, Giovanni

    2011-08-01

    We studied the use of teriparatide in postmenopausal women with severe osteoporosis. Two groups (A and B) of patients affected by severe osteoporosis (T-score ≤-2.5 at bone mineral density were analyzed and 2 vertebral fractures on radiograph). Group A was treated for 18 months with 20 µg/day of teriparatide. Group B was treated with bisphosphonates 70 mg/week. Every woman assumed 1 g of calcium and 800 IU of vitamin D3 daily. We evaluated the effects of therapy after 18 months (T18) from the beginning with bone turnover markers (alkaline phosphatase, procollagen type 1 N-terminal propeptide, and N-telopeptide cross-links) and dual-energy X-ray absorptiometry. Group A, at T18 procollagen type 1 N-terminal propeptide levels, increased 127%; bone alkaline phosphatase levels increased to 65%; N-telopeptide cross-links levels increased to 110%. Group B, at T18 procollagen type 1 N-terminal propeptide levels, decreased to 74%; bone alkaline phosphatase levels decreased to 41%; N-telopeptide cross-links levels decreased to 72%. After 18 months, lumbar bone mineral density increased to 12.4% and femoral bone mineral density increased to 5.2% in group A. Group B lumbar bone mineral density increased to 3.85% and femoral bone mineral density increased to 1.99%. Only a new vertebral fracture occurred in group A (2.4%), whereas 6 fractures occurred in group B (15.7%). The quality of life questionnaire of the European Foundation for Osteoporosis (QUALEFFO) revealed a significant improvement in daily living, performed domestic jobs, and locomotor function in groups A and B. The use of rhPTH in patients with severe osteoporosis offers more protection against fractures and improves the QoL more than bisphosphonates.

  9. 7X performance results - final report : ASCI Red vs Red Storm.

    Energy Technology Data Exchange (ETDEWEB)

    Dinge, Dennis C. (Cray Inc., Albuquerque, NM); Davis, Michael E. (Cray Inc., Albuquerque, NM); Haskell, Karen H.; Ballance, Robert A.; Gardiner, Thomas Anthony; Stevenson, Joel O.; Noe, John P.

    2011-04-01

    The goal of the 7X performance testing was to assure Sandia National Laboratories, Cray Inc., and the Department of Energy that Red Storm would achieve its performance requirements which were defined as a comparison between ASCI Red and Red Storm. Our approach was to identify one or more problems for each application in the 7X suite, run those problems at multiple processor sizes in the capability computing range, and compare the results between ASCI Red and Red Storm. The first part of this report describes the two computer systems, the applications in the 7X suite, the test problems, and the results of the performance tests on ASCI Red and Red Storm. During the course of the testing on Red Storm, we had the opportunity to run the test problems in both single-core mode and dual-core mode and the second part of this report describes those results. Finally, we reflect on lessons learned in undertaking a major head-to-head benchmark comparison.

  10. Vehicle technologies heavy vehicle program : FY 2008 benefits analysis, methodology and results --- final report.

    Energy Technology Data Exchange (ETDEWEB)

    Singh, M.; Energy Systems; TA Engineering

    2008-02-29

    This report describes the approach to estimating the benefits and analysis results for the Heavy Vehicle Technologies activities of the Vehicle Technologies (VT) Program of EERE. The scope of the effort includes: (1) Characterizing baseline and advanced technology vehicles for Class 3-6 and Class 7 and 8 trucks, (2) Identifying technology goals associated with the DOE EERE programs, (3) Estimating the market potential of technologies that improve fuel efficiency and/or use alternative fuels, and (4) Determining the petroleum and greenhouse gas emissions reductions associated with the advanced technologies. In FY 08 the Heavy Vehicles program continued its involvement with various sources of energy loss as compared to focusing more narrowly on engine efficiency and alternative fuels. These changes are the result of a planning effort that first occurred during FY 04 and was updated in the past year. (Ref. 1) This narrative describes characteristics of the heavy truck market as they relate to the analysis, a description of the analysis methodology (including a discussion of the models used to estimate market potential and benefits), and a presentation of the benefits estimated as a result of the adoption of the advanced technologies. The market penetrations are used as part of the EERE-wide integrated analysis to provide final benefit estimates reported in the FY08 Budget Request. The energy savings models are utilized by the VT program for internal project management purposes.

  11. Tank 241-S-106, cores 183, 184 and 187 analytical results for the final report

    Energy Technology Data Exchange (ETDEWEB)

    Esch, R.A.

    1997-06-30

    This document is the final laboratory report for tank 241-S-106 push mode core segments collected between February 12, 1997 and March 21, 1997. The segments were subsampled and analyzed in accordance with the Tank Push Mode Core Sampling and Analysis Plan (TSAP), the Tank Safety Screening Data Quality Objective (Safety DQO), the Historical Model Evaluation Data Requirements (Historical DQO) and the Data Quality Objective to Support Resolution of the Organic Complexant Safety Issue (Organic DQO). The analytical results are included in Table 1. Six of the twenty-four subsamples submitted for the differential scanning calorimetry (DSC) analysis exceeded the notification limit of 480 Joules/g stated in the DQO. Appropriate notifications were made. Total Organic Carbon (TOC) analyses were performed on all samples that produced exotherms during the DSC analysis. All results were less than the notification limit of three weight percent TOC. No cyanide analysis was performed, per agreement with the Tank Safety Program. None of the samples submitted for Total Alpha Activity exceeded notification limits as stated in the TSAP. Statistical evaluation of results by calculating the 95% upper confidence limit is not performed by the 222-S Laboratory and is not considered in this report. No core composites were created because there was insufficient solid material from any of the three core sampling events to generate a composite that would be representative of the tank contents.

  12. 77 FR 28851 - Lightweight Thermal Paper From Germany: Notice of Amended Final Results of the 2009-2010...

    Science.gov (United States)

    2012-05-16

    ... the 2009-2010 Antidumping Duty Administrative Review AGENCY: Import Administration, International... the 2009-2010 Antidumping Duty Administrative Review, 77 FR 21082 (April 9, 2012) (Final Results). On... Terpstra, Program Manager. Amended Final Results of Review After analyzing petitioner's comment, we have...

  13. 76 FR 56401 - Stainless Steel Bar from India: Final Results of the Antidumping Duty Administrative Review, and...

    Science.gov (United States)

    2011-09-13

    ... International Trade Administration Stainless Steel Bar from India: Final Results of the Antidumping Duty...'') published the preliminary results of the administrative review of the antidumping duty order on stainless.... Finally, we are announcing our revocation of the order on stainless steel bar from India, in part, with...

  14. 77 FR 39680 - Folding Metal Tables and Chairs From the People's Republic of China: Final Results of Antidumping...

    Science.gov (United States)

    2012-07-05

    ... Metal Tables and Chairs From the People's Republic of China: Final Results of Antidumping Duty... review of the antidumping duty order on folding metal tables and chairs from the People's Republic of... ``Final Results of Review'' section below. \\1\\ See Folding Metal Tables and Chairs From the People's...

  15. Safety and effectiveness of daily teriparatide for osteoporosis in patients with severe stages of chronic kidney disease: post hoc analysis of a postmarketing observational study.

    Science.gov (United States)

    Nishikawa, Atsushi; Yoshiki, Fumito; Taketsuna, Masanori; Kajimoto, Kenta; Enomoto, Hiroyuki

    2016-01-01

    Teriparatide (recombinant 1-34 N-terminal sequence of human parathyroid hormone) for the treatment of osteoporosis should be prescribed with caution in patients with severe stages of chronic kidney disease (CKD). However, in clinical settings, physicians and surgeons who treat such patients have few available options. We sought to further explore the safety and effectiveness of teriparatide for the treatment of osteoporosis in Japanese patients with severe stages of CKD. This was a post hoc analysis of a postmarketing surveillance study that included patients with osteoporosis at high risk of fracture and stage 4 or 5 CKD. Patients received subcutaneous teriparatide 20 μg daily for up to 24 months. Safety profiles were assessed by physician-reported adverse drug reactions (ADRs). Effectiveness was assessed by measuring bone formation (via procollagen type 1 N-terminal propeptide [P1NP]), bone mineral density (BMD), and the incidence of clinical vertebral or nonvertebral fragility fractures. A total of 33 patients with severe stages of CKD (stage 4, n=30; stage 5, n=3) were included. All patients were female, and 81.8% had a history of previous fracture. No serious ADRs were recorded; a total of 4 ADRs were recorded for 4 of 33 patients. Increases in BMD and P1NP levels were observed both overall and in most individual patients. New fractures occurred in 1 patient with stage 5 CKD, but not in patients with stage 4 CKD. In this post hoc analysis conducted in Japan, teriparatide appeared to be effective for the treatment of osteoporosis in elderly female patients with severe stages of CKD, and no new safety concerns were observed.

  16. A configuration space toolkit for automated spatial reasoning: Technical results and LDRD project final report

    Energy Technology Data Exchange (ETDEWEB)

    Xavier, P.G.; LaFarge, R.A.

    1997-02-01

    A robot`s configuration space (c-space) is the space of its kinematic degrees of freedom, e.g., the joint-space of an arm. Sets in c-space can be defined that characterize a variety of spatial relationships, such as contact between the robot and its environment. C-space techniques have been fundamental to research progress in areas such as motion planning and physically-based reasoning. However, practical progress has been slowed by the difficulty of implementing the c-space abstraction inside each application. For this reason, we proposed a Configuration Space Toolkit of high-performance algorithms and data structures meeting these needs. Our intent was to develop this robotics software to provide enabling technology to emerging applications that apply the c-space abstraction, such as advanced motion planning, teleoperation supervision, mechanism functional analysis, and design tools. This final report presents the research results and technical achievements of this LDRD project. Key results and achievements included (1) a hybrid Common LISP/C prototype that implements the basic C-Space abstraction, (2) a new, generic, algorithm for constructing hierarchical geometric representations, and (3) a C++ implementation of an algorithm for fast distance computation, interference detection, and c-space point-classification. Since the project conclusion, motion planning researchers in Sandia`s Intelligent Systems and Robotics Center have been using the CSTk libcstk.so C++ library. The code continues to be used, supported, and improved by projects in the ISRC.

  17. Tank 241-BY-101, cores 189 and 199 analytical results for the final report

    Energy Technology Data Exchange (ETDEWEB)

    Nuzum, J.L.

    1997-09-25

    This document is the final laboratory report for Tank 241-BY-101. Push mode core segments were removed from Pisers 10B and 10D between May 27, 1997, and June 1, 1997. Segments were received and extruded at 222-S Laboratory. Analyses were performed in accordance with Tank 241-.BY-101 Push Core Sampling and analysis Plan (TSAP) and Tank Safety Screening Data Quality Objective (DQO). None of the subsamples submitted for total alpha activity (AT) or differential scanning calorimetry (DSC) analysis exceeded the notification limits as stated in TSAP and DQO, The statistical results of the 95% confidence interval on the mean calculations are provided by the Tank Waste Remediation Systems (TWRS) Technical Basis Group, and are not considered in this report. Near Infrared Spectroscopy (NIR) analysis was requested in order to compare NIR results with those obtained from percent water gravimetry analysis (%H20) and thermal gravimetric analysis (TGA). The TWRS Technical Basis Group rescinded the request for this analysis, and neither NIR nor %H20 analyses were performed.

  18. Improved Limits On The Existence Of Dark Matter. The Final Results From The PICASSO Experiment

    Science.gov (United States)

    Kamaha, Alvine Christelle

    The final results of the PICASSO experiment, with 409 kg days of exposure collected from November 2012 to January 2014, have yielded new limits for Spin-Dependent and Spin-Independent Dark Matter interactions. The data collected and the various backgrounds were assiduously studied using Monte Carlo simulations and a new set of sophisticated analysis techniques including the wavelet analysis presented in this thesis. In general, a good suppression of most backgrounds was attained. The neutron background event rate was reduced to about a factor of 10 compared to the previous phase of the experiment. Electronic and acoustic noise events were thoroughly suppressed. A new class of "mystery events" were removed as well. All that remained was the irreducible alpha background. No signal consistent with a WIMP Dark Matter hypothesis was observed. Consequently, an exclusion curve was obtained with a minimum limit at 90% C.L. of sigmaSDchip = 0.0228 pb at a WIMP mass of 20 GeV/c2 in the Spin-Dependent sector. By combining results from 2012 and the current results, an improved constraint of sigmaSDchip (90% C.L.) = 0.0188 pb at 20 GeV/c2 was placed on the Dark Matter interaction with protons in the Fluorine nuclei used in the detectors. In addition, the new limits on WIMP-proton interactions in the Spin Independent sector exclude the DAMA/LIBRA results (at 90% C.L.) for low masses below 12 GeV/c2 and further constrain the published CRESST and CDMS Si discovery regions at low WIMP masses.

  19. 76 FR 14906 - Laminated Woven Sacks From the People's Republic of China: Final Results of First Antidumping...

    Science.gov (United States)

    2011-03-18

    ... classifications and from technical restrictions in CBP's electronic filing systems. As a result, the Department...., Fresh Garlic from the People's Republic of China: Final Results and Partial Rescission of the 14th...

  20. Tank 241-T-201, core 192 analytical results for the final report

    Energy Technology Data Exchange (ETDEWEB)

    Nuzum, J.L.

    1997-08-07

    This document is the final laboratory report for Tank 241-T-201. Push mode core segments were removed from Riser 3 between April 24, 1997, and April 25, 1997. Segments were received and extruded at 222-S Laboratory. Analyses were performed in accordance with Tank 241-T-201 Push Mode Core Sampling and Analysis Plan (TSAP) (Hu, 1997), Letter of Instruction for Core Sample Analysis of Tanks 241-T-201, 241-T-202, 241-T-203, and 241-T-204 (LOI) (Bell, 1997), Additional Core Composite Sample from Drainable Liquid Samples for Tank 241-T-2 01 (ACC) (Hall, 1997), and Safety Screening Data Quality Objective (DQO) (Dukelow, et al., 1995). None of the subsamples submitted for total alpha activity (AT) or differential scanning calorimetry (DSC) analyses exceeded the notification limits stated in DQO. The statistical results of the 95% confidence interval on the mean calculations are provided by the Tank Waste Remediation Systems Technical Basis Group, and are not considered in this report.

  1. Tank 241-AP-105, cores 208, 209 and 210, analytical results for the final report

    Energy Technology Data Exchange (ETDEWEB)

    Nuzum, J.L.

    1997-10-24

    This document is the final laboratory report for Tank 241-AP-105. Push mode core segments were removed from Risers 24 and 28 between July 2, 1997, and July 14, 1997. Segments were received and extruded at 222-S Laboratory. Analyses were performed in accordance with Tank 241-AP-105 Push Mode Core Sampling and Analysis Plan (TSAP) (Hu, 1997) and Tank Safety Screening Data Quality Objective (DQO) (Dukelow, et al., 1995). None of the subsamples submitted for total alpha activity (AT), differential scanning calorimetry (DSC) analysis, or total organic carbon (TOC) analysis exceeded the notification limits as stated in TSAP and DQO. The statistical results of the 95% confidence interval on the mean calculations are provided by the Tank Waste Remediation Systems Technical Basis Group, and are not considered in this report. Appearance and Sample Handling Two cores, each consisting of four segments, were expected from Tank 241-AP-105. Three cores were sampled, and complete cores were not obtained. TSAP states core samples should be transported to the laboratory within three calendar days from the time each segment is removed from the tank. This requirement was not met for all cores. Attachment 1 illustrates subsamples generated in the laboratory for analysis and identifies their sources. This reference also relates tank farm identification numbers to their corresponding 222-S Laboratory sample numbers.

  2. 75 FR 72788 - Wooden Bedroom Furniture From the People's Republic of China: Amended Final Results Pursuant to a...

    Science.gov (United States)

    2010-11-26

    ... International Trade Administration Wooden Bedroom Furniture From the People's Republic of China: Amended Final... administrative review (``AR'') with respect to Dongguan Bon Ten Furniture Co., Ltd. (``Bon Ten'') pursuant to 19... final results of the 2007 AR of wooden bedroom furniture (``WBF'') from the People's Republic of China...

  3. 75 FR 45605 - Stainless Steel Plate in Coils From Belgium: Correction to Notice of Final Results of Antidumping...

    Science.gov (United States)

    2010-08-03

    ... International Trade Administration Stainless Steel Plate in Coils From Belgium: Correction to Notice of Final... following notice: Stainless Steel Plate in Coils From Belgium: Final Results of Antidumping Duty... administrative review for all shipments of stainless steel plate in coils (``SSPC'') from Belgium entered, or...

  4. Nine-Year Wilkinson Microwave Anisotropy Probe (WMAP) Observations: Final Maps and Results

    Science.gov (United States)

    Bennett, C. L.; Larson, D.; Weiland, J. L.; Jaorsik, N.; Hinshaw, G.; Odegard, N.; Smith, K. M.; Hill, R. S.; Gold, B.; Halpern, M; hide

    2013-01-01

    We present the final nine-year maps and basic results from the Wilkinson Microwave Anisotropy Probe (WMAP) mission. The full nine-year analysis of the time-ordered data provides updated characterizations and calibrations of the experiment. We also provide new nine-year full sky temperature maps that were processed to reduce the asymmetry of the effective beams. Temperature and polarization sky maps are examined to separate cosmic microwave background (CMB) anisotropy from foreground emission, and both types of signals are analyzed in detail.We provide new point source catalogs as well as new diffuse and point source foreground masks. An updated template-removal process is used for cosmological analysis; new foreground fits are performed, and new foreground reduced are presented.We nowimplement an optimal C(exp -1)1 weighting to compute the temperature angular power spectrum. The WMAP mission has resulted in a highly constrained Lambda-CDM cosmological model with precise and accurate parameters in agreement with a host of other cosmological measurements. When WMAP data are combined with finer scale CMB, baryon acoustic oscillation, and Hubble constant measurements, we find that big bang nucleosynthesis is well supported and there is no compelling evidence for a non-standard number of neutrino species (N(sub eff) = 3.84 +/- 0.40). The model fit also implies that the age of the universe is (sub 0) = 13.772 +/- 0.059 Gyr, and the fit Hubble constant is H(sub 0) = 69.32 +/- 0.80 km/s/ Mpc. Inflation is also supported: the fluctuations are adiabatic, with Gaussian random phases; the detection of a deviation of the scalar spectral index from unity, reported earlier by the WMAP team, now has high statistical significance (n(sub s) = 0.9608+/-0.0080); and the universe is close to flat/Euclidean (Omega = -0.0027+0.0039/-0.0038). Overall, the WMAP mission has resulted in a reduction of the cosmological parameter volume by a factor of 68,000 for the standard six

  5. NINE-YEAR WILKINSON MICROWAVE ANISOTROPY PROBE (WMAP) OBSERVATIONS: FINAL MAPS AND RESULTS

    Energy Technology Data Exchange (ETDEWEB)

    Bennett, C. L.; Larson, D.; Weiland, J. L. [Department of Physics and Astronomy, The Johns Hopkins University, 3400 North Charles Street, Baltimore, MD 21218-2686 (United States); Jarosik, N.; Page, L. [Department of Physics, Jadwin Hall, Princeton University, Princeton, NJ 08544-0708 (United States); Hinshaw, G.; Halpern, M. [Department of Physics and Astronomy, University of British Columbia, Vancouver, BC V6T 1Z1 (Canada); Odegard, N.; Hill, R. S. [ADNET Systems, Inc., 7515 Mission Drive, Suite A100, Lanham, MD 20706 (United States); Smith, K. M. [Perimeter Institute for Theoretical Physics, Waterloo, ON N2L 2Y5 (Canada); Gold, B. [School of Physics and Astronomy, University of Minnesota, 116 Church Street S.E., Minneapolis, MN 55455 (United States); Komatsu, E. [Max-Planck-Institut für Astrophysik, Karl-Schwarzschild Str. 1, D-85741 Garching (Germany); Nolta, M. R. [Canadian Institute for Theoretical Astrophysics, 60 St. George Street, University of Toronto, Toronto, ON M5S 3H8 (Canada); Spergel, D. N. [Department of Astrophysical Sciences, Peyton Hall, Princeton University, Princeton, NJ 08544-1001 (United States); Wollack, E.; Kogut, A. [Code 665, NASA/Goddard Space Flight Center, Greenbelt, MD 20771 (United States); Dunkley, J. [Oxford Astrophysics, Denys Wilkinson Building, Keble Road, Oxford OX1 3RH (United Kingdom); Limon, M. [Columbia Astrophysics Laboratory, 550 West 120th Street, Mail Code 5247, New York, NY 10027-6902 (United States); Meyer, S. S. [Departments of Astrophysics and Physics, KICP and EFI, University of Chicago, Chicago, IL 60637 (United States); Tucker, G. S., E-mail: cbennett@jhu.edu [Department of Physics, Brown University, 182 Hope Street, Providence, RI 02912-1843 (United States); and others

    2013-10-01

    We present the final nine-year maps and basic results from the Wilkinson Microwave Anisotropy Probe (WMAP) mission. The full nine-year analysis of the time-ordered data provides updated characterizations and calibrations of the experiment. We also provide new nine-year full sky temperature maps that were processed to reduce the asymmetry of the effective beams. Temperature and polarization sky maps are examined to separate cosmic microwave background (CMB) anisotropy from foreground emission, and both types of signals are analyzed in detail. We provide new point source catalogs as well as new diffuse and point source foreground masks. An updated template-removal process is used for cosmological analysis; new foreground fits are performed, and new foreground-reduced CMB maps are presented. We now implement an optimal C {sup –1} weighting to compute the temperature angular power spectrum. The WMAP mission has resulted in a highly constrained ΛCDM cosmological model with precise and accurate parameters in agreement with a host of other cosmological measurements. When WMAP data are combined with finer scale CMB, baryon acoustic oscillation, and Hubble constant measurements, we find that big bang nucleosynthesis is well supported and there is no compelling evidence for a non-standard number of neutrino species (N {sub eff} = 3.84 ± 0.40). The model fit also implies that the age of the universe is t {sub 0} = 13.772 ± 0.059 Gyr, and the fit Hubble constant is H {sub 0} = 69.32 ± 0.80 km s{sup –1} Mpc{sup –1}. Inflation is also supported: the fluctuations are adiabatic, with Gaussian random phases; the detection of a deviation of the scalar spectral index from unity, reported earlier by the WMAP team, now has high statistical significance (n{sub s} = 0.9608 ± 0.0080); and the universe is close to flat/Euclidean (Ω{sub k} = -0.0027{sup +0.0039}{sub -0.0038}). Overall, the WMAP mission has resulted in a reduction of the cosmological parameter volume by a factor

  6. Levodopa-carbidopa intestinal gel in advanced Parkinson's disease: final 12-month, open-label results.

    Science.gov (United States)

    Fernandez, Hubert H; Standaert, David G; Hauser, Robert A; Lang, Anthony E; Fung, Victor S C; Klostermann, Fabian; Lew, Mark F; Odin, Per; Steiger, Malcolm; Yakupov, Eduard Z; Chouinard, Sylvain; Suchowersky, Oksana; Dubow, Jordan; Hall, Coleen M; Chatamra, Krai; Robieson, Weining Z; Benesh, Janet A; Espay, Alberto J

    2015-04-01

    Motor complications in Parkinson's disease (PD) are associated with long-term oral levodopa treatment and linked to pulsatile dopaminergic stimulation. L-dopa-carbidopa intestinal gel (LCIG) is delivered continuously by percutaneous endoscopic gastrojejunostomy tube (PEG-J), which reduces L-dopa-plasma-level fluctuations and can translate to reduced motor complications. We present final results of the largest international, prospective, 54-week, open-label LCIG study. PD patients with severe motor fluctuations (>3 h/day "off" time) despite optimized therapy received LCIG monotherapy. Additional PD medications were allowed >28 days post-LCIG initiation. Safety was the primary endpoint measured through adverse events (AEs), device complications, and number of completers. Secondary endpoints included diary-assessed off time, "on" time with/without troublesome dyskinesia, UPDRS, and health-related quality-of-life (HRQoL) outcomes. Of 354 enrolled patients, 324 (91.5%) received PEG-J and 272 (76.8%) completed the study. Most AEs were mild/moderate and transient; complication of device insertion (34.9%) was the most common. Twenty-seven (7.6%) patients withdrew because of AEs. Serious AEs occurred in 105 (32.4%), most commonly complication of device insertion (6.5%). Mean daily off time decreased by 4.4 h/65.6% (P advanced PD population, LCIG's safety profile consisted primarily of AEs associated with the device/procedure, l-dopa/carbidopa, and advanced PD. LCIG was generally well tolerated and demonstrated clinically significant improvements in motor function, daily activities, and HRQoL sustained over 54 weeks. © 2014 The Authors. Movement Disorders published by Wiley Periodicals, Inc. on behalf of International Parkinson and Movement Disorder Society.

  7. Final payload test results for the RemoveDebris active debris removal mission

    Science.gov (United States)

    Forshaw, Jason L.; Aglietti, Guglielmo S.; Salmon, Thierry; Retat, Ingo; Roe, Mark; Burgess, Christopher; Chabot, Thomas; Pisseloup, Aurélien; Phipps, Andy; Bernal, Cesar; Chaumette, François; Pollini, Alexandre; Steyn, Willem H.

    2017-09-01

    Since the beginning of the space era, a significant amount of debris has progressively been generated in space. Active Debris Removal (ADR) missions have been suggested as a way of limiting and controlling future growth in orbital space debris by actively deploying vehicles to remove debris. The European Commission FP7-sponsored RemoveDebris mission, which started in 2013, draws on the expertise of some of Europe's most prominent space institutions in order to demonstrate key ADR technologies in a cost effective ambitious manner: net capture, harpoon capture, vision-based navigation, dragsail de-orbiting. This paper provides an overview of some of the final payload test results before launch. A comprehensive test campaign is underway on both payloads and platform. The tests aim to demonstrate both functional success of the experiments and that the experiments can survive the space environment. Space environmental tests (EVT) include vibration, thermal, vacuum or thermal-vacuum (TVAC) and in some cases EMC and shock. The test flow differs for each payload and depends on the heritage of the constituent payload parts. The paper will also provide an update to the launch, expected in 2017 from the International Space Station (ISS), and test philosophy that has been influenced from the launch and prerequisite NASA safety review for the mission. The RemoveDebris mission aims to be one of the world's first in-orbit demonstrations of key technologies for active debris removal and is a vital prerequisite to achieving the ultimate goal of a cleaner Earth orbital environment.

  8. Tank 103, 219-S Facility at 222-S Laboratory, analytical results for the final report

    Energy Technology Data Exchange (ETDEWEB)

    Fuller, R.K.

    1998-06-18

    This is the final report for the polychlorinated biphenyls analysis of Tank-103 (TK-103) in the 219-S Facility at 222-S Laboratory. Twenty 1-liter bottles (Sample numbers S98SO00074 through S98SO00093) were received from TK-103 during two sampling events, on May 5 and May 7, 1998. The samples were centrifuged to separate the solids and liquids. The centrifuged sludge was analyzed for PCBs as Aroclor mixtures. The results are discussed on page 6. The sample breakdown diagram (Page 114) provides a cross-reference of sample identification of the bulk samples to the laboratory identification number for the solids. The request for sample analysis (RSA) form is provided as Page 117. The raw data is presented on Page 43. Sample Description, Handling, and Preparation Twenty samples were received in the laboratory in 1-Liter bottles. The first 8 samples were received on May 5, 1998. There were insufficient solids to perform the requested PCB analysis and 12 additional samples were collected and received on May 7, 1998. Breakdown and sub sampling was performed on May 8, 1998. Sample number S98SO00084 was lost due to a broken bottle. Nineteen samples were centrifuged and the solids were collected in 8 centrifuge cones. After the last sample was processed, the solids were consolidated into 2 centrifuge cones. The first cone contained 9.7 grams of solid and 13.0 grams was collected in the second cone. The wet sludge from the first centrifuge cone was submitted to the laboratory for PCB analysis (sample number S98SO00102). The other sample portion (S98SO00103) was retained for possible additional analyses.

  9. 75 FR 8301 - Certain Cut-to-Length Carbon Steel Plate From the People's Republic of China: Final Results of...

    Science.gov (United States)

    2010-02-24

    ... review are addressed in the Memorandum from John M. Andersen, Acting Deputy Assistant Secretary for... Cut-To- Length Carbon Steel Plate from Finland, Germany and the United Kingdom: Final Results of...

  10. 75 FR 17122 - Stainless Steel Sheet and Strip in Coils from Mexico; Notice of Amended Final Results of...

    Science.gov (United States)

    2010-04-05

    ... does not meet the definition of a ministerial error in this case, pursuant to 19 CFR 351.224(f). Rather... the review); Polyethylene Retail Carrier Bags from Thailand: Final Results of Antidumping Duty...

  11. 78 FR 36166 - Diamond Sawblades and Parts Thereof From the People's Republic of China: Final Results of...

    Science.gov (United States)

    2013-06-17

    ... appropriate instructions to CBP based on our final results.\\6\\ \\6\\ See Non-Market Economy Antidumping... Tools Co., Task Tools & Abrasives, Wuxi Lianhua Superhard Material Tools Co., Ltd., Zhejiang Tea Import...

  12. 75 FR 62100 - Purified Carboxymethylcellulose From Mexico: Final Results of Antidumping Duty Administrative Review

    Science.gov (United States)

    2010-10-07

    ... review covers one producer/exporter, Quimica Amtex, S.A. de C.V. (Amtex). The period of review (POR) is... Carboxymethylcellulose from Mexico: Final Determination Analysis Memorandum for Quimica Amtex, S.A. de C.V.,'' dated... June 30, 2009, is as follows: Weighted- average Producer/exporter margin (percentage) Quimica Amtex, S...

  13. 76 FR 67146 - Certain Preserved Mushrooms From the People's Republic of China: Final Results of Antidumping...

    Science.gov (United States)

    2011-10-31

    ... International Trade Administration Certain Preserved Mushrooms From the People's Republic of China: Final... antidumping duty order on certain preserved mushrooms from the People's Republic of China (PRC) for Guangxi...., Ltd. (Co.) (Hongda).\\1\\ See Certain Preserved Mushrooms From the People's Republic of China...

  14. 77 FR 55808 - Certain Preserved Mushrooms From the People's Republic of China: Final Results of Antidumping...

    Science.gov (United States)

    2012-09-11

    ... International Trade Administration Certain Preserved Mushrooms From the People's Republic of China: Final... administrative review of the antidumping duty order on certain preserved mushrooms from the People's Republic of...'' section below. \\1\\ See Certain Preserved Mushrooms From the People's Republic of China: Preliminary...

  15. 76 FR 39847 - Solid Fertilizer Grade Ammonium Nitrate From the Russian Federation; Final Results of the...

    Science.gov (United States)

    2011-07-07

    ... International Trade Administration Solid Fertilizer Grade Ammonium Nitrate From the Russian Federation; Final... investigation on solid fertilizer grade ammonium nitrate (``ammonium nitrate'') from the Russian Federation...: Solid Fertilizer Grade Ammonium Nitrate From the Russian Federation, 64 FR 45236 (August 19, 1999). On...

  16. 77 FR 73979 - Magnesium Metal From the Russian Federation: Notice of Reinstated Final Results of Administrative...

    Science.gov (United States)

    2012-12-12

    ... International Trade Administration Magnesium Metal From the Russian Federation: Notice of Reinstated Final... antidumping duty order on magnesium metal from the Russian Federation covering the period April 1, 2006... Corp. v. United States, 688 F.3d 751 (Fed. Cir. 2012) (AVISMA IV); see also Magnesium Metal from the...

  17. Comparison of the effect of 18-month daily teriparatide administration on patients with rheumatoid arthritis and postmenopausal osteoporosis patients.

    Science.gov (United States)

    Ebina, K; Hashimoto, J; Shi, K; Kashii, M; Hirao, M; Yoshikawa, H

    2014-12-01

    Patients with rheumatoid arthritis showed greater response to 18-month administration of daily teriparatide especially in the increase of bone formation markers at 1 month and femoral neck bone mineral density at 18 months compared to postmenopausal osteoporosis patients. The aim of this study was to evaluate the effects of 18-month administration of daily teriparatide (TPTD) in osteoporosis patients with rheumatoid arthritis (RA) by comparing that of postmenopausal osteoporosis patients (Porosis). The effects of TPTD were examined between RA (n = 70; age 68.4 years; disease activity score assessing 28 joints with CRP [DAS28-CRP] 2.8; rheumatoid factor [RF] positivity 75.5 %) with 77.1 % of prior bisphosphonate (BP), 84.3 % of oral prednisolone (PSL) (4.4 mg/day at baseline), 25.7 % of biologics, and Porosis (n = 62; age 71.3 years) with 77.4 % of prior BP. Femoral neck (FN) bone mineral density (BMD) increase at 18 months was significantly greater in RA compared to Porosis (4.7 vs. 0.7 %, P = 0.038), whereas it was 9.7 versus 7.9 % (P = 0.736) in the lumbar spine (LS). The increase of bone formation markers (bone alkaline phosphatase [bone ALP] and N-terminal type I procollagen propeptide [PINP]) at 1 month were all significantly greater in RA compared to Porosis. A multivariate logistic regression analysis revealed that the significant indicator of 18-month BMD increase in RA was a 3-month increase of under-carboxylated osteocalcin (ucOC) for LS (β = 0.446, P = 0.005) and baseline ucOC for FN (β = 0.554, P = 0.001), in which both showed significant negative correlation with baseline PSL dose. RA showed greater response to daily TPTD administration, especially in the increase of bone formation markers at 1 month and FN BMD increase at 18 months compared to Porosis.

  18. Aespoe Pillar Stability Experiment. Final experiment design, monitoring results and observations

    Energy Technology Data Exchange (ETDEWEB)

    Andersson, Christer [Swedish Nuclear Fuel and Waste Management Co., Stockholm (Sweden); Eng, Anders [Acuo Engineering AB, Linkoeping (Sweden)

    2005-12-15

    The field part of the Aespoe Pillar Stability Experiment at the Aespoe Hard Rock Laboratory (HRL) was finished in 2004. The experiment was designed to induce and monitor the process of brittle failure, spalling, in a fractured rock mass under controlled conditions. The field part was successfully conducted and a large data set was obtained. This report presents the final design of the experiment, the results of the monitoring, and the observations made during the spalling process and when the spalled rock was removed. When heating of the rock was initiated the rock responded quickly. After only a few days the spalling process was activated in the notch, as indicated by the acoustic emission system, and shortly thereafter displacement readings were recorded. Contraction (radial expansion) of the rock was recorded by several instruments before the notch reached the instrument levels. This contraction is probably the result of a 3D re-distribution of the stresses. The temperature increase in the system was both slower and reached a steady state much earlier than predicted by the numerical models. The propagation of the notch was therefore halted after approximately one month of heating. The power to the electrical heaters was therefore doubled. Spalling then started up again, and in one month's time it had propagated to a depth of approximately five metres in the hole. A second steady state was now reached, but this time the heater power was kept constant for a while to let the rock settle before the confinement pressure was reduced from 700 kPa to 0 in decrements of 50 kPa. The rock mass response to the pressure drop was very limited until the pressure was lowered to approximately 200 kPa (the atmospheric pressure is not included in the given pressure values). Large displacements and a high acoustic emission hit frequency were then measured in the open hole. After the de-pressurization of the confined hole, the heaters were left on for approximately one week

  19. 78 FR 70533 - Certain Activated Carbon From the People's Republic of China: Final Results of Antidumping Duty...

    Science.gov (United States)

    2013-11-26

    ... Activated Carbon From the People's Republic of China: Final Results of Antidumping Duty Administrative... Preliminary Results of the fifth antidumping duty administrative review on certain activated carbon from the.... \\1\\ See Certain Activated Carbon From the People's Republic of China: Preliminary Results of the...

  20. 78 FR 22227 - Stainless Steel Bar From Brazil: Final Results of Antidumping Duty Administrative Review; 2011-2012

    Science.gov (United States)

    2013-04-15

    ... International Trade Administration Stainless Steel Bar From Brazil: Final Results of Antidumping Duty... preliminary results of the administrative review of the antidumping duty order on stainless steel bar (SSB..., through January 31, 2012. \\1\\ See Stainless Steel Bar From Brazil: Preliminary Results of Antidumping Duty...

  1. 77 FR 24459 - Stainless Steel Butt-Weld Pipe Fittings From Italy: Final Results of Antidumping Duty...

    Science.gov (United States)

    2012-04-24

    ... International Trade Administration Stainless Steel Butt-Weld Pipe Fittings From Italy: Final Results of... stainless steel butt-weld pipe fittings (SSBW pipe fittings) from Italy.\\1\\ This review covers two... results remain unchanged from the preliminary results of review. \\1\\ See Stainless Steel Butt-Weld Pipe...

  2. 77 FR 28570 - Honey From Argentina: Extension of Time Limit for the Final Results of Antidumping Duty...

    Science.gov (United States)

    2012-05-15

    ... International Trade Administration Honey From Argentina: Extension of Time Limit for the Final Results of... period of review (POR) of honey from Argentina. See Honey From Argentina: Preliminary Results of.../exporters of honey from Argentina during the POR.\\1\\ \\1\\ See Preliminary Results for a detailed history of...

  3. 78 FR 37794 - Polyvinyl Alcohol from Taiwan: Final Results of Antidumping Duty Administrative Review; 2010-2012

    Science.gov (United States)

    2013-06-24

    ... International Trade Administration Polyvinyl Alcohol from Taiwan: Final Results of Antidumping Duty... results of the administrative review of the antidumping duty order on polyvinyl alcohol (PVA) from Taiwan... February 29, 2012. \\1\\ See Polyvinyl Alcohol From Taiwan: Preliminary Results of Antidumping Duty...

  4. Short-term effects of teriparatide versus placebo on bone biomarkers, structure, and fracture healing in women with lower-extremity stress fractures: A pilot study.

    Science.gov (United States)

    Almirol, Ellen A; Chi, Lisa Y; Khurana, Bharti; Hurwitz, Shelley; Bluman, Eric M; Chiodo, Christopher; Matzkin, Elizabeth; Baima, Jennifer; LeBoff, Meryl S

    2016-09-01

    In this pilot, placebo-controlled study, we evaluated whether brief administration of teriparatide (TPTD) in premenopausal women with lower-extremity stress fractures would increase markers of bone formation in advance of bone resorption, improve bone structure, and hasten fracture healing according to magnetic resonance imaging (MRI). Premenopausal women with acute lower-extremity stress fractures were randomized to injection of TPTD 20-µg subcutaneous (s.c.) (n = 6) or placebo s.c. (n = 7) for 8 weeks. Biomarkers for bone formation N-terminal propeptide of type I procollagen (P1NP) and osteocalcin (OC) and resorption collagen type-1 cross-linked C-telopeptide (CTX) and collagen type 1 cross-linked N-telopeptide (NTX) were measured at baseline, 4 and 8 weeks. The area between the percent change of P1NP and CTX over study duration is defined as the anabolic window. To assess structural changes, peripheral quantitative computed topography (pQCT) was measured at baseline, 8 and 12 weeks at the unaffected tibia and distal radius. The MRI of the affected bone assessed stress fracture healing at baseline and 8 weeks. After 8 weeks of treatment, bone biomarkers P1NP and OC increased more in the TPTD- versus placebo-treated group (both p ≤ 0.01), resulting in a marked anabolic window (p ≤ 0.05). Results from pQCT demonstrated that TPTD-treated women showed a larger cortical area and thickness compared to placebo at the weight bearing tibial site, while placebo-treated women had a greater total tibia and cortical density. No changes at the radial sites were observed between groups. According to MRI, 83.3% of the TPTD- and 57.1% of the placebo-treated group had improved or healed stress fractures (p = 0.18). In this randomized, pilot study, brief administration of TPTD showed anabolic effects that TPTD may help hasten fracture healing in premenopausal women with lower-extremity stress fractures. Larger prospective studies are warranted to determine

  5. Results of a research study on the impact of active daylighting on operating results of a retail business. Final report

    Energy Technology Data Exchange (ETDEWEB)

    1993-04-01

    In preliminary evaluations of So-Luminaire`s (SI) product in 1985 and 1986, DOE concluded that it warranted further research and evaluation and was worthy of receiving governmental financial and structural support therefor. SI, along with Safeway, had known intuitively that the So-Luminaire systems which had been previously installed in several of their Phoenix-area stores had resulted in a marked reduction in electrical energy consumption. However, a definitive determination of energy savings had been utilized in previous installations. Further, SI and Safeway both hypothesized that the high quality of natural light provided by these systems displayed goods to greater advantage and contributed to an overall increase in store sales, all other factors being held constant. A study to attempt to objectively determine these two presumed benefits of active daylighting in a commercial application was begun.

  6. Waste compatibility safety issues and final results for tank 241-T-110 push mode samples

    Energy Technology Data Exchange (ETDEWEB)

    Nuzum, J.L.

    1997-05-15

    This document is the final laboratory report for Tank 241-T-110. Push mode core segments were removed from risers 2 and 6 between January 29, 1997, and February 7, 1997. Segments were received and extruded at 222-S Laboratory. Analyses were performed in accordance with Tank 241-T-110 Push Mode Core Sampling and analysis Plan (TSAP) and Safety Screening Data Quality Objective (DQO). None of the subsamples submitted for total alpha activity (AT) or differential scanning calorimetry (DSC) analyses exceeded the notification limits stated in DQO.

  7. 76 FR 60803 - Certain Lined Paper Products From People's Republic of China: Final Results of Antidumping Duty...

    Science.gov (United States)

    2011-09-30

    ... International Trade Administration Certain Lined Paper Products From People's Republic of China: Final Results... Products from People's Republic of China: Initiation and Preliminary Results of Changed Circumstances... Less Than Fair Value: Certain Lined Paper Products from the People's Republic of China; Notice of...

  8. 78 FR 14269 - Folding Gift Boxes From the People's Republic of China: Final Results of the Second Sunset Review...

    Science.gov (United States)

    2013-03-05

    ... parties an opportunity to comment on the preliminary results. The Folding Gift Boxes Fair Trade Coalition... International Trade Administration Folding Gift Boxes From the People's Republic of China: Final Results of the..., International Trade Administration, Department of Commerce. SUMMARY: On October 26, 2012, the Department of...

  9. 76 FR 54206 - Gray Portland Cement and Clinker From Japan: Final Results of the Expedited Third Sunset Review...

    Science.gov (United States)

    2011-08-31

    ... International Trade Administration Gray Portland Cement and Clinker From Japan: Final Results of the Expedited... review of the antidumping duty order on gray portland cement and clinker from Japan. As a result of this... duty order on gray portland cement and clinker from Japan \\1\\ pursuant to section 751(c) of the Tariff...

  10. 78 FR 34342 - Certain Circular Welded Non-Alloy Steel Pipe From Mexico: Final Results and Partial Rescission of...

    Science.gov (United States)

    2013-06-07

    ... International Trade Administration Certain Circular Welded Non-Alloy Steel Pipe From Mexico: Final Results and... duty order on certain circular welded non- alloy steel pipe from Mexico.\\1\\ This administrative review.... \\1\\ See Certain Circular Welded Non-Alloy Steel Pipe From Mexico: Preliminary Results and Partial...

  11. 76 FR 77770 - Certain Circular Welded Non-Alloy Steel Pipe From Mexico: Final Results of Antidumping Duty...

    Science.gov (United States)

    2011-12-14

    ... International Trade Administration Certain Circular Welded Non-Alloy Steel Pipe From Mexico: Final Results of... welded non- alloy steel pipe from Mexico.\\1\\ This administrative review covers mandatory respondents... Certain Circular Welded Non-Alloy Steel Pipe From Mexico: Preliminary Results of Antidumping Duty...

  12. 78 FR 79664 - Certain Circular Welded Non-Alloy Steel Pipe From Mexico: Final Results of the 2011-2012...

    Science.gov (United States)

    2013-12-31

    ... Circular Welded Non-Alloy Steel Pipe From Mexico: Final Results of the 2011-2012 Antidumping Duty... circular welded non-alloy steel pipe from Mexico for the period November 1, 2011 through October 31, 2012... Non-Alloy Steel Pipe from Mexico: Preliminary Results and Partial Rescission of Antidumping Duty...

  13. 77 FR 13545 - Carbon and Certain Alloy Steel Wire Rod From Mexico: Notice of Final Results of Antidumping Duty...

    Science.gov (United States)

    2012-03-07

    ... International Trade Administration Carbon and Certain Alloy Steel Wire Rod From Mexico: Notice of Final Results... duty order on carbon and certain alloy steel wire rod (wire rod) from Mexico.\\1\\ This review covers.... \\1\\ See Carbon and Certain Alloy Steel Wire Rod from Mexico: Notice of Preliminary Results of...

  14. 75 FR 20342 - Certain Circular Welded Non-Alloy Steel Pipe From Mexico: Final Results of Antidumping Duty...

    Science.gov (United States)

    2010-04-19

    ... International Trade Administration Certain Circular Welded Non-Alloy Steel Pipe From Mexico: Final Results of... antidumping duty order on certain circular welded non- alloy steel pipe from Mexico. See Certain Circular Welded Non-Alloy Steel Pipe From Mexico; Preliminary Results of Antidumping Duty Administrative Review...

  15. 78 FR 28190 - Carbon and Certain Alloy Steel Wire Rod From Mexico: Final Results of Antidumping Duty...

    Science.gov (United States)

    2013-05-14

    ... International Trade Administration Carbon and Certain Alloy Steel Wire Rod From Mexico: Final Results of... carbon and certain alloy steel wire rod (wire rod) from Mexico. The period of review (POR) is October 1... (the Act). \\1\\ See Carbon and Certain Alloy Steel Wire Rod From Mexico: Preliminary Results of...

  16. 77 FR 38271 - Stainless Steel Bar From Japan: Final Results of Antidumping Duty Changed-Circumstances Review...

    Science.gov (United States)

    2012-06-27

    ... International Trade Administration Stainless Steel Bar From Japan: Final Results of Antidumping Duty Changed... changed-circumstances review with intent to revoke in part the order on stainless steel bar (SSBar) from... February 1, 2010. \\1\\ See Stainless Steel Bar From Japan: Initiation and Preliminary Results of Antidumping...

  17. 77 FR 21963 - Stainless Steel Plate in Coils From Belgium: Notice of Final Results of Antidumping Duty Changed...

    Science.gov (United States)

    2012-04-12

    ... International Trade Administration Stainless Steel Plate in Coils From Belgium: Notice of Final Results of... that Aperam Stainless Belgium N.V. (``Aperam'') is the successor-in- interest to ArcelorMittal Stainless Belgium N.V. (``AMSB''). As a result, Aperam will be accorded the same treatment previously...

  18. 76 FR 4289 - Honey From the People's Republic of China: Final Results and Rescission of Antidumping Duty New...

    Science.gov (United States)

    2011-01-25

    ... International Trade Administration Honey From the People's Republic of China: Final Results and Rescission of... Suzhou Shanding Honey Product Co., Ltd. (``Suzhou'') and Wuhu Fenglian Co., Ltd. (``Fenglian''), the... results, the Department has rescinded the review with respect to Suzhou and Fenglian. \\1\\ See Honey From...

  19. 77 FR 41744 - Hand Trucks and Certain Parts Thereof From the People's Republic of China: Final Results of...

    Science.gov (United States)

    2012-07-16

    ... International Trade Administration Hand Trucks and Certain Parts Thereof From the People's Republic of China... preliminary results of administrative review of the antidumping duty order on hand trucks and certain parts... changes to the margin calculations for the final results. \\1\\ See Hand Trucks and Certain Parts Thereof...

  20. Tank 241-BY-111, cores 168 and 171 analytical results for the final report

    Energy Technology Data Exchange (ETDEWEB)

    Nuzum, J.L.

    1997-05-02

    This document is the final laboratory report for Tank 241-BY-111. Push mode core segments were removed from risers 15 and 12A between August 13, 1996, and September 3, 1996. Segments were received and extruded at 222-S Laboratory. Analyses were performed in accordance with Tank 241-BY-111 Rotary Mode Core Sampling and Analysis Plan (TSAP) (Kruger, 1996) and Safety Screening Data Quality Objective (DQO) (Dukelow, et al., 1995). None of the subsamples submitted for total alpha activity (AT) or differential scanning calorimetry (DSC) analyses exceeded the notification limits stated in DQO. Two cores of nine segments were expected from this tank. Sampling problems prevented the acquisition of complete cores. Attachment 1 illustrates subsamples generated in the laboratory for analysis and identifies their sources. This reference also relates tank farm identification numbers to their corresponding 222-S Laboratory Information Management System (LIMS) sample numbers.

  1. Teriparatide use during an economic crisis: baseline data from the Greek cohort of the Extended Forsteo Observational Study (ExFOS).

    Science.gov (United States)

    Aloumanis, Kyriakos; Kapetanos, George; Bartzis, Nikolaos; Drossinos, Vangelis

    2015-06-05

    The Extended Forsteo Observational Study (ExFOS) is a multinational, non-interventional, prospective, observational study that aims to provide real-life data on patients with osteoporosis treated with teriparatide for up to 24 months. It includes the new indications of osteoporosis in men and glucocorticoid-induced osteoporosis (GIOP). We describe the Greek subpopulation enrolled in this study and compare it with a similar cohort from the previous European Forsteo Observational Study (EFOS). Baseline data were collected from the Greek cohort of ExFOS. Data included demographic characteristics, medical and osteoporosis history, disease status, prior use of medications, back pain and quality of life. Baseline data for 439 patients, enrolled at 31 sites, indicated the majority of patients were females (92.3%), elderly [mean (standard deviation; SD) age 70.1 (9.8) years] and slightly overweight [mean (SD) body mass index 26.7 (4.3) kg/m(2)], with very low bone mineral density (mean T-score EFOS cohorts; however, the rate of enrolment was faster in ExFOS (by approximately 45%) and a history of fracture was recorded in 53.8% of female patients in ExFOS versus 74.5% in EFOS. Greek patients prescribed teriparatide in ExFOS had severe osteoporosis with a high risk of fractures and back pain. Female patients shared similarities with EFOS counterparts, reflecting a constant prescribing profile for use of teriparatide, although a noticeable difference in fracture history between the two study cohorts may indicate a change towards prescribing in less severely affected patients. The economic crisis in Greece did not appear to affect patient enrolment. Data are interpreted in the context of an observational setting.

  2. Teriparatid - das erste knochenanabole Behandlungsprinzip für Patienten mit fortgeschrittener Osteoporose: Grundlagen und Überblick über die klinischen Ergebnisse

    Directory of Open Access Journals (Sweden)

    Dobnig H

    2004-01-01

    Full Text Available PTH (1-34 ist ein neues, knochenanaboles Medikament, das speziell für die Behandlung von Patienten mit schwerer bzw. fortgeschrittener Osteoporose entwickelt wurde. Es ist bislang die einzige Substanz, die eine mangelhafte Mikrostruktur des Knochens zu bessern vermag. Teriparatid wirkt sowohl auf den trabekulären wie auch kortikalen Knochen anabol, der neue Knochen zeigt hierbei einen normalen Aufbau. Eine große, randomisierte, doppelblinde und placebokontrollierte Studie zeigte deutliche Reduktionen von vertebralen und auch nicht-vertebralen Frakturen bei gleichzeitig günstigem Nebenwirkungsprofil.

  3. 77 FR 33420 - Certain Activated Carbon From the People's Republic of China: Final Results of Expedited Sunset...

    Science.gov (United States)

    2012-06-06

    ... International Trade Administration Certain Activated Carbon From the People's Republic of China: Final Results... certain activated carbon from the People's Republic of China (``PRC'') pursuant to section 751(c) of the... certain activated carbon from the PRC would be likely to lead to continuation or recurrence of dumping at...

  4. 77 FR 20788 - Foundry Coke Products From the People's Republic of China: Final Results of Expedited Second...

    Science.gov (United States)

    2012-04-06

    ... International Trade Administration Foundry Coke Products From the People's Republic of China: Final Results of... coke products (``foundry coke'') from the People's Republic of China (``PRC'') pursuant to section 751... Than Fair Value and Antidumping Duty Order: Foundry Coke Products from The People's Republic of China...

  5. 75 FR 38985 - Certain Frozen Fish Fillets From the Socialist Republic of Vietnam: Final Results of the Fifth...

    Science.gov (United States)

    2010-07-07

    ... International Trade Administration Certain Frozen Fish Fillets From the Socialist Republic of Vietnam: Final Results of the Fifth New Shipper Review AGENCY: Import Administration, International Trade Administration... review of the antidumping duty order on certain frozen fish fillets from the Socialist Republic of...

  6. 75 FR 61122 - Certain Frozen Warmwater Shrimp From the Socialist Republic of Vietnam: Amended Final Results of...

    Science.gov (United States)

    2010-10-04

    ...) (``Final Results''). On August 10, 2010, Minh Phu Seafood Corporation (and its affiliates Minh Qui Seafood....95 Minh Phat Seafood aka Minh Phu Seafood Export Import Corporation (and affiliates Minh Qui Seafood... Corporation aka Minh Qui Seafood aka Minh Qui Seafood Co., Ltd. Nha Trang Seaproduct Company (``Nha Trang 5.58...

  7. 76 FR 6601 - Certain Pasta From Italy: Notice of Amended Final Results of the Thirteenth Antidumping Duty...

    Science.gov (United States)

    2011-02-07

    ... a ministerial error with respect to the financial expense ratio (INTEX) used in the calculation of... calculation of the financial expense ratio. In the Final Results, the Department correctly stated that we... financial expense ratios to include expenses for Granoro's testing of pasta. See Issues and Decision...

  8. 75 FR 12726 - Certain Frozen Fish Fillets from the Socialist Republic of Vietnam: Final Results of the...

    Science.gov (United States)

    2010-03-17

    ... single entity in these final results. Similarly, the Department is treating Vinh Hoan, Vinh Hoan USA Inc. (``Vinh Hoan USA''), and Van Duc Food Export Joint Stock Company (``Van Duc``) as a single entity. Section... INLFPWUWOG B. Inflation of Certain Surrogate Values Comment 7: Appropriate Rate for East Sea Seafood JVC/East...

  9. 78 FR 16247 - Corrosion-Resistant Carbon Steel Flat Products From the Republic of Korea; Final Results of...

    Science.gov (United States)

    2013-03-14

    ... International Trade Administration Corrosion-Resistant Carbon Steel Flat Products From the Republic of Korea... antidumping duty order on corrosion-resistant carbon steel flat products (CORE) from the Republic of Korea... section entitled ``Final Results of Review.'' \\1\\ See Certain Corrosion-Resistant Carbon Steel Flat...

  10. 75 FR 44939 - Natural Bristle Paint Brushes and Brush Heads from the People's Republic of China: Final Results...

    Science.gov (United States)

    2010-07-30

    ... Bristle Paint Brushes and Brush Heads from the People's Republic of China: Final Results of Changed... duty order on natural bristle paint brushes and brush heads from the People's Republic of China (``PRC... antidumping duty order on natural paint brushes and brush head in March 1986. See Antidumping Duty Order...

  11. 77 FR 1915 - Light-Walled Rectangular Pipe and Tube From Mexico; Final Results of Antidumping Duty...

    Science.gov (United States)

    2012-01-12

    ... Rectangular Pipe and Tube from Mexico'' from Christian Marsh, Deputy Assistant Secretary for Antidumping and... International Trade Administration Light-Walled Rectangular Pipe and Tube From Mexico; Final Results of... antidumping duty order on light-walled rectangular pipe and tube from Mexico.\\1\\ This administrative review...

  12. 75 FR 62765 - Carbazole Violet Pigment 23 From India: Final Results of Antidumping Duty Changed-Circumstances...

    Science.gov (United States)

    2010-10-13

    ... International Trade Administration Carbazole Violet Pigment 23 From India: Final Results of Antidumping Duty... 751(b) of the Tariff Act of 1930, as amended (the Act), that Meghmani Pigments is the successor-in...)(3), we preliminarily found that Meghmani Pigments is the successor-in-interest to Alpanil Industries...

  13. 75 FR 13257 - Carbazole Violet Pigment 23 from India: Final Results of the Expedited Five-year (Sunset) Review...

    Science.gov (United States)

    2010-03-19

    ... International Trade Administration Carbazole Violet Pigment 23 from India: Final Results of the Expedited Five... Pigment 23 (CVP-23) ] from India pursuant to section 751(c) of the Tariff Act of 1930, as amended (the Act... merchandise includes the crude pigment in any form (e.g., dry powder, paste, wet cake) and finished pigment in...

  14. 75 FR 65450 - Magnesium Metal From the People's Republic of China: Final Results of the 2008-2009 Antidumping...

    Science.gov (United States)

    2010-10-25

    ... reagent mixtures, including lime, calcium metal, calcium silicon, calcium carbide, calcium carbonate, carbon, slag coagulants, fluorspar, nephaline syenite, feldspar, alumina (Al203), calcium aluminate, soda... amended (``the Act''), we verified the information submitted by TMI for use in our final results of review...

  15. 77 FR 10477 - Silicon Metal From the People's Republic of China: Final Results of the Expedited Third Sunset...

    Science.gov (United States)

    2012-02-22

    ... International Trade Administration Silicon Metal From the People's Republic of China: Final Results of the... (``the Department'') initiated the third sunset review of the antidumping duty order on silicon metal..., the Department conducted an expedited (120-day) sunset review of the antidumping duty order on silicon...

  16. 78 FR 61334 - Silicon Metal From the Russian Federation: Final Results of the Expedited Second Sunset Review of...

    Science.gov (United States)

    2013-10-03

    ... International Trade Administration Silicon Metal From the Russian Federation: Final Results of the Expedited... silicon metal from the Russian Federation.\\1\\ The Department finds that revocation of this antidumping...-0197. SUPPLEMENTARY INFORMATION: Background The antidumping duty order on silicon metal from the...

  17. 75 FR 1592 - Silicon Metal from the People's Republic of China: Final Results and Partial Rescission of...

    Science.gov (United States)

    2010-01-12

    ... International Trade Administration A-570-806 Silicon Metal from the People's Republic of China: Final Results... administrative review of the antidumping duty order on silicon metal from the People's Republic of China (``PRC... value during the period of review (``POR''), June 1, 2007, through May 31, 2008. \\1\\ See Silicon Metal...

  18. 75 FR 20812 - Silicon Metal from Brazil: Amended Final Results of Administrative Review Pursuant to Court Decision

    Science.gov (United States)

    2010-04-21

    ... International Trade Administration Silicon Metal from Brazil: Amended Final Results of Administrative Review... Commerce (``the Department'') regarding the administrative review of the antidumping duty order on Silicon Metal from Brazil for the period of review beginning July 1, 1996, through June 30, 1997. See Silicon...

  19. 76 FR 36086 - Certain Circular Welded Non-Alloy Steel Pipe From Mexico: Final Results of Antidumping Duty...

    Science.gov (United States)

    2011-06-21

    ... International Trade Administration Certain Circular Welded Non-Alloy Steel Pipe From Mexico: Final Results of... welded non- alloy steel pipe from Mexico. See Certain Circular Welded Non-Alloy Steel Pipe From Mexico... Antidumping Duty Changed Circumstances Review: Certain Circular Welded Non-Alloy Steel Pipe from Mexico, 75 FR...

  20. 78 FR 60850 - Carbon and Certain Alloy Steel Wire Rod From Brazil: Final Results of the Expedited Second Sunset...

    Science.gov (United States)

    2013-10-02

    ... International Trade Administration Carbon and Certain Alloy Steel Wire Rod From Brazil: Final Results of the... certain alloy steel wire rod (wire rod) from Brazil would be likely to lead to continuation or recurrence... Alloy Steel Wire Rod from Brazil, 67 FR 55805 (August 30, 2002). \\2\\ See Initiation of Five-Year...

  1. 78 FR 17637 - Certain Circular Welded Non-Alloy Steel Pipe from Mexico: Notice of Amended Final Results of...

    Science.gov (United States)

    2013-03-22

    ... International Trade Administration Certain Circular Welded Non-Alloy Steel Pipe from Mexico: Notice of Amended... welded non-alloy steel pipe from Mexico. The period of review (POR) is November 1, 2007, through October 31, 2008.\\1\\ \\1\\ See Certain Circular Welded Non-Alloy Steel Pipe from Mexico: Final Results of...

  2. 76 FR 44304 - Circular Welded Non-Alloy Steel Pipe From the Republic of Korea: Amended Final Results of the...

    Science.gov (United States)

    2011-07-25

    ... International Trade Administration Circular Welded Non-Alloy Steel Pipe From the Republic of Korea: Amended..., 2009. See Circular Welded Non-Alloy Steel Pipe From the Republic of Korea: Final Results of the... during the period of review. See Circular Welded Non-Alloy Steel Pipe From the Republic of Korea...

  3. 75 FR 73033 - Circular Welded Carbon Steel Pipes and Tubes from Thailand: Amended Final Results of Antidumping...

    Science.gov (United States)

    2010-11-29

    ... February 28, 2009. The final results were subsequently released to all parties in the proceeding, and... respondent in this administrative review, Saha Thai Steel Pipe (Public) Company, Limited (Saha Thai), that... and Tubes from Thailand: Saha Thai Steel Pipe (Public) Company Ltd.,'' dated November 19, 2010...

  4. 76 FR 13357 - Stainless Steel Sheet and Strip in Coils From Mexico; Correction Notice to Amended Final Results...

    Science.gov (United States)

    2011-03-11

    ... International Trade Administration Stainless Steel Sheet and Strip in Coils From Mexico; Correction Notice to... administrative review for stainless steel sheet and strip in coils from Mexico. See Stainless Steel Sheet and.... See Stainless Steel Sheet and Strip in Coils from Mexico; Final Results of Antidumping Duty...

  5. 75 FR 62103 - Stainless Steel Plate in Coils From South Africa: Final Results of Expedited Sunset Review

    Science.gov (United States)

    2010-10-07

    ... International Trade Administration Stainless Steel Plate in Coils From South Africa: Final Results of Expedited... review of the countervailing duty order (``CVD'') on stainless steel plate in coils from South Africa... review of the CVD order on stainless steel plate in coils from South Africa pursuant to section 751(c) of...

  6. 76 FR 5331 - Forged Stainless Steel Flanges From India and Taiwan: Final Results of Sunset Reviews and...

    Science.gov (United States)

    2011-01-31

    ... International Trade Administration Forged Stainless Steel Flanges From India and Taiwan: Final Results of Sunset...) initiated the sunset review of the antidumping duty orders on forged stainless steel flanges from India and...: Background On February 9, 1994, the Department issued antidumping duty orders on certain forged stainless...

  7. 76 FR 25666 - Stainless Steel Plate in Coils from Belgium: Final Results of Full Sunset Review and Revocation...

    Science.gov (United States)

    2011-05-05

    ... International Trade Administration Stainless Steel Plate in Coils from Belgium: Final Results of Full Sunset... plate in coils from Belgium (``SSPC'' or ``subject merchandise'') pursuant to section 751(c) of the... responses from ArcelorMittal Stainless Belgium N.V. (``AMS'') and the Government of Belgium (``GOB''), the...

  8. 77 FR 58524 - Honey From Argentina; Final Results of Sunset Reviews and Revocation of Antidumping Duty and...

    Science.gov (United States)

    2012-09-21

    ... International Trade Administration Honey From Argentina; Final Results of Sunset Reviews and Revocation of...) initiated sunset reviews of the antidumping duty and countervailing duty orders on honey from Argentina.\\1... deadline, the Department is revoking the antidumping duty and countervailing duty orders on honey from...

  9. 77 FR 59896 - Honey From the People's Republic of China: Final Results of Expedited Sunset Review of the...

    Science.gov (United States)

    2012-10-01

    ... International Trade Administration Honey From the People's Republic of China: Final Results of Expedited Sunset... the second five-year (``sunset'') review of the antidumping duty order on honey from the People's... Department finds that revocation of the antidumping duty order on honey from the PRC would be likely to lead...

  10. 75 FR 29314 - Hand Trucks and Parts Thereof from the People's Republic of China: Final Results of Antidumping...

    Science.gov (United States)

    2010-05-25

    ... International Trade Administration Hand Trucks and Parts Thereof from the People's Republic of China: Final... order on hand trucks and certain parts thereof from the People's Republic of China (PRC). The review... preliminary results of administrative review of the antidumping duty order on hand trucks and certain parts...

  11. 77 FR 73021 - Lemon Juice From Argentina: Final Results of the Expedited First Sunset Review of the Suspended...

    Science.gov (United States)

    2012-12-07

    ... International Trade Administration Lemon Juice From Argentina: Final Results of the Expedited First Sunset... sunset review of the suspended antidumping duty investigation on lemon juice from Argentina. The..., 2012, the Department initiated a sunset review of the suspended antidumping duty investigation on lemon...

  12. 75 FR 61130 - Fresh Garlic From the People's Republic of China: Final Results of New Shipper Review

    Science.gov (United States)

    2010-10-04

    ... International Trade Administration Fresh Garlic From the People's Republic of China: Final Results of New...-line Trading Co. Ltd. (Qingdao Sea- line) under the antidumping duty order on fresh garlic from the... its eligibility for separate rate. See Fresh Garlic From the People's Republic of China: Preliminary...

  13. 77 FR 34346 - Fresh Garlic from the People's Republic of China: Final Results of the 2009-2010 Administrative...

    Science.gov (United States)

    2012-06-11

    ... International Trade Administration Fresh Garlic from the People's Republic of China: Final Results of the 2009... duty order on fresh garlic from the People's Republic of China (PRC) covering the two mandatory.../exporters who certified no sales, exports or entries. See Fresh Garlic From the People's Republic of China...

  14. 75 FR 34976 - Fresh Garlic from the People's Republic of China: Final Results and Partial Rescission of the...

    Science.gov (United States)

    2010-06-21

    ... International Trade Administration Fresh Garlic from the People's Republic of China: Final Results and Partial... antidumping duty order on fresh garlic from the People's Republic of China (PRC) covering the period of review (POR) of November 1, 2007, through October 31, 2008. See Fresh Garlic from the People's Republic of...

  15. 77 FR 777 - Fresh Garlic From the People's Republic of China: Final Results of Expedited Sunset Review of the...

    Science.gov (United States)

    2012-01-06

    ... International Trade Administration Fresh Garlic From the People's Republic of China: Final Results of Expedited...) initiated the third sunset review of the antidumping duty order fresh garlic from the People's Republic of... fresh garlic from the PRC pursuant to section 751(c) of the Act. See Initiation of Five-Year (``Sunset...

  16. 76 FR 56397 - Small Diameter Graphite Electrodes from the People's Republic of China: Final Results of the...

    Science.gov (United States)

    2011-09-13

    ... International Trade Administration Small Diameter Graphite Electrodes from the People's Republic of China: Final... results of the first administrative review of the antidumping duty order on small diameter graphite..., through January 31, 2010. See Small Diameter Graphite Electrodes from the People's Republic of China...

  17. Tank 241-SY-102 January 2000 Compatibility Grab Samples Analytical Results for the Final Report [SEC 1 and 2

    Energy Technology Data Exchange (ETDEWEB)

    BELL, K.E.

    2000-05-11

    This document is the format IV, final report for the tank 241-SY-102 (SY-102) grab samples taken in January 2000 to address waste compatibility concerns. Chemical, radiochemical, and physical analyses on the tank SY-102 samples were performed as directed in Comparability Grab Sampling and Analysis Plan for Fiscal Year 2000 (Sasaki 1999). No notification limits were exceeded. Preliminary data on samples 2SY-99-5, -6, and -7 were reported in ''Format II Report on Tank 241-SY-102 Waste Compatibility Grab Samples Taken in January 2000'' (Lockrem 2000). The data presented here represent the final results.

  18. 78 FR 4386 - Chlorinated Isocyanurates From the People's Republic of China: Final Results of Antidumping Duty...

    Science.gov (United States)

    2013-01-22

    ... Date: January 22, 2013. FOR FURTHER INFORMATION CONTACT: Emily Halle or Andrew Huston, AD/CVD... As a Result of the Government Closure During Hurricane Sandy,'' dated October 31, 2012. Scope of the...

  19. Tank 241-A-101 cores 154 and 156 analytical results for the final report

    Energy Technology Data Exchange (ETDEWEB)

    Steen, F.H.

    1997-05-02

    This report contains tables of the analytical results from sampling Tank 241-A-101 for the following: fluorides, chlorides, nitrites, bromides, nitrates, phosphates, sulfates, and oxalates. This tank is listed on the Hydrogen Watch List.

  20. Driving simulator test results Deliverable no D6.3. Final draft

    NARCIS (Netherlands)

    Weiland, J.; Mattes, S.; Kuhn, F.; Gelau, Ch.; Schindhelm, R.; Hoedemaeker, D.D.M.

    2003-01-01

    Deliverable 6.3 reports the procedure and results from a driving simulator study. This study was carried out to test the efficiency of the principles of the in-vehicle information manager, which was developed within the Comunicar project. Thirty-six subjects were tested in a fixed-base driving

  1. The influence of experimental conditions on the final result of photoinhibition of Staphylococcus aureus.

    Science.gov (United States)

    Decarli, M C; Corrêa, T Q; Vollet-Filho, J D; Bagnato, V S; Souza, C W O

    2017-09-01

    By and large, phototherapies are a promising approach to promote inactivation of microorganisms using light exposure, providing an effective alternative to control multidrug-resistant bacterial infections. Considering this, intercomparison between experiments is vitally important. Most experiments are performed using multiwell plates in which the volume of the culture medium is not standardized. In such cases, light attenuation and the distance it travels, which also depends on the volume and vessel geometry, can lead to different results. This study investigated how the different volumes imply different depths that light will have to travel through in this volume and the relation of this parameter with the result that will be obtained. Staphylococcus aureus was exposed to 460nm light with 50, 100 and 200J/cm 2 , in 100, 200, 500 and 1000μL of inocula in a 24-well plate to investigate pure light inactivation. The literature suggests that fluence is the most important light parameter to obtain a high eradication of microbial cells in phototherapies. Our results show evidence that different geometrical configurations, taking into account the volume of the vessels, clearly affect the in vitro results, risking misinterpretation of dosimetry studies. Effects, such as dose distribution and decantation, are discussed throughout the paper. The outcome strongly depends on the volume and vessel geometry used. This study aims to encourage the standardization of phototherapies in vitro in general. Copyright © 2017 Elsevier B.V. All rights reserved.

  2. 78 FR 9884 - Purified Carboxymethylcellulose From the Netherlands: Final Results of Antidumping Duty...

    Science.gov (United States)

    2013-02-12

    ... covers two respondents, Akzo Nobel Functional Chemicals B.V. (Akzo Nobel) and CP Kelco B.V. (CP Kelco... Preliminary Results, we received a no-shipment claim from CP Kelco, and we confirmed this claim with U.S. Customs and Border Protection (CBP). Because we find that the record indicates that CP Kelco did not...

  3. 78 FR 78812 - Purified Carboxymethylcellulose From the Netherlands: Final Results of Antidumping Duty...

    Science.gov (United States)

    2013-12-27

    ... to find that sales of subject merchandise by Akzo Nobel Functional Chemicals, B.V. (Akzo Nobel) were made at less than normal value, and that CP Kelco, B.V. (CP Kelco) had no shipments of subject... noted in the Preliminary Results,\\3\\ we received a no-shipment claim from CP Kelco, and we confirmed...

  4. 1999 Transit customer satisfaction index : final report : results of survey and conclusions

    Science.gov (United States)

    2000-10-01

    The purpose of this report is to provide an overview of the results and analysis of the data collected in the 1999 Florida Transit Properties Customer Satisfaction Index project, as well as to briefly review the data sources and the weighting methodo...

  5. 76 FR 70112 - Certain Preserved Mushrooms From the People's Republic of China: Amended Final Results of...

    Science.gov (United States)

    2011-11-10

    ... International Trade Administration Certain Preserved Mushrooms From the People's Republic of China: Amended... results of administrative review of the antidumping duty order on certain preserved mushrooms from the People's Republic of China (PRC). See Certain Preserved Mushrooms From the People's Republic of China...

  6. 78 FR 14075 - Certain Orange Juice From Brazil; Notice of Amended Final Results of Antidumping Duty...

    Science.gov (United States)

    2013-03-04

    ... results, Fischer S.A. Comercio, Industria, and Agricultura (Fischer) filed a lawsuit with the United..., Industria, and Agricultura v. United States, 700 F. Supp. 1364, 1381 (Ct. Int'l Trade 2010). \\3\\ See Fischer S.A. Comercio, Industria, and Agricultura v. United States, 746 F. Supp. 1353, 1357 (Ct. Int'l Trade...

  7. Tank 241-AX-103, cores 212 and 214 analytical results for the final report

    Energy Technology Data Exchange (ETDEWEB)

    Steen, F.H.

    1998-02-05

    This document is the analytical laboratory report for tank 241-AX-103 push mode core segments collected between July 30, 1997 and August 11, 1997. The segments were subsampled and analyzed in accordance with the Tank 241-AX-103 Push Mode Core Sampling and Analysis Plan (TSAP) (Comer, 1997), the Safety Screening Data Quality Objective (DQO) (Dukelow, et al., 1995) and the Data Quality Objective to Support Resolution of the Organic Complexant Safety Issue (Organic DQO) (Turner, et al., 1995). The analytical results are included in the data summary table (Table 1). None of the samples submitted for Differential Scanning Calorimetry (DSC), Total Alpha Activity (AT), plutonium 239 (Pu239), and Total Organic Carbon (TOC) exceeded notification limits as stated in the TSAP (Conner, 1997). The statistical results of the 95% confidence interval on the mean calculations are provided by the Tank Waste Remediation Systems Technical Basis Group in accordance with the Memorandum of Understanding (Schreiber, 1997) and not considered in this report.

  8. Conceptual design and systems analysis of photovoltaic systems. Volume II. Study results. Final report

    Energy Technology Data Exchange (ETDEWEB)

    Kirpich, A.

    1977-03-19

    This investigation of terrestrial PV systems considered the technical and economic feasibility for systems in three size categories: a small system of about 12 kW peak output for on-site residential use; a large 1500 MW central power plant contributing to the bulk energy of a utility system power grid; and an intermediate size system of about 250 kW for use on public or commercial buildings. In each category, conceptual designs were developed, performance was analyzed for a range of climatic regions, economic analyses were performed, and assessments were made of pertinent institutional issues. The report consists of three volumes. Volume I contains a Study Summary of the major study results. This volume contains the detailed results pertaining to on-site residential photovoltaic systems, central power plant photovoltaic systems, and intermediate size systems applied to commercial and public buildings. Volume III contains supporting appendix material. (WHK)

  9. The Materosion project, a sediment cascade modeling for torrential sediment transfers: final results and perspectives

    Science.gov (United States)

    Rudaz, Benjamin; Loye, Alexandre; Mazotti, Benoit; Bardou, Eric; Jaboyedoff, Michel

    2013-04-01

    The Materosion project, conducted between the swiss canton of Valais (CREALP) and University of Lausanne (CRET) aims at forecasting sediment transfer in alpine torrents using the sediment cascade concept. The study site is the high Anniviers valley, around the village of Zinal (Valais). The torrents are divided in homogeneous reaches, to and from which sediments are transported by debris flows and bedload transport events. The model runs simulations of 100 years, with a 1-month time step, each with a given a random meteorological event ranging from no activity up to high magnitude debris flows. These events are calibrated using local rain data and observed corresponding debris flow frequencies. The model is applied to ten torrent systems with variable geological context, watershed geometries and sediment supplies. Given the high number of possible event scenarios, 10'000 simulations per torrent are performed, giving a statistical distribution of cumulated volumes and an event size distribution. A way to visualize the complex results data is proposed, and a back-analysis of the internal sediment cascade dynamic is performed. The back-analysis shows that the results' distribution stabilize after ~5'000 simulations. The model results, especially the range of debris flow volumes are crucial to maintain mitigation measures such as retention dams, and give clues for future sediment cascade modeling.

  10. Efficacy and safety of teriparatide in bisphosphonate-pretreated and treatment-naive patients with osteoporosis at high risk of fracture: Post hoc analysis of a prospective observational study.

    Science.gov (United States)

    Yoshiki, Fumito; Nishikawa, Atsushi; Taketsuna, Masanori; Kajimoto, Kenta; Enomoto, Hiroyuki

    2017-03-01

    Teriparatide is the first anabolic agent shown to reduce the risk of fractures in patients with osteoporosis. In Japan, teriparatide is prescribed to treat patients at high risk of fracture. Given that bisphosphonates are commonly used prior to teriparatide as treatment for osteoporosis, information on the effectiveness and safety of teriparatide with or without previous bisphosphonate treatment is helpful for physicians in clinical practice. This study aims to report the effectiveness and safety of teriparatide in treatment-naive and bisphosphonate-pretreated patients in Japan as real-world evidence. A post hoc analysis of a postmarketing surveillance study was conducted in Japanese patients with osteoporosis at high risk of fracture who received 24-month treatment of daily teriparatide. Changes in bone turnover biomarkers and bone mineral density and incidence of new fractures were analyzed in treatment-naive as well as bisphosphonate-pretreated patients. The analysis included 1433 patients (treatment-naive, n = 659; bisphosphonate-pretreated, n = 774). Bone mineral density increased significantly from baseline at 24 months in both treatment-naive (lumbar spine, 13.45%; femoral neck, 5.16%; total hip, 4.46%) and bisphosphonate-pretreated (lumbar spine, 11.20%; femoral neck, 2.22%; total hip, 0.67%) patients. The incidence rates of new vertebral and nonvertebral fractures at 24 months were 1.69% and 3.37%, respectively, in treatment-naive patients and 3.60% and 5.56%, respectively, in bisphosphonate-pretreated patients. The incidence of adverse drug reactions was 6% in treatment-naive patients and 10% in bisphosphonate-pretreated patients. The most common adverse drug reaction in treatment-naive and bisphosphonate-pretreated patients was nausea (0.91%) and hyperuricaemia (1.81%), respectively. In this post hoc analysis, no new safety concerns and similar effectiveness of teriparatide were observed in Japanese patients with osteoporosis at high risk of fracture

  11. FINAL REPORT FOR INDEPENDENT CONFIRMATORY SURVEY SUMMARY AND RESULTS FOR THE HEMATITE DECOMMISSIONING PROJECT, FESTUS, MISSOURI

    Energy Technology Data Exchange (ETDEWEB)

    Bailey, Erika N.; Lee, Jason D.

    2012-09-21

    ORAU conducted confirmatory surveys of the Hematite site during the period of June 12 through June 13, 2012. The survey activities included in-process inspections, document review, walkover surveys, sampling activities, and laboratory analysis of split samples. WEC was forthcoming with information relating to practices, procedures, and surface scan results. Scans performed by the WEC technician were extremely thorough and methodical. The WEC and ORAU technicians identified the same areas of elevated activity with comparable detector responses. WEC sampling of re-use soils, waste soils, sediments, and groundwater were conducted under ORAU observation. The sampling efforts observed by ORAU were performed in accordance with site-specific procedures and in a manner sufficient to provide quality supporting data. Three observations were made during groundwater sampling activities. First, the water level indicator was re-used without submitting rinse blank. Second, bubbles created during tubing extraction could indicate the presence of volatilized organic compounds. Third, samplers did not use a photo ionization detector prior to sample collection to indicate the presence of volatile organic vapors. Results of split samples indicated a high level of comparability between the WEC and ORAU/ORISE radiological laboratories. Analytical practices and procedures appear to be sufficient in providing quality radiochemical data. All concentrations from the Soil Re-Use Area and sediment samples are below Uniform radionuclide-specific derived concentration guideline level (DCGL{sub W}) limits; thus, comparisons to the less conservative stratified geometry were not required. Results were compared to individual DCGLs and using the sum of fractions approach. Both composite soil samples collected from the Waste Handling Area (Bins 1 and 4) were well below the prescribed USEI waste acceptance criteria.

  12. Demonstration project Klaipeda, Lithuania. Final evaluation of 2. year results after rehabilitation

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    2000-08-01

    In order to investigate various options for reducing the district heating return temperature and for introducing energy saving measures in the buildings in Klaipeda, a demonstration area comprising eight buildings was selected. The eight buildings selected were typical 5-floor buildings built in 1982-89. This enabled the experience from the project to be transferred to a maximum number of buildings in Klaipeda and in Lithuania, in general. The existing heating system in all the buildings consisted of a hydro-elevator system and a one-string radiator system. The hot tap water preparation was a tube heat exchanger and a circulation pipe including towel dryers. Since 1991, the supply temperature in the Klaipeda district heating system has been reduced due to shortage of fuel. This has led to a lower indoor temperature, which has decreased from the design value 18 deg. C to 15 deg. C in 1997 and 1998. In 1999, the supply temperature was, however, raised again. With a low room temperature, the improved installations often tend to result in better comfort rather than in energy savings. The project has been implemented during a three-year period from the heating season 97/98 to 99/00. Before the first heating season 97/98, energy and flow meters were installed for measuring the existing heating and hot water consumption in each building. For the second heating season 98/99, various energy saving measures were installed, and measurements were carried out again. After that, the energy consumption and temperature levels were analysed and compared for the two seasons. The results are shown in this report. In the third heating season 99/00, an extra set of measurements was carried out in order to verify the results from the season from 98/99 and to analyse the development in the savings and temperatures. (au)

  13. ECLSS Sustaining Metal Materials Compatibility Final Report, Electrochemical and Crevice Corrosion Test Results

    Science.gov (United States)

    Lee, R. E.

    2015-01-01

    Electrochemical test results are presented for six noble metals evaluated in two acidic test solutions which are representative of waste liquids processed in the Environmental Control and Life Support System (ECLSS) aboard the International Space Station (ISS). The two test solutions consisted of fresh waste liquid which had been modified with a proposed or alternate pretreatment formulation and its associated brine concentrate. The six test metals included three titanium grades, (Commercially Pure, 6Al-4V alloy and 6Al-4V Low Interstitial alloy), two nickel-chromium alloys (Inconel® 625 and Hastelloy® C276), and one high tier stainless steel (Cronidur® 30).

  14. Tank 241-S-102, Core 232 analytical results for the final report

    Energy Technology Data Exchange (ETDEWEB)

    STEEN, F.H.

    1998-11-04

    This document is the analytical laboratory report for tank 241-S-102 push mode core segments collected between March 5, 1998 and April 2, 1998. The segments were subsampled and analyzed in accordance with the Tank 241-S-102 Retained Gas Sampler System Sampling and Analysis Plan (TSAP) (McCain, 1998), Letter of Instruction for Compatibility Analysis of Samples from Tank 241-S-102 (LOI) (Thompson, 1998) and the Data Quality Objectives for Tank Farms Waste Compatibility Program (DQO) (Mulkey and Miller, 1998). The analytical results are included in the data summary table (Table 1).

  15. 60-Day waste compatibility safety issues and final results for AY-102 grab samples

    Energy Technology Data Exchange (ETDEWEB)

    Nuzum, J.L.

    1997-01-31

    Four grab samples (2AY-96-15, 2AY-96-16, 2AY-96-17, and 2AY-96-18) were taken from Riser 15D of Tank 241-AY-102 on October 8, 1996, and received by 222-S Laboratory on October 8, 1996. These samples were analyzed in accordance with Compatibility Grab Sampling and Analysis Plan (TSAP) and Data Quality Objectives for Tank Farms Waste Compatibility Program (DQO) in support of the Waste Compatibility Program. No notifications were required based on sample results.

  16. Tank 241-B-108, cores 172 and 173 analytical results for the final report

    Energy Technology Data Exchange (ETDEWEB)

    Nuzum, J.L., Fluoro Daniel Hanford

    1997-03-04

    The Data Summary Table (Table 3) included in this report compiles analytical results in compliance with all applicable DQOS. Liquid subsamples that were prepared for analysis by an acid adjustment of the direct subsample are indicated by a `D` in the A column in Table 3. Solid subsamples that were prepared for analysis by performing a fusion digest are indicated by an `F` in the A column in Table 3. Solid subsamples that were prepared for analysis by performing a water digest are indicated by a I.wl. or an `I` in the A column of Table 3. Due to poor precision and accuracy in original analysis of both Lower Half Segment 2 of Core 173 and the core composite of Core 173, fusion and water digests were performed for a second time. Precision and accuracy improved with the repreparation of Core 173 Composite. Analyses with the repreparation of Lower Half Segment 2 of Core 173 did not show improvement and suggest sample heterogeneity. Results from both preparations are included in Table 3.

  17. Tank 241-T-203, core 190 analytical results for the final report

    Energy Technology Data Exchange (ETDEWEB)

    Steen, F.H.

    1997-08-05

    This document is the analytical laboratory report for tank 241-T-203 push mode core segments collected on April 17, 1997 and April 18, 1997. The segments were subsainpled and analyzed in accordance with the Tank 241-T-203 Push Mode Core Sampling andanalysis Plan (TSAP) (Schreiber, 1997a), the Safety Screening Data Quality Objective (DQO)(Dukelow, et al., 1995) and Leffer oflnstructionfor Core Sample Analysis of Tanks 241-T-201, 241-T-202, 241-T-203, and 241-T-204 (LOI)(Hall, 1997). The analytical results are included in the data summary report (Table 1). None of the samples submitted for Differential Scanning Calorimetry (DSC), Total Alpha Activity (AT) and Total Organic Carbon (TOC) exceeded notification limits as stated in the TSAP (Schreiber, 1997a). The statistical results of the 95% confidence interval on the mean calculations are provided by the Tank Waste Remediation Systems (TWRS) Technical Basis Group in accordance with the Memorandum of Understanding (Schreiber, 1997b) and not considered in this report.

  18. Tank 241-TX-118, core 236 analytical results for the final report

    Energy Technology Data Exchange (ETDEWEB)

    ESCH, R.A.

    1998-11-19

    This document is the analytical laboratory report for tank 241-TX-118 push mode core segments collected between April 1, 1998 and April 13, 1998. The segments were subsampled and analyzed in accordance with the Tank 241-TX-118 Push Mode Core sampling and Analysis Plan (TSAP) (Benar, 1997), the Safety Screening Data Quality Objective (DQO) (Dukelow, et al., 1995), the Data Quality Objective to Support Resolution of the Organic Complexant Safety Issue (Organic DQO) (Turner, et al, 1995) and the Historical Model Evaluation Data Requirements (Historical DQO) (Sipson, et al., 1995). The analytical results are included in the data summary table (Table 1). None of the samples submitted for Differential Scanning Calorimetry (DSC) and Total Organic Carbon (TOC) exceeded notification limits as stated in the TSAP (Benar, 1997). One sample exceeded the Total Alpha Activity (AT) analysis notification limit of 38.4{micro}Ci/g (based on a bulk density of 1.6), core 236 segment 1 lower half solids (S98T001524). Appropriate notifications were made. Plutonium 239/240 analysis was requested as a secondary analysis. The statistical results of the 95% confidence interval on the mean calculations are provided by the Tank Waste Remediation Systems Technical Basis Group in accordance with the Memorandum of Understanding (Schreiber, 1997) and are not considered in this report.

  19. Final results of a long-term, clinical follow-up in fatty liver patients

    DEFF Research Database (Denmark)

    Dam-Larsen, Sanne; Becker, Ulrik; Franzmann, Maria-Benedicte

    2009-01-01

    OBJECTIVE: There is increasing focus on non-alcoholic fatty liver disease (NAFLD). The aim of the present study was to conduct a long-term clinical follow-up of patients with biopsy-confirmed fatty liver without inflammation or significant fibrosis (pure fatty liver), to analyse for potential risk...... factors at the time of index liver biopsy important for survival and the development of cirrhosis and to describe the causes of death. MATERIAL AND METHODS: Patients were linked through their personal identification number to the Danish National Registry of Patients and the Register of Causes of Death....... All admissions, discharge diagnoses and causes of death during follow-up were collected. All surviving patients were invited to a clinical follow-up. RESULTS: The follow-up period was 20.4 and 21.0 years, respectively, for the NAFLD and alcoholic fatty liver disease (AFLD) groups. Two NAFLD patients...

  20. Final Results from the Novel Multi-turn Extraction Studies at CERN Proton Synchrotron

    CERN Document Server

    Cappi, R; Giovannozzi, Massimo; Martini, M; Métral, E; Müller, A S; Steerenberg, R

    2005-01-01

    Recently a novel approach to perform multi-turn extraction was proposed based on beam splitting in the transverse phase space by means of trapping inside stable islands. An experimental campaign was launched since the year 2002 to assess the feasibility of such an extraction scheme at the CERN Proton Synchrotron. During the year 2004 run, a high-intensity single-bunch beam was successfully split and the generated beamlets separated without any measurable losses. The latest experimental results are presented and discussed in details in this paper. These achievements represent a substantial step forward with respect to what achieved in previous years, as only a low-intensity bunch could be split without losses. Furthermore, this opens the possibility of using such a technique for routine operation with the high-intensity proton beams required for the planned CERN Neutrino to Gran Sasso Project.

  1. Gravity Probe B: final results of a space experiment to test general relativity.

    Science.gov (United States)

    Everitt, C W F; DeBra, D B; Parkinson, B W; Turneaure, J P; Conklin, J W; Heifetz, M I; Keiser, G M; Silbergleit, A S; Holmes, T; Kolodziejczak, J; Al-Meshari, M; Mester, J C; Muhlfelder, B; Solomonik, V G; Stahl, K; Worden, P W; Bencze, W; Buchman, S; Clarke, B; Al-Jadaan, A; Al-Jibreen, H; Li, J; Lipa, J A; Lockhart, J M; Al-Suwaidan, B; Taber, M; Wang, S

    2011-06-03

    Gravity Probe B, launched 20 April 2004, is a space experiment testing two fundamental predictions of Einstein's theory of general relativity (GR), the geodetic and frame-dragging effects, by means of cryogenic gyroscopes in Earth orbit. Data collection started 28 August 2004 and ended 14 August 2005. Analysis of the data from all four gyroscopes results in a geodetic drift rate of -6601.8±18.3  mas/yr and a frame-dragging drift rate of -37.2±7.2  mas/yr, to be compared with the GR predictions of -6606.1  mas/yr and -39.2  mas/yr, respectively ("mas" is milliarcsecond; 1  mas=4.848×10(-9)  rad).

  2. Tank 241-TX-104, cores 230 and 231 analytical results for the final report

    Energy Technology Data Exchange (ETDEWEB)

    Diaz, L.A.

    1998-07-07

    This document is the analytical laboratory report for tank 241-TX-104 push mode core segments collected between February 18, 1998 and February 23, 1998. The segments were subsampled and analyzed in accordance with the Tank 241-TX-104 Push Mode Core Sampling and Analysis Plan (TSAP) (McCain, 1997), the Data Quality Objective to Support Resolution of the Organic Complexant Safety Issue (Organic DQO) (Turner, et al., 1995) and the Safety Screening Data Quality Objective (DQO) (Dukelow, et.al., 1995). The analytical results are included in the data summary table. None of the samples submitted for Differential Scanning Calorimetry (DSC) and Total Alpha Activity (AT) exceeded notification limits as stated in the TSAP. The statistical results of the 95% confidence interval on the mean calculations are provided by the Tank Waste Remediation Systems Technical Basis Group in accordance with the Memorandum of Understanding (Schreiber, 1997) and are not considered in this report. Appearance and Sample Handling Attachment 1 is a cross reference to relate the tank farm identification numbers to the 222-S Laboratory LabCore/LIMS sample numbers. The subsamples generated in the laboratory for analyses are identified in these diagrams with their sources shown. Core 230: Three push mode core segments were removed from tank 241-TX-104 riser 9A on February 18, 1998. Segments were received by the 222-S Laboratory on February 19, 1998. Two segments were expected for this core. However, due to poor sample recovery, an additional segment was taken and identified as 2A. Core 231: Four push mode core segments were removed from tank 241-TX-104 riser 13A between February 19, 1998 and February 23, 1998. Segments were received by the 222-S Laboratory on February 24, 1998. Two segments were expected for this core. However, due to poor sample recovery, additional segments were taken and identified as 2A and 2B. The TSAP states the core samples should be transported to the laboratory within three

  3. Tank 241-AN-103, cores 166 and 167 analytical results for the final report

    Energy Technology Data Exchange (ETDEWEB)

    Steen, F.H.

    1997-05-15

    This document is the analytical laboratory report for tank 241-AN-103 [Hydrogen Watch Listed] push mode core segments collected between September 13, 1996 and September 23, 1996. The segments were subsampled and analyzed in accordance with the Tank 241-AN-103 Push Mode Core Sampling and Analysis Plan (TSAP), the Safety Screening Data Quality Objective (DQO) and the Flammable Gas Data Quality Objective (DQO). The analytical results are included in the data summary table. The raw data are included in this document. None of the samples submitted for Total Alpha Activity (AT), Total Organic Carbon (TOC) and Plutonium analyses exceeded notification limits as stated in the TSAP. One sample submitted for Differential Scanning Calorimetry (DSC) analysis exceeded the notification limit of 480 Joules/g (dry weight basis) as stated in the Safety Screening DQO. Appropriate notifications were made. Statistical evaluation of results by calculating the 95% upper confidence limit is not performed by the 222-S Laboratory and is not considered in this report. Appearance and Sample Handling Attachment 1 is a cross reference to relate the tank farm identification numbers to the 222-S Laboratory LabCore/LIMS sample numbers. The subsamples generated in the laboratory for analyses are identified in these diagrams with their sources shown. The diagrams identifying the core composites are also included. Core 166 Nineteen push mode core segments were removed from tank 241-AN-103 riser 12A between September 13, 1996 and September 17, 1996. Segments were received by the 222-S Laboratory between September 20, 1996 and September 30, 1996. Table 2 summarizes the extrusion information. Selected segments (2, 5 and 14) were sampled using the Retained Gas Sampler (RGS) and extruded by the Process Chemistry and Statistical Analysis Group. Core 167 Eighteen push mode core segments were removed from tank 241-AN-103 riser 21A between September 18, 1996 and September 23, 1996. Tank Farm Operations were

  4. Final binary star results from the ESO VLT Lunar occultations program

    Energy Technology Data Exchange (ETDEWEB)

    Richichi, A. [National Astronomical Research Institute of Thailand, 191 Siriphanich Bldg., Huay Kaew Road, Suthep, Muang, Chiang Mai 50200 (Thailand); Fors, O. [Departament Astronomia i Meteorologia and Institut de Ciències del Cosmos (ICC), Universitat de Barcelona (UB/IEEC), Martí i Franqués 1, E-08028 Barcelona (Spain); Cusano, F. [INAF-Osservatorio Astronomico di Bologna, Via Ranzani 1, I-40127 Bologna (Italy); Ivanov, V. D., E-mail: andrea4work@gmail.com [European Southern Observatory, Ave. Alonso de Cordova 3107, Casilla 19001, Santiago 19 (Chile)

    2014-03-01

    We report on 13 subarcsecond binaries, detected by means of lunar occultations in the near-infrared at the ESO Very Large Telescope (VLT). They are all first-time detections except for the visual binary HD 158122, which we resolved for the first time in the near-infrared. The primaries have magnitudes in the range K = 4.5-10.0, and companions in the range K = 6.8-11.1. The magnitude differences have a median value of 2.4, with the largest being 4.6. The projected separations are in the range of 4-168 mas, with a median of 13 mas. We discuss and compare our results with the available literature. With this paper, we conclude the mining for binary star detections in the 1226 occultations recorded at the VLT with the ISAAC instrument. We expect that the majority of these binaries may be unresolvable by adaptive optics on current telescopes, and they might be challenging for long-baseline interferometry. However, they constitute an interesting sample for future larger telescopes and for astrometric missions such as GAIA.

  5. Demonstration project Klaipeda, Lithuania. Final evaluation of 1. year results after rehabilitation

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    1999-07-01

    In order to investigate various options for reduction of the district heating return temperature and for introduction of energy saving measures in the buildings, a demonstration area comprising eight buildings was selected. The eight buildings selected were typical 5-floor buildings built in 1982-89. This enabled the experience to be transferred to a maximum number of buildings in Klaipeda and in Lithuania, in general. All buildings had a one-string radiator system installed. Since 1991, the supply temperature in Klaipeda district heating system has been reduced. This has led to a lower indoor temperature, which has decreased from the design value 18 deg. C to 15 dec. C due to shortage of fuel. With such a low room temperature, the improved sytems may result in better comfort rather than in energy savings. The project has been implemented during a two-year period from heating season 97/98 to 98/99. The first year before the heating season 97/98, energy and flow meters were installed for measuring the existing heating and hot water consumption. For the next heating season 1998/1999, various energy saving measures were installed, and measurements were caried out again. After that, the energy consumption and temperature levels were analysed and compared for the two seasons. (au)

  6. RE-1000 free-piston Stirling engine sensitivity test results. Final report

    Energy Technology Data Exchange (ETDEWEB)

    Schreiber, J.G.; Geng, S.M.; Lorenz, G.V.

    1986-10-01

    The NASA Lewis Research Center has been testing a 1 kW (1.33 hp) free-piston Stirling engine at the NASA Lewis test facilities. The tests performed over the past several years have been on a single cylinder machine known as the RE-1000. The data recorded were to aid in the investigation of the dynamics and thermodynamics of the free-piston Stirling engine. The data are intended to be used primarily for computer code validation. NASA reports TM-82999, TM-83407, and TM-87126 give initial results of the engine tests. The tests were designed to investigate the sensitivity of the engine performance to variations on the mean pressure of the working space, the working fluid used, heater and cooler temperatures, regenerator porosity, power piston mass and displacer dynamics. These tests have now been completed at NASA Lewis. This report presents some of the detailed data collected in the sensitivity tests. In all, 781 data points were recorded. A complete description of the engine and test facility is given. Many of the data can be found in tabular form, while a microfiche containing all of the data points can be requested from NASA Lewis.

  7. Final COMPASS results on the deuteron spin-dependent structure function g1d and the Bjorken sum rule

    Directory of Open Access Journals (Sweden)

    C. Adolph

    2017-06-01

    Full Text Available Final results are presented from the inclusive measurement of deep-inelastic polarised-muon scattering on longitudinally polarised deuterons using a 6LiD target. The data were taken at 160 GeV beam energy and the results are shown for the kinematic range 1(GeV/c24GeV/c2 in the mass of the hadronic final state. The deuteron double-spin asymmetry A1d and the deuteron longitudinal-spin structure function g1d are presented in bins of x and Q2. Towards lowest accessible values of x, g1d decreases and becomes consistent with zero within uncertainties. The presented final g1d values together with the recently published final g1p values of COMPASS are used to again evaluate the Bjorken sum rule and perform the QCD fit to the g1 world data at next-to-leading order of the strong coupling constant. In both cases, changes in central values of the resulting numbers are well within statistical uncertainties. The flavour-singlet axial charge a0, which is identified in the MS‾ renormalisation scheme with the total contribution of quark helicities to the nucleon spin, is extracted at next-to-leading order accuracy from only the COMPASS deuteron data: a0(Q2=3(GeV/c2=0.32±0.02stat±0.04syst±0.05evol. Together with the recent results on the proton spin structure function g1p, the results on g1d constitute the COMPASS legacy on the measurements of g1 through inclusive spin-dependent deep inelastic scattering.

  8. Final results from the 16-year sumatriptan, naratriptan, and treximet pregnancy registry.

    Science.gov (United States)

    Ephross, Sara A; Sinclair, Susan M

    2014-01-01

    To monitor for a signal of major teratogenicity by determining the risk of all birth major defects following in utero exposure to sumatriptan, naratriptan, and the sumatriptan/naproxen sodium combination product (tablets marketed in the United States as Treximet [GlaxoSmithKline, Research Triangle Park, NC, USA]), and to monitor for unusual patterns of defects that might suggest teratogenicity. The prevalence of migraine is highest in women of childbearing age. Coupled with the recurrent nature of migraine attacks and the high proportion of unplanned pregnancies, intentional and inadvertent exposure to anti-migraine drugs in pregnancy is likely. The Sumatriptan, Naratriptan, and Treximet Pregnancy Registry captured data on women exposed to those drugs during pregnancy to monitor for evidence of major teratogenicity. In this primarily prospective, observational study, health care professionals from anywhere in the world enrolled, on a voluntary basis, women exposed to sumatriptan, naratriptan, or the sumatriptan/naproxen sodium combination product during their pregnancies. Only pregnancies with unknown outcomes at the time of enrollment were included in the analysis. The proportion of infants or fetuses with major birth defects was calculated as the total number of infants/fetuses with major birth defects divided by the sum of the number of infants/fetuses with major birth defects + the number of live births without defects. The risk of major birth defects was further stratified by earliest trimester of pregnancy exposure. The registry enrolled 680 evaluable exposed pregnant women, which resulted in 689 infants and fetuses (outcomes). Of these outcomes, 626 were exposed to sumatriptan, 57 were exposed to naratriptan (seven were exposed to both sumatriptan and naratriptan), and six were exposed to the sumatriptan/naproxen sodium combination product. Twenty outcomes with major birth defects were reported among 528 outcomes exposed in the first trimester to

  9. FInal Report: Site Investigation Results, 2009-2011, at Inman, Kansas

    Energy Technology Data Exchange (ETDEWEB)

    LaFreniere, Lorraine M. [Argonne National Lab. (ANL), Argonne, IL (United States). Environmental Sciences Div.

    2015-05-01

    The Commodity Credit Corporation of the U.S. Department of Agriculture (CCC/USDA) operated a grain storage facility at the southern edge of the city of Inman, Kansas, from 1954 to 1965. During this time, commercial grain fumigants containing carbon tetrachloride were in common use by the grain storage industry to preserve grain in their facilities. In 1997, trace to low levels of carbon tetrachloride (below the maximum contamination level [MCL] of 5.0 μg/L) were detected in three private wells near the former grain storage facility at Inman, as part of a statewide USDA private well sampling program that was implemented by the Kansas Department of Health and Environment (KDHE) near former CCC/USDA facilities. No public water supply wells were identified in 1998 by the KDHE within 1 mi of the town. Carbon tetrachloride is the contaminant of primary concern at sites associated with grain storage operations. To determine whether the former CCC/USDA facility at Inman is a potential contaminant source and its possible relationship to the contamination in groundwater, the CCC/USDA agreed to conduct investigations at Inman. The investigations were performed by the Environmental Science Division of Argonne National Laboratory in accordance with the Intergovernmental Agreement between the KDHE and the Farm Service Agency of the USDA. Argonne, on behalf of the CCC/USDA, developed a Work Plan (Argonne 2007) and subsequently a Summary of Investigation Results and Proposed Work Plan (Appendix A) for a phased site investigation. The proposed work was approved by the KDHE (2007, 2011). The investigations were conducted from November 2009 to September 2011, as proposed in the two work plans. This report presents the findings of the 2009-2011 investigations at Inman.

  10. Teriparatida (PTH[1-34]rh: uma nova perspectiva no tratamento da osteoporose Teriparatide (PTH[1-34]rh: a new perspective in the treatment of osteoporosis

    Directory of Open Access Journals (Sweden)

    Juliana Helena Abreu de Oliveira

    2003-08-01

    Full Text Available No momento, as medicações aprovadas para tratamento da osteoporose agem reduzindo a taxa de perda óssea e diminuindo a reabsorção óssea. A teriparatida é um fragmento recombinante sintético de 34 aminoácidos do hormônio paratireóide humano. A teriparatida se liga ao receptor de PTH da proteína G e estimula a formação e a ação dos osteoblastos, que são as células responsáveis pela formação dos ossos. Assim, a principal diferença entre o tratamento da osteoporose com teriparatida e o tratamento anti-reabsorção é que a teriparatida promove o crescimento de osso novo. Em estudos pré-clínicos, o uso intermitente de PTH foi associado com um aumento significativo da massa óssea gradeada em diversos locais. A exposição intermitente ao PTH durante 4 a 6 semanas em modelos de animais ovariectomizados leva a um aumento da espessura do osso gradeado. Há estudos clínicos que mostram que a teriparatida aumenta significativamente a densidade óssea e diminui a incidência de fraturas osteoporóticas vertebrais e não-vertebrais nas mulheres com osteoporose pós-menopáusica e têm risco alto de fratura, e aumenta a densidade óssea nos homens com osteoporose, tanto hipogonádica como idiopática. A teriparatida é dada por injeção subcutânea diária e foi associada com um mínimo de efeitos colaterais, além de não apresentar interações medicamentosas. Sendo assim, a teriparatida surge como uma abordagem completamente nova no tratamento da osteoporose, estimulando diretamente a formação do osso.Medications currently approved for treatment of osteoporosis act by slowing the rate of bone loss and decreasing bone resorption. Teriparatide is a synthetic recombinant 34-amino-acid fragment of human parathyroid hormone. Teriparatide binds to the G protein PTH receptor and stimulates the action of osteoblasts, which are the cells responsible for bone formation. Thus the main difference between teriparatide and antiresorptive

  11. Final report : results of the 2007 targeted investigation at Hilton, Kansas.

    Energy Technology Data Exchange (ETDEWEB)

    LaFreniere, L. M.; Environmental Science Division

    2008-04-29

    The Commodity Credit Corporation (CCC), an agency of the U.S. Department of Agriculture (USDA), operated a grain storage facility in Hilton, Kansas, in 1954-1965. In 1992, carbon tetrachloride was first identified, at a concentration of 910 {micro}g/L, in groundwater from well GW01 at Hilton. This discovery occurred in association with the sale of the private grain storage facility on which well GW01 is located to the current owner, the Mid-Kansas Cooperative Association. The Kansas Department of Health and Environment conducted investigations at Hilton in 1992-1994. In 1996-1997, Argonne National Laboratory conducted Phase I and Phase II investigations on behalf of the CCC/USDA to characterize the distribution of the carbon tetrachloride contamination identified in well GW01, the stratigraphic units potentially hosting contaminant migration, and local hydrogeology in the Hilton area. The 2007 targeted investigation reported here focused specifically on the former CCC/USDA property at Hilton, west of the railroad tracks. (Until a property record search in 2005, the location of the CCC/USDA's former facility at Hilton was not known with certainty.) The objectives of the investigation, as implemented, were to (1) investigate for carbon tetrachloride contamination in the shallower soil and shallow aquifer units below the former CCC/USDA property and (2) investigate groundwater flow patterns. The key results of the 2007 targeted investigation are as follows: (1) No carbon tetrachloride or chloroform contamination was found in soil or groundwater below the former CCC/USDA facility. (2) The 2007 groundwater level data support a southwesterly direction for groundwater flow in the main Hilton aquifer (Equus Beds), consistent with findings of previous investigations. Contaminated well GW01 was confirmed to be upgradient from the former CCC/USDA facility. (3) The contaminants carbon tetrachloride, chloroform, and 1,2-dibromoethane (ethylene dibromide) were found in

  12. Intravenous thrombolysis plus hypothermia for acute treatment of ischemic stroke (ICTuS-L): final results.

    Science.gov (United States)

    Hemmen, Thomas M; Raman, Rema; Guluma, Kama Z; Meyer, Brett C; Gomes, Joao A; Cruz-Flores, Salvador; Wijman, Christine A; Rapp, Karen S; Grotta, James C; Lyden, Patrick D

    2010-10-01

    Induced hypothermia is a promising neuroprotective therapy. We studied the feasibility and safety of hypothermia and thrombolysis after acute ischemic stroke. Intravenous Thrombolysis Plus Hypothermia for Acute Treatment of Ischemic Stroke (ICTuS-L) was a randomized, multicenter trial of hypothermia and intravenous tissue plasminogen activator in patients treated within 6 hours after ischemic stroke. Enrollment was stratified to the treatment time windows 0 to 3 and 3 to 6 hours. Patients presenting within 3 hours of symptom onset received standard dose intravenous alteplase and were randomized to undergo 24 hours of endovascular cooling to 33°C followed by 12 hours of controlled rewarming or normothermia treatment. Patients presenting between 3 and 6 hours were randomized twice: to receive tissue plasminogen activator or not and to receive hypothermia or not. Results- In total, 59 patients were enrolled. One patient was enrolled but not treated when pneumonia was discovered just before treatment. All 44 patients enrolled within 3 hours and 4 of 14 patients enrolled between 3 to 6 hours received tissue plasminogen activator. Overall, 28 patients randomized to receive hypothermia (HY) and 30 to normothermia (NT). Baseline demographics and risk factors were similar between groups. Mean age was 65.5±12.1 years and baseline National Institutes of Health Stroke Scale score was 14.0±5.0; 32 (55%) were male. Cooling was achieved in all patients except 2 in whom there were technical difficulties. The median time to target temperature after catheter placement was 67 minutes (Quartile 1 57.3 to Quartile 3 99.4). At 3 months, 18% of patients treated with hypothermia had a modified Rankin Scale score of 0 or 1 versus 24% in the normothermia groups (nonsignificant). Symptomatic intracranial hemorrhage occurred in 4 patients (68); all were treated with tissue plasminogen activator <3 hours (1 received hypothermia). Six patients in the hypothermia and 5 in the normothermia

  13. Final results of the second prospective AIEOP protocol for pediatric intracranial ependymoma.

    Science.gov (United States)

    Massimino, Maura; Miceli, Rosalba; Giangaspero, Felice; Boschetti, Luna; Modena, Piergiorgio; Antonelli, Manila; Ferroli, Paolo; Bertin, Daniele; Pecori, Emilia; Valentini, Laura; Biassoni, Veronica; Garrè, Maria Luisa; Schiavello, Elisabetta; Sardi, Iacopo; Cama, Armando; Viscardi, Elisabetta; Scarzello, Giovanni; Scoccianti, Silvia; Mascarin, Maurizio; Quaglietta, Lucia; Cinalli, Giuseppe; Diletto, Barbara; Genitori, Lorenzo; Peretta, Paola; Mussano, Anna; Buccoliero, Annamaria; Calareso, Giuseppina; Barra, Salvina; Mastronuzzi, Angela; Giussani, Carlo; Marras, Carlo Efisio; Balter, Rita; Bertolini, Patrizia; Giombelli, Ermanno; La Spina, Milena; Buttarelli, Francesca R; Pollo, Bianca; Gandola, Lorenza

    2016-10-01

    This prospective study stratified patients by surgical resection (complete = NED vs incomplete = ED) and centrally reviewed histology (World Health Organization [WHO] grade II vs III). WHO grade II/NED patients received focal radiotherapy (RT) up to 59.4 Gy with 1.8 Gy/day. Grade III/NED received 4 courses of VEC (vincristine, etoposide, cyclophosphamide) after RT. ED patients received 1-4 VEC courses, second-look surgery, and 59.4 Gy followed by an 8-Gy boost in 2 fractions on still measurable residue. NED children aged 1-3 years with grade II tumors could receive 6 VEC courses alone. From January 2002 to December 2014, one hundred sixty consecutive children entered the protocol (median age, 4.9 y; males, 100). Follow-up was a median of 67 months. An infratentorial origin was identified in 110 cases. After surgery, 110 patients were NED, and 84 had grade III disease. Multiple resections were performed in 46/160 children (28.8%). A boost was given to 24/40 ED patients achieving progression-free survival (PFS) and overall survival (OS) rates of 58.1% and 68.7%, respectively, in this poor prognosis subgroup. For the whole series, 5-year PFS and OS rates were 65.4% and 81.1%, with no toxic deaths. On multivariable analysis, NED status and grade II were favorable for OS, and for PFS grade II remained favorable. In a multicenter collaboration, this trial accrued the highest number of patients published so far, and results are comparable to the best single-institution series. The RT boost, when feasible, seemed effective in improving prognosis. Even after multiple procedures, complete resection confirmed its prognostic strength, along with tumor grade. Biological parameters emerging in this series will be the object of future correlatives and reports. © The Author(s) 2016. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

  14. NEOShield-2 Project: Final Results on Compositional Characterization of small NEOs

    Science.gov (United States)

    Barucci, Maria Antonieta; Perna, Davide; Fornasier, Sonia; Doressoundiram, Alain; Lantz, Cateline; Popescu, Marcel; Merlin, Frederic; Fulchignoni, Marcello

    2017-10-01

    NEOShield-2 project was selected in the framework of the European Commission H2020 program in answer to the call for “Access technologies and characterisation for Near Earth Objects (NEOs)”. NEOShield-2 project (2015-2017) is a follow-up of the first NEOShield (2012-2015) and includes 11 European Institutions and Industries. The main objectives of NEOShield-2 project are: i) technological development on techniques and instruments needed for GNC for possible asteroid missions and ii) characterization of NEOs of small sizes.Our team at LESIA is the leader of the entire observational program which involved complementary techniques to provide physical and compositional characterization of NEOs. Priority has been given to potential space-mission targets, optimized for mitigation or exploration missions. In this framework an agreement with the European Southern Observatory was signed to obtain Guaranteed Time Observations at the 3.6-meter NTT with an allocation of 30 nights to characterize by spectroscopy the composition of the smaller asteroids. The objects with an absolute magnitude larger than 20 were selected, with a priority for the very small newly discovered objects.We obtained more than 170 new spectra of NEOs. The observations were performed with EFOSC2 instrument. We covered the wavelength interval 0.4-0.92 microns, with a resolution of R=~200. The observed asteroids include 29 asteroids with diameters smaller than 100 meters and 71 with diameters between 100 and 300 m.The taxonomic type has been assigned for 137 individual objects. Our results on NEO mineralogical compositions provide a body of reference data directly applicable to the design and development of mitigation-relevant space missions. Within our survey, we found eight D-types with ΔV proximity, represent the best candidates currently known for a sample-return mission to a D-type primitive asteroid.Acknowledgments: The authors acknowledge the NEOShield-2 funding by European Commission Horizon

  15. Tank 40 final sludge batch 9 chemical and fissile radionuclide characterization results

    Energy Technology Data Exchange (ETDEWEB)

    Bannochie, C. J. [Savannah River Site (SRS), Aiken, SC (United States). Savannah River National Lab. (SRNL); Kubilius, W. P. [Savannah River Site (SRS), Aiken, SC (United States). Savannah River National Lab. (SRNL); Pareizs, J. M. [Savannah River Site (SRS), Aiken, SC (United States). Savannah River National Lab. (SRNL)

    2017-06-26

    A sample of Sludge Batch (SB) 9 was pulled from Tank 40 in order to obtain radionuclide inventory analyses necessary for compliance with the Waste Acceptance Product Specifications (WAPS)i. The SB9 WAPS sample was also analyzed for chemical composition, including noble metals, and fissile constituents, and these results are reported here. These analyses along with the WAPS radionuclide analyses will help define the composition of the sludge in Tank 40 that is fed to the Defense Waste Processing Facility (DWPF) as SB9. At the Savannah River National Laboratory (SRNL), the 3-L Tank 40 SB9 sample was transferred from the shipping container into a 4-L high density polyethylene bottle and solids were allowed to settle. Supernate was then siphoned off and circulated through the shipping container to complete the transfer of the sample. Following thorough mixing of the 3-L sample, a 547 g sub-sample was removed. This sub-sample was then utilized for all subsequent slurry sample preparations. Eight separate aliquots of the slurry were digested, four with HNO3/HCl (aqua regiaii) in sealed Teflon® vessels and four with NaOH/Na2O2 (alkali or peroxide fusioniii) using Zr crucibles. Three Analytical Reference Glass – 1iv (ARG-1) standards were digested along with a blank for each preparation. Each aqua regia digestion and blank was diluted to 1:100 with deionized water and submitted to Analytical Development (AD) for inductively coupled plasma – atomic emission spectroscopy (ICP-AES) analysis, inductively coupled plasma – mass spectrometry (ICP-MS) analysis, atomic absorption spectroscopy (AA) for As and Se, and cold vapor atomic absorption spectroscopy (CV-AA) for Hg. Equivalent dilutions of the alkali fusion digestions and blank were submitted to AD for ICP-AES analysis. Tank 40 SB9 supernate was collected from a mixed slurry sample in the SRNL Shielded Cells and submitted to AD for ICP-AES, ion chromatography (IC), total base/free OH-/other base, total inorganic

  16. Design, Manufacturing Status, First Results of the LHC Main Dipole Final Prototypes and Steps towards Series Manufacture

    CERN Document Server

    Artoos, K; Fessia, P; Bajko, M; Modena, M; Pagano, O; Perini, D; Savary, F; Scandale, Walter; Siemko, A; Spigo, G; Todesco, Ezio; Vlogaert, J; Wyss, C

    2000-01-01

    This paper reports about the program of six LHC superconducting main dipole final prototypes and the steps towards series manufacture. The above program, launched in summer 1998, relies on collared coils manufactured by industry and cold masses assembled at the CERN Magnet Assembly Facility. Following design, stability and robustness studies, the magnet design for series manufacture features a "6-block" coil and austenitic steel collars. A general description of the magnet with its main components is given and the main working parameters and the most important manufacturing features are presented. Results of mechanical and magnetic measurements are given as well as the performances of the first prototype. A comparison with results from the previous generation of dipole magnet models and prototypes is also made. Finally an outlook towards series manufacture is given.

  17. The Factors Influencing Depression Endpoints Research (FINDER study: final results of Italian patients with depression

    Directory of Open Access Journals (Sweden)

    Quail Deborah

    2010-07-01

    Full Text Available Abstract Background Factors Influencing Depression Endpoints Research (FINDER is a 6-month, prospective, observational study carried out in 12 European countries aimed at investigating health-related quality of life (HRQoL in outpatients receiving treatment for a first or new depressive episode. The Italian HRQoL data at 6 months is described in this report, and the factors associated with HRQoL changes were determined. Methods Data were collected at baseline, 3 and 6 months of treatment. HRQoL was measured using components of the 36-item Short Form Health Survey (SF-36; mental component summary (MCS, physical component summary (PCS and the European Quality of Life-5 Dimensions (EQ-5D; visual analogue scale (VAS and health status index (HSI. The Hospital Anxiety and Depression Scale (HADS was adopted to evaluate depressive symptoms, while somatic and painful physical symptoms were assessed by using the 28-item Somatic Symptom Inventory (SSI-28 and a VAS. Results Of the initial 513 patients, 472 completed the 3-month observation and 466 the 6-month observation. The SF-36 and EQ-5D mean (± SD scores showed HRQoL improvements at 3 months and a further smaller improvement at 6 months, with the most positive effects for SF-36 MCS (baseline 22.0 ± 9.2, 3 months 34.6 ± 10.0; 6 months 39.3 ± 9.5 and EQ-5D HSI (baseline 0.4 ± 0.3; 3 months 0.7 ± 0.3; 6 months 0.7 ± 0.2. Depression and anxiety symptoms (HADS-D mean at baseline 13.3 ± 4.2; HADS-A mean at baseline 12.2 ± 3.9 consistently decreased during the first 3 months (8.7 ± 4.3; 7.5 ± 3.6 and showed a further positive change at 6 months (6.9 ± 4.3; 5.8 ± 3.4. Somatic and painful symptoms (SSI and VAS significantly decreased, with the most positive changes in the SSI-28 somatic item (mean at baseline 2.4 ± 0.7; mean change at 3 months: -0.5; 95% CI -0.6 to -0.5; mean change at 6 months: -0.7; 95% CI -0.8 to -0.7; in 'interference of overall pain with daily activities' (mean at baseline 45

  18. Present status and first results of the final focus beam line at the KEK Accelerator Test Facility

    CERN Document Server

    Bambade, P; Amann, J; Angal-Kalinin, D; Apsimon, R; Araki, S; Aryshev, A; Bai, S; Bellomo, P; Bett, D; Blair, G; Bolzon, B; Boogert, S; Boorman, G; Burrows, P N; Christian, G; Coe, P; Constance, B; Delahaye, J P; Deacon, L; Elsen, E; Faus-Golfe, A; Fukuda, M; Gao, J; Geffroy, N; Gianfelice-Wendt, E; Guler, H; Hayano, H; Heo, A Y; Honda, Y; Huang, J Y; Hwang, W H; Iwashita, Y; Jeremie, A; Jones, J; Kamiya, Y; Karataev, P; Kim, E S; Kim, H S; Kim, S H; Komamiya, S; Kubo, K; Kume, T; Kuroda, S; Lam, B; Lyapin, A; Masuzawa, M; McCormick, D; Molloy, S; Naito, T; Nakamura, T; Nelson, J; Okamoto, D; Okugi, T; Oroku, M; Park, Y J; Parker, B; Paterson, E; Perry, C; Pivi, M; Raubenheimer, T; Renier, Y; Resta-Lopez, J; Rimbault, C; Ross, M; Sanuki, T; Scarfe, A; Schulte, D; Seryi, A; Spencer, C; Suehara, T; Sugahara, R; Swinson, C; Takahashi, T; Tauchi, T; Terunuma, N; Tomas, R; Urakawa, J; Urner, D; Verderi, M; Wang, M H; Warden, M; Wendt, M; White, G; Wittmer, W; Wolski, A; Woodley, M; Yamaguchi, Y; Yamanaka, T; Yan, Y; Yoda, H; Yokoya, K; Zhou, F; Zimmermann, F; 10.1103/PhysRevSTAB.13.042801

    2010-01-01

    ATF2 is a final-focus test beam line which aims to focus the low emittance beam from the ATF damping ring to a vertical size of about 37 nm and to demonstrate nanometer level beam stability. Several advanced beam diagnostics and feedback tools are used. In December 2008, construction and installation were completed and beam commissioning started, supported by an international team of Asian, European, and U.S. scientists. The present status and first results are described.

  19. SisterTalk: final results of a culturally tailored cable television delivered weight control program for Black women

    OpenAIRE

    Risica, Patricia Markham; Gans, Kim M.; Kumanyika, Shiriki; Kirtania, Usree; Lasater, Thomas M

    2013-01-01

    Background Obesity among Black women continues to exceed that of other women. Most weight loss programs created without reference to specific cultural contexts are less effective for Black than White women. Weight control approaches accessible to Black women and adapted to relevant cultural contexts are important for addressing this problem. This paper reports the final results of SisterTalk, the randomized controlled trial of a cable TV weight control program oriented toward Black women. Met...

  20. Present status and first results of the final focus beam line at the KEK Accelerator Test Facility

    Directory of Open Access Journals (Sweden)

    2010-04-01

    Full Text Available ATF2 is a final-focus test beam line which aims to focus the low emittance beam from the ATF damping ring to a vertical size of about 37 nm and to demonstrate nanometer level beam stability. Several advanced beam diagnostics and feedback tools are used. In December 2008, construction and installation were completed and beam commissioning started, supported by an international team of Asian, European, and U.S. scientists. The present status and first results are described.

  1. Tank 241-AP-103, grab sample 3AP-97-1 analytical results for the final report

    Energy Technology Data Exchange (ETDEWEB)

    Esch, R.A.

    1997-04-23

    This document is the final analytical laboratory report for the tank 241-AP-103 grab sample. One grab sample was collected from Riser 1{at}90{sup o} on March 19, 1997. Analyses were performed to verify compliance status with corrosion control criteria in accordance with the Letter of Instruction for Tank 241-AP-103 Grab Sample Analyses (LOI) (Field, 1997), the Compatibility Grab Sampling and Analysis Plan (TSAP) (Sasakid, 1997) and the Data Quality Objectives for Tank Farms Waste Compatibility Program (DQO) (Fowler, 1995). The sample results for pH were less than 12 indicating that the tank contents were caustic deficient. A notification for low hydroxide (< 0.01 M) was made to East Tank Farms Operations based on the pH result.

  2. 76 FR 19747 - Solid Urea From the Russian Federation and Ukraine: Final Results of the Expedited Sunset Reviews...

    Science.gov (United States)

    2011-04-08

    ...On December 1, 2010, the Department of Commerce (the Department) initiated the third sunset reviews of the antidumping duty orders on solid urea from the Russian Federation (Russia) and Ukraine, pursuant to section 751(c) of the Tariff Act of 1930, as amended (the Act). See Initiation of Five-Year (``Sunset'') Review, 75 FR 74685 (December 1, 2010) (Notice of Initiation). The Department has conducted expedited (120-day) sunset reviews of these orders. As a result of these sunset reviews, the Department finds that revocation of the antidumping duty orders would be likely to lead to continuation or recurrence of dumping as indicated in the ``Final Results of Reviews'' section of this notice.

  3. 78 FR 34337 - Stainless Steel Bar From India: Final Results of Antidumping Duty Administrative Review; 2011-2012

    Science.gov (United States)

    2013-06-07

    ... Stainless Steel Bar from India'' (Final IDM). The written description is dispositive. Analysis of Comments Received All issues raised in the case briefs are addressed in the Final IDM, dated concurrently and hereby... IDM is attached to this notice as an Appendix. The Final IDM is a public document and is on file...

  4. Efficacy and safety of fasudil in patients with subarachnoid hemorrhage: final results of a randomized trial of fasudil versus nimodipine.

    Science.gov (United States)

    Zhao, Jizong; Zhou, Dingbiao; Guo, Jing; Ren, Zuyuan; Zhou, Liangfu; Wang, Shuo; Zhang, Yan; Xu, Bainan; Zhao, Kuiming; Wang, Renzhi; Mao, Ying; Xu, Bin; Zhang, Xiaolin

    2011-01-01

    Fasudil is believed to be at least equally effective as nimodipine for the prevention of cerebral vasospasm and subsequent ischemic injury in patients undergoing surgery for subarachnoid hemorrhage (SAH). We report the final results of a randomized, open trial to compare the efficacy and safety of fasudil with nimodipine. A total of 63 patients undergoing surgery for SAH received fasudil and 66 received nimodipine between 1998 and 2004. Symptomatic vasospasm, low density areas on computed tomography (CT), clinical outcomes, and adverse events were all recorded, and the results were compared between the fasudil and nimodipine groups. Absence of symptomatic vasospasm, occurrence of low density areas associated with vasospasm on CT, and occurrence of adverse events were similar between the two groups. The clinical outcomes were more favorable in the fasudil group than in the nimodipine group (p = 0.040). The proportion of patients with good clinical outcome was 74.5% (41/55) in the fasudil group and 61.7% (37/60) in the nimodipine group. There were no serious adverse events reported in the fasudil group. The present results suggest that fasudil is equally or more effective than nimodipine for the prevention of cerebral vasospasm and subsequent ischemic injury in patients undergoing surgery for SAH.

  5. Levodopa-Carbidopa Intestinal Gel in Advanced Parkinson'd Disease: Final 12-Month, Open-Label Results

    Science.gov (United States)

    Fernandez, Hubert H; Standaert, David G; Hauser, Robert A; Lang, Anthony E; Fung, Victor SC; Klostermann, Fabian; Lew, Mark F; Odin, Per; Steiger, Malcolm; Yakupov, Eduard Z; Chouinard, Sylvain; Suchowersky, Oksana; Dubow, Jordan; Hall, Coleen M; Chatamra, Krai; Robieson, Weining Z; Benesh, Janet A; Espay, Alberto J

    2015-01-01

    Motor complications in Parkinson's disease (PD) are associated with long-term oral levodopa treatment and linked to pulsatile dopaminergic stimulation. l-dopa-carbidopa intestinal gel (LCIG) is delivered continuously by percutaneous endoscopic gastrojejunostomy tube (PEG-J), which reduces l-dopa-plasma–level fluctuations and can translate to reduced motor complications. We present final results of the largest international, prospective, 54-week, open-label LCIG study. PD patients with severe motor fluctuations (>3 h/day “off” time) despite optimized therapy received LCIG monotherapy. Additional PD medications were allowed >28 days post-LCIG initiation. Safety was the primary endpoint measured through adverse events (AEs), device complications, and number of completers. Secondary endpoints included diary-assessed off time, “on” time with/without troublesome dyskinesia, UPDRS, and health-related quality-of-life (HRQoL) outcomes. Of 354 enrolled patients, 324 (91.5%) received PEG-J and 272 (76.8%) completed the study. Most AEs were mild/moderate and transient; complication of device insertion (34.9%) was the most common. Twenty-seven (7.6%) patients withdrew because of AEs. Serious AEs occurred in 105 (32.4%), most commonly complication of device insertion (6.5%). Mean daily off time decreased by 4.4 h/65.6% (P Wiley Periodicals, Inc. on behalf of International Parkinson and Movement Disorder Society. PMID:25545465

  6. Estimative of final hazard dispersion distance resulting from accidental airborne releases; Estimativa de distancia final de perigo em razao de liberacoes acidentais de substancias toxicas na atmosfera

    Energy Technology Data Exchange (ETDEWEB)

    Sacramento, Arivaldo Morais do; Senne Junior, Murillo; Vasconcelos, Vanderley de [Centro de Desenvolvimento da Tecnologia Nuclear (CDTN), Belo Horizonte, MG (Brazil)

    2002-07-01

    This paper provides some easy-to-use equations, which provide quick, realistic estimates of dispersion distances resulting from accidental airborne releases. Distance to toxic endpoint is the maximum dispersion distance for which resulting, airborne chemical concentrations would be in excess of specified exposure levels; broadly speaking accidental releases of toxic chemicals to the atmosphere can occur in urban or rural areas, either during the daytime or nigh time; this article focuses only on urban releases and uses Briggs sigma functions. Similar analysis can be developed for rural area and for different sigma functions e.g. Pasquill-Gifford sigmas and Juelich sigmas. (author)

  7. The contributions of computer facility, test preparation, and learning motivation against the results of computer-based final examination result of VHS students of software engineering expertise package in Malang city

    Science.gov (United States)

    Maulida, Septiana Winda; Elmunsyah, Hakkun; Patmanthara, Syaad

    2017-09-01

    This study employed associative explanation research, because it is used to know the relationship between certain variables. This study used a quantitative approach and applied a testing technique using regression analysis. The samples in the study were 185 students. The results of this study are: (1) between computer facility and the result of computer-based final examination; (2) between examination readiness and the result of computer-based final examination; (3) between learning motivation and the result of computer-based final examination.

  8. Continued Benefit to Rectal Separation for Prostate Radiation Therapy: Final Results of a Phase III Trial

    Energy Technology Data Exchange (ETDEWEB)

    Hamstra, Daniel A., E-mail: Daniel.Hamstra@gmail.com [Texas Oncology, Texas Center for Proton Therapy, Irving, Texas (United States); Mariados, Neil [Associated Medical Professionals of NY, PLLC, Syracuse, New York (United States); Sylvester, John [21st Century Oncology, Inc, Lakewood Ranch, East Bradenton, Florida (United States); Shah, Dhiren [Western New York Urology Associates, LLC, Doing Business as Cancer Care of WNY, Cheektowaga, New York (United States); Karsh, Lawrence [The Urology Center of Colorado, Denver, Colorado (United States); Hudes, Richard [Chesapeake Urology Associates, Doing Business as Chesapeake Urology Research Associates (The Prostate Center), Owings Mills, Maryland (United States); Beyer, David [Arizona Oncology Services Foundation, Phoenix, Arizona (United States); Kurtzman, Steven [Urological Surgeons of Northern California Inc, Campbell, California (United States); Bogart, Jeffrey [The Research Foundation of State University of New York/State University of New York Upstate Medical University, Syracuse, New York (United States); Hsi, R. Alex [Peninsula Cancer Center, Poulsbo, Washington (United States); Kos, Michael [Urology Nevada, Reno, Nevada (United States); Ellis, Rodney [University Hospitals Case Medical Center, Cleveland, Ohio (United States); Logsdon, Mark [Sutter Health Sacramento Sierra Region, Doing Business as Sutter Institute for Medical Research, Sacramento, California (United States); Zimberg, Shawn [Advanced Radiation Centers of New York, Lake Success, New York (United States); Forsythe, Kevin [Oregon Urology Institute, Springfield, Oregon (United States); Zhang, Hong [University of Rochester, Rochester, New York (United States); Soffen, Edward [CentraState Medical Center, Freehold, New Jersey (United States); Francke, Patrick [Carolina Regional Cancer Center, LLC, 21st Century Oncology, Inc, Myrtle Beach, South Carolina (United States); Mantz, Constantine [21st Century Oncology, Inc, Fort Meyers, Florida (United States); and others

    2017-04-01

    Purpose: SpaceOAR, a Food and Drug Administration–approved hydrogel intended to create a rectal–prostate space, was evaluated in a single-blind phase III trial of image guided intensity modulated radiation therapy. A total of 222 men were randomized 2:1 to the spacer or control group and received 79.2 Gy in 1.8-Gy fractions to the prostate with or without the seminal vesicles. The present study reports the final results with a median follow-up period of 3 years. Methods and Materials: Cumulative (Common Terminology Criteria for Adverse Events, version 4.0) toxicity was evaluated using the log-rank test. Quality of life (QOL) was examined using the Expanded Prostate Cancer Index Composite (EPIC), and the mean changes from baseline in the EPIC domains were tested using repeated measures models. The proportions of men with minimally important differences (MIDs) in each domain were tested using repeated measures logistic models with prespecified thresholds. Results: The 3-year incidence of grade ≥1 (9.2% vs 2.0%; P=.028) and grade ≥2 (5.7% vs 0%; P=.012) rectal toxicity favored the spacer arm. Grade ≥1 urinary incontinence was also lower in the spacer arm (15% vs 4%; P=.046), with no difference in grade ≥2 urinary toxicity (7% vs 7%; P=0.7). From 6 months onward, bowel QOL consistently favored the spacer group (P=.002), with the difference at 3 years (5.8 points; P<.05) meeting the threshold for a MID. The control group had a 3.9-point greater decline in urinary QOL compared with the spacer group at 3 years (P<.05), but the difference did not meet the MID threshold. At 3 years, more men in the control group than in the spacer group had experienced a MID decline in bowel QOL (41% vs 14%; P=.002) and urinary QOL (30% vs 17%; P=.04). Furthermore, the control group were also more likely to have experienced large declines (twice the MID) in bowel QOL (21% vs 5%; P=.02) and urinary QOL (23% vs 8%; P=.02). Conclusions: The benefit of a hydrogel spacer in

  9. Early effects of zoledronic acid and teriparatide on bone microarchitecture, remodeling and collagen crosslinks: comparison between iliac crest and lumbar vertebra in ewes.

    Science.gov (United States)

    Portero-Muzy, N R; Chavassieux, P M; Bouxsein, M L; Gineyts, E; Garnero, P; Chapurlat, R D

    2012-10-01

    Iliac crest bone biopsies are used to assess the mechanism of action of drug treatments, yet there are little data comparing this site to sites prone to fracture. The purpose of this study was to compare the delay and the amplitude of responses to treatment in two different bone sites. The short-term effects of zoledronic acid and teriparatide on microarchitecture, collagen crosslinks and bone remodeling were evaluated in iliac crest and lumbar vertebrae. Aged ewes (n=8/gr) received either vehicle (CTRL) or a single injection of zoledronic acid (ZOL, 10mg) or daily injections of teriparatide (TPTD, 20 μg/d) for 3 months. Blood samples were collected monthly for assessing bone turnover markers. At the end of the study, a transiliac bone biopsy (IC) and L1 lumbar vertebrae (LV1) were collected to assess bone microarchitecture; pyridinoline (PYD), deoxypyridinoline (DPD), pentosidine (PEN) content, static and dynamic parameters of bone remodeling. In CTRL, Tb-BV/TV was significantly higher in LV1 than IC (pTV, Conn.D, Tb.N and Tb.Sp, in IC but not in LV1. Regardless of the site, ZOL markedly depressed the bone turnover: The static parameters of bone formation significantly decreased and the diminution of MS/BS, BFR/BS and Ac.f varied from -94 to -98% vs CTRL (paugmented in both sites, significantly only in LV1 (p<0.05) with a trend of increases in MS/BS and BFR/BS, compared to LV1-CTRL. In conclusion, in adult ewes, the bone mass, microarchitecture, remodeling and collagen crosslink content differ according to the bone site (iliac crest and vertebra). Furthermore, after 3 months, the responses to ZOL and TPTD were of different magnitude and delay between the two bone sites. The distinction of bone sites to study the early effects of anti-osteoporotic therapies appears meaningful in order to approach their site-specific anti-fracture efficacy. Copyright © 2012 Elsevier Inc. All rights reserved.

  10. Injectable PLGA/Hydroxyapatite/Chitosan Microcapsules Produced by Supercritical Emulsion Extraction Technology: An In Vitro Study on Teriparatide/Gentamicin Controlled Release.

    Science.gov (United States)

    Della Porta, Giovanna; Campardelli, Roberta; Cricchio, Vincenzo; Oliva, Francesco; Maffulli, Nicola; Reverchon, Ernesto

    2016-07-01

    Supercritical emulsion extraction (SEE) is proposed as a green and effective strategy for the fabrication of chitosan-covered poly-lactic-co-glycolic acid (chi-PLGA) injectable microcapsules for the controlled release of teriparatide (THA) and teriparatide/gentamicin sulfate (THA/Gen). These formulations can be used for locally bone pathologies treatment or in complex fracture healing of aged patients. Several oil-water (o-w) and water-oil-water (w-o-w) emulsions were processed by SEE to produce multifunctional microcapsules containing hydroxyapatite (HA) within a poly-lactic-co-glycolic acid (PLGA) matrix (up to 24 mg/g) and with both THA (0.45 mg/g) and Gen (up to 9 mg/g). Chitosan coating was also successfully added, as external layer (0.4 μm). SEE-fabricated microcapsules showed good encapsulation efficiency (up to 90%) for all the drugs tested and a mean size ranging between 1.4 (±0.4) μm and 2.2 (±0.5) μm. Different drug amounts loaded and microcapsules compositions assured a controlled drug release over a wide range of times and concentrations, as in vitro monitored in PBS medium at 37°C for 15/20 days. HA embedded into the biopolymer structure delayed the THA release profile; chitosan coating strongly reduced the initial drug "burst" release. In addition, the coencapsulation of both THA and Gen, which have very different water solubility, accelerated the release profile of the less water-soluble drug. No drugs degradation was also monitored after the SEE manufacturing. Apparent drug diffusivities (D) were calculated by fitting of the release profiles. In the case of Gen, D ranged between 2.9 × 10(-8) and 1.6 × 10(-9) cm(2)s(-1) if the drug was entrapped in simple PLGA or in the chitosan-coated microcapsules, respectively. In the case of THA, the calculated values ranged between 8.1 × 10(-9) and 7.4 × 10(-10) cm(2)s(-1) when the drug was entrapped in PLGA/HA microcapsules or in the chitosan-coated ones, respectively. These mass transfer values

  11. 77 FR 69790 - Certain Hot-Rolled Carbon Steel Flat Products From the People's Republic of China: Final Results...

    Science.gov (United States)

    2012-11-21

    ... steel flat products (``hot-rolled steel'') from the People's Republic of China (``PRC''). The period of...\\ See Certain Hot-Rolled Carbon Steel Flat Products From the People's Republic of China: Preliminary... Products from the People's Republic of China, 66 FR 59561 (November 29, 2001), remains dispositive. Final...

  12. 75 FR 32910 - Certain Tissue Paper Products from the People's Republic of China: Final Results of Expedited...

    Science.gov (United States)

    2010-06-10

    ... International Trade Administration Certain Tissue Paper Products from the People's Republic of China: Final... the Antidumping Duty Order on Certain Tissue Paper Products from the People's Republic of China... sunset review of the antidumping duty order on certain tissue paper products from the People's Republic...

  13. 75 FR 15415 - Certain Crepe Paper Products From the People's Republic of China: Final Results of Expedited...

    Science.gov (United States)

    2010-03-29

    ... International Trade Administration Certain Crepe Paper Products From the People's Republic of China: Final... duty order on certain crepe paper products from the People's Republic of China (``PRC''). On the basis... products from the PRC pursuant to section 751(c) of the Tariff Act of 1930, as amended (``the Act''). See...

  14. 75 FR 63806 - Certain Tissue Paper Products From the People's Republic of China: Final Results of the 2008-2009...

    Science.gov (United States)

    2010-10-18

    ... International Trade Administration Certain Tissue Paper Products From the People's Republic of China: Final... antidumping duty order on certain tissue paper products from the People's Republic of China (PRC) covering the... Review: Certain Tissue Paper Products From the People's Republic of China, 75 FR 49888 (August 16, 2010...

  15. 76 FR 21333 - Laminated Woven Sacks From the People's Republic of China: Final Results of Second Antidumping...

    Science.gov (United States)

    2011-04-15

    ... for retail packaging of consumer goods such as pet foods and bird seed. \\4\\ ``Paper suitable for high.... Reimbursement of Duties This notice also serves as a final reminder to importers of their responsibility under... reminder to parties subject to administrative protective order (``APO'') of their responsibility concerning...

  16. 77 FR 72818 - Circular Welded Carbon Steel Pipes and Tubes From Turkey; Final Results of Antidumping Duty...

    Science.gov (United States)

    2012-12-06

    ... from the calculation of the general and administrative (``G&A'') expense ratio; (3) we are including...-calculated Toscelik's U.S. credit expense by using Toscelik's own rates from short-term loans in the United...: Final Modification, 77 FR 8101 (February 14, 2012). We calculated such rates based on the ratio of the...

  17. 77 FR 27438 - Certain Corrosion-Resistant Carbon Steel Flat Products From Korea: Final Results of Expedited...

    Science.gov (United States)

    2012-05-10

    ... International Trade Administration Certain Corrosion-Resistant Carbon Steel Flat Products From Korea: Final... third five-year sunset review of the countervailing duty order on certain corrosion-resistant carbon..., plated, or coated with corrosion-resistant metals such as zinc, aluminum, or zinc-, aluminum-, nickel- or...

  18. 75 FR 23239 - Carbazole Violet Pigment 23 From India: Extension of Time Limit for Final Results of Antidumping...

    Science.gov (United States)

    2010-05-03

    ... From the Federal Register Online via the Government Publishing Office DEPARTMENT OF COMMERCE International Trade Administration Carbazole Violet Pigment 23 From India: Extension of Time Limit for Final... administrative review of the antidumping duty order on CVP 23 from India. See Carbazole Violet Pigment 23 from...

  19. 75 FR 15412 - Silicon Metal From the People's Republic of China: Notice of Amended Final Results of New Shipper...

    Science.gov (United States)

    2010-03-29

    ... International Trade Administration Silicon Metal From the People's Republic of China: Notice of Amended Final... (``the Department'') determination of the appropriate surrogate value for silica fume in Silicon Metal... Order at 14. \\1\\ Respondents referenced here are (1) Jiangxi Gangyuan Silicon Industry Co., Ltd...

  20. 76 FR 36089 - Circular Welded Non-Alloy Steel Pipe From the Republic of Korea: Final Results of the Antidumping...

    Science.gov (United States)

    2011-06-21

    ... International Trade Administration Circular Welded Non-Alloy Steel Pipe From the Republic of Korea: Final... circular welded non-alloy steel pipe (``CWP'') from the Republic of Korea (``Korea''), covering the period.... SUPPLEMENTARY INFORMATION: Background Following publication of Circular Welded Non-Alloy Steel Pipe From the...

  1. 75 FR 34980 - Circular Welded Non-Alloy Steel Pipe from the Republic of Korea: Final Results of the Antidumping...

    Science.gov (United States)

    2010-06-21

    ... International Trade Administration Circular Welded Non-Alloy Steel Pipe from the Republic of Korea: Final... circular welded non-alloy steel pipe (``CWP'') from the Republic of Korea (``Korea''), covering the period November 1, 2007, through October 31, 2008. See Circular Welded Non-Alloy Steel Pipe from the Republic of...

  2. 78 FR 35248 - Circular Welded Non-Alloy Steel Pipe From the Republic of Korea: Final Results of Antidumping...

    Science.gov (United States)

    2013-06-12

    ... International Trade Administration Circular Welded Non-Alloy Steel Pipe From the Republic of Korea: Final... order on circular welded non-alloy steel pipe (CWP) from the Republic of Korea (Korea) for the period... has been sold at less than normal value. \\1\\ See Circular Welded Non-Alloy Steel Pipe From the...

  3. 75 FR 22552 - Certain Steel Concrete Reinforcing Bars from Turkey; Notice of Amended Final Results Pursuant to...

    Science.gov (United States)

    2010-04-29

    ... International Trade Administration Certain Steel Concrete Reinforcing Bars from Turkey; Notice of Amended Final... Department) in the 2003-2004 administrative review of certain steel concrete of reinforcing bars (rebar) from...) of April 1, 2003, through March 31, 2004. See Certain Steel Concrete Reinforcing Bars From Turkey...

  4. 77 FR 11489 - Honey From the People's Republic of China: Extension of Time Limit for Final Results of the...

    Science.gov (United States)

    2012-02-27

    ... International Trade Administration Honey From the People's Republic of China: Extension of Time Limit for Final... preliminarily rescinding the antidumping duty administrative review on honey from the People's Republic of China (``PRC''), covering the period December 12, 2009, through November 30, 2010. See Honey From the People's...

  5. 76 FR 7534 - Porcelain-on-Steel Cooking Ware from the People's Republic of China: Final Results of the...

    Science.gov (United States)

    2011-02-10

    ... International Trade Administration Porcelain-on-Steel Cooking Ware from the People's Republic of China: Final... Commerce (``Department'') initiated a sunset review of the antidumping duty order on porcelain-on-steel... FR 60731 (October 1, 2010) (``Sunset Initiation''); see also Antidumping Duty Order; Porcelain-on...

  6. 76 FR 67673 - Welded ASTM A-312 Stainless Steel Pipe From South Korea and Taiwan: Final Results of Expedited...

    Science.gov (United States)

    2011-11-02

    ... International Trade Administration Welded ASTM A-312 Stainless Steel Pipe From South Korea and Taiwan: Final... (the Department) initiated sunset reviews of the antidumping duty orders on welded ASTM A-312 stainless... the antidumping duty orders on welded ASTM A-312 stainless steel pipe from South Korea and Taiwan...

  7. 77 FR 15039 - Certain Frozen Fish Fillets From the Socialist Republic of Vietnam: Final Results and Partial...

    Science.gov (United States)

    2012-03-14

    ... (10) East Sea Seafoods Joint Venture Co., Ltd 0.03 (11) Hiep Thanh 0.03 (12) South Vina 0.03 (13) Vinh... Department's policy to assign all exporters of subject merchandise in an NME country this single rate unless... People's Republic of China, 56 FR 20588 (May 6, 1991), as further developed in Notice of Final...

  8. 77 FR 40854 - Small Diameter Graphite Electrodes From the People's Republic of China: Final Results of the...

    Science.gov (United States)

    2012-07-11

    ... International Trade Administration Small Diameter Graphite Electrodes From the People's Republic of China: Final... diameter graphite electrodes (SDGEs) from the People's Republic of China (PRC). The review covers 25...: Background On March 6, 2012, the Department published Small Diameter Graphite Electrodes from the People's...

  9. SisterTalk: final results of a culturally tailored cable television delivered weight control program for Black women.

    Science.gov (United States)

    Risica, Patricia Markham; Gans, Kim M; Kumanyika, Shiriki; Kirtania, Usree; Lasater, Thomas M

    2013-12-27

    Obesity among Black women continues to exceed that of other women. Most weight loss programs created without reference to specific cultural contexts are less effective for Black than White women. Weight control approaches accessible to Black women and adapted to relevant cultural contexts are important for addressing this problem. This paper reports the final results of SisterTalk, the randomized controlled trial of a cable TV weight control program oriented toward Black women. A five group design included a comparison group and a 2 × 2 factorial comparison of a) interactive vs. passive programming and b) telephone social support vs no telephone support, with 12 weekly initial cable TV programs followed by 4 monthly booster videos. At baseline, 3, 8, and 12 months post randomization, telephone and in person surveys were administered on diet, physical activity, and physical measurements of height and weight were taken to calculate body mass index (BMI). Analysis of variance (ANOVA) was used to examine differences over time, and between treatment and comparison groups. Dose variables reflecting use of the TV/video and written materials were also assessed. At 3 months, BMI, weight, and dietary fat were significantly lower and physical activity significantly higher among women exposed to the Cable TV intervention compared to the wait-list comparison group. Significant dietary fat differences were still observed at 8 and 12 month evaluations, but not BMI or physical activity differences. Main effects were not observed for interactive programming or enhanced social support at any time point. Within the intervention group, higher watching of the TV series and higher reading of educational materials were both (separately) associated with significantly lower dietary fat. Cable TV was an effective delivery channel to assist Black women with weight control, increasing physical activity and decreasing dietary fat during an initial intervention period, but only dietary

  10. Tank 241-AP-103 08/1999 Compatibility Grab Samples and Analytical Results for the Final Report

    Energy Technology Data Exchange (ETDEWEB)

    BELL, K.E.

    1999-12-09

    This document is the format IV, final report for the tank 241-AP-103 (AP-103) grab samples taken in August 1999 to address waste compatibility concerns. Chemical, radiochemical, and physical analyses on the tank AP-103 samples were performed as directed in ''Compatibility Grub Sampling and Analysis Plan for Fiscal Year 1999'' (Sasaki 1999a). Any deviations from the instructions provided in the tank sampling and analysis plan (TSAP) were discussed in this narrative. No notification limits were exceeded.

  11. Final results of the searches for neutral Higgs bosons in e+e- collisions at /sqrt(s) up to 209 GeV

    Science.gov (United States)

    ALEPH Collaboration; Heister, A.; Schael, S.; Barate, R.; Brunelière, R.; De Bonis, I.; Decamp, D.; Goy, C.; Jezequel, S.; Lees, J.-P.; Martin, F.; Merle, E.; Minard, M.-N.; Pietrzyk, B.; Trocmé, B.; Boix, G.; Bravo, S.; Casado, M. P.; Chmeissani, M.; Crespo, J. M.; Fernandez, E.; Fernandez-Bosman, M.; Garrido, Ll.; Graugés, E.; Lopez, J.; Martinez, M.; Merino, G.; Miquel, R.; Mir, Ll. M.; Pacheco, A.; Paneque, D.; Ruiz, H.; Colaleo, A.; Creanza, D.; De Filippis, N.; de Palma, M.; Iaselli, G.; Maggi, G.; Maggi, M.; Nuzzo, S.; Ranieri, A.; Raso, G.; Ruggieri, F.; Selvaggi, G.; Silvestris, L.; Tempesta, P.; Tricomi, A.; Zito, G.; Huang, X.; Lin, J.; Quyang, Q.; Wang, T.; Xie, Y.; Xu, R.; Xue, S.; Zhang, J.; Zhang, L.; Zhao, W.; Abbaneo, D.; Azzurri, P.; Barklow, T.; Buchmüller, O.; Cattaneo, M.; Cerutti, F.; Clerbaux, B.; Drevermann, H.; Forty, R. W.; Frank, M.; Gianotti, F.; Greening, T. C.; Hansen, J. B.; Harvey, J.; Hutchcroft, D. E.; Janot, P.; Jost, B.; Kado, M.; Maley, P.; Mato, P.; Moutoussi, A.; Ranjard, F.; Rolandi, L.; Schlatter, D.; Sguazzoni, G.; Tejessy, W.; Teubert, F.; Valassi, A.; Videau, I.; Ward, J. J.; Badaud, F.; Dessagne, S.; Falvard, A.; Fayolle, D.; Gay, P.; Jousset, J.; Michel, B.; Monteil, S.; Pallin, D.; Pascolo, J. M.; Perret, P.; Hansen, J. D.; Hansen, J. R.; Hansen, P. H.; Nilsson, B. S.; Wäänänen, A.; Kyriakis, A.; Markou, C.; Simopoulou, E.; Vayaki, A.; Zachariadou, K.; Blondel, A.; Brient, J.-C.; Machefert, F.; Rougé, A.; Swynghedauw, M.; Tanaka, R.; Videau, H.; Ciulli, V.; Focardi, E.; Parrini, G.; Antonelli, A.; Antonelli, M.; Bencivenni, G.; Bologna, G.; Bossi, F.; Campana, P.; Capon, G.; Chiarella, V.; Laurelli, P.; Mannocchi, G.; Murtas, F.; Murtas, G. P.; Passalacqua, L.; Pepe-Altarelli, M.; Spagnolo, P.; Kennedy, J.; Lynch, J. G.; Negus, P.; O'Shea, V.; Smith, D.; Thompson, A. S.; Wasserbaech, S.; Cavanaugh, R.; Dhamotharan, S.; Geweniger, C.; Hanke, P.; Hepp, V.; Kluge, E. E.; Leibenguth, G.; Putzer, A.; Stenzel, H.; Tittel, K.; Werner, S.; Wunsch, M.; Beuselinck, R.; Binnie, D. M.; Cameron, W.; Davies, G.; Dornan, P. J.; Girone, M.; Hill, R. D.; Marinelli, N.; Nowell, J.; Przysiezniak, H.; Rutherford, S. A.; Sedgbeer, J. K.; Thompson, J. C.; White, R.; Ghete, V. M.; Girtler, P.; Kneringer, E.; Kuhn, D.; Rudolph, G.; Bouhova-Thacker, E.; Bowdery, C. K.; Clarke, D. P.; Ellis, G.; Finch, A. J.; Foster, F.; Hughes, G.; Jones, R. W. L.; Pearson, M. R.; Robertson, N. A.; Smizanska, M.; Lemaitre, V.; Blumenschein, U.; Hölldorfer, F.; Jakobs, K.; Kayser, F.; Kleinknecht, K.; Müller, A.-S.; Quast, G.; Renk, B.; Sander, H.-G.; Schmeling, S.; Wachsmuth, H.; Zeitnitz, C.; Ziegler, T.; Bonissent, A.; Carr, J.; Coyle, P.; Curtil, C.; Ealet, A.; Fouchez, D.; Leroy, O.; Kachelhoffer, T.; Payre, P.; Rousseau, D.; Tilquin, A.; Ragusa, F.; David, A.; Dietl, H.; Ganis, G.; Hüttmann, K.; Lütjens, G.; Mannert, C.; Männer, W.; Moser, H.-G.; Settles, R.; Wolf, G.; Boucrot, J.; Callot, O.; Davier, M.; Duflot, L.; Grivaz, J.-F.; Heusse, Ph.; Jacholkowska, A.; Loomis, C.; Serin, L.; Veillet, J.-J.; de Vivie de Régie, J.-B.; Yuan, C.; Bagliesi, G.; Boccali, T.; Foà, L.; Giammanco, A.; Giassi, A.; Ligabue, F.; Messineo, A.; Palla, F.; Sanguinetti, G.; Sciabà, A.; Tenchini, R.; Venturi, A.; Verdini, P. G.; Awunor, O.; Blair, G. A.; Coles, J.; Cowan, G.; Garcia-Bellido, A.; Green, M. G.; Jones, L. T.; Medcalf, T.; Misiejuk, A.; Strong, J. A.; Teixeira-Dias, P.; Clifft, R. W.; Edgecock, T. R.; Norton, P. R.; Tomalin, I. R.; Bloch-Devaux, B.; Boumediene, D.; Colas, P.; Fabbro, B.; Lancon, E.; Lemaire, M.-C.; Locci, E.; Perez, P.; Rander, J.; Renardy, J.-F.; Rosowsky, A.; Seager, P.; Trabelsi, A.; Tuchming, B.; Vallage, B.; Konstantinidis, N.; Litke, A. M.; Taylor, G.; Booth, C. N.; Cartwright, S.; Combley, F.; Hodgson, P. N.; Lehto, M.; Thompson, L. F.; Affholderbach, K.; Böhrer, A.; Brandt, S.; Grupen, C.; Hess, J.; Ngac, A.; Prange, G.; Sieler, U.; Borean, C.; Giannini, G.; He, H.; Putz, J.; Rothberg, J.; Armstrong, S. R.; Berkelman, K.; Cranmer, K.; Ferguson, D. P. S.; Gao, Y.; González, S.; Hayes, O. J.; Hu, H.; Jin, S.; Kile, J.; McNamara, P. A.; Nielsen, J.; Pan, Y. B.; von Wimmersperg-Toeller, J. H.; Wiedenmann, W.; Wu, J.; Wu, S. L.; Wu, X.; Zobernig, G.; Dissertori, G.

    2002-02-01

    The final results of the ALEPH search for the Standart Model Higgs boson at LEP, with data collected in the year 2000 at center-of-mass energies up to 209 GeV, are presented. The changes with respect to the preceding publication are described and a complete study of systematic effects is reported. The findings of this final analysis confirm the preliminary results published in November 2000 shortly after the closing down of the LEP collider: a significant excess of events is observed, consistent with the production of a 115 GeV/c2 Standard Model Higgs boson. The final results of the searches for the neutral Higgs bosons od the MSSM are also reported, in terms of limits on mh, mA and /tanβ. Limits are also set on mh in the case of invisible decays.

  12. Final results of the searches for neutral Higgs bosons in $e^{+}e^{-}$ collisions at $\\sqrt{s}$ up to 209 GeV

    CERN Document Server

    Heister, A.; Barate, R.; Bruneliere, R.; De Bonis, I.; Decamp, D.; Goy, C.; Jezequel, S.; Lees, J.P.; Martin, F.; Merle, E.; Minard, M.N.; Pietrzyk, B.; Trocme, B.; Boix, G.; Bravo, S.; Casado, M.P.; Chmeissani, M.; Crespo, J.M.; Fernandez, E.; Fernandez-Bosman, M.; Garrido, L.; Grauges, E.; Lopez, J.; Martinez, M.; Merino, G.; Miquel, R.; Mir, L.M.; Pacheco, A.; Paneque, D.; Ruiz, H.; Colaleo, A.; Creanza, D.; De Filippis, N.; de Palma, M.; Iaselli, G.; Maggi, G.; Maggi, M.; Nuzzo, S.; Ranieri, A.; Raso, G.; Ruggieri, F.; Selvaggi, G.; Silvestris, L.; Tempesta, P.; Tricomi, A.; Zito, G.; Huang, X.; Lin, J.; Ouyang, Q.; Wang, T.; Xie, Y.; Xu, R.; Xue, S.; Zhang, J.; Zhang, L.; Zhao, W.; Abbaneo, D.; Azzurri, P.; Barklow, T.; Buchmuller, O.; Cattaneo, M.; Cerutti, F.; Clerbaux, B.; Drevermann, H.; Forty, R.W.; Frank, M.; Gianotti, F.; Greening, T.C.; Hansen, J.B.; Harvey, J.; Hutchcroft, D.E.; Janot, P.; Jost, B.; Kado, M.; Maley, P.; Mato, P.; Moutoussi, A.; Ranjard, F.; Rolandi, Gigi; Schlatter, D.; Sguazzoni, G.; Tejessy, W.; Teubert, F.; Valassi, A.; Videau, I.; Ward, J.J.; Badaud, F.; Dessagne, S.; Falvard, A.; Fayolle, D.; Gay, P.; Jousset, J.; Michel, B.; Monteil, S.; Pallin, D.; Pascolo, J.M.; Perret, P.; Hansen, J.D.; Hansen, J.R.; Hansen, P.H.; Nilsson, B.S.; Waananen, A.; Kyriakis, A.; Markou, C.; Simopoulou, E.; Vayaki, A.; Zachariadou, K.; Blondel, A.; Brient, J.C.; Machefert, F.; Rouge, A.; Swynghedauw, M.; Tanaka, R.; Videau, H.; Ciulli, V.; Focardi, E.; Parrini, G.; Antonelli, A.; Antonelli, M.; Bencivenni, G.; Bologna, G.; Bossi, F.; Campana, P.; Capon, G.; Chiarella, V.; Laurelli, P.; Mannocchi, G.; Murtas, F.; Murtas, G.P.; Passalacqua, L.; Pepe-Altarelli, M.; Spagnolo, P.; Kennedy, J.; Lynch, J.G.; Negus, P.; O'Shea, V.; Smith, D.; Thompson, A.S.; Wasserbaech, S.; Cavanaugh, R.; Dhamotharan, S.; Geweniger, C.; Hanke, P.; Hepp, V.; Kluge, E.E.; Leibenguth, G.; Putzer, A.; Stenzel, H.; Tittel, K.; Werner, S.; Wunsch, M.; Beuselinck, R.; Binnie, D.M.; Cameron, W.; Davies, G.; Dornan, P.J.; Girone, M.; Hill, R.D.; Marinelli, N.; Nowell, J.; Przysiezniak, H.; Rutherford, S.A.; Sedgbeer, J.K.; Thompson, J.C.; White, R.; Ghete, V.M.; Girtler, P.; Kneringer, E.; Kuhn, D.; Rudolph, G.; Bouhova-Thacker, E.; Bowdery, C.K.; Clarke, D.P.; Ellis, G.; Finch, A.J.; Foster, F.; Hughes, G.; Jones, R.W.L.; Pearson, M.R.; Robertson, N.A.; Smizanska, M.; Lemaitre, V.; Blumenschein, U.; Holldorfer, F.; Jakobs, K.; Kayser, F.; Kleinknecgt, K.; Muller, A.S.; Quast, G.; Renk, B.; Sander, H.G.; Schmeling, S.; Wachsmuth, H.; Zeitnitz, C.; Ziegler, T.; Bonissent, A.; Carr, J.; Coyle, P.; Curtil, C.; Ealet, A.; Fouchez, D.; Leroy, O.; Kachelhoffer, T.; Payre, P.; Rousseau, D.; Tilquin, A.; Ragusa, F.; David, A.; Dietl, H.; Ganis, G.; Huttmann, K.; Lutjens, G.; Mannert, C.; Manner, W.; Moser, H.G.; Settles, R.; Wolf, G.; Boucrot, J.; Callot, O.; Davier, M.; Duflot, L.; Grivaz, J.F.; Heusse, P.; Jacholkowska, A.; Loomis, C.; Serin, L.; Veillet, J.J.; de Vivie de Regie, J.B.; Yuan, C.; Bagliesi, Giuseppe; Boccali, T.; Foa, L.; Giammanco, A.; Giassi, A.; Ligabue, F.; Messineo, A.; Palla, F.; Sanguinetti, G.; Sciaba, A.; Tenchini, R.; Venturi, A.; Verdini, P.G.; Awunor, O.; Blair, G.A.; Coles, J.; Cowan, G.; Garcia-Bellido, A.; Green, M.G.; Jones, L.T.; Medcalf, T.; Misiejuk, A.; Strong, J.A.; Teixeira-Dias, P.; Clifft, R.W.; Edgecock, T.R.; Norton, P.R.; Tomalin, I.R.; Bloch-Devaux, Brigitte; Boumediene, D.; Colas, P.; Fabbro, B.; Lancon, E.; Lemaire, M.C.; Locci, E.; Perez, P.; Rander, J.; Renardy, J.F.; Rosowsky, A.; Seager, P.; Trabelsi, A.; Tuchming, B.; Vallage, B.; Konstantinidis, N.; Litke, A.M.; Taylor, G.; Booth, C.N.; Cartwright, S.; Combley, F.; Hodgson, P.N.; Lehto, M.; Thompson, L.F.; Affholderbach, K.; Boehrer, Armin; Brandt, S.; Grupen, C.; Hess, J.; Ngac, A.; Prange, G.; Sieler, U.; Borean, C.; Giannini, G.; He, H.; Putz, J.; Rothberg, J.; Armstrong, S.R.; Berkelman, Karl; Cranmer, K.; Ferguson, D.P.S.; Gao, Y.; Gonzalez, S.; Hayes, O.J.; Hu, H.; Jin, S.; Kile, J.; McNamara, P.A., III; Nielsen, J.; Pan, Y.B.; von Wimmersperg-Toeller, J.H.; Wiedenmann, W.; Wu, J.; Wu, Sau Lan; Wu, X.; Zobernig, G.

    2002-01-01

    The final results of the ALEPH search for the Standard Model Higgs boson at LEP, with data collected in the year 2000 at centre-of-mass energies up to 209,GeV, are presented. The changes with respect to the preceding publication are described and a complete study of systematic effects is reported. The findings of this final analysis confirm the preliminary results published in November 2000 shortly after the closing down of the LEP collider: a significant excess of events is observed, consistent with the production of a $115, Gcs$ Standard Model Higgs boson.% The final results of the searches for the neutral Higgs bosons of the MSSM are also reported, in terms of limits on $mh$, $mA$ and $anb$.% Limits are also set on $mh$ in the case of invisible decays.

  13. 76 FR 76939 - Certain Welded Carbon Steel Pipe and Tube From Turkey: Notice of Final Results of Antidumping...

    Science.gov (United States)

    2011-12-09

    ... ] plumbing and heating systems, air conditioner units, automatic sprinkler systems, and other related uses... Results of Antidumping Duty Administrative Review AGENCY: Import Administration, International Trade... Department'') published the preliminary results of the antidumping duty administrative review of certain...

  14. 76 FR 28419 - Persulfates From the People's Republic of China: Final Results of the 2009-2010 Antidumping Duty...

    Science.gov (United States)

    2011-05-17

    ....\\1\\ We invited interested parties to comment on our Preliminary Results. FMC Corporation (``FMC''), a..., FMC submitted comments stating that it fully supports the Department's Preliminary Results. No other..., 2011, FMC submitted comments stating that it fully supports our Preliminary Results. Because no other...

  15. 77 FR 67337 - Certain Activated Carbon From the People's Republic of China; 2010-2011; Final Results of...

    Science.gov (United States)

    2012-11-09

    ... International Trade Administration Certain Activated Carbon From the People's Republic of China; 2010-2011...'') published its Preliminary Results of the antidumping duty order on certain activated carbon from the People.... \\1\\ See Certain Activated Carbon From the People's Republic of China: Preliminary Results of the...

  16. 77 FR 17409 - Fresh Garlic From the People's Republic of China: Extension of Time Limit for Final Results of...

    Science.gov (United States)

    2012-03-26

    ... International Trade Administration Fresh Garlic From the People's Republic of China: Extension of Time Limit for.... \\1\\ See Fresh Garlic From the People's Republic of China: Partial Preliminary Results, Rescission of...). \\2\\ See Fresh Garlic From the People's Republic of China: Preliminary Results of the 2009-2010...

  17. The results of the PEP`93 intercomparison of reference cell calibrations and newer technology performance measurements: Final report

    Energy Technology Data Exchange (ETDEWEB)

    Osterwald, C.R. [National Renewable Energy Lab., Golden, CO (United States); Anevsky, S. [All-Union Research Inst. for Optophysical Measurements, Moscow (Russian Federation); Barua, A.K. [Indian Association for the Cultivation of Science, Calcutta (India)] [and others

    1998-03-01

    This report presents the results of an international intercomparison of photovoltaic (PV) performance measurements and calibrations that took place from 1993 to 1997. The intercomparison, which was organized and operated by a group of representatives from national PV measurements laboratories, was accomplished by circulating two sample sets. One set, consisting of 20 silicon reference cells, was intended to form the basis of an international PV reference scale. A qualification procedure applied to the calibration results gave average calibration numbers with an overall standard deviation of less than 2% for the entire set. The second sample set was assembled from a wide range of newer technologies that present unique problems for PV measurements. As might be expected, these results showed much greater differences among the laboratories. Methods were then identified that should be used to measure such devices, along with problems to avoid. The report concludes with recommendations for future intercomparisons.

  18. Analysis and potential of once-through steam generators in line focus systems - Final results of the DUKE project

    Science.gov (United States)

    Feldhoff, Jan Fabian; Hirsch, Tobias; Pitz-Paal, Robert; Valenzuela, Loreto

    2016-05-01

    The direct steam generation in line focus systems such as parabolic troughs and linear Fresnel collectors is one option for providing `solar steam' or heat. Commercial power plants use the recirculation concept, in which the steam generation is separated from the superheating by a steam drum. This paper analyzes the once-through mode as an advanced solar field concept. It summarizes the results of the DUKE project on loop design, a new temperature control strategy, thermo-mechanical stress analysis, and an overall cost analysis. Experimental results of the temperature control concept at the DISS test facility at Plataforma Solar de Almería are presented.

  19. 78 FR 52502 - Multilayered Wood Flooring From the People's Republic of China: Final Results of Antidumping Duty...

    Science.gov (United States)

    2013-08-23

    ...On May 30, 2013, the Department of Commerce (``Department'') published the preliminary results of an antidumping duty new shipper review of multilayered wood flooring (``MLWF'') from the People's Republic of China (``PRC'').\\1\\ We invited interested parties to comment on our preliminary results. Based on our analysis of the comments, we made changes to our margin calculations for this new shipper, Power Dekor Group Co., Ltd. (``Power Dekor''). We continue to find that Power Dekor did not make a sale of subject merchandise at less than normal value. ---------------------------------------------------------------------------

  20. 75 FR 64696 - Circular Welded Carbon Steel Pipes and Tubes From Thailand: Final Results of Antidumping Duty...

    Science.gov (United States)

    2010-10-20

    ...'' field because these costs were already included in the direct materials costs field. We have also made... calculation of the total cost of manufacturing from the preliminary results to exclude the ``other materials'' (``OTHMAT'') field. We have determined that this field serves only as a subtotal of other material costs...

  1. 77 FR 59178 - Seamless Refined Copper Pipe and Tube From Mexico: Final Results of Antidumping Duty New Shipper...

    Science.gov (United States)

    2012-09-26

    ... air conditioner or heat pump to an indoor evaporator unit. The phrase ``all sets of covered products... Antidumping Duty New Shipper Review AGENCY: Import Administration, International Trade Administration... the Federal Register the preliminary results of the new shipper review of the antidumping duty order...

  2. 78 FR 19210 - Corrosion-Resistant Carbon Steel Flat Products From the Republic of Korea: Final Results of...

    Science.gov (United States)

    2013-03-29

    ... International Trade Administration Corrosion-Resistant Carbon Steel Flat Products From the Republic of Korea...) has completed its administrative review of the countervailing duty (CVD) order on corrosion-resistant...\\ See Corrosion-Resistant Carbon Steel Flat Products From the Republic of Korea: Preliminary Results of...

  3. 78 FR 16252 - Certain Hot-Rolled Carbon Steel Flat Products From India, Indonesia, and Thailand: Final Results...

    Science.gov (United States)

    2013-03-14

    ...-rectangular shapes, not in coils, which are the result of having been processed by cutting or stamping and...). Scope of the Orders The merchandise subject to these orders is hot-rolled steel of a rectangular shape... bearings steels, as defined in the HTSUS. --Tool steels, as defined in the HTSUS. --Silico-manganese (as...

  4. 75 FR 36630 - Carbazole Violet Pigment 23 from the People's Republic of China: Final Results of Antidumping...

    Science.gov (United States)

    2010-06-28

    ... International Trade Administration A-570-892 Carbazole Violet Pigment 23 from the People's Republic of China... antidumping duty order on carbazole violet pigment 23 (CVP 23) from the People's Republic of China (PRC). See Carbazole Violet Pigment 23 From the People's Republic of China: Preliminary Results of Antidumping Duty...

  5. 75 FR 50992 - Magnesium Metal from the People's Republic of China: Extension of Time for the Final Results of...

    Science.gov (United States)

    2010-08-18

    ... From the Federal Register Online via the Government Publishing Office DEPARTMENT OF COMMERCE International Trade Administration Magnesium Metal from the People's Republic of China: Extension of Time for..., 2009. See Magnesium Metal from the People's Republic of China: Preliminary Results of the 2008-2009...

  6. 75 FR 62765 - Silicon Metal From the People's Republic of China; Extension of Time Limit for the Final Results...

    Science.gov (United States)

    2010-10-13

    ... International Trade Administration Silicon Metal From the People's Republic of China; Extension of Time Limit...'') initiated the administrative review (``AR'') of the antidumping duty order on silicon metal from the People... (July 29, 2009). On July 15, 2010, the Department published its preliminary results. See Silicon Metal...

  7. 75 FR 8650 - Carbon and Certain Alloy Steel Wire Rod from Trinidad and Tobago; Final Results of Antidumping...

    Science.gov (United States)

    2010-02-25

    ... International Trade Administration (A-274-804) Carbon and Certain Alloy Steel Wire Rod from Trinidad and Tobago... of the antidumping duty order on carbon and certain alloy steel wire rod from Trinidad and Tobago. See Carbon and Certain Alloy Steel Wire Rod From Trinidad and Tobago; Preliminary Results of...

  8. 77 FR 64100 - Glycine from the People's Republic of China: Final Results of Antidumping Duty Administrative Review

    Science.gov (United States)

    2012-10-18

    ... calculation with respect to the sole company subject to this review, Baoding Mantong Fine Chemistry Co. Ltd...-Calculation Program for Baoding Mantong Fine Chemistry Co., Ltd.'' (Revised Preliminary Results). FOR FURTHER..., 2011: Margin Exporter (percent) Baoding Mantong Fine Chemistry Co., Ltd 453.79 Assessment Rates...

  9. 76 FR 64307 - Certain Frozen Warmwater Shrimp From the Socialist Republic of Vietnam: Amended Final Results and...

    Science.gov (United States)

    2011-10-18

    ... the Secretary released disclosure documents to that party or held a disclosure meeting with that party...'') and its branch Nam Hai Foodstuff Export Company Ltd. (collectively, ``Respondents''). No other party... company as Viet Hai Foods. Furthermore, as a result of correcting the error in the margin calculation for...

  10. 77 FR 74171 - Citric Acid and Certain Citrate Salts From the People's Republic of China: Final Results of...

    Science.gov (United States)

    2012-12-13

    ... International Trade Administration Citric Acid and Certain Citrate Salts From the People's Republic of China...'') published its Preliminary Results of administrative review of the antidumping duty order on citric acid and... Citric Acid and Certain Citrate Salts from the People's Republic of China: Post- Preliminary Analysis...

  11. 77 FR 72323 - Citric Acid and Certain Citrate Salts From the People's Republic of China: Final Results of...

    Science.gov (United States)

    2012-12-05

    ... International Trade Administration Citric Acid and Certain Citrate Salts From the People's Republic of China...) has completed its administrative review of the countervailing duty (CVD) order on citric acid and... 31, 2010. On June 5, 2012, we published the preliminary results of this review.\\1\\ \\1\\ See Citric...

  12. Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial.

    NARCIS (Netherlands)

    Hartgrink, H.H.; Velde, C.J. van de; Putter, H.; Bonenkamp, J.J.; Meershoek-Klein Kranenbarg, E.; Songun, I.; Welvaart, K.; Krieken, J.H.J.M. van; Meijer, S.; Plukker, J.T.; Elk, P.J. van; Obertop, H.; Gouma, D.J.; Lanschot, J.J.B. van; Taat, C.W.; Graaf, P.W. de; Meyenfeldt, M.F. von; Tilanus, H.W.; Sasako, M.

    2004-01-01

    PURPOSE: The extent of lymph node dissection appropriate for gastric cancer is still under debate. We have conducted a randomized trial to compare the results of a limited (D1) and extended (D2) lymph node dissection in terms of morbidity, mortality, long-term survival and cumulative risk of

  13. Extended lymph node dissection for gastric cancer : Who may benefit? Final results of the randomized Dutch Gastric Cancer Group Trial

    NARCIS (Netherlands)

    Hartgrink, HH; van de Velde, CJH; Putter, H; Bonenkamp, JJ; Kranenbarg, EK; Songun, [No Value; Welvaart, K; van Krieken, JHJM; Meijer, S; Plukker, JTM; van Elk, PJ; Obertop, H; Gouma, DJ; van Lanschot, JJB; Taat, CW; de Graaf, PW; von Meyenfeldt, MF; Tilanus, H; Sasako, M

    2004-01-01

    Purpose. The extent of lymph node dissection appropriate for gastric cancer is still under debate. We have conducted a randomized trial to compare the results of a limited (D1) and extended (D2) lymph node dissection in terms of morbidity, mortality, long-term survival and cumulative risk of

  14. 78 FR 28801 - Hand Trucks and Certain Parts Thereof From the People's Republic of China: Final Results of...

    Science.gov (United States)

    2013-05-16

    ... International Trade Administration Hand Trucks and Certain Parts Thereof From the People's Republic of China... preliminary results of the administrative review of the antidumping duty order \\1\\ on hand trucks and certain parts thereof (hand trucks) from the People's Republic of China (PRC).\\2\\ The period of review (POR) is...

  15. 77 FR 61738 - Circular Welded Carbon Steel Pipes and Tubes From Thailand: Final Results of Antidumping Duty...

    Science.gov (United States)

    2012-10-11

    ... galvanizing in the instances where our methodology resulted in the selection of a galvanized product as the substitute for a non- galvanized product and added galvanizing where our methodology selected non-galvanized products as a substitute for galvanized products. See Memorandum to Neal Halper, ``Cost of Production and...

  16. 77 FR 31834 - Clad Steel Plate from Japan: Final Results of the Expedited Third Sunset Review of the...

    Science.gov (United States)

    2012-05-30

    ... From the Federal Register Online via the Government Publishing Office DEPARTMENT OF COMMERCE..., Department of Commerce. SUMMARY: On February 1, 2012, the Department of Commerce (the Department) initiated....218(e)(1)(ii)(C)(2). As a result of this sunset review, the Department finds that revocation of the...

  17. 75 FR 19364 - Fresh Garlic from the People's Republic of China: Extension of Time Limits for Final Results of...

    Science.gov (United States)

    2010-04-14

    ... International Trade Administration Fresh Garlic from the People's Republic of China: Extension of Time Limits... fresh garlic from the People's Republic of China. See Initiation of Antidumping and Countervailing Duty... Fresh Garlic From the People's Republic of China: Preliminary Results of, and Intent To Rescind, in Part...

  18. 76 FR 10335 - Fresh Garlic From the People's Republic of China: Extension of Time Limit for Final Results of...

    Science.gov (United States)

    2011-02-24

    ... International Trade Administration Fresh Garlic From the People's Republic of China: Extension of Time Limit for... of the 2008-2009 administrative review of fresh garlic from the People's Republic of China. See... preliminary results of this antidumping duty administrative review. See Fresh Garlic from the People's...

  19. 75 FR 29314 - Fresh Garlic From the People's Republic of China: Extension of Time Limits for Final Results of...

    Science.gov (United States)

    2010-05-25

    ... International Trade Administration Fresh Garlic From the People's Republic of China: Extension of Time Limits...) published the initiation of an administrative review of fresh garlic from the People's Republic of China... administrative review. See Fresh Garlic From the People's Republic of China: Preliminary Results of, and Intent...

  20. 78 FR 36524 - Diamond Sawblades and Parts Thereof From the Republic of Korea: Final Results of Antidumping Duty...

    Science.gov (United States)

    2013-06-18

    ... Petitioner alleged that Hyosung Diamond Industrial Co., Ltd., Western Diamond Tools Inc., and Hyosung D&P Co., Ltd. (collectively, Hyosung); Ehwa and Shinhan, and their respective Chinese subsidiaries, Weihai... Available Consistent with the Preliminary Results, we determine that the failure of Hyosung to provide...

  1. 78 FR 11818 - Diamond Sawblades and Parts Thereof From the Republic of Korea: Final Results of Antidumping Duty...

    Science.gov (United States)

    2013-02-20

    ... into the United States bearing false country of origin designations. On April 29, 2012, Hyosung Diamond Industrial Co., Ltd., Western Diamond Tools Inc., and Hyosung D&P Co., Ltd. (collectively, ``Hyosung... Available Consistent with the Preliminary Results, we determine that Hyosung's failure to provide requested...

  2. Portable XRF analysis of occupational air filter samples from different workplaces using different samplers: final results, summary and conclusions.

    Science.gov (United States)

    Harper, Martin; Pacolay, Bruce; Hintz, Patrick; Bartley, David L; Slaven, James E; Andrew, Michael E

    2007-11-01

    This paper concludes a five-year program on research into the use of a portable X-ray fluorescence (XRF) analyzer for analyzing lead in air sampling filters from different industrial environments, including mining, manufacturing and recycling. The results from four of these environments have already been reported. The results from two additional metal processes are presented here. At both of these sites, lead was a minor component of the total airborne metals and interferences from other elements were minimal. Nevertheless, only results from the three sites where lead was the most abundant metal were used in the overall calculation of method accuracy. The XRF analyzer was used to interrogate the filters, which were then subjected to acid digestion and analysis by inductively-coupled plasma optical-emission spectroscopy (ICP-OES). The filter samples were collected using different filter-holders or "samplers" where the size (diameter), depth and homogeneity of aerosol deposit varied from sampler to sampler. The aerosol collection efficiencies of the samplers were expected to differ, especially for larger particles. The distribution of particles once having entered the sampler was also expected to differ between samplers. Samplers were paired to allow the between-sampler variability to be addressed, and, in some cases, internal sampler wall deposits were evaluated and compared to the filter catch. It was found, rather surprisingly, that analysis of the filter deposits (by ICP-OES) of all the samplers gave equivalent results. It was also found that deposits on some of the sampler walls, which in some protocols are considered part of the sample, could be significant in comparison to the filter deposit. If it is concluded that wall-deposits should be analyzed, then XRF analysis of the filter can only give a minimum estimate of the concentration. Techniques for the statistical analysis of field data were also developed as part of this program and have been reported

  3. The biopersistence of Canadian chrysotile asbestos following inhalation: final results through 1 year after cessation of exposure.

    Science.gov (United States)

    Bernstein, David; Rogers, Rick; Smith, Paul

    2005-01-01

    Chrysotile asbestos, a serpentine mineral, has been shown to be notably different from amphibole asbestos such as amosite, crocidolite, and tremolite in that chrysotile once inhaled is rapidly removed from the lung while the amphiboles persist. This has been demonstrated for three different chrysotile samples from Canada, the United States, and Brazil. The initial results of the inhalation biopersistence study on the Canadian chrysotile were reported earlier. This article presents the full results through 365 days after cessation of exposure. In order to fully understand the dynamics of the clearance of chrysotile from the lung, the study included a standardised inhalation biopersistence study following the recommendations of the European Commission (EC) Interim Protocol for the Inhalation Biopersistence of synthetic mineral fibers (Bernstein & Riego-Sintes, 1999) in which the lungs were digested to evaluate fiber content remaining. In addition, confocal microscopy was used to examine lungs in three dimensions to determine where and what size the remaining fibers were in the lung tissue. The results showed that Canadian chrysotile is cleared from the lung with a clearance half-time of 11.4 days for the fibers longer than 20 microm. Canadian chrysotile clears in a range similar to that of glass and stone wools. It remains less biopersistent than ceramic and special purpose glasses and considerably less biopersistent than amphibole asbestos. At 1 yr after cessation of exposure, no long (L>20 microm) chrysotile fibers remained in the lung. In contrast, with amosite asbestos there were 4 x 10 (5) long fibers (L>20 microm) remaining in the lungs at one year after cessation of exposure (Hesterberg et al., 1998). These results fully support the differentiation of chrysotile from amphiboles reported in recent evaluations of available epidemiological studies (Hodgson & Darnton, 2000; Berman & Crump, 2004).

  4. Final Report

    Energy Technology Data Exchange (ETDEWEB)

    Gurney, Kevin R. [Arizona Univ., Mesa, AZ (United States)

    2015-01-12

    This document constitutes the final report under DOE grant DE-FG-08ER64649. The organization of this document is as follows: first, I will review the original scope of the proposed research. Second, I will present the current draft of a paper nearing submission to Nature Climate Change on the initial results of this funded effort. Finally, I will present the last phase of the research under this grant which has supported a Ph.D. student. To that end, I will present the graduate student’s proposed research, a portion of which is completed and reflected in the paper nearing submission. This final work phase will be completed in the next 12 months. This final workphase will likely result in 1-2 additional publications and we consider the results (as exemplified by the current paper) high quality. The continuing results will acknowledge the funding provided by DOE grant DE-FG-08ER64649.

  5. Geology of the Terra Cimmeria-Utopia Planitia Highland Lowland Transitional Zone: Final Technical Approach and Scientific Results

    Science.gov (United States)

    Skinner, J. A., Jr.; Tanaka, K. L.

    2010-01-01

    The southern Utopia highland-lowland transitional zone extends from northern Terra Cimmeria to southern Utopia Planitia and contains broad, bench-like platforms with depressions, pitted cones, tholi, and lobate flows. The locally occurring geologic units and landforms contrast other transitional regions and record a spatially partitioned geologic history. We systematically delineated and described the geologic units and landforms of the southern Utopia-Cimmeria highland-lowland transitional zone for the production of a 1:1,000,000-scale geologic map (MTMs 10237, 15237, 20237, 10242, 15242, 20242, 10247, 15247, and 20247). Herein, we present technical and scientific results of this mapping project.

  6. Quality assurance in MR image guided adaptive brachytherapy for cervical cancer: Final results of the EMBRACE study dummy run

    DEFF Research Database (Denmark)

    Kirisits, Christian; Federico, Mario; Nkiwane, Karen

    2015-01-01

    PURPOSE: Upfront quality assurance (QA) is considered essential when starting a multicenter clinical trial in radiotherapy. Despite the long experience gained for external beam radiotherapy (EBRT) trials, there are only limited audit QA methods for brachytherapy (BT) and none include the specific....... A second dummy run was required in case of major deviations (score 7) for any item. RESULTS: Overall 27/30 centers passed the dummy run. 16 centers had to repeat the dummy run in order to clarify major inconsistencies to the protocol. The most pronounced variations were related to contouring for both EBRT...... and BT. Centers with experience in IGABT (>30 cases) had better performance as compared to centers with limited experience. CONCLUSION: The comprehensive dummy run designed for the EMBRACE trial has been a feasible tool for QA in IGABT of cervix cancer. It should be considered for future IGABT trials...

  7. Natural History of Malignant Bone Disease in Gastric Cancer: Final Results of a Multicenter Bone Metastasis Survey

    Science.gov (United States)

    Silvestris, Nicola; Pantano, Francesco; Ibrahim, Toni; Gamucci, Teresa; De Vita, Fernando; Di Palma, Teresa; Pedrazzoli, Paolo; Barni, Sandro; Bernardo, Antonio; Febbraro, Antonio; Satolli, Maria Antonietta; Bertocchi, Paola; Catalano, Vincenzo; Giommoni, Elisa; Comandone, Alessandro; Maiello, Evaristo; Riccardi, Ferdinando; Ferrara, Raimondo; Trogu, Antonio; Berardi, Rossana; Leo, Silvana; Bertolini, Alessandro; Angelini, Francesco; Cinieri, Saverio; Russo, Antonio; Pisconti, Salvatore; Brunetti, Anna Elisabetta; Azzariti, Amalia; Santini, Daniele

    2013-01-01

    Background Bone metastasis represents an increasing clinical problem in advanced gastric cancer (GC) as disease-related survival improves. In literature, few data on the natural history of bone disease in GC are available. Patients and Methods Data on clinicopathology, skeletal outcomes, skeletal-related events (SREs), and bone-directed therapies for 208 deceased GC patients with evidence of bone metastasis were statistically analyzed. Results Median time to bone metastasis was 8 months (CI 95%, 6.125–9.875 months) considering all included patients. Median number of SREs/patient was one. Less than half of the patients (31%) experienced at least one and only 4 and 2% experienced at least two and three events, respectively. Median times to first and second SRE were 2 and 4 months, respectively. Median survival was 6 months after bone metastasis diagnosis and 3 months after first SRE. Median survival in patients who did not experience SREs was 5 months. Among patients who received zoledronic acid before the first SRE, the median time to appearance of first SRE was significantly prolonged compared to control (7 months vs 4 months for control; P: 0.0005). Conclusions To our knowledge, this retrospective analysis is the largest multicenter study to demonstrate that bone metastases from GC are not so rare, are commonly aggressive and result in relatively early onset of SREs in the majority of patients. Indeed, our large study, which included 90 patients treated with ZOL, showed, for the first time in literature, a significant extension of time to first SRE and increase in the median survival time after diagnosis of bone metastasis. Taken together, these data may support the beneficial effects of ZOL in GC patients. PMID:24204569

  8. Final report : results of the 2006 investigation of potential contamination at the former CCC/USDA facility in Ramona, Kansas.

    Energy Technology Data Exchange (ETDEWEB)

    LaFreniere, L. M.; Environmental Science Division

    2007-10-18

    The investigation reported here was conducted by the Commodity Credit Corporation of the U.S. Department of Agriculture (CCC/USDA) in 2006. The investigation addressed carbon tetrachloride contamination on the former CCC/USDA grain storage facility at Ramona, Kansas. The results clearly demonstrate that only minimal contamination is associated with the past use of carbon tetrachloride on the former CCC/USDA property. No soil contamination was detected at concentrations above Kansas Department of Health and Environment (KDHE) risk-based screening level (RBSL) Tier 2 standard of 200 {micro}g/kg for the soil-to-groundwater protection pathway. Carbon tetrachloride concentrations in groundwater above the RBSL and maximum contaminant level (MCL) value of 5.0 {micro}g/L were detected in only two samples, collected at adjacent locations on the southeast part of the property. The relatively low concentrations detected and the limited areal extent of the contamination demonstrate that no imminent threat exists on the former CCC/USDA property to warrant remediation. The soil and groundwater contamination detected on the former CCC/USDA property is clearly separate from contamination detected at off-site locations. The carbon tetrachloride and chloroform contamination in groundwater (at concentrations above the RBSL and MCL value) associated with past activities on the former CCC/USDA property is contained within the property boundaries. Data collected independently by the KDHE in 2006 validate these findings and, furthermore, provide additional evidence that the sources identified on the Co-op property (west of the former CCC/USDA property) are separate from the comparatively minor results of past activities on the former CCC/USDA property. The KDHE concluded in its 2006 report that the sources are separate and that the Co-op is the principally responsible party for the carbon tetrachloride contamination detected during its 2006 investigation.

  9. Natural history of malignant bone disease in gastric cancer: final results of a multicenter bone metastasis survey.

    Directory of Open Access Journals (Sweden)

    Nicola Silvestris

    Full Text Available BACKGROUND: Bone metastasis represents an increasing clinical problem in advanced gastric cancer (GC as disease-related survival improves. In literature, few data on the natural history of bone disease in GC are available. PATIENTS AND METHODS: Data on clinicopathology, skeletal outcomes, skeletal-related events (SREs, and bone-directed therapies for 208 deceased GC patients with evidence of bone metastasis were statistically analyzed. RESULTS: Median time to bone metastasis was 8 months (CI 95%, 6.125-9.875 months considering all included patients. Median number of SREs/patient was one. Less than half of the patients (31% experienced at least one and only 4 and 2% experienced at least two and three events, respectively. Median times to first and second SRE were 2 and 4 months, respectively. Median survival was 6 months after bone metastasis diagnosis and 3 months after first SRE. Median survival in patients who did not experience SREs was 5 months. Among patients who received zoledronic acid before the first SRE, the median time to appearance of first SRE was significantly prolonged compared to control (7 months vs 4 months for control; P: 0.0005. CONCLUSIONS: To our knowledge, this retrospective analysis is the largest multicenter study to demonstrate that bone metastases from GC are not so rare, are commonly aggressive and result in relatively early onset of SREs in the majority of patients. Indeed, our large study, which included 90 patients treated with ZOL, showed, for the first time in literature, a significant extension of time to first SRE and increase in the median survival time after diagnosis of bone metastasis. Taken together, these data may support the beneficial effects of ZOL in GC patients.

  10. Final results of the US humanitarian device exemption study of the low-profile visualized intraluminal support (LVIS) device.

    Science.gov (United States)

    Fiorella, David; Arthur, Adam; Boulos, Alan; Diaz, Orlando; Jabbour, Pascal; Pride, Lee; Turk, Aquilla S; Woo, Henry H; Derdeyn, Colin; Millar, John; Clifton, Andrew

    2016-09-01

    The low-profile visualized intraluminal support (LVIS) device is a new, braided, intracranial microstent designed for stent-assisted coiling. To present the results of a single-arm, prospective, multicenter trial of the LVIS for treatment of wide-necked intracranial aneurysms. 31 patients with unruptured, wide-necked (neck ≥4 mm or dome:neck ratio ≤2) intracranial aneurysms were treated with the LVIS device and bare platinum coils at six US centers (investigational device exemption G110014). Clinical follow-up was conducted at 30 days and 6 months. Angiographic follow-up was performed at 6 months. The primary safety endpoint was any major stroke or death within 30 days or major ipsilateral stroke or neurological death within 6 months. 'Probable benefit' was defined as ≥90% angiographic occlusion at 6 months. An independent core laboratory adjudicated the angiographic results. An independent clinical events committee adjudicated the clinical endpoints. Average aneurysm size was 7.2 mm (SD 3.8) and average neck width was 4.6 mm (SD 1.8). 68% of patients had a dome:neck ratio ≤2. LVIS placement was technically successful in 29/31 patients (93.5%). No primary safety endpoints occurred during the study (0%). No patient had a higher modified Rankin Score at 6 months than at baseline. 26/28 (92.9%) treated aneurysms with 6-month angiographic follow-up demonstrated ≥90% angiographic occlusion. 21/28 (75%) were completely occluded at follow-up. The LVIS device facilitated the coil embolization of wide-necked intracranial aneurysms with high rates of technical success, an excellent safety profile, and very high rates of complete and near-complete occlusion at follow-up. NCT01541254. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/

  11. Results of comparative RBMK neutron computation using VNIIEF codes (cell computation, 3D statics, 3D kinetics). Final report

    Energy Technology Data Exchange (ETDEWEB)

    Grebennikov, A.N.; Zhitnik, A.K.; Zvenigorodskaya, O.A. [and others

    1995-12-31

    In conformity with the protocol of the Workshop under Contract {open_quotes}Assessment of RBMK reactor safety using modern Western Codes{close_quotes} VNIIEF performed a neutronics computation series to compare western and VNIIEF codes and assess whether VNIIEF codes are suitable for RBMK type reactor safety assessment computation. The work was carried out in close collaboration with M.I. Rozhdestvensky and L.M. Podlazov, NIKIET employees. The effort involved: (1) cell computations with the WIMS, EKRAN codes (improved modification of the LOMA code) and the S-90 code (VNIIEF Monte Carlo). Cell, polycell, burnup computation; (2) 3D computation of static states with the KORAT-3D and NEU codes and comparison with results of computation with the NESTLE code (USA). The computations were performed in the geometry and using the neutron constants presented by the American party; (3) 3D computation of neutron kinetics with the KORAT-3D and NEU codes. These computations were performed in two formulations, both being developed in collaboration with NIKIET. Formulation of the first problem maximally possibly agrees with one of NESTLE problems and imitates gas bubble travel through a core. The second problem is a model of the RBMK as a whole with imitation of control and protection system controls (CPS) movement in a core.

  12. Natural History of Malignant Bone Disease in Renal Cancer: Final Results of an Italian Bone Metastasis Survey

    Science.gov (United States)

    Santini, Daniele; Procopio, Giuseppe; Porta, Camillo; Ibrahim, Toni; Barni, Sandro; Mazzara, Calogero; Fontana, Andrea; Berruti, Alfredo; Berardi, Rossana; Vincenzi, Bruno; Ortega, Cinzia; Ottaviani, Davide; Carteni, Giacomo; Lanzetta, Gaetano; Virzì, Vladimir; Santoni, Matteo; Silvestris, Nicola; Satolli, Maria Antonietta; Collovà, Elena; Russo, Antonio; Badalamenti, Giuseppe; Fedeli, Stefano Luzi; Tanca, Francesca Maria; Adamo, Vincenzo; Maiello, Evaristo; Sabbatini, Roberto; Felici, Alessandra; Cinieri, Saverio; Tonini, Giuseppe; Bracarda, Sergio

    2013-01-01

    Background Bone metastasis represents an increasing clinical problem in advanced renal cell carcinoma (RCC) as disease-related survival improves. There are few data on the natural history of bone disease in RCC. Patients and methods Data on clinicopathology, survival, skeletal-related events (SREs), and bone-directed therapies for 398 deceased RCC patients (286 male, 112 female) with evidence of bone metastasis were statistically analyzed. Results Median time to bone metastasis was 25 months for patients without bone metastasis at diagnosis. Median time to diagnosis of bone metastasis by MSKCC risk was 24 months for good, 5 months for intermediate, and 0 months for poor risk. Median number of SREs/patient was one, and 71% of patients experienced at least one SRE. Median times to first, second, and third SRE were 2, 5, and 12 months, respectively. Median survival was 12 months after bone metastasis diagnosis and 10 months after first SRE. Among 181 patients who received zoledronic acid (ZOL), median time to first SRE was significantly prolonged versus control (n = 186) (3 months vs 1 month for control; P<0.05). Conclusions RCC patients with bone metastasis are at continuous risk of SREs, and in this survey ZOL effectively reduced this risk. PMID:24386138

  13. Final report : results of aquifer pumping and groundwater sampling at Everest, Kansas, in January-March 2006.

    Energy Technology Data Exchange (ETDEWEB)

    LaFreniere, L. M.; Environmental Science Division

    2006-09-30

    On September 8-9, 2005, representatives of the Kansas Department of Health and Environment (KDHE), the Commodity Credit Corporation of the U.S. Department of Agriculture (CCC/USDA), and Argonne National Laboratory met at the KDHE's offices in Topeka to review the status of the CCC/USDA's environmental activities in Kansas. As a result of this meeting, the KDHE recommended several additional activities to augment the CCC/USDA's investigations at Everest, Kansas, and assist in the selection of remedial approaches to be evaluated as part of a Corrective Action Study (CAS) for this site. The requested actions included the following: (1) Construction of several additional interpretive cross sections illustrating the hydrogeologic setting along the apparent main plume migration pathway to the north-northwest of the former CCC/USDA facility, as well as in the vicinity of the Nigh property. (2) Installation of additional permanent monitoring wells, to better constrain the apparent western, northern, and northwestern margins of the existing groundwater plume. (3) Development of technical recommendations for a phased pumping study of the Everest aquifer unit in the area near and to the north of the Nigh property.

  14. Clinical impact of retinoids in redifferentiation therapy of advanced thyroid cancer: final results of a pilot study

    Energy Technology Data Exchange (ETDEWEB)

    Simon, D.; Krausch, M.; Segering, J.; Roeher, H.D. [Department of Surgery, Heinrich-Heine-University, Duesseldorf (Germany); Koerber, C.; Reiners, C. [Department of Nuclear Medicine, University of Wuerzburg (Germany); Groth, P. [Department of Nuclear Medicine, University of Rostock (Germany); Goerges, R. [Department of Nuclear Medicine, University of Essen (Germany); Gruenwald, F. [Department of Nuclear Medicine, Johann-Wolfgang-Goethe University, Frankfurt (Germany); Mueller-Gaertner, H.W. [Department of Nuclear Medicine, Heinrich-Heine-University, Duesseldorf (Germany); Schmutzler, C.; Koehrle, J. [Department of Molecular Internal Medicine, University of Wuerzburg (Germany)

    2002-06-01

    Differentiated thyroid cancer is a malignant tumour that has a fairly good prognosis, with patients surviving for many years. Multimodal therapy with surgery, radioiodine therapy and TSH suppressive medication is of proven efficacy. However, loss of differentiation is observed in up to one-third of patients with differentiated thyroid cancer, paralleled by an increase in tumour grading and loss of thyroid-specific functions (thyrotropin receptor, iodine accumulation). Such tumours may no longer be amenable to standard treatment protocols, including TSH suppression and radioiodide therapy. Retinoic acids have been shown to exert re-differentiating effects on thyrocytes in various experimental studies and case reports, and it was on this basis that this pilot study was initiated. Patients with advanced thyroid cancer and without the therapeutic options of operation or radioiodide therapy were treated with 13-cis-retinoic acid at a dosage of 1.5 mg/kg body weight daily over 5 weeks. Parameters for assessment of the therapeutic effect were serum thyroglobulin (TG) levels, radioiodine uptake, and tumour size prior to and after retinoid treatment. Fifty patients were evaluated for response, classified as reduction in tumour size and TG levels, stable disease or disease progression. Thirteen patients showed a clear increase in radioiodine uptake, and eight a mild increase. TG levels were unchanged or decreased in 20 patients. Tumour size was assessable in 37 patients; tumour regression was observed in six, and there was no change in 22. In total, a response was seen in 19 patients (38%). Response to retinoid therapy did not always correlate with increased radioiodine uptake, so other direct antiproliferative effects have to be assumed. The encouraging results of the study and the low rate of side-effects with good tolerability of retinoids warrant further studies with altered inclusion criteria and employment of other redifferentiating drugs or combinations of agents

  15. Effectiveness of radiation therapy without surgery in metastatic spinal cord compression: Final results from a prospective trial

    Energy Technology Data Exchange (ETDEWEB)

    Maranzano, E.; Latini, P. [Univ. School of Medicine, Perugia (Italy)

    1995-07-15

    In assessing effectiveness of radiation therapy (RT) in metastatic spinal cord compression (MSCC), we performed a prospective trial in which patients with this complication were generally treated with RT plus steroids, and surgery was reserved for selected cases. Of the 209 evaluable cases, 110 were females and 99 males, and median age was 62 years. Median follow-up was 49 months (range, 13 to 88) and treatment consisted of 30 Gy RT (using two different schedules) together with steroids (standard or high doses, depending on motor deficit severity). Back pain total response rate was 82% (complete or partial response or stable pain, 54, 17, or 11%, respectively). About three-fourths of the patients (76%) achieved full recovery or preservation of walking ability and 44% with sphincter dysfunction improved. Early diagnosis was the most important response predictor so that a large majority of patients able to walk and with good bladder function maintained these capacities. Duration of response was also influenced by histology. Median survival time was 6 months, with a 28% probability of survival for 1 year. Survival time was longer for patients able to walk before and/or after RT, those with favourable histologies, and females. There was agreement between patient survival and duration of response, systemic relapse of disease being generally the cause of death. Early diagnosis of MSCC was a powerful predictor of outcome. Primary tumor histology had weight only when patients were nonwalking, paraplegic, or had bladder dysfunction. The effectiveness of RT plus steroids in MSCC emerged in our trial. The most important factors positively conditioning our results were: the high rate of early diagnoses (52%) and the number of tumors with favorable histologies (124 out of 209, 63%) recruited, and the choice of best treatment based on appropriate patient selection for surgery and RT or RT alone. 30 refs., 5 figs., 7 tabs.

  16. Natural History of Malignant Bone Disease in Hepatocellular Carcinoma: Final Results of a Multicenter Bone Metastasis Survey

    Science.gov (United States)

    Santini, Daniele; Pantano, Francesco; Riccardi, Ferdinando; Di Costanzo, Giovan Giuseppe; Addeo, Raffaele; Guida, Francesco Maria; Ceruso, Mariella Spalato; Barni, Sandro; Bertocchi, Paola; Marinelli, Sara; Marchetti, Paolo; Russo, Antonio; Scartozzi, Mario; Faloppi, Luca; Santoni, Matteo; Cascinu, Stefano; Maiello, Evaristo; Silvestris, Franco; Tucci, Marco; Ibrahim, Toni; Masi, Gianluca; Gnoni, Antonio; Comandone, Alessandro; Fazio, Nicola; Conti, Alessandro; Imarisio, Ilaria; Pisconti, Salvatore; Giommoni, Elisa; Cinieri, Saverio; Catalano, Vincenzo; Palmieri, Vincenzo Ostilio; Infante, Giovanni; Aieta, Michele; Trogu, Antonio; Gadaleta, Cosmo Damiano; Brunetti, Anna Elisabetta; Lorusso, Vito; Silvestris, Nicola

    2014-01-01

    Background Bone is an uncommon site of metastasis in patients with advanced hepatocellular carcinoma (HCC). Therefore, there are few studies concerning the natural history of bone metastasis in patients with HCC. Patients and Methods Data on clinicopathology, survival, skeletal-related events (SREs), and bone-directed therapies for 211 deceased HCC patients with evidence of bone metastasis were statistically analyzed. Results The median age was 70 years; 172 patients were male (81.5%). The median overall survival was 19 months. The median time to the onset of bone metastasis was 13 months (22.2% at HCC diagnosis); 64.9% patients had multiple bone metastases. Spine was the most common site of bone metastasis (59.7%). Most of these lesions were osteolytic (82.4%); 88.5% of them were treated with zoledronic acid. At multivariate analysis, only the Child Score was significantly correlated with a shorter time to diagnosis of bone metastases (p = 0.001, HR = 1.819). The median survival from bone metastasis was 7 months. At multivariate analysis, HCC etiology (p = 0.005), ECOG performance status (p = 0.002) and treatment with bisphosphonate (p = 0.024) were associated with shorter survival after bone disease occurrence. The site of bone metastasis but not the number of bone lesions was associated with the survival from first skeletal related event (SRE) (p = 0.021) and OS (p = 0.001). Conclusions This study provides a significant improvement in the understanding the natural history of skeletal disease in HCC patients. An early and appropriate management of these patients is dramatically needed in order to avoid subsequent worsening of their quality of life. PMID:25170882

  17. Radiotherapy in oncological emergencies - final results of a patterns of care study in Germany, Austria and Switzerland

    Energy Technology Data Exchange (ETDEWEB)

    Christian, Elmar (Dept. of Internal Medicine, Paracelsus Hospital, Glueckstadt (DE)); Adamietz, Irinaeus A. (Dept. of Radiotherapy, Marienhospital, Herne (DE)); Willich, Normann; Schaefer, Ulrich (Dept. of Radiotherapy, Muenster Univ. Hospital, Muenster (DE)); Micke, Oliver (Dept. of Radiotherapy, Lippe Hospital, Lemgo (DE))

    2008-01-15

    Radiotherapy (RT) is an important treatment option for emergencies in oncology. A multicenter patterns of care study (PCS) was conducted in all RT institutions in Germany, Austria and Switzerland. In 2003 a standardized structured questionnaire was sent to all RT institutions. Number and type of staff involved, number of patients, over time distribution and expense, treatment indications and concepts of emergency RT were assessed. In addition, treatment outcome for the different indications was evaluated. The PCS was structured and analyzed according to the model for quality assessment set up by Donabedian in three major components: structure, process and outcome. One hundred and forty institutions (70%) answered the questionnaire. For the baseline of 2003 a total of 3 244 emergency radiotherapy indications with a mean of 28 per institution were reported. Forty percent of all institutions provide a special 24 h service at night or weekends. Seventy percent of the emergency indications were irradiated between Monday and Thursday, 30% between Friday and Sunday. Ninety percent of all emergencies were referred to RT between 8 a.m. and 6 p.m., 10% between 6 p.m. and 8 a.m. The applied doses for emergency RT ranged between 2 Gy and 8 Gy (median: 3.5 Gy). Time expense was reported with a median of 90 min. The outcome analysis based on the treatment results of 1 033 patients: There was an improvement of myelocompression in 50% of the cases, vena cava superior compression in 70%, bronchial obstruction in 70% and bleedings in 80%. A clear dose-response relationship could not be established, but single doses of over 3 Gy in vena cava superior syndrome exhibited a significant advantage. This study represents the largest database in literature on emergency RT. RT was shown to be fast, time sparing and a very effective treatment option for special oncological emergencies

  18. Prophylactic laser treatment hastens choroidal neovascularization in unilateral age-related maculopathy: final results of the drusen laser study.

    Science.gov (United States)

    Owens, Sarah L; Bunce, Catey; Brannon, Alan J; Xing, Wen; Chisholm, Iain H; Gross, Mirjam; Guymer, Robyn H; Holz, Frank G; Bird, Alan C

    2006-02-01

    The Drusen Laser Study evaluated macular laser to prevent choroidal neovascularization (CNV) and vision loss in high-risk age-related maculopathy (ARM). Prospective, interventional, randomized, controlled clinical trial in five hospital centers. Patients in the unilateral group had neovascular ARM and drusen in the study eye. Study eyes were randomized to laser-treated or no-laser groups. For patients in the bilateral drusen group, eyes were randomized to right eye, laser or no laser; and left eye, alternative. Laser treatment comprised 12 argon spots. Outcome was best-corrected visual acuity and CNV signs, which were monitored for 3 years. In the unilateral group, vision loss occurred in 21 (28.8%) of 73 patients in laser vs 13 (19.7%) of 66 no-laser patients (P=.214). Incidence of CNV was 27 (29.7%) of 91 in laser vs 15 (17.65%) of 85 no-laser patients (P=.061). CNV onset was approximately 6 months earlier in laser-treated compared with no-laser patients (P=.05). In the bilateral group, vision loss occurred in six (8.3%) of 72 laser-treated vs 10 (13.9%) of 72 fellow eyes (P=.3877). CNV incidence was 12 (11.6%) of 103 in laser-treated vs seven (6.8%) of 103 fellow eyes (P=.225). There was no difference in onset of CNV. Results do not support prophylactic laser of the fellow eye of patients with neovascular ARM. Its role in patients with bilateral drusen remains unclear.

  19. Final Results from the High-Current, High-Action Closing Switch Test Program at Sandia National Laboratories

    Energy Technology Data Exchange (ETDEWEB)

    Savage, M.E.

    1999-06-23

    We tested a variety of high-current closing switches for lifetime and reliability on a dedicated 2 MJ, 500 kA capacitor bank facility at Sandia National Laboratories. Our interest was a switch capable of one shot every few minutes, switching a critically damped, DC-charged 6.2 mF bank at 24 kV, with a peak current of 500 kA. The desired lifetime is 24 thousand shots. Typical of high-energy systems, particularly multi-module systems, the primary parameters of interest related to the switch are: (1) reliability, meaning absence of both pre-fires and no-fires, (2) total switch lifetime or number of shots between maintenance, and (3) cost. Cost was given lower priority at this evaluation stage because there are great uncertainties in estimating higher-quantity prices of these devices, most of which have been supplied before in only small quantities. The categories of switches tested are vacuum discharge, high-pressure discharge, and solid-state. Each group varies in terms of triggering ease, ease of maintenance, and tolerance to faults such as excess current and current reversal. We tested at least two variations of each technology group. The total number of shots on the switch test facility is about 50 thousand. We will present the results from the switch testing. The observed lifetime of different switches varied greatly: the shortest life was one shot; one device was still operating after six thousand shots. On several switches we measured the voltage drop during conduction and calculated energy dissipated in the switch; we will show these data also.

  20. Natural history of malignant bone disease in hepatocellular carcinoma: final results of a multicenter bone metastasis survey.

    Directory of Open Access Journals (Sweden)

    Daniele Santini

    Full Text Available BACKGROUND: Bone is an uncommon site of metastasis in patients with advanced hepatocellular carcinoma (HCC. Therefore, there are few studies concerning the natural history of bone metastasis in patients with HCC. PATIENTS AND METHODS: Data on clinicopathology, survival, skeletal-related events (SREs, and bone-directed therapies for 211 deceased HCC patients with evidence of bone metastasis were statistically analyzed. RESULTS: The median age was 70 years; 172 patients were male (81.5%. The median overall survival was 19 months. The median time to the onset of bone metastasis was 13 months (22.2% at HCC diagnosis; 64.9% patients had multiple bone metastases. Spine was the most common site of bone metastasis (59.7%. Most of these lesions were osteolytic (82.4%; 88.5% of them were treated with zoledronic acid. At multivariate analysis, only the Child Score was significantly correlated with a shorter time to diagnosis of bone metastases (p = 0.001, HR = 1.819. The median survival from bone metastasis was 7 months. At multivariate analysis, HCC etiology (p = 0.005, ECOG performance status (p = 0.002 and treatment with bisphosphonate (p = 0.024 were associated with shorter survival after bone disease occurrence. The site of bone metastasis but not the number of bone lesions was associated with the survival from first skeletal related event (SRE (p = 0.021 and OS (p = 0.001. CONCLUSIONS: This study provides a significant improvement in the understanding the natural history of skeletal disease in HCC patients. An early and appropriate management of these patients is dramatically needed in order to avoid subsequent worsening of their quality of life.

  1. Natural history of malignant bone disease in gastric cancer: final results of a multicenter bone metastasis survey.

    Science.gov (United States)

    Silvestris, Nicola; Pantano, Francesco; Ibrahim, Toni; Gamucci, Teresa; De Vita, Fernando; Di Palma, Teresa; Pedrazzoli, Paolo; Barni, Sandro; Bernardo, Antonio; Febbraro, Antonio; Satolli, Maria Antonietta; Bertocchi, Paola; Catalano, Vincenzo; Giommoni, Elisa; Comandone, Alessandro; Maiello, Evaristo; Riccardi, Ferdinando; Ferrara, Raimondo; Trogu, Antonio; Berardi, Rossana; Leo, Silvana; Bertolini, Alessandro; Angelini, Francesco; Cinieri, Saverio; Russo, Antonio; Pisconti, Salvatore; Brunetti, Anna Elisabetta; Azzariti, Amalia; Santini, Daniele

    2013-01-01

    Bone metastasis represents an increasing clinical problem in advanced gastric cancer (GC) as disease-related survival improves. In literature, few data on the natural history of bone disease in GC are available. Data on clinicopathology, skeletal outcomes, skeletal-related events (SREs), and bone-directed therapies for 208 deceased GC patients with evidence of bone metastasis were statistically analyzed. Median time to bone metastasis was 8 months (CI 95%, 6.125-9.875 months) considering all included patients. Median number of SREs/patient was one. Less than half of the patients (31%) experienced at least one and only 4 and 2% experienced at least two and three events, respectively. Median times to first and second SRE were 2 and 4 months, respectively. Median survival was 6 months after bone metastasis diagnosis and 3 months after first SRE. Median survival in patients who did not experience SREs was 5 months. Among patients who received zoledronic acid before the first SRE, the median time to appearance of first SRE was significantly prolonged compared to control (7 months vs 4 months for control; P: 0.0005). To our knowledge, this retrospective analysis is the largest multicenter study to demonstrate that bone metastases from GC are not so rare, are commonly aggressive and result in relatively early onset of SREs in the majority of patients. Indeed, our large study, which included 90 patients treated with ZOL, showed, for the first time in literature, a significant extension of time to first SRE and increase in the median survival time after diagnosis of bone metastasis. Taken together, these data may support the beneficial effects of ZOL in GC patients.

  2. Achievements and bottlenecks in humanitarian demining EU-funded research: final results from the EC DELVE project

    Science.gov (United States)

    Sahli, Hichem; Bruschini, Claudio; Van Kempen, Luc; Schleijpen, Ric; den Breejen, Eric

    2008-04-01

    The EC DELVE Support Action project has analyzed the bottlenecks in the transfer of Humanitarian Demining (HD) technology from technology development to the use in the field, and drawn some lessons learned, basing itself on the assessment of the European Humanitarian Demining Research and Technology Development (RTD) situation from early 1990 until 2006. The situation at the European level was analyzed with emphasis on activities sponsored by the European Commission (EC). This was also done for four European countries and Japan, with emphasis on national activities. The developments in HD during the last 10 years underline the fact that in a number of cases demining related developments have been terminated or at least put on hold. The study also showed that the funding provided by the EC under the Framework Program for RTD has led directly to the creation of an extensive portfolio of Humanitarian Demining technology development projects. The latter provided a range of research and supporting measures addressing the critical issues identified as a result of the regulatory policies developed in the field of Humanitarian Demining over the last ten years. However, the range of instruments available to the EC to finance the necessary research and development were limited, to pre-competitive research. The EC had no tools or programs to directly fund actual product development. As a first consequence, the EC funding program for development of technology for Humanitarian Demining unfortunately proved to be largely unsuitable for the small-scale development needed in a field where there is only a very limited market. As a second consequence, most of the research has been demonstrator-oriented. Moreover, the timeframe for RTD in Humanitarian Demining has not been sufficiently synchronized with the timeframe of the EC policies and regulations. The separation of the Mine Action and RTD funding streams in the EC did also negatively affect the take-up of new technologies. As a

  3. Intravenous Thrombolysis plus Hypothermia for Acute Treatment of Ischemic Stroke (ICTuS-L) – Final results

    Science.gov (United States)

    Hemmen, Thomas M; Raman, Rema; Guluma, Kama Z; Meyer, Brett C; Gomes, Joao A; Cruz-Flores, Salvador; Wijman, Christine A; Rapp, Karen S; Grotta, James C; Lyden, Patrick D

    2010-01-01

    Background Induced hypothermia is a promising neuroprotective therapy. We studied the feasibility and safety of hypothermia and thrombolysis after acute ischemic stroke. Methods ICTuS-L was a randomized, multi-center trial of hypothermia and intravenous t-PA in patients treated within 6 hours after ischemic stroke. Enrollment was stratified to the treatment time windows 0–3 and 3–6 hours. Patients presenting within 3 hours of symptom onset received standard dose intravenous alteplase (IV tPA) and were randomized to undergo 24 hours of endovascular cooling to 33°C followed by 12 hours of controlled re-warming or normothermia treatment. Patients presenting between 3 and 6 hours were randomized twice: to receive t-PA or not and to receive hypothermia or not. Results In total, 59 patients were enrolled. One patient was enrolled but not treated when pneumonia was discovered just prior to treatment. All 44 patients enrolled within 3 hours and 4 of 14 patients enrolled between 3–6 hours received t-PA. Overall, 28 patients randomized to receive hypothermia (HY) and 30 to normothermia (NT). Baseline demographics and risk factors were similar between groups. Mean age was 65.5±12.1 years and baseline NIHSS was 14.0±5.0; 32 (55%) were male. Cooling was achieved in all patients except 2 in whom there were technical difficulties. The median time to target temperature after catheter placement was 67min (Q1 57.3 –Q3 99.4). At 3 months, 18% of patients treated with HY had a modified Rankin Scale (mRS) of 0 or 1, versus 24% in the NT groups (NS). Symptomatic intracranial hemorrhage occurred in 4 patients (68), all were treated with tPA less than 3 hours (1 received HY). Six patients in the HY and 5 in the NT groups died within 90 days (NS). Pneumonia occurred in 14 patients in the HY and in 3 of the NT groups (p=0.001). The pneumonia rate did not significantly adversely affect 3 month mRS (p=0.32). Conclusion This study demonstrates the feasibility and preliminary safety

  4. SMALL-DOSE CYTOKINES IN COMBINATION WITH 5-FLUOROURACIL IN OLISSEMINATED RENAL CELL CARCINOMA: FINAL RESULTS OF A RANDOMIZED TRIAL

    Directory of Open Access Journals (Sweden)

    L. V. Demidov

    2009-01-01

    Full Text Available Background: High and intermediate IL-2 regimens are difficult to recommend because of great toxicity and efficacy is not sufficient. We suggest that a combination of very low-dose cytokines is effective and safe in metastatic renal cell carcinoma (MRCC patients (pts. A prospective randomized study was started in 2003. The primary end-point was a response rate. Methods: The eligibility criteria included histopathologically confirmed MRCC, ECOG PS 0-2, no autoimmune diseases, no brain metastases, and normal organ function. All pts were randomized in three arms: IL-2 alone, 1.5 MIU, iv, t.i.w., weeks 1—3 or IL-2 1.0 MIU, iv, t.i.w., weeks 1—3 plus IFN 5 MIU, sc, t.i.w, weeks 1—3 or biochemotherapy group 5-FU, 500 mg/m2, iv, once a week, weeks 1—3 plus IL-2 1.0 MIU, iv, t.i.w., weeks 1—3 plus IFN 5 MIU, sc, t.i.w., weeks 1—3. Courses were repeated every three weeks. A response was assessed according to the RECIST every 2 courses.Results: 64 pts were enrolled, of whom 63 were analyzed. Their median age was 55.4 years (range 16—74. 42.9% of the patients had pre- viously received chemo- or immunotherapy. 55.6 percent of the pts had poor prognosis (according to Motzer et al., 2002. Bone metastases were present in 52.4% of the pts. Sixteen patients treated with IL-2 alone showed no CR, PR, 2 SD, or 14 PD. Of 23 patients in the IL-2+IFN group, there were 5 PR, 8 SD, and 10 PD, with a response rate of 21.7%. Amongst 24 patients in the 5-FU+IL-2+IFN group, there were 1 CR, 3 PR, 10 SD, and 10 PD, with a response rate of 16.7%. One-year survival was 20.0%, 81.3% and 81.0%, respectively. The influenza-like syndrome was the most common side effect in the pts who received IFN (89.1%, grade 1, CTC. Hypotension associated with IL-2 (all groups was seen in 56.3% (50%, grade 1 and 6.3%, grade 2. The other adverse reactions were 12.7% grade 1 neutropenia and vomiting in 4.7% pts (Group 3.Conclusion: All regimens are well tolerated. Small-dose IL-2

  5. Tank 241-AP-107, grab samples, 7AP-99-1, 7AP-99-3 and 7AP-99-4 analytical results for the final report

    Energy Technology Data Exchange (ETDEWEB)

    BELL, K.E.

    1999-08-12

    This document is the format IV, final report for the tank 241-AP-107 (AP-107) grab samples taken in May 1999 to address waste compatibility concerns. Chemical, radiochemical, and physical analyses on the tank AP-107 samples were performed as directed in Compatibility Grab Sampling and Analysis Plan for Fiscal year 1999. Any deviations from the instructions provided in the tank sampling and analysis plan (TSAP) were discussed in this narrative. Interim data were provided earlier to River Protection Project (RPP) personnel, however, the data presented here represent the official results. No notification limits were exceeded.

  6. Tank 241-ER-311, grab samples, ER311-98-1, ER311-98-2, ER311-98-3 analytical results for the final report

    Energy Technology Data Exchange (ETDEWEB)

    FULLER, R.K.

    1999-02-24

    This document is the final report for catch tank 241-ER-311 grab samples. Three grab samples ER311-98-1, ER311-98-2 and ER311-98-3 were taken from East riser of tank 241-ER-311 on August 4, 1998 and received by the 222-S Laboratory on August 4, 1998. Analyses were performed in accordance with the Compatibility Grab Sampling and Analysis Plan (TSAP) (Sasaki, 1998)and the Data Quality Objectives for Tank Farms Waste Compatibility Program (DQO) (Mulkey and Miller, 1997). The analytical results are presented in the data summary report (Table 1). No notification limits were exceeded.

  7. Tank 241-S-111 08/1999 Compatibility Grab Samples and Analytical Results for the Final Report [SEC 1 and SEC 2

    Energy Technology Data Exchange (ETDEWEB)

    STEEN, F.H.

    1999-12-01

    This document is the format IV, final report for the tank 241-S-111 (S-111) grab samples taken in August 1999 to address waste compatibility concerns. Chemical, radiochemical, and physical analyses on the tank S-111 samples were performed as directed in Compatibility Grab Sampling and Analysis Plan for Fiscal Year 1999 (Sasaki 1999a,b). Any deviations from the instructions provided in the tank sampling and analysis plan (TSAP) were discussed in this narrative. The notification limit for {sup 137}Cs was exceeded on two samples. Results are discussed in Section 5.3.2. No other notification limits were exceeded.

  8. Tank 241-AN-101, grab samples, 1AN-98-1, 1AN-98-2 and 1AN-98-3 analytical results for the final report

    Energy Technology Data Exchange (ETDEWEB)

    FULLER, R.K.

    1999-02-24

    This document is the final report for tank 241-AN-101 grab samples. Three grab samples 1AN-98-1, 1AN-98-2 and 1AN-98-3 were taken from riser 16 of tank 241-AN-101 on April 8, 1998 and received by the 222-S Laboratory on April 9, 1998. Analyses were performed in accordance with the ''Compatability Grab Sampling and Analysis Plan'' (TSAP) and the ''Data Quality Objectives for Tank Farms Waste Compatability Program'' (DQO). The analytical results are presented in the data summary report. No notification limits were exceeded.

  9. Final Progress Report for Collaborative Research: Aging of Black Carbon during Atmospheric Transport: Understanding Results from the DOE’s 2010 CARES and 2012 ClearfLo Campaigns

    Energy Technology Data Exchange (ETDEWEB)

    Mazzoleni, Claudio [Michigan Technological Univ., Houghton, MI (United States); Subramanian, R. [Carnegie Mellon Univ., Pittsburgh, PA (United States)

    2016-08-31

    Over the course of this project, we have analyzed data and samples from the Carbonaceous Aerosol and Radiative Effects Study (CARES) and the Clear air for London (ClearfLo) campaign, as well as conducted or participated in laboratory experiments designed to better understand black carbon mixing state and climate-relevant properties. The laboratory campaigns took place at the Pacific Northwest National Laboratory and Carnegie Mellon University to study various climate-relevant aerosol properties of different sources of soot mixing with secondary organic aerosol precursors. Results from some of these activities were summarized in the previous progress report. This final report presents the manuscripts that have been published (many in the period since the last progress report), lists presentations at different conferences based on grant-related activities, and presents some results that are likely to be submitted for publication in the near future.

  10. Final Report

    DEFF Research Database (Denmark)

    Heiselberg, Per; Brohus, Henrik; Nielsen, Peter V.

    This final report for the Hybrid Ventilation Centre at Aalborg University describes the activities and research achievement in the project period from August 2001 to August 2006. The report summarises the work performed and the results achieved with reference to articles and reports published...

  11. Tank 241-AP-107, grab samples 7AP-97-1, 7AP-97-2 and 7AP-97-3 analytical results for the final report

    Energy Technology Data Exchange (ETDEWEB)

    Steen, F.H.

    1997-12-22

    This document is the final report for tank 241-AP-107 grab samples. Three grab samples were collected from riser 1 on September 11, 1997. Analyses were performed on samples 7AP-97-1, 7AP-97-2 and 7AP-97-3 in accordance with the Compatibility Grab Sampling and Analysis Plan (TSAP) (Sasaki, 1997) and the Data Quality Objectives for Tank Farms Waste Compatibility Program (DQO) (Rev. 1: Fowler, 1995; Rev. 2: Mulkey and Nuier, 1997). The analytical results are presented in the data summary report (Table 1). A notification was made to East Tank Farms Operations concerning low hydroxide in the tank and a hydroxide (caustic) demand analysis was requested. The request for sample analysis (RSA) (Attachment 2) received for AP-107 indicated that the samples were polychlorinated biphenyl (PCB) suspects. Therefore, prior to performing the requested analyses, aliquots were made to perform PCB analysis in accordance with the 222-S Laboratory administrative procedure, LAP-101-100. The results of this analysis indicated that no PCBs were present at 50 ppm and analysis proceeded as non-PCB samples. The results and raw data for the PCB analysis will be included in a revision to this document. The sample breakdown diagrams (Attachment 1) are provided as a cross-reference for relating the tank farm customer identification numbers with the 222-S Laboratory sample numbers and the portion of sample analyzed.

  12. Tank 241-AP-106, Grab samples, 6AP-98-1, 6AP-98-2 and 6AP-98-3 Analytical results for the final report

    Energy Technology Data Exchange (ETDEWEB)

    FULLER, R.K.

    1999-02-23

    This document is the final report for tank 241-AP-106 grab samples. Three grab samples 6AP-98-1, 6AP-98-2 and 6AP-98-3 were taken from riser 1 of tank 241-AP-106 on May 28, 1998 and received by the 222-S Laboratory on May 28, 1998. Analyses were performed in accordance with the ''Compatability Grab Sampling and Analysis Plan'' (TSAP) (Sasaki, 1998) and the ''Data Quality Objectives for Tank Farms Waste Compatability Program (DQO). The analytical results are presented in the data summary report. No notification limits were exceeded. The request for sample analysis received for AP-106 indicated that the samples were polychlorinated biphenyl (PCB) suspects. The results of this analysis indicated that no PCBs were present at the Toxic Substance Control Act (TSCA) regulated limit of 50 ppm. The results and raw data for the PCB analysis are included in this document.

  13. Detection of Potential Transit Signals in 17 Quarters of Kepler Data: Results of the Final Kepler Mission Transiting Planet Search (DR25)

    Science.gov (United States)

    Twicken, Joseph D.; Jenkins, Jon M.; Seader, Shawn E.; Tenenbaum, Peter; Smith, Jeffrey C.; Brownston, Lee S.; Burke, Christopher J.; Catanzarite, Joseph H.; Clarke, Bruce D.; Cote, Miles T.; Girouard, Forrest R.; Klaus, Todd C.; Li, Jie; McCauliff, Sean D.; Morris, Robert L.; Wohler, Bill; Campbell, Jennifer R.; Kamal Uddin, Akm; Zamudio, Khadeejah A.; Sabale, Anima; Bryson, Steven T.; Caldwell, Douglas A.; Christiansen, Jessie L.; Coughlin, Jeffrey L.; Haas, Michael R.; Henze, Christopher E.; Sanderfer, Dwight T.; Thompson, Susan E.

    2016-12-01

    We present results of the final Kepler Data Processing Pipeline search for transiting planet signals in the full 17-quarter primary mission data set. The search includes a total of 198,709 stellar targets, of which 112,046 were observed in all 17 quarters and 86,663 in fewer than 17 quarters. We report on 17,230 targets for which at least one transit signature is identified that meets the specified detection criteria: periodicity, minimum of three observed transit events, detection statistic (I.e., signal-to-noise ratio) in excess of the search threshold, and passing grade on three statistical transit consistency tests. Light curves for which a transit signal is identified are iteratively searched for additional signatures after a limb-darkened transiting planet model is fitted to the data and transit events are removed. The search for additional planets adds 16,802 transit signals for a total of 34,032; this far exceeds the number of transit signatures identified in prior pipeline runs. There was a strategic emphasis on completeness over reliability for the final Kepler transit search. A comparison of the transit signals against a set of 3402 well-established, high-quality Kepler Objects of Interest yields a recovery rate of 99.8%. The high recovery rate must be weighed against a large number of false-alarm detections. We examine characteristics of the planet population implied by the transiting planet model fits with an emphasis on detections that would represent small planets orbiting in the habitable zone of their host stars.

  14. Final Results from Mexnext-I. Analysis of detailed aerodynamic measurements on a 4.5 m diameter rotor placed in the large German Dutch Wind Tunnel DNW

    Energy Technology Data Exchange (ETDEWEB)

    Schepers, J.G.; Boorsma, K. [Energy research Center of the Netherlands ECN, Petten (Netherlands); Munduate, X. [National Renewable Energy Center, CENER, Pamplona (Spain)

    2013-02-15

    The paper presents the final results from the first phase of IEA Task 29 'Mexnext'. Mexnext was a joint project in which 20 parties from 11 different countries cooperated. The main aim of Mexnext was to analyse the wind tunnel measurements which have been taken in the EU project 'MEXICO'. In the MEXICO project 10 institutes from 6 countries cooperated in doing experiments on an instrumented, three-bladed wind turbine of 4.5 m diameter placed in the 9.5 by 9.5 m{sup 2} open section of the Large Low-speed Facility (LLF) of the test facility DNW (German-Dutch Wind Tunnels). Pressure distributions on the blades were obtained from 148 Kulite pressure sensors, distributed over 5 sections at 25, 35, 60, 82 and 92% radial position respectively. Blade loads were monitored through two strain-gauge bridges at each blade root. Most interesting however are the extensive PIV flow field measurements, which have been taken simultaneously with the pressure and load measurements. As a result of the international collaboration within this task a very thorough analysis of the data could be carried out and a large number of codes were validated not only in terms of loads but also in terms of underlying flow field. The paper will present several results from Mexnext-I, i.e. validation results and conclusion on modelling deficiencies and directions for model improvement. The future plans of the Mexnext consortium are also briefly discussed. Amongst these are Mexnext-II, a project in which also aerodynamic measurements other than MEXICO are included, and 'New MEXICO' in which additional measurement on the MEXICO model are performed.

  15. Tank 241-S-302 grab samples 302S-97-1, 302S-97-2 and 302S-97-3 analytical results for the final report

    Energy Technology Data Exchange (ETDEWEB)

    Diaz, L.A.

    1998-03-20

    This document is the final report for tank 241-S-302 grab samples. Three grab samples were collected on January 30, 1998. Analyses were performed on samples 302-S-97-1, 302-S-97-2 and 302-S-97-3 in accordance with the Compatibility Grab Sampling and Analysis Plan (TSAP) (Sasaki, 1997) and the Data Quality Objectives (DQO) for Tank Farms Waste Compatibility Program (Mulkey, 1997). The analytical results are presented in Table 1. No notification limits were exceeded. The sample breakdown diagrams (Attachment 1) are provided as a cross-reference for relating the tank farm customer identification numbers with the 222-S Laboratory sample numbers and the portion of sample analyzed. Table 2 provides the appearance information. Visual observation indicated that the sample was a clear, light-yellow liquid with less than one percent solids. No organic layer was observed. The 125 mL sample was submitted to the laboratory for analysis of inorganic analytes and radionuclides.

  16. Tropical Forest Remote Sensing Services for the Democratic Republic of Congo inside the EU FP7 ReCover Project (Final Results 2000-2012)

    Science.gov (United States)

    Haarpaintner, J.; de la Fuente Blanco, D.; Enssle, F.; Datta, P.; Mazinga, A.; Singa, C.; Mane, L.

    2015-04-01

    'ReCover' was a 3-year EU-FP7 project (Nov. 2010 - Dec. 2013), aiming to develop and improve science based remote sensing services to support tropical forest management and activities to reduce emission from deforestation and forest degradation (REDD) in the tropical region (Hame et al., 2012). This is an overview of the final ReCover service delivery of 2000-2012 single-year optical (Landsat, ALOS AVNIR-2, RapidEye) and C-and L-band SAR (Envisat ASAR and ALOS Palsar, respectively) image mosaics, their derived forest/non-forest maps, a multi-sensor forest change map (2000-2010) and a biomass map (based on 2003-2009 ICESat GLAS) o he user of he De ocr ic Repub ic of Congo DRC), he Observatoir Satellitale des Fore s d'Afrique Cen r e OSFAC). The results are an improvement from a first iteration service delivery in 2012 after a critical review and validation process by both, the user and service providers, further method development and research, like a prior statistical data analysis considering temporal/seasonal variability, improved data pre-processing, and through the use of ground reference data collected in March 2013 for classification training. Validation with Kompsat-2 VHR data for the 2010 forest/non-forest maps revealed accuracies of 87% and 88% for optical and radar sensors, respectively.

  17. [Final results from four clinical studies in the field of cardiovascular diseases integrated in the "Mattoni del SSN - Mattone Outcome" Project].

    Science.gov (United States)

    D'Errigo, Paola; Seccareccia, Fulvia; Rosato, Stefano; Maraschini, Alice; Badoni, Gabriella; Perucci, Carlo Alberto; Fusco, Danilo; D'Ovidio, Mariangela; Stafoggia, Massimo; Barone, Anna Patrizia

    2011-12-01

    Observational outcome studies represent a valid approach to evaluating comparative treatment effectiveness in real populations. The main objective of outcome research is to underline what works and what does not work in the field of health assistance. In 2004 the Italian Ministry of Health launched the Project "Mattone Misura dell'Outcome" aimed at assessing the introduction of procedures and methods for the systematic evaluation of outcomes in the national health system. A new experience, the PROGRESSI program (PROGRamma ESiti per SIVeAS e LEA), started in 2008 with the aim to further develop the methodologies for outcome evaluation. In this Supplement the final results from four clinical studies named "Sperimentazioni dell'area cardiovascolare del Progetto Mattoni" are presented. These studies started between 2005 and 2007 and their main objectives were to evaluate: --the contribution of information from current informative systems and clinical studies in risk-adjustment methodologies; --the advisability of introducing some clinical items in current informative systems to improve outcome estimates; --the goodness of follow-up procedures from current informative systems; and --the role of disease registries in the validation of comparative evaluation measures. The four studies were designed as voluntary prospective multicentre studies. Results concerning the characteristics of the enrolled populations as well as the risk-adjustment models built using information from current informative systems and/or clinical information are presented. As expected, each study produced specific remarks both in terms of clinical findings and contribution of different informative systems to the risk-adjustment models. In general, models built with information from both current informative systems and clinical information show the best performance. Findings from these analyses will provide the public health system with suitable indications to improve statistical methodologies for

  18. Proof-of-principle of onchocerciasis elimination with ivermectin treatment in endemic foci in Africa: final results of a study in Mali and Senegal.

    Directory of Open Access Journals (Sweden)

    Mamadou O Traore

    Full Text Available BACKGROUND: Mass treatment with ivermectin controls onchocerciasis as a public health problem, but it was not known if it could also interrupt transmission and eliminate the parasite in endemic foci in Africa where vectors are highly efficient. A longitudinal study was undertaken in three hyperendemic foci in Mali and Senegal with 15 to 17 years of annual or six-monthly ivermectin treatment in order to assess residual levels of infection and transmission, and test whether treatment could be safely stopped. This article reports the results of the final evaluations up to 5 years after the last treatment. METHODOLOGY/PRINCIPAL FINDINGS: Skin snip surveys were undertaken in 131 villages where 29,753 people were examined and 492,600 blackflies were analyzed for the presence of Onchocerca volvulus larva using a specific DNA probe. There was a declining trend in infection and transmission levels after the last treatment. In two sites the prevalence of microfilaria and vector infectivity rate were zero 3 to 4 years after the last treatment. In the third site, where infection levels were comparatively high before stopping treatment, there was also a consistent decline in infection and transmission to very low levels 3 to 5 years after stopping treatment. All infection and transmission indicators were below postulated thresholds for elimination. CONCLUSION/SIGNIFICANCE: The study has established the proof of principle that onchocerciasis elimination with ivermectin treatment is feasible in at least some endemic foci in Africa. The study results have been instrumental for the current evolution from onchocerciasis control to elimination in Africa.

  19. Hydrological and hydrogeological effects of an open repository in Forsmark. Final MIKE SHE flow modelling results for the Environmental Impact Assessment

    Energy Technology Data Exchange (ETDEWEB)

    Maartensson, Erik; Gustafsson, Lars-Goeran (DHI Sverige AB (Sweden))

    2010-07-15

    This report presents methodology and modelling results concerning a deep-rock repository for spent nuclear fuel in Forsmark. Specifically, the modelling tools MIKE SHE, MIKE 11 and MOUSE are used to quantify the groundwater inflow to the repository and associated hydrological and hydrogeological effects during the construction and operation phases. The modelling results presented in the report provide input to the Environmental Impact Assessment (EIA) that will be part of a permit application according to the Environmental Code. Based on an existing MIKE SHE model for Forsmark, the first step of the modelling process was to implement an updated hydrogeological model of the bedrock and to increase the vertical and horizontal extents of the model domain. Other model updates involve the vegetation classification, and implementation of SFR (final repository for short-lived radioactive waste) and the subsurface drainage system at the nearby nuclear power plant. The updated model was calibrated using measured data on groundwater levels in the Quaternary deposits and the bedrock, water levels in lakes, and stream discharges. The calibrated model was then used for simulation of undisturbed conditions (i.e. without the repository) as a reference for modelling results obtained for disturbed conditions (with the repository). The modelling results for undisturbed conditions that are presented in the report closely resemble those of the final MIKE SHE site descriptive modelling (SDM-Site Forsmark). The repository layout was implemented as pipe links (segments) in the modelling tool MOUSE, and the implemented layout was used for the modelling of disturbed conditions. The study uses an updated and verified MIKE SHE-MOUSE coupling routine that is specifically adapted for calculation of groundwater inflow to grouted rock tunnels. The vertical shafts of the repository are implemented in the form of MIKE SHE grid cells with atmospheric pressure. Modelling results for disturbed

  20. Clouds and Hazes in Saturn's North Polar Vortex: New Results from Cassini/VIMS High-Spatial Resolution Spectral Imagery on the First Grand Finale Pass

    Science.gov (United States)

    Baines, Kevin H.; Sromovsky, Lawrence A.; Fry, Patrick M.; Momary, Thomas W.; Brown, Robert H.; Buratti, Bonnie J.; Clark, Roger Nelson; Nicholson, Philip D.; Sotin, Christophe

    2017-10-01

    High-spatial-resolution spectral images of Saturn's polar region obtained during the first Grand Finale pass on April 26, 2017 by the Cassini/Visual Infrared Mapping Spectrometer (VIMS) reveal a variety of cloud/haze structures exhibiting distinctively different colors in the near-infrared, corresponding to a variety of cloud compositions, altitudes and thicknesses. Two spectral images in particular, obtained from altitudes of 110,000 km and 69,600 km above the cloudtops - corresponding to VIMS pixel resolutions of 55 and 34 km, some five times better than has been obtained by VIMS on any previous orbit - reveal small (~ 200 km across) discrete clouds remarkably enhanced in 3-micron absorption compared to nearby features, indicating enhanced ammonia and/or perhaps ammonia hydrosulfide or water ice absorptions. The ~2000-km-wide eye of the vortex in which these discrete ammonia/water ice clouds are embedded is surprisingly dark, exhibiting reflectivities less than one-third of those displayed by the small discrete clouds at all near-IR continuum wavelengths. However, at 5 microns, this contrast is reversed with the vortex eye emanating eight times the thermal flux of the embedded clouds. Taken together, the small reflectivity and large 5-micron thermal transmission indicate that the eye is an optically-thin haze/cloud region, nearly devoid of aerosols. From a dynamical point of view, the stark contrast between the reflectively dark, nearly-aerosol-free polar "eye" - indicative of downwelling processes - and the clouds of 3-micron absorbers embedded within it - indicative of powerful upwelling of materials from the depths of Saturn perhaps 50-200 km below - is puzzling, revealing that a remarkable range of vertical dynamical processes occur in Saturn's north polar region over relatively small spatial scales. Quantitative results for these various clouds, including their compositional characteristics, altitudes, mass loading, and wavelength-dependent opacities will be

  1. Final results of a phase I dose-escalation, dose-expansion study of adding disulfiram with or without copper to adjuvant temozolomide for newly diagnosed glioblastoma.

    Science.gov (United States)

    Huang, Jiayi; Campian, Jian L; Gujar, Amit D; Tsien, Christina; Ansstas, George; Tran, David D; DeWees, Todd A; Lockhart, A Craig; Kim, Albert H

    2018-01-27

    Disulfiram has shown promising activity including proteasome inhibitory properties and synergy with temozolomide in preclinical glioblastoma (GBM) models. In a phase I study for newly diagnosed GBM after chemoradiotherapy, we have previously reported our initial dose-escalation results combining disulfiram with adjuvant temozolomide and established the maximum tolerated dose (MTD) as 500 mg per day. Here we report the final results of the phase I study including an additional dose-expansion cohort of disulfiram with concurrent copper. The phase I study consisted of an initial dose-escalation phase of disulfiram 500-1000 mg daily during adjuvant temozolomide, followed by a dose-expansion phase of disulfiram 500 mg daily with copper 2 mg three times daily. Proteasome inhibition was assessed using fluorometric 20S proteasome assay on peripheral blood cell. A total of 18 patients were enrolled: 7 patients received 500 mg disulfiram, 5 patients received 1000 mg disulfiram, and 6 patients received 500 mg disulfiram with copper. Two dose-limiting toxicities occurred with 1000 mg disulfiram. At disulfiram 500 mg with or without copper, only 1 patient (7%) required dose-reduction during the first month of therapy. Addition of copper to disulfiram did not increase toxicity nor proteasome inhibition. The median progression-free survival was 4.5 months (95% CI 0.8-8.2). The median overall survival (OS) was 14.0 months (95% CI 8.3-19.6), and the 2-year OS was 24%. The MTD of disulfiram at 500 mg daily in combination with adjuvant temozolomide was well tolerated by GBM patients, but 1000 mg daily was not. Toxicity and pharmacodynamic effect of disulfiram were similar with or without concurrent copper. The clinical efficacy appeared to be comparable to historical data. Additional clinical trials to combine disulfiram and copper with chemoradiotherapy or to resensitize recurrent GBM to temozolomide are ongoing.

  2. Randomized Phase III Multi-Institutional Study of TNFerade Biologic With Fluorouracil and Radiotherapy for Locally Advanced Pancreatic Cancer: Final Results

    Science.gov (United States)

    Herman, Joseph M.; Wild, Aaron T.; Wang, Hao; Tran, Phuoc T.; Chang, Kenneth J.; Taylor, Gretchen E.; Donehower, Ross C.; Pawlik, Timothy M.; Ziegler, Mark A.; Cai, Hongyan; Savage, Dionne T.; Canto, Marcia I.; Klapman, Jason; Reid, Tony; Shah, Raj J.; Hoffe, Sarah E.; Rosemurgy, Alexander; Wolfgang, Christopher L.; Laheru, Daniel A.

    2013-01-01

    Purpose TNFerade biologic is a novel means of delivering tumor necrosis factor alpha to tumor cells by gene transfer. We herein report final results of the largest randomized phase III trial performed to date among patients with locally advanced pancreatic cancer (LAPC) and the first to test gene transfer against this malignancy. Patients and Methods In all, 304 patients were randomly assigned 2:1 to standard of care plus TNFerade (SOC + TNFerade) versus standard of care alone (SOC). SOC consisted of 50.4 Gy in 28 fractions with concurrent fluorouracil (200 mg/m2 per day continuous infusion). TNFerade was injected intratumorally before the first fraction of radiotherapy each week at a dose of 4 × 1011 particle units by using either a percutaneous transabdominal or an endoscopic ultrasound approach. Four weeks after chemoradiotherapy, patients began gemcitabine (1,000 mg/m2 intravenously) with or without erlotinib (100 to 150 mg per day orally) until progression or toxicity. Results The analysis included 187 patients randomly assigned to SOC + TNFerade and 90 to SOC by using a modified intention-to-treat approach. Median follow-up was 9.1 months (range, 0.1 to 50.5 months). Median survival was 10.0 months for patients in both the SOC + TNFerade and SOC arms (hazard ratio [HR], 0.90; 95% CI, 0.66 to 1.22; P = .26). Median progression-free survival (PFS) was 6.8 months for SOC + TNFerade versus 7.0 months for SOC (HR, 0.96; 95% CI, 0.69 to 1.32; P = .51). Among patients treated on the SOC + TNFerade arm, multivariate analysis showed that TNFerade injection by an endoscopic ultrasound-guided transgastric/transduodenal approach rather than a percutaneous transabdominal approach was a risk factor for inferior PFS (HR, 2.08; 95% CI, 1.06 to 4.06; P = .032). The patients in the SOC + TNFerade arm experienced more grade 1 to 2 fever and chills than those in the SOC arm (P .05). Conclusion SOC + TNFerade is safe but not effective for prolonging survival in patients with

  3. The ARBITER 6-HALTS Trial (Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol 6-HDL and LDL Treatment Strategies in Atherosclerosis): final results and the impact of medication adherence, dose, and treatment duration

    National Research Council Canada - National Science Library

    Villines, Todd C; Stanek, Eric J; Devine, Patrick J; Turco, Mark; Miller, Michael; Weissman, Neil J; Griffen, Len; Taylor, Allen J

    2010-01-01

    This report describes the final results of the ARBITER 6-HALTS (Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol 6-HDL and LDL Treatment Strategies in Atherosclerosis) trial...

  4. Tank 241-AX-101 grab samples 1AX-97-1 through 1AX-97-3 analytical results for the final report

    Energy Technology Data Exchange (ETDEWEB)

    Esch, R.A.

    1997-11-13

    This document is the final report for tank 241-AX-101 grab samples. Four grab samples were collected from riser 5B on July 29, 1997. Analyses were performed on samples 1AX-97-1, 1AX-97-2 and 1AX-97-3 in accordance with the Compatibility Grab Sampling and Analysis Plan (TSAP) and the Data Quality Objectives for Tank Farms Waste Compatibility Program (DQO) (Rev. 1: Fowler, 1995; Rev. 2: Mulkey and Miller, 1997). The analytical results are presented in Table 1. No notification limits were exceeded. All four samples contained settled solids that appeared to be large salt crystals that precipitated upon cooling to ambient temperature. Less than 25 % settled solids were present in the first three samples, therefore only the supernate was sampled and analyzed. Sample 1AX-97-4 contained approximately 25.3 % settled solids. Compatibility analyses were not performed on this sample. Attachment 1 is provided as a cross-reference for relating the tank farm customer identification numbers with the 222-S Laboratory sample numbers and the portion of sample analyzed. Table 2 provides the appearance information. All four samples contained settled solids that appeared to be large salt crystal that precipitated upon cooling to ambient temperature. The settled solids in samples 1AX-97-1, 1AX-97-2 and 1AX-97-3 were less than 25% by volume. Therefore, for these three samples, two 15-mL subsamples were pipetted to the surface of the liquid and submitted to the laboratory for analysis. In addition, a portion of the liquid was taken from each of the these three samples to perform an acidified ammonia analysis. No analysis was performed on the settled solid portion of the samples. Sample 1AX-97-4 was reserved for the Process Chemistry group to perform boil down and dissolution testing in accordance with Letter of Instruction for Non-Routine Analysis of Single-Shell Tank 241-AX-101 Grab Samples (Field, 1997) (Correspondence 1). However, prior to the analysis, the sample was inadvertently

  5. Programa “Mejorar la calidad de la vida del paciente diabético”: Resultados finales sobre mortalidad Program to improve the quality of the diabetic patient's life: Final results on mortality

    Directory of Open Access Journals (Sweden)

    Alberto Quirantes Hernández

    2005-08-01

    Full Text Available Se presentan los resultados finales sobre mortalidad del programa Mejorar la Calidad de la Vida del Diabético, desarrollado en el municipio Cerro de Ciudad de La Habana. Se analiza la mortalidad de estos pacientes en el territorio investigado, comparando los 2 años precedentes al programa (l995-1996 con los 4 años en que fue aplicado (1997-2000. Se comparan las cifras encontradas con las del resto del país, y se analizan por sexo y por grupos etarios. En todos los casos el decrecimiento fue más ostensible en el municipio Cerro. El porcentaje de fallecidos por cetoacidosis y coma diabético en relación con el total de defunciones por diabetes no se modificó en ninguno de los 2 territorios comparados, excepto en los 2 últimos años de la investigación en que se produjo un descenso, por demás evidente, en el municipio Cerro. El programa que aquí se presenta se basa en la aplicación de un código de conducta que diseñamos para los pacientes diabéticos que decidimos llamar “Las 7 Leyes del Éxito del Paciente Diabético” y en la interrelación efectiva entre los niveles de salud primario y secundario.

  6. Data Needs in Vocational Education. "The Development of a Minimal Information System to Satisfy the Needs of Selected User Groups." Final Report. Volume V. Data Analysis: Procedures and Results. Project EDNEED I.

    Science.gov (United States)

    Drewes, D. W.; And Others

    Detailed descriptions of the data analysis procedures used in Project EDNEED (Empirical Determination of Nationally Essential Educational Data) are contained in this volume, the last of a five-volume final report. Results of the application of procedures and a narrative interpretation of the results are included. Priority rankings of 323 questions…

  7. District heating and cooling systems for communities through power plant retrofit and distribution networks. Phase 1: identificatzon and assessment. Final report, Volume II. Detailed results

    Energy Technology Data Exchange (ETDEWEB)

    1979-09-01

    The Phase I Identification and Assessment Study was aimed at surveying the State of Wisconsin to identify potential sites for a district heating system and evaluating these sites in terms of their technical, institutional and economic merits. Specific objectives of the study were to: identify candidate plants and service areas and to perform an energy market analysis for selected areas; identify and evaluate plant retrofit and distribution alternatives for the selected service areas; identify and evaluate institutional problems within the infrastructure; and perform an economic analysis for the candidate sites. The overall approach consisted of surveying the State of Wisconsin to identify all existing intermediate and base-loaded electric generating facilities. Once identified, screening criteria were developed to narrow the list to the three most promising sites. For each of the three sites, an extensive market analysis was performed to identify and characterize thermal loads and survey potential users on their views and concerns on the concept. Parallel to this effort, each of the three sites was evaluated on its technical and institutional merits. The technical evaluation centered on identifying and evaluating utility plant retrofit schemes and distribution system alternatives to service the identified thermal market. The institutional analysis evaluated potential barriers such as environmental, distribution system right-of-way and legal issues within the infrastructure of the state, city and community. Finally, all previous aspects of the analysis were combined to determine the economic viability of each site. The most promising site is Green Bay where process heat loads as well as building heat loads are located near the Pulliam Power Plant.

  8. Final Report

    Energy Technology Data Exchange (ETDEWEB)

    DeTar, Carleton [P.I.

    2012-12-10

    This document constitutes the Final Report for award DE-FC02-06ER41446 as required by the Office of Science. It summarizes accomplishments and provides copies of scientific publications with significant contribution from this award.

  9. Trastuzumab retreatment after relapse on adjuvant trastuzumab therapy for human epidermal growth factor receptor 2-positive breast cancer: final results of the Retreatment after HErceptin Adjuvant trial.

    Science.gov (United States)

    Láng, I; Bell, R; Feng, F Y; Lopez, R I; Jassem, J; Semiglazov, V; Al-Sakaff, N; Heinzmann, D; Chang, J

    2014-02-01

    Trastuzumab, in combination with chemotherapy, is the standard of care for patients with early and metastatic human epidermal growth factor receptor 2 (HER2)-positive breast cancer. The Retreatment after HErceptin Adjuvant trial assessed the efficacy and safety of trastuzumab plus a taxane as first-line treatment for patients with metastatic breast cancer (MBC) who had relapsed after adjuvant trastuzumab for HER2-positive early breast cancer. In total, 43 patients with HER2-positive MBC who had received previous adjuvant trastuzumab for ≥10 months, with a relapse-free interval of ≥6 months after the last adjuvant trastuzumab dose, were recruited. Eligible patients (n = 41) were assigned to receive trastuzumab, either weekly or every 3 weeks, in combination with docetaxel or paclitaxel until disease progression. At the final analysis, with a median follow-up time of 40 months, a positive response was observed in 25/41 patients (61%; 95% confidence interval: 48.7-80.4%), stable disease in 7/41 (17.1%) and progressive disease in 6/41 (14.6%). Three patients had missing response assessments (one had no measurable lesions at baseline and two had no post-baseline tumour assessments). The median progression-free survival (PFS) was 8.0 months (95% confidence interval: 6-11 months) and the median overall survival was 25.0 months (16-33 months). No correlation was found between response rate, PFS or overall survival and the duration of adjuvant trastuzumab treatment, trastuzumab-free interval, relapse-free interval, hormone receptor status or type of pre-metastatic treatment. The most common adverse events (all grades) were alopecia (32%) and diarrhoea (32%). Six patients (14.6%) developed at least one serious adverse event. No congestive heart failure or any unexpected adverse events were reported. Trastuzumab, in combination with a taxane, is an effective and well-tolerated first-line treatment for MBC in patients who relapse after trastuzumab-based adjuvant therapy

  10. A study of toxic emissions from a coal-fired power plant: Niles Station Boiler No. 2. Volume 1, Sampling/results/special topics: Final report

    Energy Technology Data Exchange (ETDEWEB)

    1994-06-01

    This study was one of a group of assessments of toxic emissions from coal-fired power plants, conducted for US Department of Energy, Pittsburgh Energy Technology Center (DOE-PETC) during 1993. The motivation for those assessments was the mandate in the 1990 Clean Air Act Amendments that a study be made of emissions of hazardous air pollutants (HAPs) from electrical utilities. The results of this study will be used by the US Environmental Protection Agency to evaluate whether regulation of HAPs emissions from utilities is warranted. This report is organized in two volumes. Volume 1: Sampling/Results/Special Topics describes the sampling effort conducted as the basis for this study, presents the concentration data on toxic chemicals in the several power plant streams, and reports the results of evaluations and calculations conducted with those data. The Special Topics section of Volume 1 reports on issues such as comparison of sampling methods and vapor/particle distributions of toxic chemicals. Volume 2: Appendices include field sampling data sheets, quality assurance results, and uncertainty calculations. The chemicals measured at Niles Boiler No. 2 were the following: five major and 16 trace elements, including mercury, chromium, cadmium, lead, selenium, arsenic, beryllium, and nickel; acids and corresponding anions (HCl, HF, chloride, fluoride, phosphate, sulfate); ammonia and cyanide; elemental carbon; radionuclides; volatile organic compounds (VOC); semivolatile compounds (SVOC) including polynuclear aromatic hydrocarbons (PAH), and polychlorinated dioxins and furans; and aldehydes.

  11. 60-day safety screen results and final report for tank 241-C-111, auger samples 95-Aug-002, 95-Aug-003, 95-Aug-016, and 95-Aug-017

    Energy Technology Data Exchange (ETDEWEB)

    Rice, A.D.

    1995-05-30

    This report presents the details of the auger sampling events for underground waste tank C-111. The samples were shipped to the 222-S laboratories were they underwent safety screening analysis and primary ferricyanide analysis. The samples were analyzed for alpha total, total organic carbon, cyanide, Ni, moisture, and temperature differentials. The results of this analysis are presented in this document.

  12. Long-term analysis of the efficacy and tolerability of sorafenib in advanced radio-iodine refractory differentiated thyroid carcinoma: final results of a phase II trial

    NARCIS (Netherlands)

    Schneider, T.C.; Abdulrahman, R.M.; Corssmit, E.P.; Morreau, H.; Smit, J.W.A.; Kapiteijn, E.

    2012-01-01

    OBJECTIVE: We conducted a prospective phase II clinical trial to determine the efficacy of sorafenib in patients with advanced radio-iodine refractory differentiated thyroid cancer. In this article, the long-term results are presented. PATIENTS AND METHODS: Thirty-one patients with progressive

  13. Impact of methodological choices on findings from pharmacoepidemiological studies: Final results of the IMI-protect (pharmacoepidemiological research on outcomes of therapeutics by a European consortium) project

    NARCIS (Netherlands)

    Klungel, Olaf|info:eu-repo/dai/nl/181447649; De Groot, Mark|info:eu-repo/dai/nl/313936455; Gardarsdottir, Helga|info:eu-repo/dai/nl/321858131; Brauer, Ruth; Grimaldi-Bensouda, Lamiae; Kurz, Xavier; Gasse, Christiane; Reynolds, Robert

    2014-01-01

    Background: Pharmacoepidemiological (PE) research should provide consistent, reliable and reproducible results to contribute to the benefit-risk assessment of medicines. IMI-PROTECT aims to identify sources of methodological variations in PE studies using a common protocol and analysis plan across

  14. 75 FR 10207 - Certain Cut-to-Length Carbon-Quality Steel Plate From the Republic of Korea: Final Results of...

    Science.gov (United States)

    2010-03-05

    ... Preliminary Results. On October 26, 2009, we received a case brief from Hyosung Corporation (Hyosung). On November 2, 2009, we received a rebuttal brief from Nucor Corporation (Nucor). Because Hyosung's case brief... factual information Hyosung included in its case brief, we rejected and returned Hyosung's case brief and...

  15. Narrative Finality

    Directory of Open Access Journals (Sweden)

    Armine Kotin Mortimer

    1981-01-01

    Full Text Available The cloturai device of narration as salvation represents the lack of finality in three novels. In De Beauvoir's Tous les hommes sont mortels an immortal character turns his story to account, but the novel makes a mockery of the historical sense by which men define themselves. In the closing pages of Butor's La Modification , the hero plans to write a book to save himself. Through the thrice-considered portrayal of the Paris-Rome relationship, the ending shows the reader how to bring about closure, but this collective critique written by readers will always be a future book. Simon's La Bataille de Pharsale , the most radical attempt to destroy finality, is an infinite text. No new text can be written. This extreme of perversion guarantees bliss (jouissance . If the ending of De Beauvoir's novel transfers the burden of non-final world onto a new victim, Butor's non-finality lies in the deferral to a future writing, while Simon's writer is stuck in a writing loop, in which writing has become its own end and hence can have no end. The deconstructive and tragic form of contemporary novels proclaims the loss of belief in a finality inherent in the written text, to the profit of writing itself.

  16. Comparative ranking of 0. 1 to 10 MW(e) solar thermal electric power systems. Volume I. Summary of results. Final report

    Energy Technology Data Exchange (ETDEWEB)

    Thornton, J.P.; Brown, K.C.; Finegold, J.G.; Gresham, J.B.; Herlevich, F.A.; Kowalik, J.S.; Kriz, T.A.

    1980-08-01

    This report is part of a two-volume set summarizing the results of a comparative ranking of generic solar thermal concepts designed specifically for electric power generation. The original objective of the study was to project the mid-1990 cost and performance of selected generic solar thermal electric power systems for utility applications and to rank these systems by criteria that reflect their future commercial acceptance. This study considered plants with rated capacities of 1 to 10 MW(e), operating over a range of capacity factors from the no-storage case to 0.7 and above. Later, the study was extended to include systems with capacities from 0.1 to 1 MW(e), a range that is attractive to industrial and other non-utility applications. This volume summarizes the results for the full range of capacities from 0.1 to 10 MW(e). Volume II presents data on performance and cost and ranking methodology.

  17. AT-21FINAL RESULTS OF A PHASE 1 TRIAL OF AN ONCOLYTIC POLIO/RHINOVIRUS RECOMBINANT (PVSRIPO) AGAINST RECURRENT GLIOBLASTOMA (GBM)

    OpenAIRE

    Desjardins, Annick; Sampson, John; Peters, Katherine; Vlahovic, Gordana; Threatt, Stevie; Herndon, James; Boulton, Susan; Lally-Goss, Denise; McSherry, Frances; Lipp, Eric; Friedman, Allan; Friedman, Henry; Bigner, Darell; Gromeier, Matthias

    2014-01-01

    BACKGROUND: PVSRIPO is the live attenuated, oral (SABIN) serotype 1 poliovirus vaccine containing a heterologous internal ribosomal entry site stemming from human rhinovirus type 2. PVSRIPO recognizes nectin-like molecule-5, an oncofetal cell adhesion molecule and tumor antigen widely expressed ectopically in malignancy. We report results of a phase 1 trial evaluating PVSRIPO delivered intratumorally by convection-enhanced delivery (CED). METHODS: Eligible patients were adults with recurrent ...

  18. Final report on the Background Soil Characterization Project at the Oak Ridge Reservation, Oak Ridge, Tennessee. Volume 1: Results of Field Sampling Program

    Energy Technology Data Exchange (ETDEWEB)

    Watkins, D.R.; Ammons, J.T.; Branson, J.L. [and others

    1993-10-01

    This report presents, evaluates, and documents data and results obtained in the Background Soil Characterization Project (BSCP). It is intended to be a stand-alone document for application and use in structuring and conducting remedial investigation and remedial action projects in the Environmental Restoration (ER) Program. The objectives of the BSCP consist of the following: determine background concentrations of organics, metals, and radionuclides in natural soils that are key to environmental restoration projects; provide remediation projects with 100% validated data on background concentrations, which are technically and legally defensible; and quantify baseline risks from background constituents for comparison of risks associated with contaminated sites.

  19. A study of toxic emissions from a coal-fired power plant utilizing an ESP/Wet FGD system. Volume 1, Sampling, results, and special topics: Final report

    Energy Technology Data Exchange (ETDEWEB)

    1994-07-01

    This was one of a group of assessments of toxic emissions from coal-fired power plants, conducted for DOE-PETC in 1993 as mandated by the 1990 Clean Air Act. It is organized into 2 volumes; Volume 1 describes the sampling effort, presents the concentration data on toxic chemicals in several power plant streams, and reports the results of evaluations and calculations. The study involved solid, liquid, and gaseous samples from input, output, and process streams at Coal Creek Station Unit No. 1, Underwood, North Dakota (1100 MW mine-mouth plant burning lignite from the Falkirk mine located adjacent to the plant). This plant had an electrostatic precipitator and a wet scrubber flue gas desulfurization unit. Measurements were conducted on June 21--24, 26, and 27, 1993; chemicals measured were 6 major and 16 trace elements (including Hg, Cr, Cd, Pb, Se, As, Be, Ni), acids and corresponding anions (HCl, HF, chloride, fluoride, phosphate, sulfate), ammonia and cyanide, elemental C, radionuclides, VOCs, semivolatiles (incl. PAH, polychlorinated dioxins, furans), and aldehydes. Volume 2: Appendices includes process data log sheets, field sampling data sheets, uncertainty calculations, and quality assurance results.

  20. High-solids black liquor firing in pulp and paper industry kraft recovery boilers: Phase 1 -- Final report. Volume 2: Project technical results

    Energy Technology Data Exchange (ETDEWEB)

    Southards, W.T.; Clement, J.L.; McIlroy, R.A.; Tharp, M.R.; Verrill, C.L.; Wessell, R.A.

    1995-11-01

    This project is a multiple-phase effort to develop technologies to improve high-solids black liquor firing in pulp mill recovery boilers. The principal means to this end is to construct and operate a pilot-scale recovery furnace simulator (RFS) in which these technologies can be tested. The Phase 1 objectives are to prepare a preliminary design for the RFS, delineate a project concept for evaluating candidate technologies, establish industrial partners, and report the results. Phase 1 addressed the objectives with seven tasks: Develop a preliminary design of the RFS; estimate the detailed design and construction costs of the RFS and the balance of the project; identify interested parties in the paper industry and key suppliers; plan the Phase 2 and Phase 3 tests to characterize the RFS; evaluate the economic justification for high-solids firing deployment in the industry; evaluate high-solids black liquor property data to support the RFS design; manage the project and reporting results, which included planning the future program direction.

  1. Long-term effects of dredging operations program. Effects of sediment organic-matter composition on bioaccumulation of sediment organic contaminants: Interim results. Final report

    Energy Technology Data Exchange (ETDEWEB)

    Brannon, J.M.; Price, C.B.; Reilly, F.J.; Pennington, J.C.; McFarland, V.A.

    1991-06-01

    The relationship of sediment-bound polychlorinated biphenyl (PCB) 153 and fluoranthene to bioaccumulation by worms and clams and the relationship of sediment-bound PCB 153 and fluoranthene to concentrations in the interstitial water were examined. Bioaccumulation by both worms and clams was observed in all sediments. Apparent preference factor (APF) values showed that steady state was reached between sediment-bound contaminants and organism lipid pools. The APF values of organisms were close to the theoretical value for both contaminants in all sediments. These results showed that sediment total organic carbon (TOC) in conjunction with octanol water partition coefficients of nonpolar organic contaminants is a viable approach for predicting bioaccumulation of such compounds by infaunal organisms. Actual concentrations of contaminants in interstitial water were either overestimated or underestimated by the relationship between TOC and humic + fulvic acid organic matter fractions and sediment contaminant concentrations. Prediction of interstitial water concentrations was not as successful as use of APFs. The lack of agreement between predicted and actual interstitial water results was due to factors such as the presence of interstitial water contaminants bounds to microparticulates and dissolved organic material and the kind of organic material in the sediment.

  2. Implementation and adoption of nationwide electronic health records in secondary care in England: final qualitative results from prospective national evaluation in “early adopter” hospitals

    Science.gov (United States)

    Cornford, Tony; Barber, Nicholas; Avery, Anthony; Takian, Amirhossein; Lichtner, Valentina; Petrakaki, Dimitra; Crowe, Sarah; Marsden, Kate; Robertson, Ann; Morrison, Zoe; Klecun, Ela; Prescott, Robin; Quinn, Casey; Jani, Yogini; Ficociello, Maryam; Voutsina, Katerina; Paton, James; Fernando, Bernard; Jacklin, Ann; Cresswell, Kathrin

    2011-01-01

    Objectives To evaluate the implementation and adoption of the NHS detailed care records service in “early adopter” hospitals in England. Design Theoretically informed, longitudinal qualitative evaluation based on case studies. Setting 12 “early adopter” NHS acute hospitals and specialist care settings studied over two and a half years. Data sources Data were collected through in depth interviews, observations, and relevant documents relating directly to case study sites and to wider national developments that were perceived to impact on the implementation strategy. Data were thematically analysed, initially within and then across cases. The dataset consisted of 431 semistructured interviews with key stakeholders, including hospital staff, developers, and governmental stakeholders; 590 hours of observations of strategic meetings and use of the software in context; 334 sets of notes from observations, researchers’ field notes, and notes from national conferences; 809 NHS documents; and 58 regional and national documents. Results Implementation has proceeded more slowly, with a narrower scope and substantially less clinical functionality than was originally planned. The national strategy had considerable local consequences (summarised under five key themes), and wider national developments impacted heavily on implementation and adoption. More specifically, delays related to unrealistic expectations about the capabilities of systems; the time needed to build, configure, and customise the software; the work needed to ensure that systems were supporting provision of care; and the needs of end users for training and support. Other factors hampering progress included the changing milieu of NHS policy and priorities; repeatedly renegotiated national contracts; different stages of development of diverse NHS care records service systems; and a complex communication process between different stakeholders, along with contractual arrangements that largely excluded NHS

  3. Efficacy of the HPV-16/18 Vaccine: Final according to protocol results from the blinded phase of the randomized Costa Rica HPV-16/18 Vaccine Trial

    Science.gov (United States)

    Hildesheim, Allan; Wacholder, Sholom; Catteau, Gregory; Struyf, Frank; Dubin, Gary; Herrero, Rolando

    2014-01-01

    Background A community-based randomized trial was conducted in Costa Rica to evaluate the HPV-16/18 AS04-adjuvanted vaccine (NCT00128661). The primary objective was to evaluate efficacy of the vaccine to prevent cervical intraepithelial neoplasia 2 or more severe disease (CIN2+) associated with incident HPV-16/18 cervical infections. Secondary objectives were to evaluate efficacy against CIN2+ associated with incident cervical infection by any oncogenic HPVs and to evaluate duration of protection against incident cervical infection with HPV-16/18. Vaccine safety and immunogenicity over the 4-year follow-up were also evaluated. Methods We randomized (3,727 HPV arm; 3,739 Control arm), vaccinated (HPV-16/18 or Hepatitis A) and followed (median 53.8 months) 7,466 healthy women aged 18-25 years. 5,312 women (2,635 HPV arm; 2,677 Control arm) were included in the according to protocol analysis for efficacy. The full cohort was evaluated for safety. Immunogenicity was considered on a subset of 354 (HPV-16) and 379 (HPV-18) women. HPV type was assessed by PCR on cytology specimens. Immunogenicity was assessed using ELISA and inhibition enzyme immunoassays. Disease outcomes were histologically confirmed. Vaccine efficacy and 95% confidence intervals (95%CI) were computed. Results Vaccine efficacy was 89.8% (95% CI: 39.5 - 99.5; N=11 events total) against HPV-16/18 associated CIN2+, 59.9% (95% CI: 20.7 - 80.8; N=39 events total) against CIN2+ associated with non-HPV-16/18 oncogenic HPVs and 61.4% (95% CI: 29.5-79.8; N=51 events total) against CIN2+ irrespective of HPV type. The vaccine had an acceptable safety profile and induced robust and long-lasting antibody responses. Conclusions Our findings confirm the high efficacy and immunogenicity of the HPV-16/18 vaccine against incident HPV infections and cervical disease associated with HPV-16/18 and other oncogenic HPV types. These results will serve as a benchmark to which we can compare future findings from ongoing extended

  4. THE FINAL ANALYSIS: 10-YEAR TREATMENT RESULTS OF ACUTE LYMPHOBLASTIC LEUKEMIA IN CHILDREN OF SAINT-PETERSBURG ON THE PROTOCOL COALL-92–SAINT-PETERSBURG

    Directory of Open Access Journals (Sweden)

    E.G. Boichenko

    2010-01-01

    Full Text Available The article demonstrates the treatment results on the protocol the treatment of children with acute lymphoblastic leukemia (ALL (COALL-92–Saint-Petersburg after 10 years of follow-up. Between January, 1999 and August, 2008, a total of 272 children and adolescents 0–18 yr of age, from Saint-Petersburg and its area were eligible for the protocol. All the patients have met diagnostic criteria for ALL. Those with a mature B-cell phenotype and FAB-L3 morphology were excluded. The diagnosis was based on morphological evaluation of the peripheral blood and bone marrow smears, immunophenotyping and cytogenetic analysis. All patients were classified as being at lower (LR, 47% or higher (HR, 53% risk of relapse. The intensive phase of treatment lasted 5, 5 months in low risk group and 8 months in high risk group and consisted of 4 parts (induction, consolidation, CNS-treatment and reinduction. It was followed by maintenance treatment until 2 years from date of diagnosis. After an observation time of 11 years, the estimate for EFS of all 272 evaluable patients was 67,7 ± 3,1%, the estimate of probability of RFS was 74,1 ± 3,3%, and probability of overall survival was 75,6 ± 3,0%. Key words: acute lymphoblastic leukemia, intensive chemotherapy, children. (Pediatric Pharmacology. – 2010; 7(6:50-56

  5. Final results of EFC6663: a multicenter, international, phase 2 study of alvocidib for patients with fludarabine-refractory chronic lymphocytic leukemia.

    Science.gov (United States)

    Lanasa, Mark C; Andritsos, Leslie; Brown, Jennifer R; Gabrilove, Janice; Caligaris-Cappio, Federico; Ghia, Paolo; Larson, Richard A; Kipps, Thomas J; Leblond, Veronique; Milligan, Donald W; Janssens, Ann; Johnson, Amy J; Heerema, Nyla A; Bühler, Andreas; Stilgenbauer, Stephan; Devin, Jeanne; Hallek, Michael; Byrd, John C; Grever, Michael R

    2015-05-01

    Early phase studies of alvocidib showed activity in relapsed CLL including patients with high risk genomic features and those refractory to fludarabine. A multi-center, international, phase II study of alvocidib in fludarabine refractory CLL was undertaken to validate these early results. Patients with fludarabine refractory CLL or prolymphocytic leukemia arising from CLL were treated with single agent alvocidib. The primary outcome measure was overall response rate, with secondary outcomes including survival, toxicity, and response duration. One hundred and sixty five patients were enrolled and 159 patients were treated. The median age was 61 years, the median number of prior therapies was 4, and 96% of patients were fludarabine refractory. The investigator-assessed overall response rate was 25%; the majority of responses were partial. Response rates were lower among patients with del(17p) (14%), but equivalent in patients with del(11q) or bulky lymphadenopathy. Median progression free and overall survival were 7.6 and 14.6 months, respectively. Tumor lysis occurred in 39 patients (25%), and 13 received hemodialysis. Diarrhea, fatigue, and hematologic toxicities were common. Alvocidib has clinical activity in patients with advanced, fludarabine refractory CLL. Future studies should focus on discovery of biomarkers of clinical response and tumor lysis, and enhanced supportive care measures. Copyright © 2015 Elsevier Ltd. All rights reserved.

  6. Thyroid exposure of Belarusian and Ukrainian children due to the Chernobyl accident and resulting thyroid cancer risk. Final report of BfS project StSch 4240

    Energy Technology Data Exchange (ETDEWEB)

    Jacob, P.; Meckbach, R.; Ulanovski, A.; Schotola, C.; Proehl, G. [GSF-Institute of Radiation Protection, Neuherberg (Germany); Kenigsberg, J.; Buglova, E.; Kruk, J. [Institute of Radiation Medicine and Endocrinology, Minsk (Belarus); Likhtarev, I.; Kovgan, L.; Vavilov, S.; Chepurniy, M. [Ukrainian Radiation Protection Inst., Kyiv (Ukraine); Tronko, M.; Bogdanova, T. [Institute of Endocrinolgoy and Metabolism of the Academy of Medical Sciences of Ukraine, Kyiv (Ukraine); Shinkarev, S.; Gavrilin, Y. [All-Russian Public Organization of Invalids ' Chernobylets' , Scientific Center ' FENIX' , Moscow (Russian Federation); Demidchik, Y. [Thyroid Cancer Center, Minsk (Belarus)

    2005-07-01

    Main objectives of the BfS Project StSch4240 Thyroid Exposure of Belarusian and Ukrainian Children due to the Chernobyl Accident and Resulting Thyroid Cancer Risk were: to establish improved estimates of average thyroid dose for both genders and for each birth-year cohort of the period 1968 - 1985 in Ukrainian and Belarusian settlements, in which more than 10 measurements of the {sup 131}I activity in the human thyroid have been performed in May/June 1986, to explore, whether this dosimetric database can be extended to neighboring settlements, to establish improved estimates of average thyroid dose for both genders and for each birth-year cohort of the period 1968 - 1985 in Ukrainian and Belarusian oblasts (regions) and larger cities, to document the thyroid cancer incidence for the period 1986 - 2001 in Ukraine and Belarus and describe morphological characteristics of the cancer cases, to assess the contribution of the baseline incidence to the total thyroid cancer incidence in the two countries and identify regional and temporal dependencies, to perform analyses of excess risks in settlements with more than 10 measurements of the {sup 131}I activity in the human thyroid. The project has been conducted in the period 6 December 1999 to 31 March 2004. (orig.)

  7. Comparison of Calidria chrysotile asbestos to pure tremolite: final results of the inhalation biopersistence and histopathology examination following short-term exposure.

    Science.gov (United States)

    Bernstein, David M; Chevalier, Jörg; Smith, Paul

    2005-08-01

    Calidria chrysotile asbestos, which is a serpentine mineral, has been shown to be considerably less biopersistent than the durable amphibole mineral tremolite asbestos, which persists once deposited in the lung. The initial results of this inhalation biopersistence study in rats that demonstrates this difference were reported in Bernstein et al. (2003). This article presents the full results through 1 yr after cessation of the 5-day exposure. This study was based upon the recommendations of the European Commission (EC) Interim Protocol for the Inhalation Biopersistence of synthetic mineral fibers (Bernstein & Riego-Sintes, 1999). In addition, the histopathological response in the lung was evaluated following exposure. In order to quantify the dynamics and rate by which these fibers are removed from the lung, the biopersistence of a sample of commercial-grade chrysotile from the Coalinga mine in New Idria, CA, of the type Calidria RG144 and that of a long-fiber tremolite were studied. For synthetic vitreous fibers, the biopersistence of the fibers longer than 20 microm has been found to be directly related to their potential to cause disease. This study was designed to determine lung clearance (biopersistence) and the histopathological response. As the long fibers have been shown to have the greatest potential for pathogenicity, the aerosol generation technique was designed to maximize the number of long respirable fibers. The chrysotile samples were specifically chosen to have 200 fibers/cm3 longer than 20 microm in length present in the exposure aerosol. These longer fibers were found to be largely composed of multiple shorter fibrils. The tremolite samples were chosen to have 100 fibers/cm3 longer than 20 microm in length present in the exposure aerosol. Calidria chrysotile has been found to be one of the most rapidly cleared mineral fibers from the lung. The fibers longer than 20 microm in length are cleared with a half-time of 7 h. By 2 days postexposure all

  8. Final overall survival results of phase III GCIG CALYPSO trial of pegylated liposomal doxorubicin and carboplatin vs paclitaxel and carboplatin in platinum-sensitive ovarian cancer patients

    Science.gov (United States)

    Wagner, U; Marth, C; Largillier, R; Kaern, J; Brown, C; Heywood, M; Bonaventura, T; Vergote, I; Piccirillo, M C; Fossati, R; Gebski, V; Lauraine, E P

    2012-01-01

    Background: The CALYPSO phase III trial compared CD (carboplatin-pegylated liposomal doxorubicin (PLD)) with CP (carboplatin-paclitaxel) in patients with platinum-sensitive recurrent ovarian cancer (ROC). Overall survival (OS) data are now mature. Methods: Women with ROC relapsing >6 months after first- or second-line therapy were randomised to CD or CP for six cycles in this international, open-label, non-inferiority trial. The primary endpoint was progression-free survival. The OS analysis is presented here. Results: A total of 976 patients were randomised (467 to CD and 509 to CP). With a median follow-up of 49 months, no statistically significant difference was observed between arms in OS (hazard ratio=0.99 (95% confidence interval 0.85, 1.16); log-rank P=0.94). Median survival times were 30.7 months (CD) and 33.0 months (CP). No statistically significant difference in OS was observed between arms in predetermined subgroups according to age, body mass index, treatment-free interval, measurable disease, number of lines of prior chemotherapy, or performance status. Post-study cross-over was imbalanced between arms, with a greater proportion of patients randomised to CP receiving post-study PLD (68%) than patients randomised to CD receiving post-study paclitaxel (43% P<0.001). Conclusion: Carboplatin-PLD led to delayed progression and similar OS compared with carboplatin-paclitaxel in platinum-sensitive ROC. PMID:22836511

  9. Impact of lamivudine monotherapy in failing patients with multidrug-resistant HIV: final 48 weeks results (MONO-AIFA FARM7PAZS3

    Directory of Open Access Journals (Sweden)

    A Castagna

    2012-11-01

    Full Text Available Purpose of the study: To assess the impact of lamivudine (3TC monotherapy in failing patients with multidrug-resistant HIV and limited therapeutic options. Methods: Prospective, open-label, multicenter, randomised (1:1, pilot study. HIV-1 failing pts with M184V mutation, HBsAg negative were assigned to 3TC 300mg QD for 24 weeks followed by a new regimen for 24 weeks (Arm A or to a new regimen for 48 weeks (Arm B. The new HAART regimen was decided before randomisation in both groups, based on clinical history, genotype and viral tropism. Primary endpoint was the proportion of pts with HIV-RNA<50 copies/mL (VS at week 48 (W48. ITT and OT analysis performed. Results described by median (IQR. Summary of results: 109 screened, 34 screening failures, 75 randomised, 72 initiated the assigned treatment [38 and 34 pts in Arm A and B, respectively]: 69% males; age: 47.4 (43.2–51.9 years; years of HIV infection: 17 (14–23; nadir CD4+: 150 (47–231 cells/μL. Similar baseline demographic and clinical characteristics were found in Arm A vs Arm B [CD4+: 413 (294–550 vs 377 227–520 cells/µL; HIV-RNA: 3.94 (2.89–4.43 vs 3.66 (2.78–4.20 log10copies/mL; number of mutations: 9 (5–13 vs 9 (3–19; R5-virus: 67% vs 50%; new regimen GSS: 2 (2–3 vs 2 (2–2; 60% vs 56% pts included in the new regimen at least two of the following drugs: DRV/r, MVC, RAL, ETR, T-20]. At W48, pts with VS were 15/38 (39% vs 17/34 (50% in Arm A and B, respectively (ITT: P=0.477. In Arm A, 25/38 (66% completed the 24-weeks of monotherapy and 21 reached week 48 vs 27 pts in Arm B (P=0.045. Pts with VS were 15/21 (71% vs 17/27 (63% in Arm A and B, respectively (OT: P=0.758. VS according to nadir CD4+, screening HIVRNA and GSS of the new regimen shown in 1. SAEs occurred in 4 (11% and 2 (6% in Arm A and B, respectively; all but 1 in Arm A unrelated to the regimen; 4 CDC events: 3 oral candidiasis and 1 recurrence of CMV infection in Arm A; 1 oral candidiasis in Arm B. W48 CD4

  10. Overall survival and final efficacy and safety results from a Japanese phase II study of axitinib in cytokine-refractory metastatic renal cell carcinoma

    Science.gov (United States)

    Eto, Masatoshi; Uemura, Hirotsugu; Tomita, Yoshihiko; Kanayama, Hiroomi; Shinohara, Nobuo; Kamei, Yoichi; Fujii, Yosuke; Umeyama, Yoshiko; Ozono, Seiichiro; Naito, Seiji; Akaza, Hideyuki

    2014-01-01

    In an open-label, multicenter phase II study of Japanese patients with cytokine-refractory metastatic renal cell carcinoma, axitinib showed substantial antitumor activity with an acceptable safety profile. Here, we report overall survival and updated efficacy and safety results. Sixty-four Japanese patients with metastatic renal cell carcinoma following prior therapy with cytokines were treated with axitinib at a starting dose of 5 mg b.i.d. Following median treatment duration of 14.2 months, median overall survival was 37.3 months (95% CI, 28.6–49.9). The objective response rate, the primary endpoint of the study, was 51.6% (95% CI, 38.7–64.2); the median duration of response, 11.1 months (95% CI, 8.2–13.7); and the median progression-free survival was 11.0 months (95% CI, 9.2–12.0), assessed by the independent review committee. Common treatment-related all-grade adverse events were hypertension (88%), hand-foot syndrome (75%), diarrhea (66%), proteinuria (63%), fatigue (55%) and dysphonia (53%). In an exploratory analysis, median overall survival was found to be significantly longer in patients who had greater decreases in plasma levels of soluble vascular endothelial growth factor receptor-2 during the first cycle of treatment. In conclusion, the present study showed axitinib to be effective, and toxicities with long-term treatment were generally controllable with axitinib dose modification and/or standard medications in these Japanese patients. Some frequently reported adverse events warrant close monitoring and management. Changes in the plasma levels of soluble vascular endothelial growth factor receptor-2 may be used as a prognostic factor for overall survival in metastatic renal cell carcinoma following axitinib treatment. This study is registered at http://ClinicalTrial.gov (identifier NCT00569946). PMID:25283266

  11. Primary chemotherapy with gemcitabine as prolonged infusion, non-pegylated liposomal doxorubicin and docetaxel in patients with early breast cancer: final results of a phase II trial.

    Science.gov (United States)

    Schmid, P; Krocker, J; Jehn, C; Michniewicz, K; Lehenbauer-Dehm, S; Eggemann, H; Heilmann, V; Kümmel, S; Schulz, C O; Dieing, A; Wischnewsky, M B; Hauptmann, S; Elling, D; Possinger, K; Flath, B

    2005-10-01

    Combinations of anthracyclines, taxanes and gemcitabine have shown high activity in breast cancer. This trial was designed to evaluate a modified combination regimen as primary chemotherapy. Non-pegylated liposomal doxorubicin (NPLD) was used instead of conventional doxorubicin to improve cardiac safety. Gemcitabine was given 72 h after NPLD and docetaxel as a prolonged infusion over 4 h in order to optimize synergistic effects and accumulation of active metabolites. Forty-four patients with histologically confirmed stage II or III breast cancer were treated with NPLD (60 mg/m(2)) and docetaxel (75 mg/m(2)) on day 1 and gemcitabine as 4-h infusion (350 mg/m(2)) on day 4. Treatment was repeated every 3 weeks for a maximum of six cycles. All patients received prophylactically recombinant granulocyte colony-stimulating factor. Patients with axillary lymph node involvement after primary chemotherapy received adjuvant treatment with cyclophosphamide, methotrexate and fluorouracil. The clinical response rate was 80%, and complete remissions of the primary tumor occurred in 10 patients (25%). Breast conservation surgery was performed in 19 out of 20 patients (95%) with an initial tumor size of less than 3 cm and in 14 patients (70%) with a tumor size resulted. Non-hematological toxicity was generally moderate with grade 3 or 4 toxicity in 10.0% of cycles. Most common non-hematologic toxicities were nausea, vomiting, alopecia, mucositis, asthenia and elevation of liver enzymes. The evaluated schedule provides a safe and highly effective combination treatment for patients with early

  12. Legacy Compliance Final Report: Results of the Navy/Encapo Soil Stabilization Study at the Nevada Test Site, Nye County, Nevada

    Energy Technology Data Exchange (ETDEWEB)

    Desotell, Lloyd; Anderson, David; Rawlinson, Stuart; Hudson, David; Yucel, Vefa

    2008-03-01

    Historic atmospheric testing of nuclear devices at the Nevada Test Site (NTS) has resulted in large areas of plutonium-contaminated surface soils. The potential transport of these contaminated soils to onsite and offsite receptors is a concern to the land steward and local stakeholders. The primary transport pathways of interest at the NTS are sediment entrained in surface water runoff and windblown dust. This project was initially funded by the U.S. Navy and subsequently funded by the USDOE Stockpile Stewardship Program. Field tests were conducted over a 20.5 month period to evaluate the efficacy of an organic-based, surface applied emulsion to reduce sediment transport from plutonium-contaminated soils. The patented emulsion was provided by Encapco Technologies LLC. Field tests were conducted within the SMOKY radioactive contamination area (CA). The SMOKY above ground nuclear test was conducted on 08/31/1957, with a reported yield of 44 kilotons and was located at N 37 degrees 10.5 minutes latitude and W 116 degrees 04.5 minutes longitude. Three 'safety tests' were also conducted within approximately 1,500 meters (5,000 feet) of the SMOKY ground zero in 1958. Safety tests are designed to test the response of a nuclear device to an unplanned external force (e.g., nearby detonation of conventional explosives). These three safety tests (CERES, OBERON, and TITANIA) resulted in dispersal of plutonium over a wide area (Bechtel Nevada, 2002). Ten 3 x 4.6 meter test plots were constructed within the SMOKY CA to conduct rainfall-runoff simulations. Six of the ten test plots were treated with the emulsion at the manufacturer recommended loading of 1.08 gallons per square meter, and four plots were held untreated as experimental controls. Separate areas were also treated to assess impacts to native vegetation and surface infiltration rate. Field tests were conducted at approximately 6, 13, and 20.5 months post emulsion treatment. Field tests consisted of rainfall

  13. Final Results of a Randomized Phase 2 Trial Investigating the Addition of Cetuximab to Induction Chemotherapy and Accelerated or Hyperfractionated Chemoradiation for Locoregionally Advanced Head and Neck Cancer

    Energy Technology Data Exchange (ETDEWEB)

    Seiwert, Tanguy Y., E-mail: tseiwert@medicine.bsd.uchicago.edu [Departments of Medicine, University of Chicago, Chicago, Illinois (United States); Melotek, James M. [Department of Radiation and Cellular Oncology, University of Chicago, Chicago, Illinois (United States); Blair, Elizabeth A. [Department of Otolaryngology, University of Chicago, Chicago, Illinois (United States); Stenson, Kerstin M. [Department of Otolaryngology, Rush University, Chicago, Illinois (United States); Salama, Joseph K. [Department of Radiation Oncology, Duke University, Durham, North Carolina (United States); Witt, Mary Ellyn [Department of Radiation and Cellular Oncology, University of Chicago, Chicago, Illinois (United States); Brisson, Ryan J.; Chawla, Apoorva; Dekker, Allison [Departments of Medicine, University of Chicago, Chicago, Illinois (United States); Lingen, Mark W. [Department of Pathology, University of Chicago, Chicago, Illinois (United States); Kocherginsky, Masha [Department of Public Health Sciences, University of Chicago, Chicago, Illinois (United States); Villaflor, Victoria M. [Departments of Medicine, University of Chicago, Chicago, Illinois (United States); Cohen, Ezra E.W. [Moores Cancer Center, University of California, San Diego, San Diego, California (United States); Haraf, Daniel J. [Department of Radiation and Cellular Oncology, University of Chicago, Chicago, Illinois (United States); Vokes, Everett E. [Departments of Medicine, University of Chicago, Chicago, Illinois (United States)

    2016-09-01

    Purpose: The role of cetuximab in the treatment of locoregionally advanced head and neck squamous cell cancer (LA-HNSCC) remains poorly defined. In this phase 2 randomized study, we investigated the addition of cetuximab to both induction chemotherapy (IC) and hyperfractionated or accelerated chemoradiation. Methods and Materials: Patients with LA-HNSCC were randomized to receive 2 cycles of weekly IC (cetuximab, paclitaxel, carboplatin) and either Cetux-FHX (concurrent cetuximab, 5-fluorouracil, hydroxyurea, and 1.5 Gy twice-daily radiation therapy every other week to 75 Gy) or Cetux-PX (cetuximab, cisplatin, and accelerated radiation therapy with delayed concomitant boost to 72 Gy in 42 fractions). The primary endpoint was progression-free survival (PFS), with superiority compared with historical control achieved if either arm had 2-year PFS ≥70%. Results: 110 patients were randomly assigned to either Cetux-FHX (n=57) or Cetux-PX (n=53). The overall response rate to IC was 91%. Severe toxicity on IC was limited to rash (23% grade ≥3) and myelosuppression (38% grade ≥3 neutropenia). The 2-year rates of PFS for both Cetux-FHX (82.5%) and Cetux-PX (84.9%) were significantly higher than for historical control (P<.001). The 2-year overall survival (OS) was 91.2% for Cetux-FHX and 94.3% for Cetux-PX. With a median follow-up time of 72 months, there were no significant differences in PFS (P=.35) or OS (P=.15) between the treatment arms. The late outcomes for the entire cohort included 5-year PFS, OS, locoregional failure, and distant metastasis rates of 74.1%, 80.3%, 15.7%, and 7.4%, respectively. The 5-year PFS and OS were 84.4% and 91.3%, respectively, among human papillomavirus (HPV)-positive patients and 65.9% and 72.5%, respectively, among HPV-negative patients. Conclusions: The addition of cetuximab to IC and chemoradiation was tolerable and produced long-term control of LA-HNSCC, particularly among poor-prognosis HPV-negative patients. Further

  14. Efficacy of the HPV-16/18 vaccine: final according to protocol results from the blinded phase of the randomized Costa Rica HPV-16/18 vaccine trial.

    Science.gov (United States)

    Hildesheim, Allan; Wacholder, Sholom; Catteau, Gregory; Struyf, Frank; Dubin, Gary; Herrero, Rolando

    2014-09-03

    A community-based randomized trial was conducted in Costa Rica to evaluate the HPV-16/18 AS04-adjuvanted vaccine (NCT00128661). The primary objective was to evaluate efficacy of the vaccine to prevent cervical intraepithelial neoplasia 2 or more severe disease (CIN2+) associated with incident HPV-16/18 cervical infections. Secondary objectives were to evaluate efficacy against CIN2+ associated with incident cervical infection by any oncogenic HPVs and to evaluate duration of protection against incident cervical infection with HPV-16/18. Vaccine safety and immunogenicity over the 4-year follow-up were also evaluated. We randomized (3727 HPV arm; 3739 control arm), vaccinated (HPV-16/18 or Hepatitis A) and followed (median 53.8 months) 7466 healthy women aged 18-25 years. 5312 women (2635 HPV arm; 2677 control arm) were included in the according to protocol analysis for efficacy. The full cohort was evaluated for safety. Immunogenicity was considered on a subset of 354 (HPV-16) and 379 (HPV-18) women. HPV type was assessed by PCR on cervical specimens. Immunogenicity was assessed using ELISA and inhibition enzyme immunoassays. Disease outcomes were histologically confirmed. Vaccine efficacy and 95% confidence intervals (95%CI) were computed. Vaccine efficacy was 89.8% (95% CI: 39.5-99.5; N=11 events total) against HPV-16/18 associated CIN2+, 59.9% (95% CI: 20.7-80.8; N=39 events total) against CIN2+ associated with non-HPV-16/18 oncogenic HPVs and 61.4% (95% CI: 29.5-79.8; N=51 events total) against CIN2+ irrespective of HPV type. The vaccine had an acceptable safety profile and induced robust and long-lasting antibody responses. Our findings confirm the high efficacy and immunogenicity of the HPV-16/18 vaccine against incident HPV infections and cervical disease associated with HPV-16/18 and other oncogenic HPV types. These results will serve as a benchmark to which we can compare future findings from the ongoing extended follow-up of participants in the Costa Rica

  15. Modified Atkins diet in advanced malignancies - final results of a safety and feasibility trial within the Veterans Affairs Pittsburgh Healthcare System.

    Science.gov (United States)

    Tan-Shalaby, Jocelyn L; Carrick, Jennifer; Edinger, Krystal; Genovese, Dana; Liman, Andrew D; Passero, Vida A; Shah, Rashmikant B

    2016-01-01

    Dysfunctional mitochondrial processes limit malignant cells ability to use energy from fatty acids and ketones. Animal studies using ketogenic diets for cancer show encouraging results. We tested the diet's safety and feasibility in cancer patients across a broad variety of solid tumors. We recruited 17 advanced cancer patients who were not on chemotherapy. They consumed 20 to 40 g of carbohydrates daily with evaluations performed weekly until week 4, then every 4 weeks until 16 weeks. Quality of life questionnaires monitored for tolerability and compliance. Positron emission/computerized tomography was ordered at baseline, 4,8 and 16 weeks. Student t-testing evaluated differences between baseline and last visit scores for quality of life, weight, body mass index, and serum parameters. Correlations between weight loss and serum ketones, glucose, lipids and creatinine were done. Two-tailed unpaired t-testing of the mean weight loss compared responders against non-responders. Eleven out of seventeen enrolled patients were evaluable. Mean age was 65+/- 11.7 years, weight 203 +/- 4.98 lbs. (92 ± 2.3 kgs.) and previous treatment failures was 1.7, +/- 0.97. All lost significant weight with hematologic, biochemical and lipid tests remaining stable. Quality of life scores slightly improved. At 4,8 and 16 weeks, six (54.5 %), five (45.4 %) and four (36 %) patients were stable or improved. We observed no correlations between serum glucose, ketones or lipids. Clinical response did not correlate with ketosis or glycemia. Responders (stable disease or partial responders) lost statistically more weight than non-responders. Dietary compliance was difficult. Only three patients continued dieting past 16 weeks. Out of these, two patients developed brain metastases and were on steroids. They survived 80 and 116 weeks respectively. The third patient underwent residual tumor resection and has no disease at 131 weeks. Modified Atkins diets are safe and feasible in

  16. Successful knowledge translation intervention in long-term care: final results from the vitamin D and osteoporosis study (ViDOS) pilot cluster randomized controlled trial.

    Science.gov (United States)

    Kennedy, Courtney C; Ioannidis, George; Thabane, Lehana; Adachi, Jonathan D; Marr, Sharon; Giangregorio, Lora M; Morin, Suzanne N; Crilly, Richard G; Josse, Robert G; Lohfeld, Lynne; Pickard, Laura E; van der Horst, Mary-Lou; Campbell, Glenda; Stroud, Jackie; Dolovich, Lisa; Sawka, Anna M; Jain, Ravi; Nash, Lynn; Papaioannou, Alexandra

    2015-05-12

    Few studies have systematically examined whether knowledge translation (KT) strategies can be successfully implemented within the long-term care (LTC) setting. In this study, we examined the effectiveness of a multifaceted, interdisciplinary KT intervention for improving the prescribing of vitamin D, calcium and osteoporosis medications over 12-months. We conducted a pilot, cluster randomized controlled trial in 40 LTC homes (21 control; 19 intervention) in Ontario, Canada. LTC homes were eligible if they had more than one prescribing physician and received services from a large pharmacy provider. Participants were interdisciplinary care teams (physicians, nurses, consultant pharmacists, and other staff) who met quarterly. Intervention homes participated in three educational meetings over 12 months, including a standardized presentation led by expert opinion leaders, action planning for quality improvement, and audit and feedback review. Control homes did not receive any additional intervention. Resident-level prescribing and clinical outcomes were collected from the pharmacy database; data collectors and analysts were blinded. In addition to feasibility measures, study outcomes were the proportion of residents taking vitamin D (≥800 IU/daily; primary), calcium ≥500 mg/day and osteoporosis medications (high-risk residents) over 12 months. Data were analyzed using the generalized estimating equations technique accounting for clustering within the LTC homes. At baseline, 5,478 residents, mean age 84.4 (standard deviation (SD) 10.9), 71% female, resided in 40 LTC homes, mean size = 137 beds (SD 76.7). In the intention-to-treat analysis (21 control; 19 intervention clusters), the intervention resulted in a significantly greater increase in prescribing from baseline to 12 months between intervention versus control arms for vitamin D (odds ratio (OR) 1.82, 95% confidence interval (CI): 1.12, 2.96) and calcium (OR 1.33, 95% CI: 1.01, 1.74), but not for osteoporosis

  17. Continuation or reintroduction of bevacizumab beyond progression to first-line therapy in metastatic colorectal cancer: final results of the randomized BEBYP trial.

    Science.gov (United States)

    Masi, G; Salvatore, L; Boni, L; Loupakis, F; Cremolini, C; Fornaro, L; Schirripa, M; Cupini, S; Barbara, C; Safina, V; Granetto, C; Fea, E; Antonuzzo, L; Boni, C; Allegrini, G; Chiara, S; Amoroso, D; Bonetti, A; Falcone, A

    2015-04-01

    The combination of bevacizumab with fluorouracil-based chemotherapy is a standard first-line treatment option in metastatic colorectal cancer (mCRC). We studied the efficacy of continuing or reintroducing bevacizumab in combination with second-line chemotherapy after progression to bevacizumab-based first-line therapy. In this phase III study, patients with mCRC treated with fluoropyrimidine-based first-line chemotherapy plus bevacizumab were randomized to receive in second-line mFOLFOX-6 or FOLFIRI (depending on first-line regimen) with or without bevacizumab. The primary end point was progression-free survival. To detect a hazard ratio (HR) for progression of 0.70 with an α and β error of 0.05 and 0.20, respectively, 262 patients were required. In consideration of the results of the ML18147 trial, the study was prematurely stopped. Between April 2008 and May 2012, a total of 185 patients were randomized. Bevacizumab-free interval was longer than 3 months in 43% of patients in chemotherapy alone arm and in 50% of patients in the bevacizumab arm. At a median follow-up of 45.3 months, the median progression-free survival was 5.0 months in the chemotherapy group and 6.8 months in the bevacizumab group [adjusted HR = 0.70; 95% confidence interval (CI) 0.52-0.95; stratified log-rank P = 0.010]. Subgroup analyses showed a consistent benefit in all subgroups analyzed and in particular in patients who had continued or reintroduced bevacizumab. An improved overall survival was also observed in the bevacizumab arm (adjusted HR = 0.77; 95% CI 0.56-1.06; stratified log-rank P = 0.043). Responses (RECIST 1.0) were similar in the chemotherapy and bevacizumab groups (17% and 21%; P = 0.573). Toxicity profile was consistent with previously reported data. This study demonstrates that the continuation or the reintroduction of bevacizumab with second-line chemotherapy beyond first progression improves the outcome and supports the use of this strategy in the treatment of m

  18. Interpretation criteria for FDG PET/CT in multiple myeloma (IMPeTUs): final results. IMPeTUs (Italian myeloma criteria for PET USe).

    Science.gov (United States)

    Nanni, Cristina; Versari, Annibale; Chauvie, Stephane; Bertone, Elisa; Bianchi, Andrea; Rensi, Marco; Bellò, Marilena; Gallamini, Andrea; Patriarca, Francesca; Gay, Francesca; Gamberi, Barbara; Ghedini, Pietro; Cavo, Michele; Fanti, Stefano; Zamagni, Elena

    2017-12-21

    ᅟ: FDG PET/CT ( 18 F-fluoro-deoxy-glucose positron emission tomography/computed tomography) is a useful tool to image multiple myeloma (MM). However, simple and reproducible reporting criteria are still lacking and there is the need for harmonization. Recently, a group of Italian nuclear medicine experts defined new visual descriptive criteria (Italian Myeloma criteria for Pet Use: IMPeTUs) to standardize FDG PET/CT evaluation in MM patients. The aim of this study was to assess IMPeTUs reproducibility on a large prospective cohort of MM patients. Patients affected by symptomatic MM who had performed an FDG PET/CT at baseline (PET0), after induction (PET-AI), and the end of treatment (PET-EoT) were prospectively enrolled in a multicenter trial (EMN02)(NCT01910987; MMY3033). After anonymization, PET images were uploaded in the web platform WIDEN® and hence distributed to five expert nuclear medicine reviewers for a blinded independent central review according to the IMPeTUs criteria. Consensus among reviewers was measured by the percentage of agreement and the Krippendorff's alpha. Furthermore, on a patient-based analysis, the concordance among all the reviewers in terms of positivity or negativity of the FDG PET/CT scan was tested for different thresholds of positivity (Deauville score (DS 2, 3, 4, 5) for the main parameters (bone marrow, focal score, extra-medullary disease). Eighty-six patients (211 FDG PET/CT scans) were included in this analysis. Median patient age was 58 years (range, 35-66 years), 45% were male, 15% of them were in stage ISS (International Staging System) III, and 42% had high-risk cytogenetics. The percentage agreement was superior to 75% for all the time points, reaching 100% of agreement in assessing the presence skull lesions after therapy. Comparable results were obtained when the agreement analysis was performed using the Krippendorff's alpha coefficient, either in every single time point of scanning (PET0, PET-AI or PET-EoT) or

  19. Phase 1/2 Trials of Temozolomide, Motexafin Gadolinium, and 60-Gy Fractionated Radiation for Newly Diagnosed Supratentorial Glioblastoma Multiforme: Final Results of RTOG 0513

    Energy Technology Data Exchange (ETDEWEB)

    Brachman, David G., E-mail: david.brachman@dignityhealth.org [Arizona Oncology Services Foundation, Scottsdale, Arizona (United States); Barrow Neurological Institute, St. Joseph' s Hospital and Medical Center, Phoenix, Arizona (United States); Pugh, Stephanie L. [Radiation Therapy Oncology Group Statistical Center, Philadelphia, Pennsylvania (United States); Ashby, Lynn S. [Barrow Neurological Institute, St. Joseph' s Hospital and Medical Center, Phoenix, Arizona (United States); Thomas, Theresa A. [Arizona Oncology Services Foundation, Scottsdale, Arizona (United States); Dunbar, Erin M. [University of Florida College of Medicine, Gainesville, Florida (United States); Narayan, Samir [St. Joseph Mercy Hospital, Ann Arbor, Michigan (United States); Robins, H. Ian [University of Wisconsin Hospital, Madison, Wisconsin (United States); Bovi, Joseph A. [Medical College of Wisconsin, Milwaukee, Wisconsin (United States); Rockhill, Jason K. [University of Washington Medical Center, Seattle, Washington (United States); Won, Minhee [Barrow Neurological Institute, St. Joseph' s Hospital and Medical Center, Phoenix, Arizona (United States); Curran, Walter P. [Emory University, Atlanta, Georgia (United States)

    2015-04-01

    Purpose: The purpose of phase 1 was to determine the maximum tolerated dose (MTD) of motexafin gadolinium (MGd) given concurrently with temozolomide (TMZ) and radiation therapy (RT) in patients with newly diagnosed supratentorial glioblastoma multiforme (GBM). Phase 2 determined whether this combination improved overall survival (OS) and progression-free survival (PFS) in GBM recursive partitioning analysis class III to V patients compared to therapies for recently published historical controls. Methods and Materials: Dose escalation in phase 1 progressed through 3 cohorts until 2 of 6 patients experienced dose-limiting toxicity or a dose of 5 mg/kg was reached. Once MTD was established, a 1-sided 1-sample log-rank test at significance level of .1 had 85% power to detect a median survival difference (13.69 vs 18.48 months) with 60 deaths over a 12-month accrual period and an additional 18 months of follow-up. OS and PFS were estimated using the Kaplan-Meier method. Results: In phase 1, 24 patients were enrolled. The MTD established was 5 mg/kg, given intravenously 5 days a week for the first 10 RT fractions, then 3 times a week for the duration of RT. The 7 patients enrolled in the third dose level and the 94 enrolled in phase 2 received this dose. Of these 101 patients, 87 were eligible and evaluable. Median survival time was 15.6 months (95% confidence interval [CI]: 12.9-17.6 months), not significantly different from that of the historical control (P=.36). Median PFS was 7.6 months (95% CI: 5.7-9.6 months). One patient (1%) experienced a grade 5 adverse event possibly related to therapy during the concurrent phase, and none experience toxicity during adjuvant TMZ therapy. Conclusions: Treatment was well tolerated, but median OS did not reach improvement specified by protocol compared to historical control, indicating that the combination of standard RT with TMZ and MGd did not achieve a significant survival advantage.

  20. Final Results of Local-Regional Control and Late Toxicity of RTOG 9003: A Randomized Trial of Altered Fractionation Radiation for Locally Advanced Head and Neck Cancer

    Energy Technology Data Exchange (ETDEWEB)

    Beitler, Jonathan J., E-mail: jjbeitl@emory.edu [Winship Cancer Institute of Emory University School of Medicine, Atlanta, Georgia (United States); Zhang, Qiang [Radiation Therapy Oncology Group Statistical Center, Philadelphia, Pennsylvania (United States); Fu, Karen K. [University of California San Francisco, San Francisco, California (United States); Trotti, Andy [H. Lee Moffitt Cancer Center at the University of South Florida, Tampa, Florida (United States); Spencer, Sharon A. [University of Alabama at Birmingham Medical Center, Birmingham, Alabama (United States); Jones, Christopher U. [Radiological Associates of Sacramento, Sacramento, California (United States); Garden, Adam S. [MD Anderson Cancer Center, University of Texas, Houston, Texas (United States); Shenouda, George [McGill University, Montréal, Quebec (Canada); Harris, Jonathan [Radiation Therapy Oncology Group Statistical Center, Philadelphia, Pennsylvania (United States); Ang, Kian K. [MD Anderson Cancer Center, University of Texas, Houston, Texas (United States)

    2014-05-01

    Purpose: To test whether altered radiation fractionation schemes (hyperfractionation [HFX], accelerated fractionation, continuous [AFX-C], and accelerated fractionation with split [AFX-S]) improved local-regional control (LRC) rates for patients with squamous cell cancers (SCC) of the head and neck when compared with standard fractionation (SFX) of 70 Gy. Methods and Materials: Patients with stage III or IV (or stage II base of tongue) SCC (n=1076) were randomized to 4 treatment arms: (1) SFX, 70 Gy/35 daily fractions/7 weeks; (2) HFX, 81.6 Gy/68 twice-daily fractions/7 weeks; (3) AFX-S, 67.2 Gy/42 fractions/6 weeks with a 2-week rest after 38.4 Gy; and (4) AFX-C, 72 Gy/42 fractions/6 weeks. The 3 experimental arms were to be compared with SFX. Results: With patients censored for LRC at 5 years, only the comparison of HFX with SFX was significantly different: HFX, hazard ratio (HR) 0.79 (95% confidence interval 0.62-1.00), P=.05; AFX-C, 0.82 (95% confidence interval 0.65-1.05), P=.11. With patients censored at 5 years, HFX improved overall survival (HR 0.81, P=.05). Prevalence of any grade 3, 4, or 5 toxicity at 5 years; any feeding tube use after 180 days; or feeding tube use at 1 year did not differ significantly when the experimental arms were compared with SFX. When 7-week treatments were compared with 6-week treatments, accelerated fractionation appeared to increase grade 3, 4 or 5 toxicity at 5 years (P=.06). When the worst toxicity per patient was considered by treatment only, the AFX-C arm seemed to trend worse than the SFX arm when grade 0-2 was compared with grade 3-5 toxicity (P=.09). Conclusions: At 5 years, only HFX improved LRC and overall survival for patients with locally advanced SCC without increasing late toxicity.

  1. Platelet-Rich Fibrin (PRF) in Implants Dentistry in Combination with New Bone Regenerative Flapless Technique: Evolution of the Technique and Final Results.

    Science.gov (United States)

    Cortese, Antonio; Pantaleo, Giuseppe; Amato, Massimo; Howard, Candace M; Pedicini, Lorenzo; Claudio, Pier Paolo

    2017-01-01

    Most common techniques for alveolar bone augmentation are guided bone regeneration (GBR) and autologous bone grafting. GBR studies demonstrated long-term reabsorption using heterologous bone graft. A general consensus has been achieved in implant surgery for a minimal amount of 2 mm of healthy bone around the implant. A current height loss of about 3-4 mm will result in proper deeper implant insertion when alveolar bone expansion is not planned because of the dome shape of the alveolar crest. To manage this situation a split crest technique has been proposed for alveolar bone expansion and the implants' insertion in one stage surgery. Platelet-rich fibrin (PRF) is a healing biomaterial with a great potential for bone and soft tissue regeneration without inflammatory reactions, and may be used alone or in combination with bone grafts, promoting hemostasis, bone growth, and maturation. The aim of this study was to demonstrate the clinical effectiveness of PRF combined with a new split crest flapless modified technique in 5 patients vs. 5 control patients. Ten patients with horizontal alveolar crests deficiency were treated in this study, divided into 2 groups: Group 1 (test) of 5 patients treated by the flapless split crest new procedure; Group 2 (control) of 5 patients treated by traditional technique with deeper insertion of smaller implants without split crest. The follow-up was performed with x-ray orthopantomography and intraoral radiographs at T0 (before surgery), T1 (operation time), T2 (3 months) and T3 (6 months) post-operation. All cases were successful; there were no problems at surgery and post-operative times. All implants succeeded osteointegration and all patients underwent uneventful prosthetic rehabilitation. Mean height bone loss was 1 mm, measured as bone-implant most coronal contact (Δ-BIC), and occurred at immediate T2 post-operative time (3 months). No alveolar bone height loss was detected at implant insertion time, which was instead

  2. Evaluation of policies and practices to prevent mother to child transmission of hepatitis B virus in China: results from China GAVI project final evaluation.

    Science.gov (United States)

    Cui, Fuqiang; Luo, Huiming; Wang, Fuzhen; Zheng, Hui; Gong, Xiaohong; Chen, Yuansheng; Wu, Zhenhua; Miao, Ning; Kane, Mark; Hennessey, Karen; Hadler, Stephen C; Hutin, Yvan J; Liang, Xiaofeng; Yang, Weizhong

    2013-12-27

    Mother to Child Transmission (MTCT) has remained a leading cause of HBV infection in China, accounting for 40% of total infections. Providing hepatitis B vaccine (HepB) to all infants within 24h of birth (Timely Birth Dose, TBD), and subsequent completion of at least 3 vaccine doses is key to preventing perinatal HBV infection. In 2002, with the financial support of the Global Alliance on Vaccine and Immunization (GAVI) targeted to Western region and 223 poverty-affected counties in Central region, hepatitis B vaccine was provided for free. In 2010, we evaluated the China GAVI project in terms of its activities to prevent perinatal infections. The objectives of the evaluation were to (1) measure achievements in the China GAVI project in terms of TBD coverage, and (2) describe practices for HBsAg screening of pregnant women and HBIG use outside the GAVI China project. We used the methods recommended by WHO to select a cluster sample of health care facilities for the purpose of an injection safety assessment. We stratified China into three regions based on economic criteria, and selected eight counties with a probability proportional to population size in each region. In each selected county, we selected (a) 10 townships at random among the list of townships of the county and (b) the one county level hospital. In each hospital, we abstracted 2002 through 2009 records to collect information regarding birth cohorts, hospitals deliveries, vaccine management, hepatitis B vaccination delivery, HBsAg screening practices and results, and HBIG administration. In addition, in all hospitals, we abstracted records regarding the delivery of TBD. We visited 244 facilities in the three regions, including 24 county hospitals and 220 township hospitals. We reviewed 837,409 birth summary records, 699,249 for infants born at county or township hospitals. Hospital delivery rates increased from 58% in 2002 to 93% in 2009. Surveyed TBD coverage increased from 60% in 2002 to 91% in 2009

  3. Final Report-Confirmatory Survey Results for the ABB Combustion Engineering Site, Windsor, Connecticut; Revision 1 (DCN 5158-SR-02-1) (Docket No. 030-03754; RFTA No. 12-003)

    Energy Technology Data Exchange (ETDEWEB)

    ADAMS, WADE C

    2013-01-28

    The objectives of the confirmatory activities were to provide independent contractor field data reviews and to generate independent radiological data for use by the NRC in evaluating the adequacy and accuracy of the contractor's procedures and FSS results. ORAU reviewed ABB CE's decommissioning plan, final status survey plan, and the applicable soil DCGLs, which were developed based on an NRC-approved radiation dose assessment. The surveys included gamma surface scans, gamma direct measurements, and soil sampling.

  4. Final Report

    Energy Technology Data Exchange (ETDEWEB)

    Stinis, Panos [Pacific Northwest National Lab. (PNNL), Richland, WA (United States)

    2016-08-07

    This is the final report for the work conducted at the University of Minnesota (during the period 12/01/12-09/18/14) by PI Panos Stinis as part of the "Collaboratory on Mathematics for Mesoscopic Modeling of Materials" (CM4). CM4 is a multi-institution DOE-funded project whose aim is to conduct basic and applied research in the emerging field of mesoscopic modeling of materials.

  5. Balloons on planet Venus - Final results

    Science.gov (United States)

    Blamont, J.; Boloh, L.; Kerzhanovich, V.; Kogan, L.; Kurganskii, M.; Linkin, V.; Matveenko, L.; Roy, M.; Patsaev, D.; Pichkhadze, K.

    1993-01-01

    On June 11 and 15, 1985 two packages with balloons have been inserted in the atmosphere of Venus from the Soviet VEGA landing modules. This paper summarizes the pressure, temperature, wind illumination and backscattering data from the balloons.

  6. Final Report

    Energy Technology Data Exchange (ETDEWEB)

    R Paul Drake

    2004-01-12

    OAK-B135 This is the final report from the project Hydrodynamics by High-Energy-Density Plasma Flow and Hydrodynamics and Radiation Hydrodynamics with Astrophysical Applications. This project supported a group at the University of Michigan in the invention, design, performance, and analysis of experiments using high-energy-density research facilities. The experiments explored compressible nonlinear hydrodynamics, in particular at decelerating interfaces, and the radiation hydrodynamics of strong shock waves. It has application to supernovae, astrophysical jets, shock-cloud interactions, and radiative shock waves.

  7. Optimización del mantenimiento preventivo, utilizando las técnicas de diagnóstico integral. Resultados finales y evaluación económica; Optimization of the Preventive Maintenance Using the Techniques of Integral Diagnosis. Final Results and Economic Evalua

    Directory of Open Access Journals (Sweden)

    Pedro L Hernández Domínguez

    2011-02-01

    Full Text Available En este trabajo se obtienen los resultados finales y la evaluación económica de la aplicación de la metodologíaque aporta el diagnóstico integral (DI, presentada por los autores en los artículos anteriores, con la finalidad deintroducir el mantenimiento basado en la condición (MBC como una forma de mejoramiento o perfeccionamientodel mantenimiento preventivo planificado (MPP que se desarrolla en las centrales termoeléctricas (CCTT cubanas. In this paper, the authors obtained the final results and the economic evaluation of the application methodologythat contributes the integral diagnosis (ID, presented by they in a previous articles, with the purpose of introducingthe condition based maintenance (CBM like a form of improvement the Planned Preventive Maintenance(PPM that is developed in the cuban thermoelectric power stations.

  8. Final report

    Energy Technology Data Exchange (ETDEWEB)

    Jarillo-Herrero, Pablo [Massachusetts Inst. of Technology (MIT), Cambridge, MA (United States)

    2017-02-07

    This is the final report of our research program on electronic transport experiments on Topological Insulator (TI) devices, funded by the DOE Office of Basic Energy Sciences. TI-based electronic devices are attractive as platforms for spintronic applications, and for detection of emergent properties such as Majorana excitations , electron-hole condensates , and the topological magneto-electric effect . Most theoretical proposals envision geometries consisting of a planar TI device integrated with materials of distinctly different physical phases (such as ferromagnets and superconductors). Experimental realization of physics tied to the surface states is a challenge due to the ubiquitous presence of bulk carriers in most TI compounds as well as degradation during device fabrication.

  9. Final Report

    Energy Technology Data Exchange (ETDEWEB)

    Webb, Robert C. [Texas A& M University; Kamon, Teruki [Texas A& M University; Toback, David [Texas A& M University; Safonov, Alexei [Texas A& M University; Dutta, Bhaskar [Texas A& M University; Dimitri, Nanopoulos [Texas A& M University; Pope, Christopher [Texas A& M University; White, James [Texas A& M University

    2013-11-18

    Overview The High Energy Physics Group at Texas A&M University is submitting this final report for our grant number DE-FG02-95ER40917. This grant has supported our wide range of research activities for over a decade. The reports contained here summarize the latest work done by our research team. Task A (Collider Physics Program): CMS & CDF Profs. T. Kamon, A. Safonov, and D. Toback co-lead the Texas A&M (TAMU) collider program focusing on CDF and CMS experiments. Task D: Particle Physics Theory Our particle physics theory task is the combined effort of Profs. B. Dutta, D. Nanopoulos, and C. Pope. Task E (Underground Physics): LUX & NEXT Profs. R. Webb and J. White(deceased) lead the Xenon-based underground research program consisting of two main thrusts: the first, participation in the LUX two-phase xenon dark matter search experiment and the second, detector R&D primarily aimed at developing future detectors for underground physics (e.g. NEXT and LZ).

  10. Schedulability Analysis for Java Finalizers

    DEFF Research Database (Denmark)

    Bøgholm, Thomas; Hansen, Rene Rydhof; Søndergaard, Hans

    2010-01-01

    Java finalizers perform clean-up and finalisation of objects at garbage collection time. In real-time Java profiles the use of finalizers is either discouraged (RTSJ, Ravenscar Java) or even disallowed (JSR-302), mainly because of the unpredictability of finalizers and in particular their impact...... on the schedulability analysis. In this paper we show that a controlled scoped memory model results in a structured and predictable execution of finalizers, more reminiscent of C++ destructors than Java finalizers. Furthermore, we incorporate finalizers into a (conservative) schedulability analysis for Predictable Java...

  11. Impact of energy conservation policy measures on innovation, investment and long-term development of the Swiss economy. Results from the computable induced technical change and energy (CITE) model - Final report

    Energy Technology Data Exchange (ETDEWEB)

    Bretschger, L.; Ramer, R.; Schwark, F.

    2010-09-15

    This comprehensive final report for the Swiss Federal Office of Energy (SFOE) presents the results of a study made on the Computable Induced Technical Change and Energy (CITE) model. The authors note that, in the past two centuries, the Swiss economy experienced an unprecedented increase in living standards. At the same time, the stock of various natural resources declined and the environmental conditions changed substantially. The evaluation of the sustainability of a low energy and low carbon society as well as an optimum transition to this state is discussed. An economic analysis is made and the CITE and GCE (Computable General Equilibrium) numerical simulation models are discussed. The results obtained are presented and discussed.

  12. Final Report

    Energy Technology Data Exchange (ETDEWEB)

    Issen, Kathleen [Clarkson Univ., Potsdam, NY (United States)

    2017-06-05

    This project employed a continuum approach to formulate an elastic constitutive model for Castlegate sandstone. The resulting constitutive framework for high porosity sandstone is thermodynamically sound, (i.e., does not violate the 1st and 2nd law of thermodynamics), represents known material constitutive response, and is able to be calibrated using available mechanical response data. To authenticate the accuracy of this model, a series of validation criteria were employed, using an existing mechanical response data set for Castlegate sandstone. The resulting constitutive framework is applicable to high porosity sandstones in general, and is tractable for scientists and researchers endeavoring to solve problems of practical interest.

  13. Tank 241U102 Grab Samples 2U-99-1 and 2U-99-2 and 2U-99-3 Analytical Results for the Final Report

    Energy Technology Data Exchange (ETDEWEB)

    STEEN, F.H.

    1999-08-03

    This document is the final report for tank 241-U-102 grab samples. Five grab samples were collected from riser 13 on May 26, 1999 and received by the 222-S laboratory on May 26 and May 27, 1999. Samples 2U-99-3 and 2U-99-4 were submitted to the Process Chemistry Laboratory for special studies. Samples 2U-99-1, 2U-99-2 and 2U-99-5 were submitted to the laboratory for analyses. Analyses were performed in accordance with the Compatibility Grab Sampling and Analysis Plan for Fiscal year 1999 (TSAP) (Sasaki, 1999) and the Data Quality Objectives for Tank Farms Waste Compatibility Program (DQO) (Fowler 1995, Mulkey and Miller 1998). The analytical results are presented in the data summary report. None of the subsamples submitted for differential scanning calorimetry (DSC), total organic carbon (TOC) and plutonium 239 (Pu239) analyses exceeded the notification limits as stated in TSAP.

  14. High dose teriparatide (rPTH1-34 therapy increases callus volume and enhances radiographic healing at 8-weeks in a massive canine femoral allograft model.

    Directory of Open Access Journals (Sweden)

    Kohei Nishitani

    Full Text Available Small animal studies have demonstrated significant high-dose recombinant parathyroid hormone1-34 (rPTH1-34 effects on intercalary allograft healing. Towards a human adjuvant therapy to decrease non-unions, we evaluated rPTH1-34 safety and efficacy in a clinically relevant canine femoral allograft model. Adult female mongrel hounds (n = 20 received a 5cm mid-diaphyseal osteotomy reconstructed with a plated allograft, and were randomized to: 1 Placebo (n = 5; daily saline, 2 Continuous rPTH1-34 (n = 7; 5 μg/kg/day s.c. from day 1-55 post-op, or 3 Delayed rPTH1-34 (n = 8; 5 μg/kg/day s.c. from day 14-28 post-op. Safety was assessed by physical behavior and blood calcium monitoring. Cone beam CT (CB-CT was performed on days 14, 28 and 56 post-op to assess 2D cortical healing, 3D bone volume, and Union Ratio. Biomechanical testing and dynamic histomorphometry were also performed. The high drug dose was poorly tolerated, as most dogs receiving rPTH1-34 had to be given intravenous saline, and one dog died from hypercalcemia. Continuous rPTH1-34 significantly increased 2D healing and callus volumes at 4-weeks versus Placebo, and sustained the significant increase in cortical union at 8-week (p<0.05. These rPTH1-34 effects were confirmed by histomorphometry, revealing significant increases in mineral apposition rates (MAR on host bone and graft-host junctions (p<0.05. Delayed rPTH1-34 significantly increased callus volume and MAR at 8 weeks (p<0.05. Although no biomechanical differences were observed, as expected for early healing, the results demonstrated that 2D RUST scoring significantly correlated with torsional biomechanics (p<0.01. In conclusion, 8-weeks of intermittent high-dose rPTH1-34 treatment significantly increases callus formation and accelerates bony union of intercalary massive allografts in a clinically relevant canine model, but with serious side-effects from hypercalcemia.

  15. Final Report

    Energy Technology Data Exchange (ETDEWEB)

    J. Toulouse

    2012-04-05

    The purpose of this project was to better understand the 'Multiscale Dynamics of Relaxor Ferroelectrics'. The output of the project is summarized in the narrative. The results of the work were presented at a number of different conferences and four papers were written, the references to which are also indicated in the report and which have also been uploaded on e-link. The multiscale dynamics of relaxors was clearly identified in the three characteristic temperatures that were identified. In particular, we were the first group to identify an intermediate temperature, T*, at which the correlations between off-center ions in relaxor cross-over from being dynamic to being static and giving rise to the characteristic relaxor behavior in the dielectric constant. Other groups have now confirmed the existence of such an intermediate temperature. We also made and reported two other observations: (1) a coherent interference phenomena (EIT-like effect) near the transition of several relaxors, which provides information on the nature and mechanism of the transition; and (2) in a similar way, inelastic neutron scattering results were interpreted as resonant scattering of acoustic phonons by localized modes in polar nanodomains. In parallel with the neutron scattering work, we also developed a theory of the scattering of phonons by the above localized modes. The theoretical development is very formal at this point and did not allow an easy comparison with the experimental results. This work is in progress.

  16. Final Report

    Energy Technology Data Exchange (ETDEWEB)

    Michael C. Weinberg; Lori L. Burgner; Joseph H. Simmons

    2003-05-23

    OAK B135 The formation of metastable crystalline phases in lithium disilicate glass has been a subject of controversy for decades. Here, one aspect of this problem relating to the stability of these non-equilibrium phases when glasses are heated for extended time periods in the nucleation regime is addressed. The results of a systematic experimental investigation on the persistence of metastable phases and the factors that may influence the appearance of such phases, e.g., water content, impurities, glass composition, and glass preparation procedure are presented. Growth rates of lithium disilicate crystals in lithium disilicate glass are measured as a function water concentration in the glass and of temperature in the deeply undercooled regime. The growth rate data obtained in this work are combined with data reported in the literature and used to assess the applicability of standard models of crystal growth for the description of experimental results over a very broad temperature range. The reduced growth rate versus undercooling graph is found to consist of three regimes. For undercoolings less than 140°C, the reduced growth rate curve is suggestive of either 2-D surface nucleation or screw dislocation growth. For undercoolings greater than 400°C, the reduced growth rate plot suggests the operative crystal growth mechanism is 2-D surface nucleation, but detailed calculations cast doubt upon this conclusion. In the intermediate undercooling range, there appears to be some sort of transitional behavior for which none of the standard models appear to be applicable. Further, it is observed that small differences in the viscosity data employed can produce enormous differences in the predicted growth rates at larger undercoolings. Results of the kinetic analyses conducted herein seem to indicate that the nature of the kinetic rate coefficient used in the standard growth models may be incorrect. Nucleation rates of sodium metasilicate crystals in a sodium silicate

  17. Final Report

    Energy Technology Data Exchange (ETDEWEB)

    Taylor, Philip L.

    2012-11-11

    Our research program was aimed at elucidating the nature of proton transport in ionomer membranes by means of a combination of analytical theory and molecular modeling. There were two broad thrusts. The first of these was directed towards understanding the equilibrium structure of Nafion and related polymers at various levels of hydration. The second thrust was concerned with the transport of protons through a membrane of this type. The research on structure proceeded by building on existing work, but with the introduction of some novel techniques, among which is a hybrid Molecular Dynamics--Monte Carlo approach. This method permits rapid computations by temporarily decoupling the motion of the polar side chains from that of the perfluorinated backbone, while still retaining the essential aspects of the constraint that phase separation can only continue to a very limited degree. Competition between an elastic energy due to this constraint and the tendency to phase separation lead to the equilibrium structure, which turns out to be qualitatively different at different levels of hydration. The use of a carefully formulated dielectric function was necessary to achieve accurate results. The work on transport of protons in Nafion-like membranes also involved a combination of theory and simulation. Atomistic molecular-dynamics simulations were employed to determine some of the characteristic parameters for the diffusion of hydronium in hydrated membranes. These results were used in a theoretical model of non-linear diffusion to predict transport coefficients. Among our results was the discovery that treatment with strong electric fields may enhance the properties of the polymer membranes. Our computer simulations showed that the vigorous application of a stretching force or an electric field can modify the structure of the ionomer that lies at the heart of a polymer-electrolyte-membrane fuel cell. If these predictions are verified experimentally, then it should be

  18. Schedulability Analysis for Java Finalizers

    DEFF Research Database (Denmark)

    Bøgholm, Thomas; Hansen, Rene Rydhof; Ravn, Anders P.

    2010-01-01

    Java finalizers perform clean-up and finalisation of objects at garbage collection time. In real-time Java profiles the use of finalizers is either discouraged (RTSJ, Ravenscar Java) or even disallowed (JSR-302), mainly because of the unpredictability of finalizers and in particular their impact...... on the schedulability analysis. In this paper we show that a controlled scoped memory model results in a structured and predictable execution of finalizers, more reminiscent of C++ destructors than Java finalizers. Furthermore, we incorporate finalizers into a (conservative) schedulability analysis for Predictable Java...... programs. Finally, we extend the SARTS tool for automated schedulability analysis of Java bytecode programs to handle finalizers in a fully automated way....

  19. FINAL REPORT

    Energy Technology Data Exchange (ETDEWEB)

    Juergen Eckert; Anthony K. Cheetham (Principal Investigator)

    2011-03-11

    Hydrogen storage systems based on the readily reversible adsorption of H{sub 2} in porous materials have a number of very attractive properties with the potential to provide superior performance among candidate materials currently being investigated were it not for the fact that the interaction of H{sub 2} with the host material is too weak to permit viable operation at room temperature. Our study has delineated in quantitative detail the structural elements which we believe to be the essential ingredients for the future synthesis of porous materials, where guest-host interactions are intermediate between those found in the carbons and the metal hydrides, i.e. between physisorption and chemisorption, which will result in H{sub 2} binding energies required for room temperature operation. The ability to produce porous materials with much improved hydrogen binding energies depends critically on detailed molecular level analysis of hydrogen binding in such materials. However, characterization of H{sub 2} sorption is almost exclusively carried by thermodynamic measurements, which give average properties for all the sites occupied by H{sub 2} molecules at a particular loading. We have therefore extensively utilized the most powerful of the few molecular level experimental probes available to probe the interactions of hydrogen with porous materials, namely inelastic neutron scattering (INS) spectroscopy of the hindered rotations of the hydrogen molecules adsorbed at various sites, which in turn can be interpreted in a very direct way in by computational studies. This technique can relate spectral signatures of various H{sub 2} molecules adsorbed at binding sites with different degrees of interaction. In the course of this project we have synthesized a rather large number of entirely new hybrid materials, which include structural modifications for improved interactions with adsorbed hydrogen. The results of our systematic studies on many porous materials provide detailed

  20. Final Report

    Energy Technology Data Exchange (ETDEWEB)

    J. K. Blasie; W.F. DeGrado; J.G. Saven; M.J. Therien

    2012-05-24

    The overall objective is to create robust artificial protein modules as scaffolds to control both (a) the conformation of novel cofactors incorporated into the modules thereby making the modules possess a desired functionality and (b) the organization of these functional modules into ordered macroscopic ensembles, whose macroscopic materials properties derive from the designed microscopic function of the modules. We focus on two specific types of cofactors for imparting functionality in this project; primarily nonlinear optical (NLO) chromophores designed to exhibit extraordinary molecular hyperpolarizabilities, as well as donor-bridge-acceptor cofactors designed to exhibit highly efficient, 'through-bonds' light-induced electron transfer (LIET) over nano-scale distances. The ensembles range from 2-D to 3-D, designed to possess the degree of orientational and positional order necessary to optimize their macroscopic response, the latter ranging from liquid-crystalline or glass-like to long-range periodic. Computational techniques, firmly based in statistical thermodynamics, are utilized for the design the artificial protein modules, based on robust {alpha}-helical bundle motifs, necessarily incorporating the desired conformation, location, and environment of the cofactor. Importantly, this design approach also includes optimization of the interactions between the modules to promote their organization into ordered macroscopic ensembles in 2-D and 3-D via either directed-assembly or self-assembly. When long-range periodic order is required, the design can be optimized to result a specified lattice symmetry. The structure and functionality of the individual modules are fully characterized at the microscopic level, as well as that of the ensembles at the macroscopic level, employing modern experimental physical-chemical and computational techniques. These include, for example, multi-dimensional NMR, various pump-probe transient spectroscopies to ultrafast time

  1. FINAL REPORT

    Energy Technology Data Exchange (ETDEWEB)

    Horn, Mark W; McDaniel, Anthony; Schweighardt, Frank K

    2003-05-23

    In this program the teams at Penn State University (PSU), Sandia National Laboratories (SNL), DCH Technology (DCHT), and Air Products and Chemicals Inc. (APCI), have aggressively pursued engineering solutions to eliminate barriers to solid-state chemiresistor hydrogen sensor technology. The metallurgical effects of alloying palladium with nickel have been shown to prevent phase transitions in the thin films at high H2 overpressures, making the devices more suitable for IOF process conditions. We investigated the use of thin, semi-permeable membranes that protect the catalytic surface from poisoning or other undesirable surface reactions that would otherwise reduce sensitivity or operability in harsh IOF process environments. The results of this project have provided new insight into the effects of metallurgy and protective coatings on device behavior, and open new avenues for research in this field. Commercialization of this sensor technology could be easily achieved, although not yet realized. The benefits to society, once this technology is commercialized, is a dramatic cost and energy savings to the industry, which employs these sensors. In addition, the fundamental understandings gained in this program could have an impact on both cost and safety in the future hydrogen economy utilizing hydrogen fuel cells and hydrogen storage.

  2. Final Report

    Energy Technology Data Exchange (ETDEWEB)

    Hollingsworth, Jeff

    2014-07-31

    The purpose of this project was to develop tools and techniques to improve the ability of computational scientists to investigate and correct problems (bugs) in their programs. Specifically, the University of Maryland component of this project focused on the problems associated with the finite number of bits available in a computer to represent numeric values. In large scale scientific computation, numbers are frequently added to and multiplied with each other billions of times. Thus even small errors due to the representation of numbers can accumulate into big errors. However, using too many bits to represent a number results in additional computation, memory, and energy costs. Thus it is critical to find the right size for numbers. This project focused on several aspects of this general problem. First, we developed a tool to look for cancelations, the catastrophic loss of precision in numbers due to the addition of two numbers whose actual values are close to each other, but whose representation in a computer is identical or nearly so. Second, we developed a suite of tools to allow programmers to identify exactly how much precision is required for each operation in their program. This tool allows programmers to both verify that enough precision is available, but more importantly find cases where extra precision could be eliminated to allow the program to use less memory, computer time, or energy. These tools use advanced binary modification techniques to allow the analysis of actual optimized code. The system, called Craft, has been applied to a number of benchmarks and real applications.

  3. Final Report

    Energy Technology Data Exchange (ETDEWEB)

    Callis, Judy [Univ. of California, Davis, CA (United States)

    2016-11-30

    This report summarizes our research activities. In the award period, we have made significant progress on the first aim, with new discoveries reported in one published paper (1) and in one submitted manuscript (2) currently under review. The published manuscript reports on our discovery of plant ribokinase and the metabolic pathway in which it functions; the submitted manuscript is identification and characterization of the plant fructokinase family of enzymes from expression studies, sequence comparisons, subcellular localizations and enzymatic activities of recombinant proteins. Our study of loss-of-function mutants in the fructokinase family members (2) revealed that there were no phenotypic differences observed for the five genes analyzed, so we have adopted the Crispr/Cas9 system to isolate mutants in the two genes for which there are no currently available insertion mutants, and we are generating higher order mutants (double, triples, etc) to discern the relative roles and significance for each fructokinase. These mutants will be an important resource to understand regulation of carbohydrate movement and catabolism in plants. As studies from others indicate, alteration of fructokinases results in changes in cell walls and vasculatures, which have importance relative to biofuel yield and quality. In the second aim, we have characterized the protein-protein interactions for the pkfB proteins FLN1 and FLN2 that are localized to chloroplast transcriptional complexes and have proposed a new model for how chloroplast transcription is regulated. This work has been submitted for publication, been revised and will be re-submitted in December 2016

  4. Final Report

    Energy Technology Data Exchange (ETDEWEB)

    Hameed A. Naseem, Husam H. Abu-Safe

    2007-02-09

    The purpose of this project was to investigate metal-induced crystallization of amorphous silicon at low temperatures using excitation sources such as laser and rapid thermal annealing, as well as, electric field. Deposition of high quality crystalline silicon at low temperatures allows the use of low cost soda-lime glass and polymeric films for economically viable photovoltaic solar cells and low cost large area flat panel displays. In light of current and expected demands on Si supply due to expanding use of consumer electronic products throughout the world and the incessant demand for electric power the need for developing high grade Si thin films on low cost substrate becomes even more important. We used hydrogenated and un-hydrogenated amorphous silicon deposited by plasma enhanced chemical vapor deposition and sputtering techniques (both of which are extensively used in electronic and solar cell industries) to fabricate nano-crystalline, poly-crystalline (small as well as large grain), and single-crystalline (epitaxial) films at low temperatures. We demonstrated Si nanowires on flat surfaces that can be used for fabricating nanometer scale transistors. We also demonstrated lateral crystallization using Al with and without an applied electric field. These results are critical for high mobility thin film transistors (TFT) for large area display applications. Large grain silicon (~30-50 µm grain size for < 0.5 µm thick films) was demonstrated on glass substrates at low temperatures. We also demonstrated epitaxial growth of silicon on (100) Si substrates at temperatures as low as 450°C. Thin film Si solar cells are being projected as the material of choice for low cost high efficiency solar cells when properly coupled with excellent light-trapping schemes. Ar ion laser (CW) was shown to produce dendritic nanowire structures at low power whereas at higher powers yielded continuous polycrystalline films. The power density required for films in contact with Al

  5. Final Report

    Energy Technology Data Exchange (ETDEWEB)

    David W. Mazyck; Angela Lindner; CY Wu, Rick Sheahan, Ashok Jain

    2007-06-30

    Forest products provide essential resources for human civilization, including energy and materials. In processing forest products, however, unwanted byproducts, such as volatile organic compounds (VOCs) and hazardous air pollutants (HAPs) are generated. The goal of this study was to develop a cost effective and reliable air pollution control system to reduce VOC and HAP emissions from pulp, paper and paperboard mills and solid wood product facilities. Specifically, this work focused on the removal of VOCs and HAPs from high volume low concentration (HVLC) gases, particularly methanol since it is the largest HAP constituent in these gases. Three technologies were developed and tested at the bench-scale: (1) A novel composite material of activated carbon coated with a photocatalyst titanium dioxide (TiO{sub 2}) (referred to as TiO{sub 2}-coated activated carbon or TiO{sub 2}/AC), (2) a novel silica gel impregnated with nanosized TiO{sub 2} (referred to as silica-titania composites or STC), and (3) biofiltration. A pilot-scale reactor was also fabricated and tested for methanol removal using the TiO{sub 2}/AC and STC. The technical feasibility of removing methanol with TiO{sub 2}/AC was studied using a composite synthesized via a spay desiccation method. The removal of methanol consists of two consecutive operation steps: removal of methanol using fixed-bed activated carbon adsorption and regeneration of spent activated carbon using in-situ photocatalytic oxidation. Regeneration using photocatalytic oxidation employed irradiation of the TiO{sub 2} catalyst with low-energy ultraviolet (UV) light. Results of this technical feasibility study showed that photocatalytic oxidation can be used to regenerate a spent TiO{sub 2}/AC adsorbent. A TiO{sub 2}/AC adsorbent was then developed using a dry impregnation method, which performed better than the TiO{sub 2}/AC synthesized using the spray desiccation method. The enhanced performance was likely a result of the better

  6. Final report SmartProofS. Results of projects of the SmartProofS program; Eindrapport SmartProofS. Projectresultaten van het SmartProofS programma

    Energy Technology Data Exchange (ETDEWEB)

    Van Hoorik, P.; Westerga, R. [Energy Valley, Groningen (Netherlands)

    2011-05-15

    The SmartProofs program aims to develop tools which must show that the principle of a Smart Power System (SPS) works and how. An SPS can ensure that the supply and demand of electricity in the grid is balanced, even in case more decentralized energy techniques will be put into use. This final report summarizes the main results and conclusions of the SmartProofs program. As part of the SPS program attention is paid to the impacts on the girds, the effects of centralized and decentralized management, disaster resilience, pricing models, potential benefits of control and new business models [Dutch] Het SmartProofs programma heeft tot doel om een concept van een Smart Power System (SPS) te ontwikkelen waarmee kan worden aangetoond dat het principe van een SPS werkt en op welke manier. Een SPS kan zorgen dat het aanbod van elektriciteit op het net op elk moment van de dag overeenkomt met de vraag, ook als er straks veel meer decentrale energietechnieken gebruikt worden waarmee zowel de vraag als het aanbod van elektriciteit onvoorspelbaar wordt. Dit eindrapport geeft een overzicht van de belangrijkste resultaten en conclusies van het SmartProofs programma. Het programma heeft in de werkpakketten deelvraagstukken rondom SmartProofS onderzocht rondom de effecten op onze energienetten, de effecten van zowel centrale- als decentrale aansturing, disaster resilience, prijsmodellen, mogelijke baten van aansturing en nieuwe business modellen.

  7. Tank 241-TX-302C grab samples 302C-TX-97-1A through 302C-TX-97-3B analytical results for the final report

    Energy Technology Data Exchange (ETDEWEB)

    Esch, R.A.

    1998-03-12

    This document is the final report for tank 241-TX-302C grab samples. Six grabs samples (302C-TX-97-1A, 302C-TX-97-1B, 302C-TX-97-2A, 302C-TX-97-2B, 302C-TX-97-3A, and 302C-TX-97-3B) were collected from the catch tank level gauge riser on December 19, 1997. The ``A`` and ``B`` portions from each sample location were composited and analyses were performed on the composites in accordance with the Compatibility Grab Sampling and Analysis Plan (TSAP) (Sasaki, 1997) and the Data Quality Objectives for Tank Farms Waste Compatibility Program (DQO) (Rev. 1: Fowler, 1995; Rev. 2: Mulkey and Miller, 1997). The analytical results are presented in Table 1. No notification limits were exceeded. Appearance and Sample Handling Attachment 1 is provided as a cross-reference for relating the tank farm customer identification numbers with the 222-S Laboratory sample numbers and the portion of sample analyzed. Table 2 provides the appearance information.

  8. Final Analysis of Efficacy and Safety of Omacetaxine Mepesuccinate in Patients With Chronic Phase (CP) or Accelerated Phase (AP) Chronic Myeloid Leukemia (CML): 24-Month Minimum Follow-Up Results

    Science.gov (United States)

    Cortes, Jorge; Kantarjian, Hagop M.; Rea, Delphine; Wetzler, Meir; Lipton, Jeffrey H.; Akard, Luke; Khoury, H. Jean; Michallet, Mauricette; Guerci-Bresler, Agnès; Chuah, Charles; Hellmann, Andrzej; Digumarti, Raghunadharao; Parikh, Purvish M.; Legros, Laurence; Warzocha, Krzysztof; Baccarani, Michele; Li, Elizabeth; Munteanu, Mihaela; Nicolini, Franck E.

    2017-01-01

    Background Omacetaxine, a protein synthesis inhibitor, is indicated in the US for the treatment of patients with chronic (CP) or accelerated phase (AP) chronic myeloid leukemia (CML) with resistance and/or intolerance to two or more tyrosine kinase inhibitors. Methods This final analysis, with 24-month follow-up, includes additional efficacy and safety analyses to assess the benefit of long-term omacetaxine administration (1.25 mg/m2 bid for 14 days q 28 days followed by 7 days q 28 days) in CP- and AP-CML patients receiving >3 cycles. Results Eighteen percent of CP-CML patients achieved major cytogenetic response (MCyR) with a median duration 12.5 months (95% confidence interval [CI], 3.5-not reached [NR]); responses were maintained for ≥12 months in 3 of 14 responders and median overall survival (OS) was 40.3 months (95% CI, 23.8-not reached). In patients with AP-CML, 14% achieved or maintained major hematologic response for a median of 4.7 months (95% CI, 3.6-NR); MCyR was not achieved and median OS was 14.3 months (95% CI, 6.7–18.7). In patients with CP- or AP-CML who received >3 cycles of treatment (n=50 and 14, respectively), median OS was 49.3 months (95% CI, 23.8-NR) and 24.6 months (95% CI, 12–37.2), respectively. Grade ≥3 hematologic toxicity was the major side effect (79%/73% in CP-CML/AP-CML), with discontinuation due to toxicity in 10% of CP and 5% of AP patients. Conclusions These results suggest that long-term administration of omacetaxine is feasible with dose adjustments to manage toxicities, and that omacetaxine provides durable benefit in some patients. PMID:25586015

  9. The ARBITER 6-HALTS Trial (Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol 6-HDL and LDL Treatment Strategies in Atherosclerosis): final results and the impact of medication adherence, dose, and treatment duration.

    Science.gov (United States)

    Villines, Todd C; Stanek, Eric J; Devine, Patrick J; Turco, Mark; Miller, Michael; Weissman, Neil J; Griffen, Len; Taylor, Allen J

    2010-06-15

    This report describes the final results of the ARBITER 6-HALTS (Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol 6-HDL and LDL Treatment Strategies in Atherosclerosis) trial. The ARBITER 6-HALTS trial was terminated early on the basis of a pre-specified interim analysis showing superiority of niacin over ezetimibe on change in carotid intima-media thickness (CIMT). After termination, an additional 107 subjects completed a close-out assessment. Patients with coronary heart disease (CHD) or CHD equivalent with low-density lipoprotein cholesterol <100 mg/dl and high-density lipoprotein cholesterol <50 mg/dl for men or 55 mg/dl for women while receiving stable statin treatment were randomly assigned to ezetimibe (10 mg/day) or extended-release niacin (target dose, 2,000 mg/day). The primary end point was change in mean CIMT, analyzed according to a last observation carried forward method. The relationships of study medication adherence, dosage, and cumulative exposure (product of adherence, dose, and time) with change in CIMT were explored. Results in 315 patients included 208 with 14-month follow-up and 107 after mean treatment of 7 +/- 3 months. Niacin (n = 154) resulted in significant reduction (regression) in mean CIMT (-0.0102 +/- 0.0026 mm; p < 0.001) and maximal CIMT (-0.0124 +/- 0.0036 mm; p = 0.001), whereas ezetimibe (n = 161) did not reduce mean CIMT (-0.0016 +/- 0.0024 mm; p = 0.88) or maximal CIMT (-0.0005 +/- 0.0029 mm; p = 0.88) compared with baseline. There was a significant difference between ezetimibe and niacin treatment groups on mean changes in CIMT, favoring niacin, for both mean CIMT (p = 0.016) and maximal CIMT (p = 0.01). Increased cumulative drug exposure was related to regression of CIMT with niacin, and progression of CIMT with ezetimibe. Niacin induces regression of CIMT and is superior to ezetimibe for patients taking statins. (Comparative Study of the Effect of Ezetimibe Versus Extended

  10. Drug-eluting versus plain balloon angioplasty for the treatment of failing dialysis access: Final results and cost-effectiveness analysis from a prospective randomized controlled trial (NCT01174472)

    Energy Technology Data Exchange (ETDEWEB)

    Kitrou, Panagiotis M., E-mail: panoskitrou@gmail.com [Department of Interventional Radiology, Patras University Hospital, School of Medicine, Rion 26504 (Greece); Katsanos, Konstantinos [Department of Interventional Radiology, Guy' s and St. Thomas’ Hospitals, NHS Foundation Trust, King' s Health Partners, London SE1 7EH (United Kingdom); Spiliopoulos, Stavros; Karnabatidis, Dimitris; Siablis, Dimitris [Department of Interventional Radiology, Patras University Hospital, School of Medicine, Rion 26504 (Greece)

    2015-03-15

    Highlights: •1-Year target lesion primary patency significantly higher after PCB application compared to plain balloon angioplasty in the failing dialysis access. •Significant difference in favor of PCB in cumulative primary patency of AVGs at 1 year. •No significant difference in cumulative primary patency of AVFs treated with PCB at 1 year. •Cost effectiveness analysis performed. •Paclitaxel-coated balloon angioplasty proves to be a cost-effective option for treating dialysis access. -- Abstract: Objective: To report the final results and cost-effectiveness analysis of a prospective randomized controlled trial investigating drug-eluting balloon (DEB) versus plain balloon angioplasty (BA) for the treatment of failing dialysis access ( (NCT01174472)). Methods: 40 patients were randomized to angioplasty with either DEB (n = 20) or BA (n = 20) for treatment of significant venous stenosis causing a failing dialysis access. Both arteriovenous fistulas (AVF) and synthetic arteriovenous grafts (AVG) were included. Angiographic follow up was scheduled every two months. Primary endpoints were technical success and target lesion primary patency at 1 year. Cumulative and survival analysis was performed. Incremental net benefit (INB) and incremental cost effectiveness ratio (ICER) were calculated and the cost-effectiveness acceptability curve (CEAC) was drawn. Results: Baseline variables were equally distributed between the two groups. At 1 year, cumulative target lesion primary patency was significantly higher after DEB application (35% vs. 5% after BA, p < 0.001). Overall, median primary patency was 0.64 years in case of DEB vs. 0.36 years in case of BA (p = 0.0007; unadjusted HR = 0.27 [95%CI: 0.13–0.58]; Cox adjusted HR = 0.23 [95%CI: 0.10–0.50]). ICER was 2198 Euros (€) per primary patency year of dialysis access gained. INB was 1068€ (95%CI: 31–2105€) for a willingness-to-pay (WTP) threshold of 5000€ (corresponding acceptability probability >97

  11. Final Technical Report

    Energy Technology Data Exchange (ETDEWEB)

    Maxwell, Mike, J., P.E.

    2012-08-30

    The STI product is the Final Technical Report from ReliOn, Inc. for contract award DE-EE0000487: Recovery Act PEM Fuel Cell Systems Providing Emergency Reserve and Backup Power. The program covered the turnkey deployment of 431 ReliOn fuel cell systems at 189 individual sites for AT&T and PG&E with ReliOn functioning as the primary equipment supplier and the project manager. The Final Technical Report provides an executive level summary, a comparison of the actual accomplishments vs. the goals and objectives of the project, as well as a summary of the project activity from the contract award date of August 1, 2009 through the contract expiration date of December 31, 2011. Two photos are included in the body of the report which show hydrogen storage and bulk hydrogen refueling technologies developed as a result of this program.

  12. More with thermal energy storage. Report 1. Coupling with policy. Coupling of research results MMB with policy aspects. Final report; Meer met bodemenergie. Rapport 1. Koppeling met beleid. Koppeling onderzoeksresultaten MMB met beleidsaspecten. Eindrapport

    Energy Technology Data Exchange (ETDEWEB)

    Luitwieler, M. [Bioclear, Groningen (Netherlands); Van Beek, D.; De Boer, S.; Koenders, M. [IF Technology, Arnhem (Netherlands)

    2012-06-25

    The project More With Thermal Energy Storage (MMB, abbreviated in Dutch) focuses on knowledge gaps and potential opportunities regarding open systems. The main questions to be answered are: (1) What effects (hydrological, thermal, microbiological and chemical) occur in the soil system by application of thermal energy storage; (2) Which technical options are available for a sustainable integration of thermal energy storage in the water and energy chain?; (3) Is it possible to achieve multiple objectives by using smart combinations? The project is organized in different work packages. In work package 2, the effects of individual and collective thermal energy storage storage systems on subsoils and the environment are determined. In work package 3 the opportunities for thermal energy storage and soil remediation are examined, while in work package 4 the focus is on new sustainable combinations of heat and cold storage. Work package is the umbrella part where communication and policy of and participation in MMB are the main subjects. This final report provides (a) an overview of the activities that have taken place in the context of work package 1, (b) the results of the other work packages in the light of four policy frameworks, and (c) a view on future policy [Dutch] Het project Meer Met Bodemenergie (MMB) richt zich op het invullen van kennisleemtes en mogelijke kansen ten aanzien van open systemen. De belangrijkste vragen waarop het onderzoeksprogramma MMB antwoord geeft zijn: (1) Welke effecten (hydrologisch, thermisch, microbiologisch en chemisch) treden op in het bodemsysteem bij toepassing van bodemenergie?; (2) Welke technische mogelijkheden zijn er voor het duurzaam inpassen van bodem-energie in de water- en energieketen?; (3) Is het mogelijk om meerdere doelstellingen tegelijk te verwezenlijken door slimme combinaties te maken? Het project is ingericht met verschillende werkpakketten. In werkpakket 2 worden de effecten van individuele en collectieve

  13. Efficacy and tolerability of chemotherapy with modified dose-dense TCF regimen (TCF-dd) in locally advanced or metastatic gastric cancer: final results of a phase II trial.

    Science.gov (United States)

    Tomasello, Gianluca; Liguigli, Wanda; Poli, Rossana; Lazzarelli, Silvia; Brighenti, Matteo; Negri, Federica; Curti, Alessandra; Martinotti, Mario; Olivetti, Lucio; Rovatti, Massimo; Donati, Gianvito; Passalacqua, Rodolfo

    2014-10-01

    We previously studied a dose-dense TCF (TCF-dd) regimen demonstrating its feasibility and an activity comparable to epirubicin-based chemotherapy and TCF q3w in terms of overall survival and time to progression (TTP). We report here the final results of a phase II study of chemotherapy with a modified TCF-dd regimen in locally advanced or metastatic gastric cancer (MGC). Patients with histologically confirmed measurable MGC, not previously treated for advanced disease, received docetaxel 70 mg/m(2) day 1, cisplatin 60 mg/m(2) day 1, l-folinic acid 100 mg/m(2) days 1 and 2, followed by 5-fluorouracil (5-FU) 400 mg/m(2) bolus days 1 and 2, and then 600 mg/m(2) as a 22-h continuous infusion days 1 and 2, every 14 days, plus pegfilgrastim 6 mg on day 3. Patients aged ≥65 years received the same schedule with a dose reduction of 30 %. Study duration: December 2007-November 2010. Forty-six consecutive patients were enrolled (78 % male, 22 % female; median age, 66 years, range, 38-76 years; ECOG PS: 0, 48 %, 1, 46 %). Primary endpoint was overall response rate (ORR). A median of four cycles (range, one to six) was administered. Forty-three patients were evaluated for response (93.5 %) and all for toxicity: 3 complete response (CR), 25 partial response (PR), 10 stable disease (SD), and 5 progressive disease (PD) were observed, for an ORR by intention to treat (ITT) of 61 % (95 % CI 47-75). Median overall survival (OS) was 17.63 months (95 % CI, 13.67-20.67); median progression-free survival was 8.9 months (95 % CI, 6.5-13.4). Twenty-one patients (46.0 %) were treated at full doses without any delay, thus respecting the dose-dense criterion. Most frequent grade 3-4 toxicities were neutropenia (20 %), leukopenia (4 %), thrombocytopenia (2 %), anemia (2 %), febrile neutropenia (6 %), asthenia (22 %), diarrhea (4 %), nausea/vomiting (11 %), and hypokalemia (6 %). Overall, TCF-dd was shown to be safe. The TCF-dd regimen in locally advanced or MGC

  14. Verb-Final Typology

    Science.gov (United States)

    Ogihara, Saeko

    2010-01-01

    This dissertation is a typological study of verb-final languages, the purpose of which is to examine various grammatical phenomena in verb-final languages to discover whether there are correlations between the final position of the verb and other aspects of grammar. It examines how finality of the verb interacts with argument coding in simple…

  15. DANAERO MW: Final Report

    DEFF Research Database (Denmark)

    Troldborg, Niels; Bak, Christian; Aagaard Madsen, Helge

    This report describes the results of the EUDP funded DANAERO MW II project carried out by DTU Wind Energy (formerly Risø DTU) and the industrial partners, LM Wind Power, Vestas Wind Systems A/S and Siemens Wind Power. An overview of the data available from the project as well as the results from ...... analysis of the data is given with the main objective to explore in detail the influence of atmospheric and wake turbulence on MW turbine performance, loading and stability. Finally, validation and demonstration of simulation codes are carried out.......This report describes the results of the EUDP funded DANAERO MW II project carried out by DTU Wind Energy (formerly Risø DTU) and the industrial partners, LM Wind Power, Vestas Wind Systems A/S and Siemens Wind Power. An overview of the data available from the project as well as the results from...

  16. Final Technical Report

    Energy Technology Data Exchange (ETDEWEB)

    Sobecky, Patricia A; Taillefert, Martial

    2013-03-29

    This final technical report describes results and findings from a research project to examine the role of microbial phosphohydrolase enzymes in naturally occurring subsurface microorganisms for the purpose of promoting the immobilization of the radionuclide uranium through the production of insoluble uranium phosphate minerals. The research project investigated the microbial mechanisms and the physical and chemical processes promoting uranium biomineralization and sequestration in oxygenated subsurface soils. Uranium biomineralization under aerobic conditions can provide a secondary biobarrier strategy to immobilize radionuclides should the metal precipitates formed by microbial dissimilatory mechanisms remobilize due to a change in redox state.

  17. The PHENIX final texts

    Energy Technology Data Exchange (ETDEWEB)

    Vasile, A.; Fontaine, B.; Vanier, M.; Gauthe, P.; Pascal, V.; Prulhiere, G.; Jaecki, P.; Martin, L. [CEA Cadarache, 13 - Saint Paul lez Durance (France); Tenchine, D. [CEA Grenoble, 38 (France); Sauvage, J.F. [Electricite de France (EDF/SEPTEN), 69 - Villeurbanne (France); Dupraz, R.; Woaye Hune, A. [AREVA NP, 75 - Paris (France)

    2010-11-15

    The 250 MWe (140 MWe since 1993) PHENIX sodium cooled fast reactor was shut down on March 6, 2009. Before decommissioning, a final set of tests was performed during May 2009 - January 2010. These tests covered core physics, fuel behaviour and thermal-hydraulics areas. Detailed analysis of the tests results is ongoing. It will be used for the extension of the validation of ERANOS and DARWIN codes for core physics, TRIO{sub U} and CATHARE for thermal-hydraulics and GERMINAL for fuel behaviour. In addition, the program included 2 tests related to the comprehension of the four negative reactivity transients (AURN) experienced during the reactor operation in 1989 and 1990 and not yet fully explained. This was also a great opportunity to involve young engineers in the different processes like the design of the tests, their carrying out and the analysis of the results. The standard instrumentation of the reactor was completed by specifically designed devices. (authors)

  18. Final Technical Report

    Energy Technology Data Exchange (ETDEWEB)

    John Tanis

    2005-11-25

    This document comprises the final technical report for atomic collisions research supported by DOE grant No. DE-FG02-87ER13778 from September 1, 2001 through August 31, 2004. The research involved the experimental investigation of excitation and charge-changing processes occurring in ion-atom and ion-molecule collisions. Major emphases of the study were: (1) interference effects resulting from coherent electron emission in H2, (2) production of doubly vacant K-shell (hollow ion) states due to electron correlation, and (3) formation of long-lived metastable states in electron transfer processes. During the period of the grant, this research resulted in 23 publications, 12 invited presentations, and 39 contributed presentations at national and international meetings and other institutions. Brief summaries of the completed research are presented below.

  19. Final Technical Report

    Energy Technology Data Exchange (ETDEWEB)

    Schuur, Edward [Northern Arizona Univ., Flagstaff, AZ (United States); Luo, Yiqi [Univ. of Oklahoma, Norman, OK (United States)

    2016-12-01

    This final grant report is a continuation of the final grant report submitted for DE-SC0006982 as the Principle Investigator (Schuur) relocated from the University of Florida to Northern Arizona University. This report summarizes the original project goals, as well as includes new project activities that were completed in the final period of the project.

  20. The use of particulate bone grafts from the mandible for maxillary sinus floor augmentation before placement of surface-modified implants: results from bone grafting to delivery of the final fixed prosthesis.

    Science.gov (United States)

    Becktor, Jonas P; Hallström, Hadar; Isaksson, Sten; Sennerby, Lars

    2008-04-01

    This prospective study followed 61 patients who were partially dentulous and considered to have insufficient bone volume for routine implant treatment and consequently underwent sinus inlay bone grafting. The patients were treated with maxillary sinus floor augmentation with particulated autogenous bone from the mandibular ramus/corpus. After a healing period, dental implants (n = 180) were installed. Radiographic examination revealed average residual vertical bone heights of 6.5 mm in the first premolar region, 3.8 mm in the second premolar region, 3.5 mm in the first molar region, and 2.6 mm in the second molar region. The average implant lengths were 12 mm in the first premolar region and 11 mm in the second premolar, first, and second molar regions. All patients received a fixed partial prosthesis. All bone grafts were stable, and the implant survival rate was 98.9%. There were few cases of minor complications postoperatively and no record of any injured teeth, heavy bruising, bleeding, or swelling in either the donor site or the recipient site. The present clinical study demonstrated a low failure rate of surface-modified dental implants when placed into the maxillary sinus an average of 7 months after augmentation with particulate mandibular bone grafts and followed up to delivery of the final fixed prosthesis. The findings indicate that treatment with endosseous implants may be as predictable in patients with inadequate bone who underwent sinus floor augmentation as in patients with adequate bone volume.

  1. Vet Centers. Final rule.

    Science.gov (United States)

    2016-03-02

    The Department of Veterans Affairs (VA) adopts as final an interim final rule that amends its medical regulation that governs Vet Center services. The National Defense Authorization Act for Fiscal Year 2013 (the 2013 Act) requires Vet Centers to provide readjustment counseling services to broader groups of veterans, members of the Armed Forces, including a member of a reserve component of the Armed Forces, and family members of such veterans and members. This final rule adopts as final the regulatory criteria to conform to the 2013 Act, to include new and revised definitions.

  2. The Phenix final tests

    Energy Technology Data Exchange (ETDEWEB)

    Vasile, A.; Fontaine, B.; Vanier, M.; Gauthe, P.; Pascal, V.; Prulhiere, G.; Jaecki, P. [CEA Cadarache, BP 1, 13108 St Paul Lez Durance (France); Tenchine, D. [CEA Grenoble (France); Martin, L. [Centrale Phenix - CEA Marcoule (France); Sauvage, J.F. [EDF / SEPTEN - 12 av. Dutrievoz 69628 Villeurbanne (France); Dupraz, R.; Woaye-Hune, A. [AREVA NP - 10 rue Juliette Recamier 69456 LYON Cedex (France)

    2010-07-01

    The 250 MWe (140 MWe since 1993) Phenix sodium cooled fast reactor was shut down on March 6, 2009. Before decommissioning, a final set of tests were performed during the May 2009 - January 2010 period covering core physics, fuel behaviour and thermal-hydraulics areas. Detailed analysis of the tests results is ongoing. It will be used for the extension of the validation of ERANOS and DARWIN codes for core physics, TRIO-U and CATHARE for Thermal-hydraulics and GERMINAL for fuel behaviour. In addition, the program included two tests related to the comprehension of the four negative reactivity transients (AURN in French acronym) experienced during the reactor operation in '89 and '90 and not yet fully explained. This was also a great opportunity to involve young engineers in the different processes like the design of the tests, their carrying out, and the analysis of the results. The standard instrumentation of the reactor was completed by specifically designed devises. (authors)

  3. Final Technical Report

    Energy Technology Data Exchange (ETDEWEB)

    Held, Isaac [Princeton Univ., NJ (United States); Balaji, V. [Princeton Univ., NJ (United States); Fueglistaler, Stephan [Princeton Univ., NJ (United States)

    2016-09-19

    We have constructed and analyzed a series of idealized models of tropical convection interacting with large-scale circulations, with 25-50km resolution and with 1-2km cloud resolving resolution to set the stage for rigorous tests of convection closure schemes in high resolution global climate models. Much of the focus has been on the climatology of tropical cyclogenesis in rotating systems and the related problem of the spontaneous aggregation of convection in non-rotating systems. The PI (Held) will be delivering the honorary Bjerknes lecture at the Fall 2016 AGU meeting in December on this work. We have also provided new analyses of long-standing issues related to the interaction between convection and the large-scale circulation: Kelvin waves in the upper troposphere and lower stratosphere, water vapor transport into the stratosphere, and upper tropospheric temperature trends. The results of these analyses help to improve our understanding of processes, and provide tests for future high resolution global modeling. Our final goal of testing new convections schemes in next-generation global atmospheric models at GFDL has been left for future work due to the complexity of the idealized model results meant as tests for these models uncovered in this work and to computational resource limitations. 11 papers have been published with support from this grant, 2 are in review, and another major summary paper is in preparation.

  4. Final Technical Report

    Energy Technology Data Exchange (ETDEWEB)

    Glasser, Alan H. [Fusion Theory and Computation Inc., Kingston, WA (United States)

    2018-02-02

    Final technical report on DE-SC0016106. This is the final technical report for a portion of the multi-institutional CEMM project. This report is centered around 3 publications and a seminar presentation, which have been submitted to E-Link.

  5. Final Design, Special Magnets

    CERN Document Server

    Borburgh, J; Fowler, A; Hourican, M; Metzmacher, K; Sermeus, L; CERN. Geneva. AB Department

    2003-01-01

    The final design review for the 5 different Septa and 5 different Bumper, Chopper and Kicker systems is given. The specifications for all items have been finalized and the parameters have been fixed and these are shown in two tables. The present status of each special magnet is reported on.

  6. Strategies for the long-term climate policy. The results of the Cool project. Final report of the second phase of the Dutch National Research Programme on Global Air Pollution and Climate Change (NRP II) 1995-2001. Part 2

    NARCIS (Netherlands)

    Berk M; Hisschemoller M; Mol T; Hordijk L; Kok M; Metz B; NOP

    2002-01-01

    This report, Climate Change, a Permanent Concern, presents the results of research that was conducted in over 90 projects during the second phase of the National Research Programme on Global Air Pollution and Climate Change (NRP-II, 1995-2001). The report is intended for policymakers, members of

  7. Final results of a self-apposing paclitaxel-eluting stent fOr the PErcutaNeous treatment of de novo lesions in native bifurcated coronary arteries study

    DEFF Research Database (Denmark)

    Naber, Christoph K; Pyxaras, Stylianos A; Nef, Holger

    2016-01-01

    AIMS: We aimed to evaluate the long-term safety and efficacy of the STENTYS self-apposing paclitaxeleluting stent (STENTYS-PES) in bifurcation lesions in routine clinical practice. METHODS AND RESULTS: The primary endpoint of the study was the composite major adverse cardiac events (MACE: cardiac...

  8. Connected Cruise Control : Final report

    NARCIS (Netherlands)

    van Arem, B.

    2013-01-01

    This report describes the final results of the Connected Cruise Control project. The
    Connected Cruise Control project was conducted from December 2009-April 2013 as a High Tech Automotive System Innovation project (HTASD09002), subsidized by
    Agentschap NL. The project was conducted by a

  9. A study of toxic emissions from a coal-fired power plant utilizing the SNOX innovative clean coal technology demonstration. Volume 1, Sampling/results/special topics: Final report

    Energy Technology Data Exchange (ETDEWEB)

    1994-07-01

    This study was one of a group of assessments of toxic emissions from coal-fired power plants, conducted for DOE during 1993. The motivation for those assessments was the mandate in the 1990 Clean Air Act Amendments that a study be made of emissions of hazardous air pollutants (HAPs) from electric utilities. The report is organized in two volumes. Volume 1: Sampling describes the sampling effort conducted as the basis for this study; Results presents the concentration data on HAPs in the several power plant streams, and reports the results of evaluations and calculations conducted with those data; and Special Topics report on issues such as comparison of sampling methods and vapor/solid distributions of HAPs. Volume 2: Appendices include quality assurance/quality control results, uncertainty analysis for emission factors, and data sheets. This study involved measurements of a variety of substances in solid, liquid, and gaseous samples from input, output, and process streams at the Innovative Clean Coal Technology Demonstration (ICCT) of the Wet Sulfuric Acid-Selective Catalytic Reduction (SNOX) process. The SNOX demonstration is being conducted at Ohio Edison`s Niles Boiler No. 2 which uses cyclone burners to burn bituminous coal. A 35 megawatt slipstream of flue gas from the boiler is used to demonstrate SNOX. The substances measured at the SNOX process were the following: 1. Five major and 16 trace elements, including mercury, chromium, cadmium, lead, selenium, arsenic, beryllium, and nickel; 2. Acids and corresponding anions (HCl, HF, chloride, fluoride, phosphate, sulfate); 3. Ammonia and cyanide; 4. Elemental carbon; 5. Radionuclides; 6. Volatile organic compounds (VOC); 7. Semi-volatile compounds (SVOC) including polynuclear aromatic hydrocarbons (PAH); and 8. Aldehydes.

  10. Final Technical Report

    Energy Technology Data Exchange (ETDEWEB)

    Alexander Fridman

    2005-06-01

    This DOE project DE-FC36-04GO14052 ''Plasma Pilot Plant Test for Treating VOC Emissions from Wood Products Plants'' was conducted by Drexel University in cooperation with Georgia-Pacific (G-P) and Kurchatov Institute (KI). The objective of this project was to test the Plasma Pilot Plant capabilities in wood industry. The final goal of the project was to replace the current state-of-the-art, regenerative thermal oxidation (RTO) technology by Low-Temperature Plasma Technology (LTPT) in paper and wood industry for Volatile Organic Components (VOC) destruction in High Volume Low Concentration (HVLC) vent emissions. MetPro Corporation joined the team as an industrial partner from the environmental control business and a potential leader for commercialization. Concurrent Technology Corporation (CTC) has a separate contract with DOE for this technology evaluation. They prepared questionnaires for comparison of this technology and RTO, and made this comparison. These data are presented in this report along with the description of the technology itself. Experiments with the pilot plant were performed with average plasma power up to 3.6 kW. Different design of the laboratory and pilot plant pulsed coronas, as well as different analytical methods revealed many new peculiarities of the VOC abatement process. The work reported herein describes the experimental results for the VOCs removal efficiency with respect to energy consumption, residence time, water effect and initial concentration.

  11. MIXMETER - the final steps

    Energy Technology Data Exchange (ETDEWEB)

    Harrison, P.S. [Melverley Consultants Ltd (United Kingdom); Parry, S.J. [Imperial College, London (United Kingdom). Dept. of Chemical Engineering and Chemical Technology; Shires, G.L. [Imperial College, London (United Kingdom). TH Huxley School of Environment

    1999-07-01

    The MIXMETER multiphase flow meter has been in development since 1992 by Imperial College, London, through a project sponsored by the UK Offshore Supplies Office (OSO) and a consortium of oil companies. During the final stage of this development in 1997 a 3 inch (75mm) Production Prototype meter was built by the licensees, Jiskoot Autocontrol Ltd, and has since been tested under The National Engineering Laboratory (NEL) 'Multiflow' programme. Tests in the vertical orientation (upward flow) have also been performed together with heavy oil tests at the Texaco Flow Facility in Humble, Texas. Key aspects of these tests are discussed. An important element of the NEL tests was to assess the performance of the meter when salt concentration of the water phase varies. These results are discussed together with a novel technique for enhancement of the dual energy gamma system to allow salt concentration to be measured and the necessary corrections to be performed without the need for additional equipment. (author)

  12. O10.05FINAL ANALYSIS OF THE BELOB TRIAL (A RANDOMIZED PHASE II STUDY ON BEVACIZUMAB VERSUS BEVACIZUMAB PLUS LOMUSTINE VERSUS LOMUSTINE SINGLE AGENT IN RECURRENT GLIOBLASTOMA) AND FIRST RADIOLOGY REVIEW RESULTS

    Science.gov (United States)

    Taal, W.; Oosterkamp, H.M.; Walenkamp, A.M.E.; Dubbink, H.J.; Beerepoot, L.V.; Hanse, M.; Buter, J.; Honkoop, A.; Boerman, D.; Vos, F.Y.F.; Dinjens, W.N.M.; Enting, R.H.; Taphoorn, M.J.B.; van den Berkmortel, F.W.P.J.; Jansen, R.; Brandsma, D.; Bromberg, J.E.; van Heuvel, I.; Vernhout, R.M.; van der Holt, B.; van den Bent, M.J.

    2014-01-01

    INTRODUCTION: Treatment options for recurrent glioblastoma remain limited, with only modest activity of second line chemotherapy. Despite the absence of well controlled trials, bevacizumab is widely used for recurrent glioblastoma. Nonetheless, it remains unclear if the high response rates observed after treatment with bevacizumab translate into an overall survival (OS) benefit. We report the first randomized phase II trial on bevacizumab in recurrent glioblastoma with a control arm without bevacizumab. METHODS: This was multicenter phase II study conducted in 14 Dutch sites. Patients with a first recurrence of a glioblastoma after chemo-irradiation with temozolomide were randomized between treatment with oral lomustine 110 mg/m2 once every 6 weeks, with bevacizumab 10 mg/kg once every 2 weeks intravenously or with the combination lomustine 110 mg/m2 every 6 weeks and bevacizumab 10 mg/kg every 2 weeks. Response was assessed using the RANO criteria. Primary endpoint was OS at 9 months. A safety analysis was planned after the first ten patients completed two cycles of 6 weeks in the combination arm. RESULTS: 153 patients were randomized, of which 148 were eligible. After the safety analysis the lomustine dosage in the combination arm was reduced to 90 mg/m2 because of thrombocytopenia, resulting in bevacizumab dose delays. After reduction the treatment in the combination arm was well tolerated. The percentage 9 month OS (95% confidence interval) was 43% (29, 57) in the lomustine arm, 38% (25, 51) in the bevacizumab arm, and 59% (43, 72) in the bevacizumab/lomustine 90 arm. Response rates were 35-40% for bevacizumab treated patients, and 5% in the lomustine single agent arm. CONCLUSION: This study does not show a meaningful OS at 9 months after treatment with bevacizumab alone. However, the results of combination therapy of bevacizumab with lomustine met the prespecified criterion for further phase III studies. AKNOWLEDGMENTS: This study was supported by an

  13. Measurements of the physical and thermodynamic properties of products resulting from coal hydroliquefaction. Mesures de proprietes physiques et thermodynamiques de produits issus de l'hydroliquefaction du charbon; Rapport final

    Energy Technology Data Exchange (ETDEWEB)

    Lauret, A.; Laugier, S.; Valtz, A.; Richon, D.; Renon, H. (Armines, Fontainebleu (France). Centre Reacteurs et Processus)

    1991-01-01

    The aim of this work was to design and set up special equipment to measure vapour-liquid equilibria of oil-hydrogen systems, and to measure these equilibria at temperatures between 523 and 673 K for pressures between 5 and 25 MPa. These thermodynamic data are useful for the optimisation of hydrogenation plants. The equilibrium cell with its peripherals, the analytical method and the experimental procedure are presented, together with the experimental results. Improvements carried out included the use of a microprocessor to monitor the samples and the different stages of the sample analyses. Very few sample analyses were found to be usable because most of them were performed under incorrect conditions (during the period of setting up the apparatus). Among the few analyses retained, some are not reliable, and only trends in hydrogen solubilities and oil compositions can be described as a function of total pressure.

  14. Hawaii demand-side management resource assessment. Final report, Reference Volume 3 -- Residential and commercial sector DSM analyses: Detailed results from the DBEDT DSM assessment model; Part 1, Technical potential

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    1995-04-01

    The Hawaii Demand-Side Management Resource Assessment was the fourth of seven projects in the Hawaii Energy Strategy (HES) program. HES was designed by the Department of Business, Economic Development, and Tourism (DBEDT) to produce an integrated energy strategy for the State of Hawaii. The purpose of Project 4 was to develop a comprehensive assessment of Hawaii`s demand-side management (DSM) resources. To meet this objective, the project was divided into two phases. The first phase included development of a DSM technology database and the identification of Hawaii commercial building characteristics through on-site audits. These Phase 1 products were then used in Phase 2 to identify expected energy impacts from DSM measures in typical residential and commercial buildings in Hawaii. The building energy simulation model DOE-2.1E was utilized to identify the DSM energy impacts. More detailed information on the typical buildings and the DOE-2.1E modeling effort is available in Reference Volume 1, ``Building Prototype Analysis``. In addition to the DOE-2.1E analysis, estimates of residential and commercial sector gas and electric DSM potential for the four counties of Honolulu, Hawaii, Maui, and Kauai through 2014 were forecasted by the new DBEDT DSM Assessment Model. Results from DBEDTs energy forecasting model, ENERGY 2020, were linked with results from DOE-2.1E building energy simulation runs and estimates of DSM measure impacts, costs, lifetime, and anticipated market penetration rates in the DBEDT DSM Model. Through its algorithms, estimates of DSM potential for each forecast year were developed. Using the load shape information from the DOE-2.1E simulation runs, estimates of electric peak demand impacts were developed. Numerous tables and figures illustrating the technical potential for demand-side management are included.

  15. Analysis of factors related to military training injury and the effect of self-rescue and buddy rescue on the final result of the injury in tank crew of the armored forces

    Directory of Open Access Journals (Sweden)

    Rong-bin ZHOU

    2011-09-01

    Full Text Available Objective To analyze the factors related to military training injury and the effect of self-rescue and buddy rescue on the result of the injury in the soldiers.Methods All data were statistically classified with cluster sampling according to the diagnosis standard of Chinese PLA for analysis.Investigation was conducted in 1028 soldiers of the armored forces with questionnaire,and non-condition logistic regression analysis was applied.Results The total incidence of military training injury was 40.2%.Of all the injured soldiers,36.80% of them served for one year only,and the incidence of injury was obviously higher than those who had served in armed forces for 2 or 3 years.Unconditioned regression analysis revealed that the main causes related to military training injury in the soldiers were as follows: the items of training,the terrain feature,motion sickness,self-rescue and buddy rescue training,and whether the action consistent with the standards.The rehabilitation rate within one month was significantly higher in those who underwent self-rescue or buddy rescue(93.8% and 94.2%,respectively than those who did not undergo self-rescue or buddy rescue(76.3%,76.7%,respectively,P < 0.001.Conclusions The incidence of military training injury in the armored forces is high.It should be emphysized that soldiers with one year of military service should be partioularly taken care to prevent from injuries.Many factors may influence the military training injury,and protective measures should be taken.Those who have the knowledge of self-rescue or undergo buddy rescue will have higher rehabilitation rate within one month.

  16. Final Technical Report

    Energy Technology Data Exchange (ETDEWEB)

    Aristos Aristidou Natureworks); Robert Kean (NatureWorks); Tom Schechinger (IronHorse Farms, Mat); Stuart Birrell (Iowa State); Jill Euken (Wallace Foundation & Iowa State)

    2007-10-01

    The two main objectives of this project were: 1) to develop and test technologies to harvest, transport, store, and separate corn stover to supply a clean raw material to the bioproducts industry, and 2) engineer fermentation systems to meet performance targets for lactic acid and ethanol manufacturers. Significant progress was made in testing methods to harvest corn stover in a “single pass” harvest mode (collect corn grain and stover at the same time). This is technically feasible on small scale, but additional equipment refinements will be needed to facilitate cost effective harvest on a larger scale. Transportation models were developed, which indicate that at a corn stover yield of 2.8 tons/acre and purchase price of $35/ton stover, it would be unprofitable to transport stover more than about 25 miles; thus suggesting the development of many regional collection centers. Therefore, collection centers should be located within about 30 miles of the farm, to keep transportation costs to an acceptable level. These collection centers could then potentially do some preprocessing (to fractionate or increase bulk density) and/or ship the biomass by rail or barge to the final customers. Wet storage of stover via ensilage was tested, but no clear economic advantages were evident. Wet storage eliminates fire risk, but increases the complexity of component separation and may result in a small loss of carbohydrate content (fermentation potential). A study of possible supplier-producer relationships, concluded that a “quasi-vertical” integration model would be best suited for new bioproducts industries based on stover. In this model, the relationship would involve a multiyear supply contract (processor with purchase guarantees, producer group with supply guarantees). Price will likely be fixed or calculated based on some formula (possibly a cost plus). Initial quality requirements will be specified (but subject to refinement).Producers would invest in harvest

  17. A Phase 3 Trial of 2 Years of Androgen Suppression and Radiation Therapy With or Without Adjuvant Chemotherapy for High-Risk Prostate Cancer: Final Results of Radiation Therapy Oncology Group Phase 3 Randomized Trial NRG Oncology RTOG 9902.

    Science.gov (United States)

    Rosenthal, Seth A; Hunt, Daniel; Sartor, A Oliver; Pienta, Kenneth J; Gomella, Leonard; Grignon, David; Rajan, Raghu; Kerlin, Kevin J; Jones, Christopher U; Dobelbower, Michael; Shipley, William U; Zeitzer, Kenneth; Hamstra, Daniel A; Donavanik, Viroon; Rotman, Marvin; Hartford, Alan C; Michalski, Jeffrey; Seider, Michael; Kim, Harold; Kuban, Deborah A; Moughan, Jennifer; Sandler, Howard

    2015-10-01

    Long-term (LT) androgen suppression (AS) with radiation therapy (RT) is a standard treatment of high-risk, localized prostate cancer (PCa). Radiation Therapy Oncology Group 9902 was a randomized trial testing the hypothesis that adjuvant combination chemotherapy (CT) with paclitaxel, estramustine, and oral etoposide plus LT AS plus RT would improve overall survival (OS). Patients with high-risk PCa (prostate-specific antigen 20-100 ng/mL and Gleason score [GS] ≥ 7 or clinical stage ≥ T2 and GS ≥ 8) were randomized to RT and AS (AS + RT) alone or with adjuvant CT (AS + RT + CT). CT was given as four 21-day cycles, delivered beginning 28 days after 70.2 Gy of RT. AS was given as luteinizing hormone-releasing hormone for 24 months, beginning 2 months before RT plus an oral antiandrogen for 4 months before and during RT. The study was designed based on a 6% improvement in OS from 79% to 85% at 5 years, with 90% power and a 2-sided alpha of 0.05. A total of 397 patients (380 eligible) were randomized. The patients had high-risk PCa, 68% with GS 8 to 10 and 34% T3 to T4 tumors, and median prostate-specific antigen of 22.6 ng/mL. The median follow-up period was 9.2 years. The trial closed early because of excess thromboembolic toxicity in the CT arm. The 10-year results for all randomized patients revealed no significant difference between the AS + RT and AS + RT + CT arms in OS (65% vs 63%; P=.81), biochemical failure (58% vs 54%; P=.82), local progression (11% vs 7%; P=.09), distant metastases (16% vs 14%; P=.42), or disease-free survival (22% vs 26%; P=.61). NRG Oncology RTOG 9902 showed no significant differences in OS, biochemical failure, local progression, distant metastases, or disease-free survival with the addition of adjuvant CT to LT AS + RT. The trial results provide valuable data regarding the natural history of high-risk PCa treated with LT AS + RT and have implications for the feasibility of clinical trial accrual and tolerability using CT for PCa

  18. More with thermal energy storage. Report 6. High temperature storage. Overview of knowledge and results of measurements with regard to high temperature storage systems. Final report; Meer met bodemenergie. Rapport 6. Hogetemperatuuropslag. Kennisoverzicht en praktijkmetingen rondom hogetemperatuuropslagsystemen. Eindrapport

    Energy Technology Data Exchange (ETDEWEB)

    Drijver, B. [IF Technology, Arnhem (Netherlands)

    2012-03-30

    The project More With Thermal Energy Storage (MMB, abbreviated in Dutch) focuses on knowledge gaps and potential opportunities regarding open systems. The main questions to be answered are: (1) What effects (hydrological, thermal, microbiological and chemical) occur in the soil system by application of thermal energy storage; (2) Which technical options are available for a sustainable integration of thermal energy storage in the water and energy chain?; (3) Is it possible to achieve multiple objectives by using smart combinations? The project is organized in different work packages. In work package 2, the effects of individual and collective thermal energy storage storage systems on subsoils and the environment are determined. In work package 3 the opportunities for thermal energy storage and soil remediation are examined, while in work package 4 the focus is on new sustainable combinations of heat and cold storage. Work package 1 is the umbrella part where communication and policy of and participation in MMB are the main subjects. This report includes the results of research in the field of high temperature heat storage. Residual heat, which comes available in the summer can be used for heating purposes in the winter. To realize that heat can be stored temporarily. It appears that the subsurface can be used, which has resulted in a strong growth of heat and cold storage systems [Dutch] Het project Meer Met Bodemenergie (MMB) richt zich op het invullen van kennisleemtes en mogelijke kansen ten aanzien van open systemen. De belangrijkste vragen waarop het onderzoeksprogramma MMB antwoord geeft zijn: (1) Welke effecten (hydrologisch, thermisch, microbiologisch en chemisch) treden op in het bodemsysteem bij toepassing van bodemenergie?; (2) Welke technische mogelijkheden zijn er voor het duurzaam inpassen van bodem-energie in de water- en energieketen?; (3) Is het mogelijk om meerdere doelstellingen tegelijk te verwezenlijken door slimme combinaties te maken? Het

  19. Heel melanoma: the final result of wrong diagnostic and therapeutic approach in another bulgarian patient. First documented case from the board of the “adcrstr-association for dermatohistopathologic control, reevaluation and subsequent therapeutic recomme.

    Science.gov (United States)

    Chokoeva, A A; Tchernev, G; Gianfaldoni, S; Patterson, J W; Wollina, U; Lotti, T

    2015-01-01

    Difficulties with frequent misdiagnoses and incorrectly defined tumor thicknesses applied to the same histopathological preparation occurring among Bulgarian patients, has led to the creation of national and/or international associations or boards for control in problematic circumstances, particularly for patients with melanocytic and non melanocytic cutaneous tumors. Once again we report a problematic case of a patient with acral lentiginous melanomа, localized in the heel area of the right foot, in an otherwise healthy 69-year old woman. A pigmented lesion gradually developed in her heel area, where the patient had been previously treated several times with invasive therapeutic methods (cryosurgery, shave curettage) due to misdiagnosis as a verrucous lesion or as a viral wart in the absence of any prior histopathology report. Years later, the lesion progressed and changed in color, leading to surgical removal, followed by several histopathological evaluations that produced very different results on three separate occasions. The first result described the lesion as melanocytic nevus, and removed with tumor-free margins. The second report from the Department of Dermatology and Venereology, Military Academy in Sofia , Bulgaria, stated “no data for Verrucous carcinoma”. Only on the third assessment the correct diagnosis of “malignant melanoma” was given. A relapse of the melanoma occurred as only at the time of the last histopathologic evaluation, (following surgical resection of the lesion with adequate margins, performed in the “Onkoderma”- Policlinic for Dermatology, Venereology and Dermatologic Surgery, Sofia, Bulgaria) were criteria followed for appropriate pathological evaluation consistent with the recommendations of the AJCC for reporting of melanomas. Tumor thickness at that time was 1.31 mm. Removal of the draining lymph node, followed by inguinal lymphadenectomy was performed in the National Oncological Hospital in accordance with the

  20. Final focus test beam

    Energy Technology Data Exchange (ETDEWEB)

    1991-03-01

    This report discusses the following: the Final Focus Test Beam Project; optical design; magnets; instrumentation; magnetic measurement and BPM calibration; mechanical alignment and stabilization; vacuum system; power supplies; control system; radiation shielding and personnel protection; infrastructure; and administration.